data_1mg8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mg8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.544 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 3.1 ttm . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 121.594 0.712 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -73.18 144.26 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.855 . . . . 0.0 111.85 -177.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.462 ' CG2' HG12 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -103.43 163.84 3.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.555 ' CB ' HD13 ' A' ' 68' ' ' ILE . 6.7 t80 -101.73 103.3 14.05 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.306 -1.496 . . . . 0.0 109.676 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.599 HG11 ' CG2' ' A' ' 71' ' ' ILE . 6.0 t -91.69 112.77 26.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.117 -0.989 . . . . 0.0 109.132 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.554 ' O ' HG21 ' A' ' 71' ' ' ILE . 24.3 mmm-85 -82.26 97.94 8.53 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.727 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.727 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.3 Cg_endo -78.41 126.26 7.48 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.454 2.103 . . . . 0.0 110.695 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.608 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 11.3 p -111.75 148.05 15.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.499 -0.751 . . . . 0.0 109.235 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.493 ' C ' HG13 ' A' ' 19' ' ' VAL . 5.6 tt0 -102.2 112.06 24.59 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.792 -1.192 . . . . 0.0 108.755 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.493 HG13 ' C ' ' A' ' 18' ' ' GLU . 0.7 OUTLIER -139.03 160.17 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.03 -1.044 . . . . 0.0 109.714 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -97.97 176.18 5.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.2 m -69.28 -0.19 5.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.083 -1.01 . . . . 0.0 110.278 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -102.88 -19.48 14.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.145 -0.972 . . . . 0.0 111.063 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.567 ' CB ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -45.32 124.11 4.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.573 -1.329 . . . . 0.0 109.157 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.84 -142.4 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.575 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 23.7 mm -130.17 -31.11 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 120.909 -1.119 . . . . 0.0 109.457 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.642 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -81.78 -34.92 30.09 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 175.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -60.0 -33.15 71.59 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 175.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.647 HD11 ' CG2' ' A' ' 45' ' ' VAL . 1.4 tm? -68.88 -38.04 79.42 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.746 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 7.0 mttt -72.3 -20.3 61.52 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 7.3 mm-40 -76.34 -49.99 15.45 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.449 -0.782 . . . . 0.0 109.623 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.579 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 2.4 t -64.08 -48.03 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.635 HG11 ' CE1' ' A' ' 9' ' ' PHE . 85.5 t -63.23 -32.98 58.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -67.03 -29.68 69.56 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 14.5 mmmt -64.2 -53.8 43.62 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.774 0.797 . . . . 0.0 109.578 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -69.71 -22.4 63.4 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.837 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.664 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.89 -14.95 55.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.925 -1.109 . . . . 0.0 110.373 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.05 25.08 67.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.535 ' CG2' HD11 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -142.0 164.24 35.17 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 34.0 Cg_endo -78.15 141.36 18.46 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 123.662 2.908 . . . . 0.0 111.554 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB3' ' CB ' ' A' ' 29' ' ' LYS . . . -53.05 -22.22 5.66 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.438 -0.789 . . . . 0.0 110.122 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.61 -57.73 11.47 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 108.775 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.538 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 7.3 mt-30 -64.15 -44.75 91.17 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.283 1.04 . . . . 0.0 108.407 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.61 ' CD2' HG12 ' A' ' 32' ' ' VAL . 1.3 tp -67.49 143.1 56.37 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.538 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.746 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -154.35 116.99 4.37 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.638 -1.225 . . . . 0.0 111.539 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.647 ' CG2' HD11 ' A' ' 28' ' ' LEU . 1.4 t -91.17 127.01 43.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.261 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 50' ' ' LYS . 5.5 mt -130.03 119.94 48.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.2 t80 -87.67 127.34 35.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.909 -1.119 . . . . 0.0 112.76 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.591 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 59.61 7.76 1.11 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.977 -0.452 . . . . 0.0 111.297 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.45 6.47 57.48 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.878 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.64 119.28 34.84 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.564 -1.551 . . . . 0.0 108.718 179.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.72 109.27 2.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.381 -0.824 . . . . 0.0 108.79 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -93.72 146.61 32.07 Favored Pre-proline 0 C--N 1.303 -1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.456 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 56' ' ' LEU . 33.3 Cg_endo -76.5 142.39 23.42 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.358 2.039 . . . . 0.0 108.879 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.525 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 4.6 m-20 -65.19 -5.15 6.18 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.32 -0.863 . . . . 0.0 111.057 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.471 ' CD2' ' C ' ' A' ' 55' ' ' HIS . 5.7 p-80 -104.26 0.16 29.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.647 -1.283 . . . . 0.0 111.201 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.545 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 12.4 mt -89.92 162.97 15.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.645 -1.285 . . . . 0.0 109.055 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.465 ' OG1' ' OD1' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -91.53 171.16 9.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.099 -1.001 . . . . 0.0 110.887 -178.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.567 HG21 ' CB ' ' A' ' 23' ' ' THR . 8.7 t -62.17 -40.09 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.657 -0.652 . . . . 0.0 110.43 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.533 ' CG ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -87.46 18.47 3.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.617 -1.302 . . . . 0.0 109.957 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.545 ' ND2' HD21 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -88.86 -62.3 1.52 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.314 -0.866 . . . . 0.0 110.339 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.652 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 42.1 t -69.46 -14.23 62.77 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.252 -0.905 . . . . 0.0 108.609 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 8.4 t70 103.78 30.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.569 ' CD2' ' HB2' ' A' ' 47' ' ' PHE . 1.2 mt -72.9 -59.81 2.53 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.214 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HG2' ' CG ' ' A' ' 59' ' ' GLN . 3.5 mm-40 59.96 152.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.544 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 1.4 pt20 -48.73 140.14 8.82 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 7.8 tp-100 74.6 106.4 0.07 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.81 130.38 0.66 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.555 HD13 ' CB ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -84.92 116.03 27.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 C-N-CA 117.698 -1.601 . . . . 0.0 107.595 -179.018 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.578 ' HB ' HG11 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -112.97 163.67 9.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -178.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -124.83 106.8 10.3 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.93 -1.106 . . . . 0.0 108.759 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.604 HG12 ' HA ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -80.82 141.2 15.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.41 125.95 38.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.961 -1.087 . . . . 0.0 109.877 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.538 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.574 ' HB3' ' CB ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.51 ' N ' ' HG3' ' A' ' 3' ' ' MET . 0.8 OUTLIER -70.41 143.83 14.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 111.755 -178.007 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.425 HG21 HG13 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -108.24 163.06 5.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 176.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.59 ' CB ' HD11 ' A' ' 68' ' ' ILE . 3.9 t80 -98.66 118.01 34.4 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 120.285 -1.509 . . . . 0.0 109.411 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.596 ' CG1' HG21 ' A' ' 71' ' ' ILE . 8.7 t -105.96 112.21 38.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.529 ' O ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -79.37 100.44 7.62 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 117.625 -1.63 . . . . 0.0 108.274 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.697 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.54 0 CA-C-O 121.679 0.752 . . . . 0.0 111.101 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.613 ' CZ ' ' HD3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.6 Cg_endo -76.18 127.83 10.16 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.124 1.882 . . . . 0.0 111.018 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.605 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 8.4 p -116.08 142.3 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -100.7 116.55 32.87 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.579 -1.325 . . . . 0.0 109.108 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.465 HG23 ' OG1' ' A' ' 23' ' ' THR . 1.8 m -149.43 165.81 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.132 -0.98 . . . . 0.0 109.641 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.44 ' N ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -119.5 -178.79 3.69 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.621 -0.674 . . . . 0.0 109.56 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.582 ' CB ' ' HG3' ' A' ' 59' ' ' GLN . 3.5 m -63.53 -3.31 2.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.491 -0.756 . . . . 0.0 110.692 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 23' ' ' THR . 5.7 m-20 -95.69 -35.8 11.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.071 -1.018 . . . . 0.0 110.867 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.575 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.96 126.38 3.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.852 -1.155 . . . . 0.0 109.41 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 27' ' ' GLN . 0.9 OUTLIER -61.24 -142.61 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.596 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 30.0 mm -129.57 -33.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 120.937 -1.102 . . . . 0.0 108.681 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.608 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -80.35 -34.68 36.35 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 176.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -56.79 -31.88 65.11 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 175.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.605 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -64.13 -45.34 88.97 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.73 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 3.9 mptt -68.95 -18.68 64.12 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.589 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.2 mm-40 -77.28 -50.69 12.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 109.493 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.576 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 71.1 t -63.94 -46.23 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.697 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 68.3 t -64.82 -35.81 76.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -60.21 -27.54 67.25 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 4.0 mmmm -65.79 -50.95 62.82 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.656 0.741 . . . . 0.0 109.391 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.613 ' HD3' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -71.33 -22.51 61.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.691 -0.63 . . . . 0.0 111.026 -178.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.674 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 1.8 mm-40 -87.98 -17.64 30.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.899 -1.125 . . . . 0.0 110.502 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.63 17.42 79.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.511 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 1.4 m -124.39 164.11 32.26 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 31.2 Cg_endo -77.31 138.53 17.85 Favored 'Trans proline' 0 C--N 1.293 -2.386 0 C-N-CA 123.037 2.491 . . . . 0.0 110.843 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.558 ' HB1' ' CB ' ' A' ' 29' ' ' LYS . . . -51.84 -19.64 1.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.646 -0.659 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.498 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -62.3 -59.08 5.52 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.183 -0.948 . . . . 0.0 109.156 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.567 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 1.7 mt-30 -60.53 -48.96 79.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.132 0.967 . . . . 0.0 108.623 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.576 HD23 ' CG1' ' A' ' 32' ' ' VAL . 3.5 tp -63.8 140.49 58.88 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.659 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.73 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -152.84 117.2 4.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.058 -1.457 . . . . 0.0 111.797 178.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.605 ' CG2' HD13 ' A' ' 28' ' ' LEU . 17.8 t -88.77 119.24 35.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.055 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 50' ' ' LYS . 6.0 mt -128.8 117.53 44.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.585 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -93.78 129.86 39.99 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -174.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.584 ' HB1' ' CE1' ' A' ' 47' ' ' PHE . . . 60.3 7.42 1.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.906 -0.496 . . . . 0.0 111.737 177.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.75 -3.47 45.71 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.689 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -96.18 114.55 26.25 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 120.454 -1.615 . . . . 0.0 108.715 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -74.75 105.16 5.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -91.98 152.27 42.72 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.588 ' HG2' ' HG ' ' A' ' 56' ' ' LEU . 34.2 Cg_endo -75.79 -170.92 0.91 Allowed 'Trans proline' 0 C--N 1.296 -2.198 0 C-N-CA 122.322 2.015 . . . . 0.0 108.595 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.486 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 10.5 p30 -91.71 -39.93 11.55 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 110.399 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 21.0 p-80 -62.11 -39.2 91.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 111.272 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HG ' ' HG2' ' A' ' 53' ' ' PRO . 12.4 mt -50.04 158.04 0.57 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.656 -1.278 . . . . 0.0 110.252 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 172.84 8.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.433 -0.792 . . . . 0.0 110.802 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.575 HG22 ' CB ' ' A' ' 23' ' ' THR . 21.1 t -62.07 -44.21 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.587 0.708 . . . . 0.0 110.317 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.582 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 23.0 mt-30 -90.18 25.1 2.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.819 -1.176 . . . . 0.0 109.782 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.567 ' ND2' ' CD2' ' A' ' 56' ' ' LEU . 1.8 t30 -84.33 -63.32 1.36 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.05 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.563 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 10.2 t -75.3 -48.78 21.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 4.6 m-20 155.02 36.61 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.511 ' HB2' HG13 ' A' ' 58' ' ' VAL . 1.3 mt -82.37 -57.66 3.27 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.419 -1.313 . . . . 0.0 108.306 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' HG2' ' A' ' 59' ' ' GLN . 0.1 OUTLIER 46.99 -154.34 0.06 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.574 ' CB ' ' HB3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.64 137.51 33.65 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 36.1 tp60 74.39 109.35 0.07 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -176.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.48 ' OG ' ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -175.87 129.84 0.24 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -177.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.59 HD11 ' CB ' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -83.26 122.56 37.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 117.861 -1.536 . . . . 0.0 108.076 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' A' ' 70' ' ' HIS . 2.5 t -109.9 160.64 8.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 121.725 0.774 . . . . 0.0 110.411 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.573 ' N ' ' CG1' ' A' ' 69' ' ' VAL . 3.5 t60 -122.8 102.55 8.09 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -89.57 143.17 11.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.564 -0.71 . . . . 0.0 109.186 -178.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 42' ' ' GLN . 11.3 p -139.49 137.92 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.011 -1.056 . . . . 0.0 109.172 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.567 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 110.403 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.544 ' HB3' ' CB ' ' A' ' 65' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.527 ' N ' ' HG3' ' A' ' 3' ' ' MET . 0.1 OUTLIER -73.2 143.28 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.093 -1.005 . . . . 0.0 112.367 -177.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.485 HG11 ' N ' ' A' ' 67' ' ' SER . 0.5 OUTLIER -106.23 164.63 4.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.55 ' HB3' ' CD1' ' A' ' 68' ' ' ILE . 12.8 t80 -102.73 109.31 20.85 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.373 -1.454 . . . . 0.0 109.406 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.634 ' CG1' HG23 ' A' ' 71' ' ' ILE . 13.7 t -94.65 120.58 44.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.519 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.551 ' O ' HG21 ' A' ' 71' ' ' ILE . 14.5 mmm-85 -88.39 98.62 11.71 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.753 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.061 0.458 . . . . 0.0 110.745 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.753 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HB2' HD11 ' A' ' 4' ' ' ILE . 34.2 Cg_endo -75.9 127.82 10.35 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.328 2.019 . . . . 0.0 111.23 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.62 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 5.9 p -117.94 144.84 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.509 -0.744 . . . . 0.0 109.56 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' N ' HG21 ' A' ' 17' ' ' VAL . 4.8 tt0 -106.93 117.36 33.84 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.426 -1.422 . . . . 0.0 108.406 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.511 ' HB ' HG23 ' A' ' 23' ' ' THR . 1.2 m -139.26 160.71 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.91 -1.119 . . . . 0.0 110.526 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -107.29 176.08 5.28 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -66.34 -5.09 9.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.932 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.95 16.83 10.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.087 -1.008 . . . . 0.0 109.873 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.514 ' HB ' ' CG2' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -66.46 -9.36 33.53 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.136 -0.977 . . . . 0.0 109.548 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.529 ' OG ' ' HB2' ' A' ' 27' ' ' GLN . 5.7 p 69.31 -142.81 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 108.988 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.588 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 39.0 mm -144.15 -25.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.895 -1.128 . . . . 0.0 111.126 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.671 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -83.42 -37.41 23.27 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 177.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.529 ' HB2' ' OG ' ' A' ' 24' ' ' SER . 0.0 OUTLIER -60.75 -33.7 73.32 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 176.103 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.616 HD12 ' CG2' ' A' ' 45' ' ' VAL . 2.4 tm? -69.4 -37.17 77.37 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.703 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 4.3 mttt -70.0 -20.46 63.28 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.642 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.9 mm-40 -74.33 -52.81 11.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.697 -0.627 . . . . 0.0 109.674 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.51 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 27.5 t -61.79 -48.92 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.645 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 60.5 t -62.06 -33.47 58.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -68.23 -28.72 67.48 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.4 -0.813 . . . . 0.0 109.265 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 2.7 mmmm -65.61 -52.37 52.53 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.774 0.797 . . . . 0.0 109.39 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -71.85 -22.77 61.49 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.27 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.661 ' CG ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.27 -15.5 55.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.713 -1.242 . . . . 0.0 110.583 -179.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.2 21.22 61.15 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 36' ' ' GLN . 1.6 m -142.78 164.82 30.1 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.738 -0.86 . . . . 0.0 108.679 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.469 ' N ' HG23 ' A' ' 38' ' ' VAL . 33.0 Cg_endo -78.67 143.02 18.52 Favored 'Trans proline' 0 C--N 1.293 -2.387 0 C-N-CA 123.437 2.758 . . . . 0.0 111.444 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 29' ' ' LYS . . . -50.6 -21.06 1.38 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.755 -0.591 . . . . 0.0 110.196 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -61.49 -60.75 3.23 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 109.246 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 29.8 mt-30 -63.5 -43.68 96.54 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.618 ' CD2' HG13 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -66.01 144.61 56.63 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.504 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.703 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -155.15 115.72 3.87 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.362 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.616 ' CG2' HD12 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -93.84 117.29 37.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.715 0.769 . . . . 0.0 110.602 -178.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 50' ' ' LYS . 6.4 mt -116.59 122.4 69.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.584 ' CE1' ' HB1' ' A' ' 48' ' ' ALA . 1.7 t80 -87.92 129.76 35.13 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.765 -1.209 . . . . 0.0 113.426 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.584 ' HB1' ' CE1' ' A' ' 47' ' ' PHE . . . 61.0 7.92 1.71 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.803 -0.561 . . . . 0.0 111.234 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.73 6.42 60.76 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.333 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -95.63 130.33 42.54 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.613 -1.522 . . . . 0.0 108.75 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.441 ' C ' HD22 ' A' ' 52' ' ' LEU . 26.4 tt0 -75.85 114.96 15.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.775 . . . . 0.0 109.092 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.528 HD22 ' O ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -105.06 144.98 29.84 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.103 -0.998 . . . . 0.0 110.129 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.549 ' HG2' ' CG ' ' A' ' 56' ' ' LEU . 32.2 Cg_endo -77.34 131.25 11.55 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 122.342 2.028 . . . . 0.0 108.216 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 2.3 m120 -48.88 -37.58 20.05 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.692 -0.63 . . . . 0.0 111.802 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.521 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 7.0 p-80 -70.57 -31.42 68.43 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.781 -1.199 . . . . 0.0 112.053 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.551 HD22 ' ND2' ' A' ' 60' ' ' ASN . 10.9 mt -54.74 164.67 0.73 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.392 -1.443 . . . . 0.0 109.029 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -91.89 171.07 9.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.119 -0.988 . . . . 0.0 110.932 -178.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' A' ' 23' ' ' THR . 16.9 t -61.97 -39.65 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.403 0.62 . . . . 0.0 110.153 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -88.17 18.1 4.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.668 -1.27 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.551 ' ND2' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -88.14 -62.34 1.51 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 110.681 -178.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.668 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -72.17 -15.56 61.97 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.214 -0.929 . . . . 0.0 108.94 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.668 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 51.4 t0 109.13 32.77 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 1.0 OUTLIER -79.4 -50.89 10.12 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.43 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.6 -157.51 0.12 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.573 0.701 . . . . 0.0 109.579 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.544 ' CB ' ' HB3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.52 129.56 41.27 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 14.8 tm0? 80.23 111.54 0.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.485 ' N ' HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -173.34 129.72 0.45 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -177.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -83.18 117.96 29.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 118.267 -1.373 . . . . 0.0 107.906 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.536 ' HB ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -116.03 167.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -177.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -124.58 109.32 13.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.956 -1.09 . . . . 0.0 108.435 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.634 HG23 ' CG1' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -84.32 142.95 12.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.263 -0.898 . . . . 0.0 110.109 -179.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -135.95 143.65 35.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 8.8 tt0 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.018 -1.051 . . . . 0.0 110.339 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.601 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 1.2 ttm . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 122.36 1.076 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.589 HG12 ' HB2' ' A' ' 16' ' ' PRO . 1.1 tp -77.46 139.31 18.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.262 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.519 HG13 ' CB ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -95.72 153.18 3.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.522 ' CB ' HD11 ' A' ' 68' ' ' ILE . 5.4 t80 -91.34 108.58 19.98 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 120.769 -1.207 . . . . 0.0 109.248 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.585 HG13 ' CG2' ' A' ' 71' ' ' ILE . 2.1 t -94.92 110.77 24.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.26 -0.9 . . . . 0.0 109.692 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.543 ' O ' HG22 ' A' ' 71' ' ' ILE . 24.1 mmm-85 -78.2 93.01 4.52 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.701 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.457 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.633 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HB2' HG12 ' A' ' 4' ' ' ILE . 34.6 Cg_endo -78.95 131.81 10.24 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.722 2.282 . . . . 0.0 111.062 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.598 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 3.3 p -113.98 151.18 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 0.0 109.013 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HA ' HD11 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -102.28 119.33 38.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.554 -1.341 . . . . 0.0 108.793 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.53 HG11 HD22 ' A' ' 28' ' ' LEU . 1.3 m -144.04 159.64 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.727 -1.233 . . . . 0.0 110.343 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 m-20 -102.53 177.06 4.97 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.528 ' CB ' ' HG3' ' A' ' 59' ' ' GLN . 37.3 m -71.62 0.73 7.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.01 . . . . 0.0 109.936 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' HA ' HG23 ' A' ' 57' ' ' THR . 0.8 OUTLIER -110.58 -10.05 14.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 111.427 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.564 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -45.98 131.93 9.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.618 -1.301 . . . . 0.0 108.432 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.621 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 9.4 m -74.74 6.75 3.62 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.333 -0.854 . . . . 0.0 111.795 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.621 ' HB ' ' O ' ' A' ' 24' ' ' SER . 14.5 mm 72.35 -30.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 O-C-N 121.892 -0.505 . . . . 0.0 112.27 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.641 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -82.08 -35.57 28.5 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 176.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.418 ' N ' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -59.51 -35.59 74.45 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.605 HD11 ' CG2' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -63.46 -40.5 97.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 176.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.72 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 7.8 mttt -69.62 -20.97 63.6 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.63 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.6 mt-10 -75.08 -50.34 16.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.297 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.515 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.1 t -65.36 -48.15 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.701 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 87.5 t -62.07 -34.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -64.43 -29.67 70.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -64.5 -54.16 36.72 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.819 0.819 . . . . 0.0 109.672 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -64.79 -30.21 71.21 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.595 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.672 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 1.5 mm100 -81.34 -7.39 59.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.712 -1.243 . . . . 0.0 110.216 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.53 17.24 72.54 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.533 ' CG2' HD13 ' A' ' 43' ' ' LEU . 16.2 m -125.85 158.35 65.86 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 33.5 Cg_endo -78.41 143.38 19.44 Favored 'Trans proline' 0 C--N 1.294 -2.297 0 C-N-CA 123.152 2.568 . . . . 0.0 111.08 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 29' ' ' LYS . . . -49.67 -20.49 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.376 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.18 -63.27 1.35 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.336 -0.853 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.528 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 34.6 mt-30 -61.3 -49.19 78.03 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.455 1.121 . . . . 0.0 108.395 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.589 ' CD2' HG12 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -64.94 141.04 58.91 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.71 -179.078 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.72 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 3.9 mpp_? -155.64 115.05 3.6 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.476 -1.29 . . . . 0.0 111.269 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.605 ' CG2' HD11 ' A' ' 28' ' ' LEU . 1.3 t -86.63 121.61 37.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.763 0.792 . . . . 0.0 110.704 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.536 ' O ' ' CG1' ' A' ' 69' ' ' VAL . 19.7 mt -118.35 151.62 20.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 9.0 t80 -107.95 120.03 41.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 119.835 -1.79 . . . . 0.0 113.621 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . . . 55.66 7.74 0.27 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.95 -15.07 11.18 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 118.965 -1.588 . . . . 0.0 111.202 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.513 ' O ' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -97.21 114.14 25.82 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.488 -1.595 . . . . 0.0 108.894 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HA ' ' CG2' ' A' ' 46' ' ' ILE . 44.3 tt0 -56.94 117.12 3.65 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.492 -0.755 . . . . 0.0 109.596 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.579 ' CD2' ' CB ' ' A' ' 61' ' ' CYS . 6.0 mt -85.72 132.36 44.55 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 109.349 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.601 ' HB2' ' CE1' ' A' ' 55' ' ' HIS . 30.9 Cg_endo -75.07 132.15 15.0 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 121.844 1.696 . . . . 0.0 108.246 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.524 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 4.5 m-20 -59.82 -30.64 69.07 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 110.411 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.601 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 13.6 p-80 -70.73 -22.87 62.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.61 -1.306 . . . . 0.0 110.06 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.561 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 14.3 mt -78.92 168.35 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.936 -1.102 . . . . 0.0 108.151 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.464 HG23 ' HA ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -95.79 172.52 7.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.062 -1.024 . . . . 0.0 111.031 -178.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.564 HG22 ' CB ' ' A' ' 23' ' ' THR . 24.0 t -59.86 -41.04 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.762 -0.586 . . . . 0.0 110.547 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.528 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 9.2 mt-30 -86.97 19.58 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.62 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.543 ' OD1' ' CD1' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -84.44 -60.22 2.14 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.628 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 17.5 t -70.6 -16.16 62.82 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.628 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 16.3 t0 103.26 37.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 58' ' ' VAL . 1.3 mt -66.6 -83.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.597 -1.241 . . . . 0.0 107.728 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 63' ' ' LEU . 2.9 tt0 76.45 162.26 0.23 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.833 0.825 . . . . 0.0 111.287 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.601 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 1.8 pt20 -40.88 121.97 1.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER 76.0 112.3 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.519 ' CB ' HG13 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -163.18 118.58 1.72 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.529 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.1 mp -81.99 117.49 28.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -116.92 151.16 18.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -107.76 110.16 21.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.376 -1.452 . . . . 0.0 108.231 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.585 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -80.49 141.48 15.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.424 -0.798 . . . . 0.0 109.473 -178.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 42' ' ' GLN . 16.5 t -130.15 122.96 55.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.226 -0.921 . . . . 0.0 108.963 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.528 ' HG2' ' CB ' ' A' ' 42' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 110.155 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.559 ' CG ' ' CB ' ' A' ' 65' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.828 0.823 . . . . 0.0 109.877 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -69.98 141.05 17.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.868 0.842 . . . . 0.0 110.841 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.526 HG23 ' CG1' ' A' ' 19' ' ' VAL . 1.4 t -110.05 165.47 5.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.496 ' HB3' ' CD1' ' A' ' 68' ' ' ILE . 4.9 t80 -103.69 106.49 17.01 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.458 -1.401 . . . . 0.0 109.381 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.597 ' CG1' HG23 ' A' ' 71' ' ' ILE . 14.8 t -91.18 115.72 30.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.583 ' O ' HG21 ' A' ' 71' ' ' ILE . 11.6 mmm180 -82.18 92.31 6.87 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 117.144 -1.822 . . . . 0.0 106.985 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.718 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.718 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HB2' HG12 ' A' ' 4' ' ' ILE . 34.1 Cg_endo -75.88 124.69 8.23 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.358 2.039 . . . . 0.0 110.248 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 7.5 p -110.73 154.24 12.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.433 -0.792 . . . . 0.0 109.724 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.7 tt0 -101.3 114.75 29.01 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.775 -1.203 . . . . 0.0 108.341 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.526 ' CG1' HG23 ' A' ' 5' ' ' VAL . 2.0 m -148.14 165.9 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 110.152 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' N ' HG21 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -127.42 -179.46 4.91 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' A' ' 59' ' ' GLN . 1.0 OUTLIER -61.55 -8.54 4.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.152 -0.967 . . . . 0.0 110.435 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.86 18.47 13.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.894 -1.129 . . . . 0.0 110.693 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.512 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -72.04 -5.73 37.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.074 -1.016 . . . . 0.0 109.672 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 27' ' ' GLN . 52.5 m 65.78 -144.53 0.2 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.625 HD12 ' CD2' ' A' ' 52' ' ' LEU . 9.4 mm -144.94 -28.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.739 -1.226 . . . . 0.0 110.607 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.674 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -80.82 -33.84 34.37 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 176.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -61.81 -33.78 74.75 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.659 ' CD1' ' CG2' ' A' ' 45' ' ' VAL . 2.9 tm? -72.31 -32.58 66.67 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.674 ' HD2' ' HA ' ' A' ' 26' ' ' LEU . 3.0 mttt -71.33 -23.54 61.95 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.9 mm-40 -76.3 -52.19 10.46 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.631 -0.668 . . . . 0.0 110.114 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.502 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 85.1 t -61.77 -45.84 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.635 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 98.7 t -65.75 -32.63 59.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -66.78 -27.15 67.35 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.4 OUTLIER -69.25 -53.08 21.68 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.883 0.849 . . . . 0.0 109.287 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -70.97 -22.04 62.24 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.856 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.641 ' HG3' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -82.12 -14.07 56.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.801 -1.187 . . . . 0.0 110.241 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.63 25.78 66.82 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -144.27 161.7 43.5 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HG2' ' HG3' ' A' ' 42' ' ' GLN . 30.8 Cg_endo -76.86 141.9 21.9 Favored 'Trans proline' 0 C--N 1.293 -2.382 0 C-N-CA 123.224 2.616 . . . . 0.0 111.091 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 29' ' ' LYS . . . -50.34 -20.4 1.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.602 -0.686 . . . . 0.0 110.046 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -60.45 -61.81 2.32 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.213 -0.929 . . . . 0.0 109.087 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 2.7 mt-30 -63.16 -43.83 97.19 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -66.61 143.69 56.86 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.467 -179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.593 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -157.06 116.31 3.38 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.008 -1.057 . . . . 0.0 109.717 178.179 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.659 ' CG2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -101.84 116.99 46.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.641 0.734 . . . . 0.0 111.735 -177.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.9 mt -114.65 128.51 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.643 ' CE1' ' CB ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -86.46 132.98 33.8 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.559 -1.338 . . . . 0.0 113.169 -176.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.643 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 62.14 10.06 3.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.326 0.584 . . . . 0.0 110.637 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.6 6.76 89.15 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -96.79 120.54 37.31 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.601 -1.529 . . . . 0.0 108.088 179.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -48.36 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.652 0.739 . . . . 0.0 110.333 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.625 ' CD2' HD12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -101.74 113.69 65.78 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.545 ' CG ' HD12 ' A' ' 56' ' ' LEU . 28.2 Cg_endo -63.55 163.78 23.03 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 123.46 2.773 . . . . 0.0 116.117 -172.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.608 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -66.56 -43.24 85.58 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.976 -178.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 42.8 p-80 -74.62 -43.9 53.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.987 -1.071 . . . . 0.0 111.721 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.545 HD12 ' CG ' ' A' ' 53' ' ' PRO . 12.5 mt -42.47 162.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.988 -1.07 . . . . 0.0 109.482 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.13 168.49 13.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.136 -0.977 . . . . 0.0 109.946 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.559 ' HA ' HD13 ' A' ' 63' ' ' LEU . 16.5 t -61.47 -37.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.514 -0.741 . . . . 0.0 110.073 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 0.5 OUTLIER -89.34 20.17 3.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.887 -1.133 . . . . 0.0 109.449 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.465 ' ND2' HD13 ' A' ' 56' ' ' LEU . 1.3 t30 -82.61 -60.17 2.27 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.608 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -73.26 -17.9 61.28 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 65.3 m-20 105.56 36.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.559 HD13 ' HA ' ' A' ' 58' ' ' VAL . 1.5 mt -61.7 -65.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.76 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 28.5 mt-10 62.94 144.33 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.303 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.559 ' CB ' ' CG ' ' A' ' 3' ' ' MET . 2.8 pp0? -37.14 135.83 0.46 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 17.8 tt0 73.59 105.55 0.07 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.467 ' N ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -167.66 128.57 1.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.496 ' CD1' ' HB3' ' A' ' 6' ' ' PHE . 1.2 mp -86.39 119.31 34.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 118.372 -1.331 . . . . 0.0 108.059 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.601 ' HB ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.94 169.81 3.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -126.15 107.3 10.26 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 109.332 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -86.84 141.65 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.351 -0.843 . . . . 0.0 110.161 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 42' ' ' GLN . 94.9 t -136.59 133.62 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 2.5 tt0 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.133 -0.979 . . . . 0.0 109.999 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.627 ' CB ' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 121.924 0.868 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -71.77 137.94 22.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.172 0.511 . . . . 0.0 109.664 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.544 ' CG2' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -99.31 146.54 8.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 176.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.55 ' CB ' HD12 ' A' ' 68' ' ' ILE . 5.0 t80 -90.92 107.91 19.51 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.786 -1.196 . . . . 0.0 109.951 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.575 ' CG1' HG22 ' A' ' 71' ' ' ILE . 16.9 t -96.94 117.26 41.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.028 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.627 ' O ' HG23 ' A' ' 71' ' ' ILE . 22.1 mmm-85 -83.4 93.99 7.88 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.696 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.334 0.588 . . . . 0.0 110.161 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.696 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.66 128.34 9.35 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.467 2.111 . . . . 0.0 110.667 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.613 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 14.7 p -120.14 145.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.58 -0.7 . . . . 0.0 109.445 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.73 115.06 27.52 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.917 -1.115 . . . . 0.0 109.007 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.544 ' CG1' ' CG2' ' A' ' 5' ' ' VAL . 2.0 m -145.55 167.59 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.526 ' N ' HG23 ' A' ' 19' ' ' VAL . 9.4 m-20 -129.73 -176.2 3.84 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.51 ' OG ' ' HG3' ' A' ' 59' ' ' GLN . 64.9 m -60.28 -5.59 1.17 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.037 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 23' ' ' THR . 1.8 m-20 -87.76 -41.82 13.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 110.378 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.57 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -43.25 116.46 0.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.748 -1.22 . . . . 0.0 109.425 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -60.61 -135.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.157 -0.964 . . . . 0.0 108.548 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.58 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 32.6 mm -135.81 -33.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.667 -1.271 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.599 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -78.36 -35.33 47.53 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 175.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.488 ' N ' HD11 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -54.63 -32.09 58.42 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 175.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.618 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -65.52 -50.83 63.8 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.803 ' HA ' HG13 ' A' ' 32' ' ' VAL . 3.8 mptt -61.56 -19.85 62.62 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.067 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.7 mm-40 -76.14 -54.76 6.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.548 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 84.4 t -64.35 -46.81 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.803 HG13 ' HA ' ' A' ' 29' ' ' LYS . 6.2 p -63.53 -27.68 43.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.604 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -71.94 -29.61 64.46 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.152 -0.968 . . . . 0.0 108.93 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 3.2 mmmm -66.53 -49.78 65.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.782 0.801 . . . . 0.0 109.078 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -78.37 -21.51 49.31 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.32 -178.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.667 ' CG ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -82.2 -12.07 58.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.654 -1.279 . . . . 0.0 110.593 -179.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.8 26.99 67.89 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.574 ' CG1' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -148.66 159.93 37.16 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.574 ' HD2' ' CG1' ' A' ' 38' ' ' VAL . 31.2 Cg_endo -78.06 140.71 18.14 Favored 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 122.853 2.369 . . . . 0.0 111.691 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.557 ' HB3' ' CB ' ' A' ' 29' ' ' LYS . . . -46.4 -27.34 1.04 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.429 0.633 . . . . 0.0 110.011 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.71 -64.14 1.04 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.434 -0.791 . . . . 0.0 109.535 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.538 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 35.3 mt-30 -61.21 -43.45 98.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.051 0.929 . . . . 0.0 108.782 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.594 ' CD1' ' CD1' ' A' ' 71' ' ' ILE . 3.2 tp -66.05 144.52 56.66 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.748 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -153.03 116.44 4.67 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.049 -1.46 . . . . 0.0 111.173 178.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.618 ' CG2' HD13 ' A' ' 28' ' ' LEU . 2.6 t -92.98 124.51 45.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.237 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 50' ' ' LYS . 4.1 mt -129.0 118.51 46.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.591 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -86.18 127.02 34.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.018 -1.051 . . . . 0.0 111.965 -176.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 60.6 10.85 2.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.483 -0.761 . . . . 0.0 110.131 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.04 18.91 60.15 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.499 ' O ' HG22 ' A' ' 46' ' ' ILE . 3.0 mmmm -100.35 120.17 39.54 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.819 -1.401 . . . . 0.0 109.201 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.28 104.81 4.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.498 -0.752 . . . . 0.0 110.037 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.534 ' CD1' ' HB3' ' A' ' 61' ' ' CYS . 0.4 OUTLIER -100.17 147.29 33.31 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.284 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.609 ' HB2' ' CE1' ' A' ' 55' ' ' HIS . 29.7 Cg_endo -76.37 132.88 14.04 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.267 1.978 . . . . 0.0 108.881 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.57 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 19.5 m-80 -50.74 -19.54 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.609 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 7.0 p-80 -91.83 20.75 5.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.359 -1.463 . . . . 0.0 111.272 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HG ' ' HG2' ' A' ' 53' ' ' PRO . 14.3 mt -105.79 165.31 11.27 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.828 -1.17 . . . . 0.0 108.526 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -91.76 171.75 8.94 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.096 -1.002 . . . . 0.0 110.808 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.57 HG22 ' CB ' ' A' ' 23' ' ' THR . 3.4 t -59.94 -39.35 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.477 0.656 . . . . 0.0 110.543 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.51 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 3.0 mt-30 -90.49 22.19 3.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.624 -1.298 . . . . 0.0 109.712 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.545 ' ND2' HD11 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -83.21 -62.46 1.59 Allowed 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.341 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.629 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -72.27 -16.85 61.92 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.629 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 16.6 t70 106.56 31.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.473 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.53 ' CD2' ' HB2' ' A' ' 47' ' ' PHE . 1.5 mt -59.84 -67.51 0.38 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HG3' ' HG2' ' A' ' 59' ' ' GLN . 0.2 OUTLIER 61.96 165.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.966 0.889 . . . . 0.0 111.718 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.627 ' CB ' ' CB ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -44.47 124.73 4.3 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 8.5 tt0 75.27 108.23 0.07 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -165.73 120.23 1.22 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -177.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.55 HD12 ' CB ' ' A' ' 6' ' ' PHE . 1.1 mp -86.02 121.26 37.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.714 -1.195 . . . . 0.0 108.114 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.547 ' HB ' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -113.65 164.63 9.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -120.71 109.03 14.71 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.705 -1.247 . . . . 0.0 109.536 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.627 HG23 ' O ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -88.31 141.79 13.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.227 -0.92 . . . . 0.0 109.121 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 71' ' ' ILE . 2.5 t -145.44 137.61 20.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.104 -0.997 . . . . 0.0 109.333 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.538 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 1.2 tt0 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.446 -0.784 . . . . 0.0 109.765 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.569 ' CG ' ' N ' ' A' ' 4' ' ' ILE . 1.1 ttm . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.569 ' N ' ' CG ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -73.49 145.35 11.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.091 0.948 . . . . 0.0 112.099 -177.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.11 168.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CB ' HD12 ' A' ' 68' ' ' ILE . 9.1 t80 -104.32 102.94 12.61 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.401 -1.437 . . . . 0.0 110.19 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.603 ' CG1' HG22 ' A' ' 71' ' ' ILE . 38.9 t -91.27 112.65 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.081 -1.012 . . . . 0.0 109.666 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -82.92 95.7 8.05 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 117.969 -1.493 . . . . 0.0 107.08 177.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.726 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.553 -0.717 . . . . 0.0 109.782 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.726 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HB2' HG12 ' A' ' 4' ' ' ILE . 33.7 Cg_endo -76.73 128.2 10.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.419 2.079 . . . . 0.0 110.502 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 14.3 p -112.35 153.43 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 0.0 109.398 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -108.56 116.73 32.53 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.621 -1.3 . . . . 0.0 108.533 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.519 HG12 ' CD2' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -149.51 159.26 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.784 -1.197 . . . . 0.0 110.311 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.09 176.82 4.96 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.535 ' HB3' ' CG ' ' A' ' 59' ' ' GLN . 0.8 OUTLIER -64.25 -6.56 7.05 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 109.98 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.45 ' HA ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -96.5 -13.61 22.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.98 -1.075 . . . . 0.0 111.446 -178.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.581 ' CB ' HG23 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -48.43 128.91 15.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.356 -1.465 . . . . 0.0 108.35 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.606 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 19.4 m -73.47 6.17 3.21 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.028 -1.045 . . . . 0.0 112.082 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.606 ' HB ' ' O ' ' A' ' 24' ' ' SER . 1.7 mm 72.04 -35.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 O-C-N 121.927 -0.483 . . . . 0.0 111.866 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.63 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -79.27 -35.37 41.47 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 102.656 -3.091 . . . . 0.0 102.656 176.355 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.445 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -61.22 -33.7 73.91 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.617 HD12 ' CG2' ' A' ' 45' ' ' VAL . 1.6 tm? -64.52 -38.9 92.61 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 5.4 mttt -69.7 -22.93 63.37 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 58.6 mt-10 -73.54 -51.55 16.58 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.759 -0.588 . . . . 0.0 109.545 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.557 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 98.5 t -64.21 -49.18 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.65 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 83.9 t -61.59 -32.06 52.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -68.67 -29.82 68.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.451 -0.781 . . . . 0.0 108.899 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 12.0 mmmm -64.76 -52.92 54.39 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.897 0.856 . . . . 0.0 109.565 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -22.33 60.67 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.857 -0.527 . . . . 0.0 111.421 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.65 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.71 -18.71 43.42 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.546 -1.346 . . . . 0.0 110.591 -178.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.88 23.45 45.7 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -146.67 163.42 29.37 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.593 -0.945 . . . . 0.0 108.615 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 31.0 Cg_endo -75.0 143.07 28.62 Favored 'Trans proline' 0 C--N 1.291 -2.459 0 C-N-CA 123.328 2.685 . . . . 0.0 111.21 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 29' ' ' LYS . . . -49.7 -20.1 0.75 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.704 -0.622 . . . . 0.0 109.803 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -64.12 -62.74 1.43 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 108.935 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 19.5 mt-30 -59.19 -44.63 92.22 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.426 1.108 . . . . 0.0 108.072 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.616 ' CD2' HG12 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -68.68 144.19 54.52 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.029 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.731 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -156.43 117.3 3.74 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.37 -1.332 . . . . 0.0 111.467 178.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.617 ' CG2' HD12 ' A' ' 28' ' ' LEU . 1.6 t -93.77 122.77 45.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.643 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.9 mt -124.38 118.87 54.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.624 ' CD1' ' C ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -83.8 133.52 34.76 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.58 -0.7 . . . . 0.0 112.356 -176.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.608 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 63.17 9.93 4.25 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.44 0.638 . . . . 0.0 109.802 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 14.82 80.69 Favored Glycine 0 C--N 1.296 -1.642 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -98.2 122.49 41.41 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.67 -1.488 . . . . 0.0 108.956 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -48.48 96.88 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.558 HD23 ' CB ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -116.96 117.99 36.65 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.497 ' O ' HD11 ' A' ' 52' ' ' LEU . 32.1 Cg_endo -72.81 -160.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 123.05 2.5 . . . . 0.0 113.313 -175.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.538 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 3.4 p30 -111.02 -52.34 2.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -0.794 . . . . 0.0 110.996 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.476 ' C ' ' O ' ' A' ' 54' ' ' ASN . 41.7 p-80 -43.07 -25.99 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.798 -1.189 . . . . 0.0 109.026 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 54' ' ' ASN . 29.0 mt -74.43 159.38 32.38 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -89.51 172.02 9.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.757 -1.214 . . . . 0.0 110.285 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.581 HG23 ' CB ' ' A' ' 23' ' ' THR . 2.2 t -62.43 -28.73 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.601 -0.687 . . . . 0.0 110.477 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.535 ' CG ' ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -88.45 17.3 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 109.425 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.458 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -86.63 -60.11 2.08 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.788 0.804 . . . . 0.0 108.922 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 5.3 t -72.66 -9.13 58.25 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 9.1 t0 90.49 33.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 25' ' ' ILE . 1.1 mt -75.86 -58.21 3.42 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.694 0.759 . . . . 0.0 109.678 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.458 ' OE2' ' OE1' ' A' ' 59' ' ' GLN . 34.0 mt-10 51.86 -154.61 0.18 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.558 ' CB ' ' HB3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.44 143.08 26.71 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.1 tt0 72.9 106.25 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.423 ' OG ' ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -175.41 131.93 0.29 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.577 HD11 ' N ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -83.89 114.76 24.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 117.613 -1.635 . . . . 0.0 107.691 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.573 ' HB ' ' CG1' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -108.74 163.31 6.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -125.8 107.16 10.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.967 -1.083 . . . . 0.0 109.777 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.612 HG23 ' O ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -85.11 142.54 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.317 -0.864 . . . . 0.0 109.127 179.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.1 t -144.03 135.9 22.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.032 -1.043 . . . . 0.0 109.628 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.491 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.608 ' CB ' ' CB ' ' A' ' 65' ' ' GLN . 21.7 tpp . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.901 0.858 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -72.91 140.92 17.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.555 HG21 ' CG1' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -101.03 142.67 15.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 177.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.536 ' CB ' ' CD1' ' A' ' 68' ' ' ILE . 1.3 t80 -86.11 106.38 17.2 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 120.789 -1.194 . . . . 0.0 109.462 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.559 HG11 ' CG2' ' A' ' 71' ' ' ILE . 2.1 t -93.38 108.19 20.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.177 -0.952 . . . . 0.0 109.289 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.533 ' O ' HG23 ' A' ' 71' ' ' ILE . 1.8 mmm180 -77.21 95.14 4.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.733 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.507 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.847 -177.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.663 ' CZ ' ' CG2' ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.497 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 35.8 Cg_endo -76.69 145.14 25.57 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.72 2.28 . . . . 0.0 111.616 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 2.7 t -124.84 155.86 33.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.149 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -117.8 113.56 21.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.562 -1.336 . . . . 0.0 108.808 177.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.567 ' CG1' HG11 ' A' ' 17' ' ' VAL . 1.4 m -148.26 163.02 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.836 -1.165 . . . . 0.0 110.43 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' O ' HG21 ' A' ' 19' ' ' VAL . 55.9 m-20 -114.81 -178.65 3.42 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.457 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 74.7 m -66.38 -1.14 3.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.928 -1.108 . . . . 0.0 110.511 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -98.81 -23.87 15.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.05 -1.031 . . . . 0.0 111.371 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.556 ' CB ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.8 129.04 4.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.735 -1.228 . . . . 0.0 109.092 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.588 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 25.1 m -74.93 6.16 4.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.476 -0.765 . . . . 0.0 111.6 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.61 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 28.3 mm 72.16 -32.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -78.75 -35.38 44.69 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.508 ' N ' HD11 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -58.28 -32.79 68.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 176.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.593 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -63.04 -42.95 99.88 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.787 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 5.6 mptt -70.25 -19.34 63.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 28.6 mm-40 -76.24 -49.9 15.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.572 -0.705 . . . . 0.0 109.502 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.574 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 46.8 t -65.14 -46.53 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.733 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 89.4 t -63.69 -34.14 66.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 29' ' ' LYS . . . -63.34 -29.08 70.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 21.9 mmmt -65.13 -47.45 77.07 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.691 0.758 . . . . 0.0 109.505 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -30.77 64.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.664 -0.647 . . . . 0.0 111.597 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.624 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -81.43 -15.17 55.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.685 -1.26 . . . . 0.0 110.525 -178.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.21 15.64 80.75 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.466 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -126.86 160.9 56.6 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.506 ' HG2' ' HG3' ' A' ' 42' ' ' GLN . 32.8 Cg_endo -76.75 140.48 20.86 Favored 'Trans proline' 0 C--N 1.292 -2.444 0 C-N-CA 123.311 2.674 . . . . 0.0 111.26 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.545 ' HB3' ' CB ' ' A' ' 29' ' ' LYS . . . -48.7 -20.17 0.44 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.774 -0.579 . . . . 0.0 110.372 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -63.0 -62.58 1.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.891 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.506 ' HG3' ' HG2' ' A' ' 39' ' ' PRO . 23.6 mt-30 -58.67 -50.67 73.0 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.616 1.198 . . . . 0.0 108.112 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.61 HD23 ' CG1' ' A' ' 32' ' ' VAL . 2.7 tp -62.95 142.18 58.44 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.627 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.787 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -154.71 117.79 4.44 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.249 -1.38 . . . . 0.0 111.855 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.593 ' CG2' HD13 ' A' ' 28' ' ' LEU . 1.4 t -87.8 120.86 37.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.093 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.461 HG22 ' HA ' ' A' ' 51' ' ' GLU . 10.4 mt -125.11 121.28 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.629 ' CE1' ' CB ' ' A' ' 48' ' ' ALA . 3.7 t80 -92.14 131.98 36.97 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.837 -1.164 . . . . 0.0 113.812 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.629 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 59.41 9.61 1.52 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.869 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.05 -9.95 58.25 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.183 -1.484 . . . . 0.0 110.118 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.471 ' O ' HD23 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -94.73 118.47 31.79 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.678 -1.484 . . . . 0.0 108.239 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.461 ' HA ' HG22 ' A' ' 46' ' ' ILE . 2.0 tt0 -74.46 106.39 6.04 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.282 -0.887 . . . . 0.0 108.766 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.565 ' CD2' ' CB ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -81.93 134.31 50.12 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.166 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HB2' ' CE1' ' A' ' 55' ' ' HIS . 31.4 Cg_endo -76.4 133.86 14.96 Favored 'Trans proline' 0 C--N 1.298 -2.11 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.605 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 3.0 p-10 -48.75 -51.66 27.8 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.35 -0.844 . . . . 0.0 111.771 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 2.4 p-80 -45.24 -35.24 3.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.403 -1.435 . . . . 0.0 109.734 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD12 ' CG ' ' A' ' 53' ' ' PRO . 14.2 mt -65.53 160.86 21.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.068 -1.02 . . . . 0.0 108.37 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -94.62 172.31 8.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.952 -1.092 . . . . 0.0 111.144 -178.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.556 HG23 ' CB ' ' A' ' 23' ' ' THR . 23.1 t -58.4 -35.98 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.389 0.614 . . . . 0.0 110.837 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.419 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -93.05 24.71 3.59 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.964 -1.085 . . . . 0.0 109.769 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.493 ' OD1' HD23 ' A' ' 56' ' ' LEU . 1.6 t30 -83.03 -62.88 1.48 Allowed 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 119.444 -0.903 . . . . 0.0 108.693 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.627 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -72.76 -14.89 61.64 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.627 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 4.1 t70 100.47 34.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.547 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.535 ' CD1' ' CD1' ' A' ' 52' ' ' LEU . 1.3 mt -55.72 -63.99 1.0 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 65' ' ' GLN . 19.8 mt-10 60.31 151.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.636 0.731 . . . . 0.0 111.871 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.608 ' CB ' ' CB ' ' A' ' 3' ' ' MET . 1.1 pp0? -33.89 127.51 0.4 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.984 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 17.2 tt0 74.58 110.18 0.07 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.452 ' OG ' ' CD2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -167.53 122.93 1.05 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 108.607 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.536 ' CD1' ' CB ' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -85.41 121.49 37.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.588 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -117.06 163.39 14.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -118.07 108.4 15.18 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.892 -1.13 . . . . 0.0 108.909 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.561 HD12 HD11 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -82.32 141.05 15.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.341 -0.849 . . . . 0.0 109.257 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 71' ' ' ILE . 58.4 t -140.08 132.62 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.989 -1.069 . . . . 0.0 109.131 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 6.0 tt0 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 109.701 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.612 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 4.3 ttm . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.828 0.823 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -71.77 141.24 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.634 -0.666 . . . . 0.0 109.814 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.554 ' CG2' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -97.51 148.15 5.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.525 ' CB ' HD11 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -93.79 108.41 20.18 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.219 -0.926 . . . . 0.0 109.196 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.576 ' CG1' HG22 ' A' ' 71' ' ' ILE . 41.3 t -90.96 112.06 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.781 -1.2 . . . . 0.0 109.164 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 2.7 mmm180 -91.38 93.84 9.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.843 ' CD1' HG12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.512 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.522 ' CE2' ' CD2' ' A' ' 9' ' ' PHE . 99.0 m-85 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.299 0.095 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -81.87 90.33 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.437 2.091 . . . . 0.0 108.004 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.535 ' CG1' HG21 ' A' ' 5' ' ' VAL . 3.2 p -85.54 144.82 8.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 110.148 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.16 114.78 27.39 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.823 -1.173 . . . . 0.0 108.811 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.554 ' CG1' ' CG2' ' A' ' 5' ' ' VAL . 1.2 m -142.92 162.47 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.935 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' N ' HG21 ' A' ' 19' ' ' VAL . 2.1 m-20 -114.44 -179.08 3.53 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.479 ' OG ' ' HG3' ' A' ' 59' ' ' GLN . 20.0 m -61.72 -5.26 1.83 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.051 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -90.55 -34.29 15.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 110.862 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.59 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.29 116.14 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.91 -1.119 . . . . 0.0 109.444 -179.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 23' ' ' THR . 1.4 m -60.01 -131.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.598 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 36.6 mm -139.69 -32.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 120.417 -1.427 . . . . 0.0 109.772 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -77.84 -34.26 51.95 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 175.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.486 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.37 -31.68 61.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 175.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.612 HD12 ' CG2' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -64.99 -50.08 67.71 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.736 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 3.8 mptt -63.6 -20.17 65.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.446 -0.784 . . . . 0.0 109.06 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 44.5 mt-10 -77.09 -48.73 17.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 109.476 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.54 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . 74.0 t -63.01 -44.67 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.77 ' CG1' ' CE2' ' A' ' 9' ' ' PHE . 97.9 t -64.37 -35.22 73.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' VAL . . . -62.0 -24.44 67.04 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -69.54 -50.03 48.76 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.928 0.871 . . . . 0.0 110.012 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.581 ' NH1' ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -64.85 -34.4 78.28 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.714 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 1.1 mt-30 -108.52 -11.25 15.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.478 -1.389 . . . . 0.0 112.435 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.62 10.01 85.73 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.548 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -90.75 146.29 33.75 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.507 ' HD2' HG13 ' A' ' 38' ' ' VAL . 30.7 Cg_endo -73.83 124.1 8.96 Favored 'Trans proline' 0 C--N 1.293 -2.368 0 C-N-CA 122.212 1.942 . . . . 0.0 110.25 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.543 ' HB2' ' CB ' ' A' ' 29' ' ' LYS . . . -45.46 -23.38 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.228 0.537 . . . . 0.0 109.679 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -61.69 -66.34 0.55 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.622 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.529 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 3.2 mt-30 -62.18 -42.67 99.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.089 -1.007 . . . . 0.0 108.601 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.599 HD13 ' CD1' ' A' ' 71' ' ' ILE . 3.1 tp -63.1 140.64 58.89 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.736 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -153.57 116.41 4.5 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 117.616 -1.633 . . . . 0.0 111.922 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.612 ' CG2' HD12 ' A' ' 28' ' ' LEU . 2.3 t -87.73 123.94 40.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.46 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.446 HG21 ' O ' ' A' ' 50' ' ' LYS . 8.1 mt -128.02 120.26 53.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 3.3 t80 -87.1 129.58 34.86 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.012 -1.055 . . . . 0.0 112.817 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . . . 59.35 7.33 0.91 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.979 -0.451 . . . . 0.0 111.764 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.47 -0.01 56.84 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.987 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.518 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -95.3 117.87 31.06 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.331 -1.688 . . . . 0.0 109.092 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HA ' HG21 ' A' ' 46' ' ' ILE . 29.9 tt0 -67.14 103.0 1.11 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.567 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 1.2 mt -85.18 135.43 39.27 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 121.395 -0.815 . . . . 0.0 109.843 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HD2' ' CD2' ' A' ' 56' ' ' LEU . 28.8 Cg_endo -67.69 133.83 30.83 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.821 1.681 . . . . 0.0 109.51 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.572 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 6.2 m-20 -53.02 -11.74 0.27 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 112.203 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.548 ' NE2' ' HB2' ' A' ' 53' ' ' PRO . 1.2 p-80 -99.38 27.51 5.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.248 -1.532 . . . . 0.0 112.214 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.592 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 1.1 pp -115.65 164.74 13.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.661 -1.275 . . . . 0.0 108.361 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -92.38 171.43 9.05 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 110.287 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.59 HG22 ' CB ' ' A' ' 23' ' ' THR . 5.4 t -61.48 -38.98 81.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.6 -0.687 . . . . 0.0 110.486 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.479 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 1.5 mt-30 -89.2 18.95 4.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.579 -1.326 . . . . 0.0 109.673 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.533 ' CB ' HD11 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -87.54 -62.68 1.44 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.481 -0.762 . . . . 0.0 110.128 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.661 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 26.3 t -71.32 -15.26 62.39 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.661 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 15.7 t0 105.43 30.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.3 mt -69.16 -62.76 1.25 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 65' ' ' GLN . 8.7 tt0 56.87 163.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.88 0.847 . . . . 0.0 111.913 177.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.612 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -37.85 122.84 1.02 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.931 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER 73.97 107.89 0.07 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -155.85 117.02 3.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.525 HD11 ' CB ' ' A' ' 6' ' ' PHE . 1.1 mp -83.35 120.29 34.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.581 ' CG1' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -115.42 166.65 9.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.43 0.633 . . . . 0.0 109.671 -176.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -121.48 106.21 11.2 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.944 -1.097 . . . . 0.0 108.972 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.843 HG12 ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -78.67 144.7 10.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 p -145.11 128.75 11.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 109.609 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.529 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 O-C-N 121.306 -0.871 . . . . 0.0 109.075 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.6 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 122.393 1.092 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -76.6 146.95 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.931 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.546 ' CG2' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -105.56 144.75 14.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.515 ' O ' HG21 ' A' ' 69' ' ' VAL . 1.8 t80 -87.47 106.89 18.28 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.728 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.585 ' CG1' HG23 ' A' ' 71' ' ' ILE . 54.1 t -90.51 115.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.957 -1.089 . . . . 0.0 109.133 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 1.6 mmm180 -94.96 96.2 9.13 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.522 -1.271 . . . . 0.0 108.247 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.813 ' CD1' HG12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.604 ' CE2' ' HB3' ' A' ' 35' ' ' ARG . 85.0 m-85 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 120.303 0.097 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 4' ' ' ILE . 36.1 Cg_endo -80.31 85.78 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.434 2.089 . . . . 0.0 107.336 177.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 4' ' ' ILE . 5.8 p -79.42 150.12 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.708 -0.62 . . . . 0.0 111.133 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.429 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.1 tt0 -95.27 114.04 25.78 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 108.323 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.546 ' CG1' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -136.99 158.7 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.07 -1.019 . . . . 0.0 109.489 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -103.21 176.71 5.06 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 108.913 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 59' ' ' GLN . 9.7 m -67.73 -2.97 7.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.907 . . . . 0.0 109.56 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HA ' HG22 ' A' ' 57' ' ' THR . 58.9 m-20 -111.16 -9.58 14.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.11 -0.993 . . . . 0.0 110.532 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.578 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -58.28 125.12 21.89 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -56.78 -149.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.007 . . . . 0.0 110.955 -176.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.59 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 17.1 mm -126.01 -33.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.631 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -78.15 -32.21 50.16 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 102.628 -3.101 . . . . 0.0 102.628 175.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.503 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.7 OUTLIER -56.66 -32.45 65.39 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 175.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.614 HD12 ' CG2' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -65.68 -51.67 57.55 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.592 177.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.736 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 3.8 mptt -61.7 -21.55 64.57 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.507 -0.746 . . . . 0.0 109.601 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 13.5 mt-10 -76.82 -50.13 14.18 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.045 -1.034 . . . . 0.0 109.704 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.562 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 71.6 t -61.14 -47.28 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.769 ' CG1' ' CE2' ' A' ' 9' ' ' PHE . 78.9 t -62.35 -38.66 81.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 38' ' ' VAL . . . -58.9 -27.38 65.17 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -66.97 -52.96 36.37 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.785 0.802 . . . . 0.0 110.069 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.604 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -60.13 -33.89 72.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.914 -0.491 . . . . 0.0 112.103 -177.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.707 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -104.74 -6.76 20.06 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.841 -1.162 . . . . 0.0 111.587 -176.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.3 15.86 75.06 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -100.89 150.5 37.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.553 ' N ' HG21 ' A' ' 38' ' ' VAL . 31.2 Cg_endo -71.94 125.43 10.97 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 123.041 2.494 . . . . 0.0 111.991 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.55 ' HB1' ' CB ' ' A' ' 29' ' ' LYS . . . -50.39 -22.37 1.83 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.462 0.649 . . . . 0.0 109.502 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 4.4 m-20 -58.83 -61.65 2.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.453 -0.78 . . . . 0.0 109.786 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.521 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 19.7 mt-30 -68.13 -41.62 81.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.076 -1.015 . . . . 0.0 108.354 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.626 HD13 ' CD1' ' A' ' 71' ' ' ILE . 2.2 tp -62.84 141.74 58.52 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.736 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -154.53 116.21 4.15 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.062 -1.455 . . . . 0.0 111.3 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.614 ' CG2' HD12 ' A' ' 28' ' ' LEU . 2.4 t -88.64 125.14 41.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.802 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.433 ' CG2' ' O ' ' A' ' 50' ' ' LYS . 7.2 mt -129.58 118.12 44.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.607 ' CD1' ' C ' ' A' ' 47' ' ' PHE . 1.1 t80 -85.16 131.04 34.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 112.798 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.592 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . . . 62.26 10.87 4.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.718 -0.614 . . . . 0.0 110.341 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.66 12.46 77.73 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -94.75 122.61 37.54 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.942 -1.328 . . . . 0.0 108.332 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.439 ' C ' HD23 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -62.58 107.49 0.96 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.633 -0.667 . . . . 0.0 110.413 -178.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.553 HD23 ' N ' ' A' ' 52' ' ' LEU . 3.2 mt -97.44 148.93 35.14 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.057 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 56' ' ' LEU . 34.3 Cg_endo -77.75 -164.29 0.26 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 N-CA-C 107.281 -1.853 . . . . 0.0 107.281 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.524 ' CB ' ' HB2' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -113.99 -30.78 6.59 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.653 -1.279 . . . . 0.0 109.711 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -80.66 -1.1 41.01 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.401 -0.812 . . . . 0.0 110.837 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.545 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 9.8 mt -80.7 169.54 17.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.654 -1.279 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -96.39 171.78 8.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.935 . . . . 0.0 110.549 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.578 HG22 ' CB ' ' A' ' 23' ' ' THR . 4.1 t -63.41 -46.6 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.596 -0.69 . . . . 0.0 109.98 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.481 ' CG ' ' HG3' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -84.84 15.78 3.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.074 -1.016 . . . . 0.0 109.956 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -86.04 -59.1 2.39 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.698 0.761 . . . . 0.0 109.39 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.654 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 6.1 m -69.59 -16.74 63.46 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.654 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 37.7 t0 107.12 31.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.708 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.509 ' CD2' ' HB2' ' A' ' 47' ' ' PHE . 1.4 mt -72.9 -77.84 0.1 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HG3' ' CG ' ' A' ' 59' ' ' GLN . 1.9 tt0 71.24 159.47 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.655 0.741 . . . . 0.0 111.612 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.6 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -37.99 122.62 1.03 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.487 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.1 tm0? 75.82 108.95 0.07 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.14 121.69 1.46 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.183 -0.948 . . . . 0.0 108.488 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.52 HD11 ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -85.63 122.06 37.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.57 ' HB ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -114.33 168.81 5.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.313 0.578 . . . . 0.0 109.668 -177.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -125.86 107.14 10.21 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.063 -1.023 . . . . 0.0 108.911 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.813 HG12 ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -80.21 142.56 13.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.194 -0.941 . . . . 0.0 109.616 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.3 t -138.91 120.41 16.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 3.9 tt0 . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.228 -0.92 . . . . 0.0 110.084 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mtt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.282 0.563 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 121.45 143.22 6.58 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.544 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 3.1 ttm -105.13 164.06 12.1 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.447 -1.031 . . . . 0.0 109.394 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -73.18 144.26 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.855 . . . . 0.0 111.85 -177.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.462 ' CG2' HG12 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -103.43 163.84 3.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.555 ' CB ' HD13 ' A' ' 68' ' ' ILE . 6.7 t80 -101.73 103.3 14.05 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.306 -1.496 . . . . 0.0 109.676 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.599 HG11 ' CG2' ' A' ' 71' ' ' ILE . 6.0 t -91.69 112.77 26.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.117 -0.989 . . . . 0.0 109.132 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.554 ' O ' HG21 ' A' ' 71' ' ' ILE . 24.3 mmm-85 -82.26 97.94 8.53 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.727 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -68.89 96.64 0.78 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 61.61 -131.31 0.68 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.192 -0.942 . . . . 0.0 108.507 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 12' ' ' SER . 30.6 p -126.27 137.86 53.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.755 -1.216 . . . . 0.0 109.839 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 11' ' ' SER . 2.9 t 77.6 -1.43 2.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.439 -0.788 . . . . 0.0 109.96 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.414 ' O ' ' N ' ' A' ' 9' ' ' PHE . 5.9 t80 -130.81 112.73 13.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.137 -0.977 . . . . 0.0 109.306 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -123.41 134.48 9.43 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.727 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -129.75 131.46 23.56 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.154 -1.204 . . . . 0.0 108.955 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.3 Cg_endo -78.41 126.26 7.48 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.454 2.103 . . . . 0.0 110.695 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.608 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 11.3 p -111.75 148.05 15.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.499 -0.751 . . . . 0.0 109.235 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.493 ' C ' HG13 ' A' ' 19' ' ' VAL . 5.6 tt0 -102.2 112.06 24.59 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.792 -1.192 . . . . 0.0 108.755 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.493 HG13 ' C ' ' A' ' 18' ' ' GLU . 0.7 OUTLIER -139.03 160.17 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.03 -1.044 . . . . 0.0 109.714 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -97.97 176.18 5.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.2 m -69.28 -0.19 5.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.083 -1.01 . . . . 0.0 110.278 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -102.88 -19.48 14.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.145 -0.972 . . . . 0.0 111.063 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.567 ' CB ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -45.32 124.11 4.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.573 -1.329 . . . . 0.0 109.157 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.84 -142.4 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.575 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 23.7 mm -130.17 -31.11 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 120.909 -1.119 . . . . 0.0 109.457 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.642 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -81.78 -34.92 30.09 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 175.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -60.0 -33.15 71.59 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 175.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.647 HD11 ' CG2' ' A' ' 45' ' ' VAL . 1.4 tm? -68.88 -38.04 79.42 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.746 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 7.0 mttt -72.3 -20.3 61.52 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 7.3 mm-40 -76.34 -49.99 15.45 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.449 -0.782 . . . . 0.0 109.623 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.579 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 2.4 t -64.08 -48.03 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.635 HG11 ' CE1' ' A' ' 9' ' ' PHE . 85.5 t -63.23 -32.98 58.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -67.03 -29.68 69.56 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 14.5 mmmt -64.2 -53.8 43.62 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.774 0.797 . . . . 0.0 109.578 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -69.71 -22.4 63.4 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.837 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.664 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.89 -14.95 55.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.925 -1.109 . . . . 0.0 110.373 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.05 25.08 67.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.535 ' CG2' HD11 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -142.0 164.24 35.17 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 34.0 Cg_endo -78.15 141.36 18.46 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 123.662 2.908 . . . . 0.0 111.554 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB3' ' CB ' ' A' ' 29' ' ' LYS . . . -53.05 -22.22 5.66 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.438 -0.789 . . . . 0.0 110.122 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.61 -57.73 11.47 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 108.775 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.538 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 7.3 mt-30 -64.15 -44.75 91.17 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.283 1.04 . . . . 0.0 108.407 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.61 ' CD2' HG12 ' A' ' 32' ' ' VAL . 1.3 tp -67.49 143.1 56.37 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.538 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.746 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -154.35 116.99 4.37 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.638 -1.225 . . . . 0.0 111.539 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.647 ' CG2' HD11 ' A' ' 28' ' ' LEU . 1.4 t -91.17 127.01 43.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.261 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 50' ' ' LYS . 5.5 mt -130.03 119.94 48.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.2 t80 -87.67 127.34 35.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.909 -1.119 . . . . 0.0 112.76 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.591 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 59.61 7.76 1.11 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.977 -0.452 . . . . 0.0 111.297 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.45 6.47 57.48 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.878 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.64 119.28 34.84 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.564 -1.551 . . . . 0.0 108.718 179.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.72 109.27 2.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.381 -0.824 . . . . 0.0 108.79 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -93.72 146.61 32.07 Favored Pre-proline 0 C--N 1.303 -1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.456 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 56' ' ' LEU . 33.3 Cg_endo -76.5 142.39 23.42 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.358 2.039 . . . . 0.0 108.879 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.525 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 4.6 m-20 -65.19 -5.15 6.18 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.32 -0.863 . . . . 0.0 111.057 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.471 ' CD2' ' C ' ' A' ' 55' ' ' HIS . 5.7 p-80 -104.26 0.16 29.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.647 -1.283 . . . . 0.0 111.201 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.545 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 12.4 mt -89.92 162.97 15.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.645 -1.285 . . . . 0.0 109.055 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.465 ' OG1' ' OD1' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -91.53 171.16 9.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.099 -1.001 . . . . 0.0 110.887 -178.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.567 HG21 ' CB ' ' A' ' 23' ' ' THR . 8.7 t -62.17 -40.09 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.657 -0.652 . . . . 0.0 110.43 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.533 ' CG ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -87.46 18.47 3.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.617 -1.302 . . . . 0.0 109.957 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.545 ' ND2' HD21 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -88.86 -62.3 1.52 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.314 -0.866 . . . . 0.0 110.339 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.652 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 42.1 t -69.46 -14.23 62.77 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.252 -0.905 . . . . 0.0 108.609 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 8.4 t70 103.78 30.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.569 ' CD2' ' HB2' ' A' ' 47' ' ' PHE . 1.2 mt -72.9 -59.81 2.53 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.214 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HG2' ' CG ' ' A' ' 59' ' ' GLN . 3.5 mm-40 59.96 152.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.544 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 1.4 pt20 -48.73 140.14 8.82 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 7.8 tp-100 74.6 106.4 0.07 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.81 130.38 0.66 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.555 HD13 ' CB ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -84.92 116.03 27.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 C-N-CA 117.698 -1.601 . . . . 0.0 107.595 -179.018 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.578 ' HB ' HG11 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -112.97 163.67 9.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -178.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -124.83 106.8 10.3 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.93 -1.106 . . . . 0.0 108.759 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.604 HG12 ' HA ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -80.82 141.2 15.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.41 125.95 38.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.961 -1.087 . . . . 0.0 109.877 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.538 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -123.57 111.39 16.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' C ' ' O ' ' A' ' 73' ' ' GLN . 1.1 mtm180 -39.57 96.95 0.12 Allowed Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.524 ' N ' ' O ' ' A' ' 73' ' ' GLN . 34.7 Cg_endo -82.44 124.5 4.17 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.829 2.353 . . . . 0.0 112.737 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.563 ' O ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -64.46 168.81 5.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 176.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 92.98 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.917 -1.513 . . . . 0.0 108.418 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 76' ' ' ARG . 7.4 tpt85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.195 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' C ' ' A' ' 2' ' ' GLY . 5.0 ttt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.241 0.543 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 19' ' ' VAL . . . -42.66 107.35 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.574 ' HB3' ' CB ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -67.1 166.21 14.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.51 ' N ' ' HG3' ' A' ' 3' ' ' MET . 0.8 OUTLIER -70.41 143.83 14.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 111.755 -178.007 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.425 HG21 HG13 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -108.24 163.06 5.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 176.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.59 ' CB ' HD11 ' A' ' 68' ' ' ILE . 3.9 t80 -98.66 118.01 34.4 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 120.285 -1.509 . . . . 0.0 109.411 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.596 ' CG1' HG21 ' A' ' 71' ' ' ILE . 8.7 t -105.96 112.21 38.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.529 ' O ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -79.37 100.44 7.62 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 117.625 -1.63 . . . . 0.0 108.274 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.697 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -81.69 136.24 35.49 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.679 0.752 . . . . 0.0 111.101 -177.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 62.12 -90.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.613 -0.679 . . . . 0.0 110.559 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 m -128.35 -71.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.6 -1.312 . . . . 0.0 110.383 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.8 -10.77 11.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.011 -1.055 . . . . 0.0 110.284 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -75.72 100.99 4.86 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 108.749 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 7' ' ' VAL . . . -94.86 127.14 9.0 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.052 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.613 ' CZ ' ' HD3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -102.31 135.81 19.53 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.6 Cg_endo -76.18 127.83 10.16 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.124 1.882 . . . . 0.0 111.018 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.605 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 8.4 p -116.08 142.3 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -100.7 116.55 32.87 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.579 -1.325 . . . . 0.0 109.108 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.475 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 1.8 m -149.43 165.81 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.132 -0.98 . . . . 0.0 109.641 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.44 ' N ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -119.5 -178.79 3.69 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.621 -0.674 . . . . 0.0 109.56 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.582 ' CB ' ' HG3' ' A' ' 59' ' ' GLN . 3.5 m -63.53 -3.31 2.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.491 -0.756 . . . . 0.0 110.692 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 23' ' ' THR . 5.7 m-20 -95.69 -35.8 11.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.071 -1.018 . . . . 0.0 110.867 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.575 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.96 126.38 3.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.852 -1.155 . . . . 0.0 109.41 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 27' ' ' GLN . 0.9 OUTLIER -61.24 -142.61 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.596 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 30.0 mm -129.57 -33.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 120.937 -1.102 . . . . 0.0 108.681 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.608 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -80.35 -34.68 36.35 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 176.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -56.79 -31.88 65.11 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 175.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.605 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -64.13 -45.34 88.97 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.73 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 3.9 mptt -68.95 -18.68 64.12 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.589 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.2 mm-40 -77.28 -50.69 12.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 109.493 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.576 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 71.1 t -63.94 -46.23 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.697 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 68.3 t -64.82 -35.81 76.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -60.21 -27.54 67.25 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 4.0 mmmm -65.79 -50.95 62.82 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.656 0.741 . . . . 0.0 109.391 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.613 ' HD3' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -71.33 -22.51 61.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.691 -0.63 . . . . 0.0 111.026 -178.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.674 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 1.8 mm-40 -87.98 -17.64 30.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.899 -1.125 . . . . 0.0 110.502 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.63 17.42 79.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.511 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 1.4 m -124.39 164.11 32.26 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 31.2 Cg_endo -77.31 138.53 17.85 Favored 'Trans proline' 0 C--N 1.293 -2.386 0 C-N-CA 123.037 2.491 . . . . 0.0 110.843 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.558 ' HB1' ' CB ' ' A' ' 29' ' ' LYS . . . -51.84 -19.64 1.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.646 -0.659 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.498 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -62.3 -59.08 5.52 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.183 -0.948 . . . . 0.0 109.156 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.567 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 1.7 mt-30 -60.53 -48.96 79.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.132 0.967 . . . . 0.0 108.623 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.576 HD23 ' CG1' ' A' ' 32' ' ' VAL . 3.5 tp -63.8 140.49 58.88 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.659 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.73 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -152.84 117.2 4.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.058 -1.457 . . . . 0.0 111.797 178.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.605 ' CG2' HD13 ' A' ' 28' ' ' LEU . 17.8 t -88.77 119.24 35.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.055 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 50' ' ' LYS . 6.0 mt -128.8 117.53 44.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.585 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -93.78 129.86 39.99 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -174.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.584 ' HB1' ' CE1' ' A' ' 47' ' ' PHE . . . 60.3 7.42 1.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.906 -0.496 . . . . 0.0 111.737 177.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.75 -3.47 45.71 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.689 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -96.18 114.55 26.25 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 120.454 -1.615 . . . . 0.0 108.715 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -74.75 105.16 5.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -91.98 152.27 42.72 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.588 ' HG2' ' HG ' ' A' ' 56' ' ' LEU . 34.2 Cg_endo -75.79 -170.92 0.91 Allowed 'Trans proline' 0 C--N 1.296 -2.198 0 C-N-CA 122.322 2.015 . . . . 0.0 108.595 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.486 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 10.5 p30 -91.71 -39.93 11.55 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 110.399 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 21.0 p-80 -62.11 -39.2 91.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 111.272 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HG ' ' HG2' ' A' ' 53' ' ' PRO . 12.4 mt -50.04 158.04 0.57 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.656 -1.278 . . . . 0.0 110.252 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 172.84 8.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.433 -0.792 . . . . 0.0 110.802 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.575 HG22 ' CB ' ' A' ' 23' ' ' THR . 21.1 t -62.07 -44.21 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.587 0.708 . . . . 0.0 110.317 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.582 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 23.0 mt-30 -90.18 25.1 2.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.819 -1.176 . . . . 0.0 109.782 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.567 ' ND2' ' CD2' ' A' ' 56' ' ' LEU . 1.8 t30 -84.33 -63.32 1.36 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.05 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.563 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 10.2 t -75.3 -48.78 21.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 4.6 m-20 155.02 36.61 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.511 ' HB2' HG13 ' A' ' 58' ' ' VAL . 1.3 mt -82.37 -57.66 3.27 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.419 -1.313 . . . . 0.0 108.306 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' HG2' ' A' ' 59' ' ' GLN . 0.1 OUTLIER 46.99 -154.34 0.06 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.574 ' CB ' ' HB3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.64 137.51 33.65 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 36.1 tp60 74.39 109.35 0.07 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -176.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.48 ' OG ' ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -175.87 129.84 0.24 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -177.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.59 HD11 ' CB ' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -83.26 122.56 37.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 117.861 -1.536 . . . . 0.0 108.076 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' A' ' 70' ' ' HIS . 2.5 t -109.9 160.64 8.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 121.725 0.774 . . . . 0.0 110.411 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.573 ' N ' ' CG1' ' A' ' 69' ' ' VAL . 3.5 t60 -122.8 102.55 8.09 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -89.57 143.17 11.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.564 -0.71 . . . . 0.0 109.186 -178.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 42' ' ' GLN . 11.3 p -139.49 137.92 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.011 -1.056 . . . . 0.0 109.172 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.567 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -120.36 117.06 26.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 110.403 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.447 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 2.1 mmm180 -53.64 108.35 1.09 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 108.469 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 73' ' ' GLN . 33.2 Cg_endo -78.29 128.84 9.17 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.414 2.076 . . . . 0.0 112.245 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -64.32 171.79 2.9 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -53.7 92.28 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.411 -1.43 . . . . 0.0 108.77 -179.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 76' ' ' ARG . 2.2 ttt180 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.39 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.538 ' CA ' ' HA ' ' A' ' 20' ' ' ASP . . . -119.97 90.25 0.47 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.544 ' HB3' ' CB ' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -68.31 169.08 11.21 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.59 -0.947 . . . . 0.0 108.897 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.527 ' N ' ' HG3' ' A' ' 3' ' ' MET . 0.1 OUTLIER -73.2 143.28 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.093 -1.005 . . . . 0.0 112.367 -177.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.485 HG11 ' N ' ' A' ' 67' ' ' SER . 0.5 OUTLIER -106.23 164.63 4.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.55 ' HB3' ' CD1' ' A' ' 68' ' ' ILE . 12.8 t80 -102.73 109.31 20.85 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.373 -1.454 . . . . 0.0 109.406 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.634 ' CG1' HG23 ' A' ' 71' ' ' ILE . 13.7 t -94.65 120.58 44.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.519 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.551 ' O ' HG21 ' A' ' 71' ' ' ILE . 14.5 mmm-85 -88.39 98.62 11.71 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.753 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -71.3 96.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.061 0.458 . . . . 0.0 110.745 -177.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER 54.46 162.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 0.0 110.892 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 22.7 m 34.89 -109.21 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.949 -0.469 . . . . 0.0 110.273 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -128.8 -6.64 5.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.931 -1.106 . . . . 0.0 109.724 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -48.12 153.74 0.65 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 108.376 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 7' ' ' VAL . . . -146.53 121.73 1.49 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.731 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.753 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -113.9 142.28 27.57 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HB2' HD11 ' A' ' 4' ' ' ILE . 34.2 Cg_endo -75.9 127.82 10.35 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.328 2.019 . . . . 0.0 111.23 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.62 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 5.9 p -117.94 144.84 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.509 -0.744 . . . . 0.0 109.56 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' N ' HG21 ' A' ' 17' ' ' VAL . 4.8 tt0 -106.93 117.36 33.84 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.426 -1.422 . . . . 0.0 108.406 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.518 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 1.2 m -139.26 160.71 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.91 -1.119 . . . . 0.0 110.526 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.538 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 2.5 m-20 -107.29 176.08 5.28 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -66.34 -5.09 9.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.932 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.95 16.83 10.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.087 -1.008 . . . . 0.0 109.873 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.514 ' HB ' ' CG2' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -66.46 -9.36 33.53 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.136 -0.977 . . . . 0.0 109.548 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.529 ' OG ' ' HB2' ' A' ' 27' ' ' GLN . 5.7 p 69.31 -142.81 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 108.988 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.588 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 39.0 mm -144.15 -25.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.895 -1.128 . . . . 0.0 111.126 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.671 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -83.42 -37.41 23.27 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 177.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.529 ' HB2' ' OG ' ' A' ' 24' ' ' SER . 0.0 OUTLIER -60.75 -33.7 73.32 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 176.103 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.616 HD12 ' CG2' ' A' ' 45' ' ' VAL . 2.4 tm? -69.4 -37.17 77.37 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.703 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 4.3 mttt -70.0 -20.46 63.28 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.642 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.9 mm-40 -74.33 -52.81 11.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.697 -0.627 . . . . 0.0 109.674 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.51 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 27.5 t -61.79 -48.92 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.645 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 60.5 t -62.06 -33.47 58.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -68.23 -28.72 67.48 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.4 -0.813 . . . . 0.0 109.265 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 2.7 mmmm -65.61 -52.37 52.53 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.774 0.797 . . . . 0.0 109.39 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -71.85 -22.77 61.49 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.27 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.661 ' CG ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.27 -15.5 55.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.713 -1.242 . . . . 0.0 110.583 -179.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.2 21.22 61.15 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 36' ' ' GLN . 1.6 m -142.78 164.82 30.1 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.738 -0.86 . . . . 0.0 108.679 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.469 ' N ' HG23 ' A' ' 38' ' ' VAL . 33.0 Cg_endo -78.67 143.02 18.52 Favored 'Trans proline' 0 C--N 1.293 -2.387 0 C-N-CA 123.437 2.758 . . . . 0.0 111.444 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 29' ' ' LYS . . . -50.6 -21.06 1.38 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.755 -0.591 . . . . 0.0 110.196 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -61.49 -60.75 3.23 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 109.246 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 29.8 mt-30 -63.5 -43.68 96.54 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.618 ' CD2' HG13 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -66.01 144.61 56.63 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.504 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.703 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -155.15 115.72 3.87 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.362 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.616 ' CG2' HD12 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -93.84 117.29 37.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.715 0.769 . . . . 0.0 110.602 -178.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 50' ' ' LYS . 6.4 mt -116.59 122.4 69.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.584 ' CE1' ' HB1' ' A' ' 48' ' ' ALA . 1.7 t80 -87.92 129.76 35.13 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.765 -1.209 . . . . 0.0 113.426 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.584 ' HB1' ' CE1' ' A' ' 47' ' ' PHE . . . 61.0 7.92 1.71 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.803 -0.561 . . . . 0.0 111.234 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.73 6.42 60.76 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.333 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -95.63 130.33 42.54 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.613 -1.522 . . . . 0.0 108.75 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.441 ' C ' HD22 ' A' ' 52' ' ' LEU . 26.4 tt0 -75.85 114.96 15.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.775 . . . . 0.0 109.092 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.528 HD22 ' O ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -105.06 144.98 29.84 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.103 -0.998 . . . . 0.0 110.129 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.549 ' HG2' ' CG ' ' A' ' 56' ' ' LEU . 32.2 Cg_endo -77.34 131.25 11.55 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 122.342 2.028 . . . . 0.0 108.216 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 2.3 m120 -48.88 -37.58 20.05 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.692 -0.63 . . . . 0.0 111.802 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.521 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 7.0 p-80 -70.57 -31.42 68.43 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.781 -1.199 . . . . 0.0 112.053 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.551 HD22 ' ND2' ' A' ' 60' ' ' ASN . 10.9 mt -54.74 164.67 0.73 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.392 -1.443 . . . . 0.0 109.029 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -91.89 171.07 9.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.119 -0.988 . . . . 0.0 110.932 -178.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' A' ' 23' ' ' THR . 16.9 t -61.97 -39.65 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.403 0.62 . . . . 0.0 110.153 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -88.17 18.1 4.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.668 -1.27 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.551 ' ND2' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -88.14 -62.34 1.51 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 110.681 -178.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.668 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -72.17 -15.56 61.97 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.214 -0.929 . . . . 0.0 108.94 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.668 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 51.4 t0 109.13 32.77 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 1.0 OUTLIER -79.4 -50.89 10.12 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.43 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.6 -157.51 0.12 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.573 0.701 . . . . 0.0 109.579 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.544 ' CB ' ' HB3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.52 129.56 41.27 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 14.8 tm0? 80.23 111.54 0.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.485 ' N ' HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -173.34 129.72 0.45 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -177.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -83.18 117.96 29.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 118.267 -1.373 . . . . 0.0 107.906 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.536 ' HB ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -116.03 167.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -177.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -124.58 109.32 13.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.956 -1.09 . . . . 0.0 108.435 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.634 HG23 ' CG1' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -84.32 142.95 12.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.263 -0.898 . . . . 0.0 110.109 -179.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -135.95 143.65 35.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 8.8 tt0 -115.49 129.13 56.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.018 -1.051 . . . . 0.0 110.339 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.477 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 8.3 mmt85 -104.27 162.02 21.15 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.381 -0.825 . . . . 0.0 109.028 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 30.0 Cg_endo -78.31 156.12 29.12 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.761 2.308 . . . . 0.0 110.747 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -60.48 169.2 1.81 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 177.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.9 90.79 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 117.88 -1.528 . . . . 0.0 108.817 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 O-C-N 121.077 -1.014 . . . . 0.0 109.387 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.348 0.594 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.11 151.34 6.0 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.601 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 1.2 ttm -124.83 170.89 10.61 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.36 1.076 . . . . 0.0 111.128 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.589 HG12 ' HB2' ' A' ' 16' ' ' PRO . 1.1 tp -77.46 139.31 18.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.262 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.519 HG13 ' CB ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -95.72 153.18 3.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.522 ' CB ' HD11 ' A' ' 68' ' ' ILE . 5.4 t80 -91.34 108.58 19.98 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 120.769 -1.207 . . . . 0.0 109.248 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.585 HG13 ' CG2' ' A' ' 71' ' ' ILE . 2.1 t -94.92 110.77 24.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.26 -0.9 . . . . 0.0 109.692 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.543 ' O ' HG22 ' A' ' 71' ' ' ILE . 24.1 mmm-85 -78.2 93.01 4.52 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.701 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.97 112.46 6.38 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 9' ' ' PHE . 3.6 t-20 61.62 -91.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.359 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.8 t -165.3 -63.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 109.751 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 m -72.63 -1.86 17.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.01 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 15.9 m-30 -105.3 -160.92 0.78 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.005 . . . . 0.0 109.61 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.36 118.07 0.5 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.633 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -137.94 136.05 19.38 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.077 -1.249 . . . . 0.0 109.465 -179.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HB2' HG12 ' A' ' 4' ' ' ILE . 34.6 Cg_endo -78.95 131.81 10.24 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.722 2.282 . . . . 0.0 111.062 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.598 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 3.3 p -113.98 151.18 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 0.0 109.013 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HA ' HD11 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -102.28 119.33 38.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.554 -1.341 . . . . 0.0 108.793 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.53 HG11 HD22 ' A' ' 28' ' ' LEU . 1.3 m -144.04 159.64 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.727 -1.233 . . . . 0.0 110.343 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 m-20 -102.53 177.06 4.97 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.528 ' CB ' ' HG3' ' A' ' 59' ' ' GLN . 37.3 m -71.62 0.73 7.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.01 . . . . 0.0 109.936 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' HA ' HG23 ' A' ' 57' ' ' THR . 0.8 OUTLIER -110.58 -10.05 14.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 111.427 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.564 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -45.98 131.93 9.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.618 -1.301 . . . . 0.0 108.432 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.621 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 9.4 m -74.74 6.75 3.62 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.333 -0.854 . . . . 0.0 111.795 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.621 ' HB ' ' O ' ' A' ' 24' ' ' SER . 14.5 mm 72.35 -30.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 O-C-N 121.892 -0.505 . . . . 0.0 112.27 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.641 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -82.08 -35.57 28.5 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 176.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.418 ' N ' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -59.51 -35.59 74.45 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.605 HD11 ' CG2' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -63.46 -40.5 97.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 176.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.72 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 7.8 mttt -69.62 -20.97 63.6 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.63 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.6 mt-10 -75.08 -50.34 16.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.297 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.515 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.1 t -65.36 -48.15 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.701 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 87.5 t -62.07 -34.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -64.43 -29.67 70.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -64.5 -54.16 36.72 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.819 0.819 . . . . 0.0 109.672 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -64.79 -30.21 71.21 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.595 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.672 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 1.5 mm100 -81.34 -7.39 59.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.712 -1.243 . . . . 0.0 110.216 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.53 17.24 72.54 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.533 ' CG2' HD13 ' A' ' 43' ' ' LEU . 16.2 m -125.85 158.35 65.86 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 33.5 Cg_endo -78.41 143.38 19.44 Favored 'Trans proline' 0 C--N 1.294 -2.297 0 C-N-CA 123.152 2.568 . . . . 0.0 111.08 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 29' ' ' LYS . . . -49.67 -20.49 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.376 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.18 -63.27 1.35 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.336 -0.853 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.528 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 34.6 mt-30 -61.3 -49.19 78.03 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.455 1.121 . . . . 0.0 108.395 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.589 ' CD2' HG12 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -64.94 141.04 58.91 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.71 -179.078 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.72 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 3.9 mpp_? -155.64 115.05 3.6 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.476 -1.29 . . . . 0.0 111.269 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.605 ' CG2' HD11 ' A' ' 28' ' ' LEU . 1.3 t -86.63 121.61 37.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.763 0.792 . . . . 0.0 110.704 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.536 ' O ' ' CG1' ' A' ' 69' ' ' VAL . 19.7 mt -118.35 151.62 20.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 9.0 t80 -107.95 120.03 41.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 119.835 -1.79 . . . . 0.0 113.621 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . . . 55.66 7.74 0.27 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.95 -15.07 11.18 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 118.965 -1.588 . . . . 0.0 111.202 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.513 ' O ' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -97.21 114.14 25.82 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.488 -1.595 . . . . 0.0 108.894 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HA ' ' CG2' ' A' ' 46' ' ' ILE . 44.3 tt0 -56.94 117.12 3.65 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.492 -0.755 . . . . 0.0 109.596 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.579 ' CD2' ' CB ' ' A' ' 61' ' ' CYS . 6.0 mt -85.72 132.36 44.55 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 109.349 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.601 ' HB2' ' CE1' ' A' ' 55' ' ' HIS . 30.9 Cg_endo -75.07 132.15 15.0 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 121.844 1.696 . . . . 0.0 108.246 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.524 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 4.5 m-20 -59.82 -30.64 69.07 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 110.411 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.601 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 13.6 p-80 -70.73 -22.87 62.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.61 -1.306 . . . . 0.0 110.06 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.561 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 14.3 mt -78.92 168.35 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.936 -1.102 . . . . 0.0 108.151 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.464 HG23 ' HA ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -95.79 172.52 7.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.062 -1.024 . . . . 0.0 111.031 -178.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.564 HG22 ' CB ' ' A' ' 23' ' ' THR . 24.0 t -59.86 -41.04 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.762 -0.586 . . . . 0.0 110.547 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.528 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 9.2 mt-30 -86.97 19.58 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.62 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.543 ' OD1' ' CD1' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -84.44 -60.22 2.14 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.628 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 17.5 t -70.6 -16.16 62.82 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.628 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 16.3 t0 103.26 37.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 58' ' ' VAL . 1.3 mt -66.6 -83.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.597 -1.241 . . . . 0.0 107.728 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 63' ' ' LEU . 2.9 tt0 76.45 162.26 0.23 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.833 0.825 . . . . 0.0 111.287 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.601 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 1.8 pt20 -40.88 121.97 1.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER 76.0 112.3 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.519 ' CB ' HG13 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -163.18 118.58 1.72 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.529 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.1 mp -81.99 117.49 28.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -116.92 151.16 18.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -107.76 110.16 21.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.376 -1.452 . . . . 0.0 108.231 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.585 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -80.49 141.48 15.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.424 -0.798 . . . . 0.0 109.473 -178.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 42' ' ' GLN . 16.5 t -130.15 122.96 55.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.226 -0.921 . . . . 0.0 108.963 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.528 ' HG2' ' CB ' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -120.51 109.24 15.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 110.155 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' O ' ' OE1' ' A' ' 73' ' ' GLN . 2.6 mmp_? -48.24 105.02 0.45 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.197 -0.939 . . . . 0.0 109.191 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 73' ' ' GLN . 30.8 Cg_endo -74.15 138.06 24.71 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.372 2.048 . . . . 0.0 111.75 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 78' ' ' ARG . 18.5 mtt180 -62.08 167.61 3.82 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -56.42 92.33 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 117.808 -1.557 . . . . 0.0 108.414 -179.132 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 109.228 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.366 0.603 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.97 146.35 6.91 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.559 ' CG ' ' CB ' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -122.22 174.14 7.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.367 -1.078 . . . . 0.0 109.877 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -69.98 141.05 17.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.868 0.842 . . . . 0.0 110.841 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.526 HG23 ' CG1' ' A' ' 19' ' ' VAL . 1.4 t -110.05 165.47 5.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.496 ' HB3' ' CD1' ' A' ' 68' ' ' ILE . 4.9 t80 -103.69 106.49 17.01 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.458 -1.401 . . . . 0.0 109.381 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.597 ' CG1' HG23 ' A' ' 71' ' ' ILE . 14.8 t -91.18 115.72 30.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.583 ' O ' HG21 ' A' ' 71' ' ' ILE . 11.6 mmm180 -82.18 92.31 6.87 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 117.144 -1.822 . . . . 0.0 106.985 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.718 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -67.53 130.39 42.9 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 1.4 m120 68.18 -84.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.416 -0.802 . . . . 0.0 109.376 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.2 -32.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.974 -1.079 . . . . 0.0 110.543 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 -5.4 17.41 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.967 -1.083 . . . . 0.0 110.346 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -111.75 166.12 11.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.188 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 7' ' ' VAL . . . -152.25 119.22 0.95 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.718 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -110.7 138.71 21.12 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.296 -1.12 . . . . 0.0 108.91 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HB2' HG12 ' A' ' 4' ' ' ILE . 34.1 Cg_endo -75.88 124.69 8.23 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.358 2.039 . . . . 0.0 110.248 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 7.5 p -110.73 154.24 12.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.433 -0.792 . . . . 0.0 109.724 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.7 tt0 -101.3 114.75 29.01 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.775 -1.203 . . . . 0.0 108.341 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.526 ' CG1' HG23 ' A' ' 5' ' ' VAL . 2.0 m -148.14 165.9 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 110.152 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' N ' HG21 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -127.42 -179.46 4.91 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' A' ' 59' ' ' GLN . 1.0 OUTLIER -61.55 -8.54 4.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.152 -0.967 . . . . 0.0 110.435 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.86 18.47 13.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.894 -1.129 . . . . 0.0 110.693 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.512 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -72.04 -5.73 37.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.074 -1.016 . . . . 0.0 109.672 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 27' ' ' GLN . 52.5 m 65.78 -144.53 0.2 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.625 HD12 ' CD2' ' A' ' 52' ' ' LEU . 9.4 mm -144.94 -28.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.739 -1.226 . . . . 0.0 110.607 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.674 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -80.82 -33.84 34.37 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 176.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -61.81 -33.78 74.75 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.659 ' CD1' ' CG2' ' A' ' 45' ' ' VAL . 2.9 tm? -72.31 -32.58 66.67 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.674 ' HD2' ' HA ' ' A' ' 26' ' ' LEU . 3.0 mttt -71.33 -23.54 61.95 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.9 mm-40 -76.3 -52.19 10.46 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.631 -0.668 . . . . 0.0 110.114 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.502 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 85.1 t -61.77 -45.84 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.635 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 98.7 t -65.75 -32.63 59.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -66.78 -27.15 67.35 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.4 OUTLIER -69.25 -53.08 21.68 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.883 0.849 . . . . 0.0 109.287 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -70.97 -22.04 62.24 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.856 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.641 ' HG3' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -82.12 -14.07 56.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.801 -1.187 . . . . 0.0 110.241 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.63 25.78 66.82 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -144.27 161.7 43.5 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HG2' ' HG3' ' A' ' 42' ' ' GLN . 30.8 Cg_endo -76.86 141.9 21.9 Favored 'Trans proline' 0 C--N 1.293 -2.382 0 C-N-CA 123.224 2.616 . . . . 0.0 111.091 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 29' ' ' LYS . . . -50.34 -20.4 1.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.602 -0.686 . . . . 0.0 110.046 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -60.45 -61.81 2.32 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.213 -0.929 . . . . 0.0 109.087 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 2.7 mt-30 -63.16 -43.83 97.19 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -66.61 143.69 56.86 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.467 -179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.593 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -157.06 116.31 3.38 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.008 -1.057 . . . . 0.0 109.717 178.179 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.659 ' CG2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -101.84 116.99 46.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.641 0.734 . . . . 0.0 111.735 -177.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.9 mt -114.65 128.51 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.643 ' CE1' ' CB ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -86.46 132.98 33.8 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.559 -1.338 . . . . 0.0 113.169 -176.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.643 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 62.14 10.06 3.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.326 0.584 . . . . 0.0 110.637 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.6 6.76 89.15 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -96.79 120.54 37.31 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.601 -1.529 . . . . 0.0 108.088 179.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -48.36 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.652 0.739 . . . . 0.0 110.333 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.625 ' CD2' HD12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -101.74 113.69 65.78 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.545 ' CG ' HD12 ' A' ' 56' ' ' LEU . 28.2 Cg_endo -63.55 163.78 23.03 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 123.46 2.773 . . . . 0.0 116.117 -172.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.608 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -66.56 -43.24 85.58 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.976 -178.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 42.8 p-80 -74.62 -43.9 53.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.987 -1.071 . . . . 0.0 111.721 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.545 HD12 ' CG ' ' A' ' 53' ' ' PRO . 12.5 mt -42.47 162.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.988 -1.07 . . . . 0.0 109.482 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.13 168.49 13.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.136 -0.977 . . . . 0.0 109.946 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.559 ' HA ' HD13 ' A' ' 63' ' ' LEU . 16.5 t -61.47 -37.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.514 -0.741 . . . . 0.0 110.073 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 0.5 OUTLIER -89.34 20.17 3.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.887 -1.133 . . . . 0.0 109.449 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.465 ' ND2' HD13 ' A' ' 56' ' ' LEU . 1.3 t30 -82.61 -60.17 2.27 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.608 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -73.26 -17.9 61.28 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 65.3 m-20 105.56 36.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.559 HD13 ' HA ' ' A' ' 58' ' ' VAL . 1.5 mt -61.7 -65.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.76 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 28.5 mt-10 62.94 144.33 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.303 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.559 ' CB ' ' CG ' ' A' ' 3' ' ' MET . 2.8 pp0? -37.14 135.83 0.46 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 17.8 tt0 73.59 105.55 0.07 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.467 ' N ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -167.66 128.57 1.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.496 ' CD1' ' HB3' ' A' ' 6' ' ' PHE . 1.2 mp -86.39 119.31 34.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 118.372 -1.331 . . . . 0.0 108.059 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.601 ' HB ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.94 169.81 3.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -126.15 107.3 10.26 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 109.332 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.597 HG23 ' CG1' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -86.84 141.65 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.351 -0.843 . . . . 0.0 110.161 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 42' ' ' GLN . 94.9 t -136.59 133.62 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 2.5 tt0 -116.9 127.22 54.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.133 -0.979 . . . . 0.0 109.999 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.09 109.12 1.45 Allowed Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 73' ' ' GLN . 33.1 Cg_endo -78.94 129.08 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.207 1.938 . . . . 0.0 111.42 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 78' ' ' ARG . 13.4 mtt180 -62.33 165.11 6.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.88 92.06 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.237 -1.539 . . . . 0.0 108.735 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.572 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 mtt . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.468 ' HA3' ' OD1' ' A' ' 20' ' ' ASP . . . 90.75 168.23 42.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.627 ' CB ' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -124.37 169.07 12.18 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.442 -1.034 . . . . 0.0 110.35 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -71.77 137.94 22.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.172 0.511 . . . . 0.0 109.664 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.544 ' CG2' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -99.31 146.54 8.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 176.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.55 ' CB ' HD12 ' A' ' 68' ' ' ILE . 5.0 t80 -90.92 107.91 19.51 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.786 -1.196 . . . . 0.0 109.951 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.575 ' CG1' HG22 ' A' ' 71' ' ' ILE . 16.9 t -96.94 117.26 41.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.028 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.627 ' O ' HG23 ' A' ' 71' ' ' ILE . 22.1 mmm-85 -83.4 93.99 7.88 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.696 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -69.98 132.1 45.4 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.334 0.588 . . . . 0.0 110.161 -177.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 11' ' ' SER . 58.0 t30 66.77 -82.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.554 -0.716 . . . . 0.0 109.766 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 16.7 t 179.3 -31.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.719 -1.238 . . . . 0.0 109.811 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 m -107.66 -0.02 22.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.878 . . . . 0.0 110.005 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.51 166.66 15.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.725 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.52 122.92 1.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.696 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -112.38 126.49 28.29 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.096 -1.238 . . . . 0.0 109.469 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.66 128.34 9.35 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.467 2.111 . . . . 0.0 110.667 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.613 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 14.7 p -120.14 145.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.58 -0.7 . . . . 0.0 109.445 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.73 115.06 27.52 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.917 -1.115 . . . . 0.0 109.007 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.544 ' CG1' ' CG2' ' A' ' 5' ' ' VAL . 2.0 m -145.55 167.59 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.526 ' N ' HG23 ' A' ' 19' ' ' VAL . 9.4 m-20 -129.73 -176.2 3.84 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.51 ' OG ' ' HG3' ' A' ' 59' ' ' GLN . 64.9 m -60.28 -5.59 1.17 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.037 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 23' ' ' THR . 1.8 m-20 -87.76 -41.82 13.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 110.378 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.57 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -43.25 116.46 0.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.748 -1.22 . . . . 0.0 109.425 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -60.61 -135.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.157 -0.964 . . . . 0.0 108.548 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.58 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 32.6 mm -135.81 -33.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.667 -1.271 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.599 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -78.36 -35.33 47.53 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 175.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.488 ' N ' HD11 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -54.63 -32.09 58.42 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 175.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.618 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -65.52 -50.83 63.8 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.803 ' HA ' HG13 ' A' ' 32' ' ' VAL . 3.8 mptt -61.56 -19.85 62.62 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.067 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.7 mm-40 -76.14 -54.76 6.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.548 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 84.4 t -64.35 -46.81 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.803 HG13 ' HA ' ' A' ' 29' ' ' LYS . 6.2 p -63.53 -27.68 43.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.604 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -71.94 -29.61 64.46 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.152 -0.968 . . . . 0.0 108.93 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 3.2 mmmm -66.53 -49.78 65.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.782 0.801 . . . . 0.0 109.078 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -78.37 -21.51 49.31 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.32 -178.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.667 ' CG ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -82.2 -12.07 58.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.654 -1.279 . . . . 0.0 110.593 -179.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.8 26.99 67.89 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.574 ' CG1' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -148.66 159.93 37.16 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.574 ' HD2' ' CG1' ' A' ' 38' ' ' VAL . 31.2 Cg_endo -78.06 140.71 18.14 Favored 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 122.853 2.369 . . . . 0.0 111.691 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.557 ' HB3' ' CB ' ' A' ' 29' ' ' LYS . . . -46.4 -27.34 1.04 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.429 0.633 . . . . 0.0 110.011 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.71 -64.14 1.04 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.434 -0.791 . . . . 0.0 109.535 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.538 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 35.3 mt-30 -61.21 -43.45 98.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.051 0.929 . . . . 0.0 108.782 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.594 ' CD1' ' CD1' ' A' ' 71' ' ' ILE . 3.2 tp -66.05 144.52 56.66 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.748 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -153.03 116.44 4.67 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.049 -1.46 . . . . 0.0 111.173 178.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.618 ' CG2' HD13 ' A' ' 28' ' ' LEU . 2.6 t -92.98 124.51 45.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.237 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 50' ' ' LYS . 4.1 mt -129.0 118.51 46.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.591 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -86.18 127.02 34.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.018 -1.051 . . . . 0.0 111.965 -176.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 60.6 10.85 2.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.483 -0.761 . . . . 0.0 110.131 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.04 18.91 60.15 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' O ' HG22 ' A' ' 46' ' ' ILE . 3.0 mmmm -100.35 120.17 39.54 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.819 -1.401 . . . . 0.0 109.201 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.28 104.81 4.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.498 -0.752 . . . . 0.0 110.037 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.534 ' CD1' ' HB3' ' A' ' 61' ' ' CYS . 0.4 OUTLIER -100.17 147.29 33.31 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.284 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.609 ' HB2' ' CE1' ' A' ' 55' ' ' HIS . 29.7 Cg_endo -76.37 132.88 14.04 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.267 1.978 . . . . 0.0 108.881 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.57 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 19.5 m-80 -50.74 -19.54 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.609 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 7.0 p-80 -91.83 20.75 5.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.359 -1.463 . . . . 0.0 111.272 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HG ' ' HG2' ' A' ' 53' ' ' PRO . 14.3 mt -105.79 165.31 11.27 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.828 -1.17 . . . . 0.0 108.526 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -91.76 171.75 8.94 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.096 -1.002 . . . . 0.0 110.808 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.57 HG22 ' CB ' ' A' ' 23' ' ' THR . 3.4 t -59.94 -39.35 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.477 0.656 . . . . 0.0 110.543 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.51 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 3.0 mt-30 -90.49 22.19 3.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.624 -1.298 . . . . 0.0 109.712 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.545 ' ND2' HD11 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -83.21 -62.46 1.59 Allowed 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.341 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.629 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -72.27 -16.85 61.92 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.629 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 16.6 t70 106.56 31.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.473 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.53 ' CD2' ' HB2' ' A' ' 47' ' ' PHE . 1.5 mt -59.84 -67.51 0.38 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HG3' ' HG2' ' A' ' 59' ' ' GLN . 0.2 OUTLIER 61.96 165.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.966 0.889 . . . . 0.0 111.718 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.627 ' CB ' ' CB ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -44.47 124.73 4.3 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 8.5 tt0 75.27 108.23 0.07 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -165.73 120.23 1.22 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -177.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.55 HD12 ' CB ' ' A' ' 6' ' ' PHE . 1.1 mp -86.02 121.26 37.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.714 -1.195 . . . . 0.0 108.114 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.547 ' HB ' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -113.65 164.63 9.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -120.71 109.03 14.71 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.705 -1.247 . . . . 0.0 109.536 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.627 HG23 ' O ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -88.31 141.79 13.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.227 -0.92 . . . . 0.0 109.121 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 71' ' ' ILE . 2.5 t -145.44 137.61 20.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.104 -0.997 . . . . 0.0 109.333 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.538 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 1.2 tt0 -119.25 124.41 46.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.446 -0.784 . . . . 0.0 109.765 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -73.13 134.82 80.28 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 0.0 108.961 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -79.06 138.88 14.75 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.521 2.147 . . . . 0.0 111.243 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 78' ' ' ARG . 4.2 mtt-85 -62.88 166.9 5.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.94 91.83 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.134 -1.426 . . . . 0.0 108.727 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 76' ' ' ARG . 17.0 mtp180 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.581 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' O ' ' N ' ' A' ' 3' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -51.61 97.1 0.02 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.569 ' CG ' ' N ' ' A' ' 4' ' ' ILE . 1.1 ttm -69.15 168.85 13.15 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.358 -1.083 . . . . 0.0 108.988 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.569 ' N ' ' CG ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -73.49 145.35 11.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.091 0.948 . . . . 0.0 112.099 -177.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.11 168.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CB ' HD12 ' A' ' 68' ' ' ILE . 9.1 t80 -104.32 102.94 12.61 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.401 -1.437 . . . . 0.0 110.19 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.603 ' CG1' HG22 ' A' ' 71' ' ' ILE . 38.9 t -91.27 112.65 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.081 -1.012 . . . . 0.0 109.666 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -82.92 95.7 8.05 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 117.969 -1.493 . . . . 0.0 107.08 177.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.726 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -70.01 131.91 45.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.553 -0.717 . . . . 0.0 109.782 -178.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 58.27 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.701 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -145.95 -83.34 0.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.089 -1.007 . . . . 0.0 110.021 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.06 -8.67 47.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.822 . . . . 0.0 109.559 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.545 ' HB3' ' CB ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -76.97 158.14 30.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.341 -0.85 . . . . 0.0 109.585 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.07 94.12 0.12 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.726 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -103.63 138.45 19.54 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.23 -1.159 . . . . 0.0 109.457 -179.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HB2' HG12 ' A' ' 4' ' ' ILE . 33.7 Cg_endo -76.73 128.2 10.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.419 2.079 . . . . 0.0 110.502 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 14.3 p -112.35 153.43 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 0.0 109.398 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -108.56 116.73 32.53 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.621 -1.3 . . . . 0.0 108.533 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.519 HG12 ' CD2' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -149.51 159.26 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.784 -1.197 . . . . 0.0 110.311 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.09 176.82 4.96 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.535 ' HB3' ' CG ' ' A' ' 59' ' ' GLN . 0.8 OUTLIER -64.25 -6.56 7.05 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 109.98 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.45 ' HA ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -96.5 -13.61 22.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.98 -1.075 . . . . 0.0 111.446 -178.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.581 ' CB ' HG23 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -48.43 128.91 15.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.356 -1.465 . . . . 0.0 108.35 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.606 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 19.4 m -73.47 6.17 3.21 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.028 -1.045 . . . . 0.0 112.082 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.606 ' HB ' ' O ' ' A' ' 24' ' ' SER . 1.7 mm 72.04 -35.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 O-C-N 121.927 -0.483 . . . . 0.0 111.866 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.63 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -79.27 -35.37 41.47 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 102.656 -3.091 . . . . 0.0 102.656 176.355 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.445 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -61.22 -33.7 73.91 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.617 HD12 ' CG2' ' A' ' 45' ' ' VAL . 1.6 tm? -64.52 -38.9 92.61 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 5.4 mttt -69.7 -22.93 63.37 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 58.6 mt-10 -73.54 -51.55 16.58 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.759 -0.588 . . . . 0.0 109.545 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.557 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 98.5 t -64.21 -49.18 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.65 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 83.9 t -61.59 -32.06 52.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 29' ' ' LYS . . . -68.67 -29.82 68.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.451 -0.781 . . . . 0.0 108.899 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 12.0 mmmm -64.76 -52.92 54.39 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.897 0.856 . . . . 0.0 109.565 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -22.33 60.67 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.857 -0.527 . . . . 0.0 111.421 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.65 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.71 -18.71 43.42 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.546 -1.346 . . . . 0.0 110.591 -178.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.88 23.45 45.7 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -146.67 163.42 29.37 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.593 -0.945 . . . . 0.0 108.615 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 31.0 Cg_endo -75.0 143.07 28.62 Favored 'Trans proline' 0 C--N 1.291 -2.459 0 C-N-CA 123.328 2.685 . . . . 0.0 111.21 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 29' ' ' LYS . . . -49.7 -20.1 0.75 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.704 -0.622 . . . . 0.0 109.803 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -64.12 -62.74 1.43 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 108.935 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 19.5 mt-30 -59.19 -44.63 92.22 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.426 1.108 . . . . 0.0 108.072 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.616 ' CD2' HG12 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -68.68 144.19 54.52 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.029 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.731 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -156.43 117.3 3.74 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.37 -1.332 . . . . 0.0 111.467 178.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.617 ' CG2' HD12 ' A' ' 28' ' ' LEU . 1.6 t -93.77 122.77 45.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.643 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.9 mt -124.38 118.87 54.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.624 ' CD1' ' C ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -83.8 133.52 34.76 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.58 -0.7 . . . . 0.0 112.356 -176.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.608 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 63.17 9.93 4.25 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.44 0.638 . . . . 0.0 109.802 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 14.82 80.69 Favored Glycine 0 C--N 1.296 -1.642 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -98.2 122.49 41.41 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.67 -1.488 . . . . 0.0 108.956 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -48.48 96.88 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.558 HD23 ' CB ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -116.96 117.99 36.65 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.497 ' O ' HD11 ' A' ' 52' ' ' LEU . 32.1 Cg_endo -72.81 -160.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 123.05 2.5 . . . . 0.0 113.313 -175.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.538 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 3.4 p30 -111.02 -52.34 2.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -0.794 . . . . 0.0 110.996 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.476 ' C ' ' O ' ' A' ' 54' ' ' ASN . 41.7 p-80 -43.07 -25.99 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.798 -1.189 . . . . 0.0 109.026 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 54' ' ' ASN . 29.0 mt -74.43 159.38 32.38 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -89.51 172.02 9.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.757 -1.214 . . . . 0.0 110.285 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.581 HG23 ' CB ' ' A' ' 23' ' ' THR . 2.2 t -62.43 -28.73 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.601 -0.687 . . . . 0.0 110.477 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.535 ' CG ' ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -88.45 17.3 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 109.425 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.458 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -86.63 -60.11 2.08 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.788 0.804 . . . . 0.0 108.922 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 5.3 t -72.66 -9.13 58.25 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 9.1 t0 90.49 33.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 25' ' ' ILE . 1.1 mt -75.86 -58.21 3.42 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.694 0.759 . . . . 0.0 109.678 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' OE2' ' OE1' ' A' ' 59' ' ' GLN . 34.0 mt-10 51.86 -154.61 0.18 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.558 ' CB ' ' HB3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.44 143.08 26.71 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.1 tt0 72.9 106.25 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.423 ' OG ' ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -175.41 131.93 0.29 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.577 ' N ' HD11 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -83.89 114.76 24.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 117.613 -1.635 . . . . 0.0 107.691 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.573 ' HB ' ' CG1' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -108.74 163.31 6.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -125.8 107.16 10.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.967 -1.083 . . . . 0.0 109.777 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.612 HG23 ' O ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -85.11 142.54 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.317 -0.864 . . . . 0.0 109.127 179.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.1 t -144.03 135.9 22.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.032 -1.043 . . . . 0.0 109.628 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.491 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -107.83 124.48 50.14 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 73' ' ' GLN . 9.4 mmm180 -42.52 136.59 2.45 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.556 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -79.52 135.13 11.54 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.703 2.269 . . . . 0.0 110.93 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 78' ' ' ARG . 17.1 mtp180 -61.42 161.64 9.09 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 177.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.486 ' HG2' ' NH1' ' A' ' 77' ' ' ARG . 2.3 ttt-85 -56.47 91.66 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 117.961 -1.496 . . . . 0.0 108.571 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.368 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.337 0.589 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.459 ' HA3' ' OD1' ' A' ' 20' ' ' ASP . . . -125.04 156.01 18.83 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.608 ' CB ' ' CB ' ' A' ' 65' ' ' GLN . 21.7 tpp -124.55 165.35 17.99 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.394 -1.063 . . . . 0.0 110.352 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -72.91 140.92 17.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.555 HG21 ' CG1' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -101.03 142.67 15.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 177.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.536 ' CB ' ' CD1' ' A' ' 68' ' ' ILE . 1.3 t80 -86.11 106.38 17.2 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 120.789 -1.194 . . . . 0.0 109.462 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.559 HG11 ' CG2' ' A' ' 71' ' ' ILE . 2.1 t -93.38 108.19 20.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.177 -0.952 . . . . 0.0 109.289 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.533 ' O ' HG23 ' A' ' 71' ' ' ILE . 1.8 mmm180 -77.21 95.14 4.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.733 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -68.11 139.92 56.2 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.847 -177.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 11' ' ' SER . 0.6 OUTLIER -32.86 150.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.133 0.492 . . . . 0.0 110.19 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 1.8 m 79.47 -141.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.494 -0.753 . . . . 0.0 109.106 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.96 0.87 14.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.852 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -87.27 133.28 33.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 110.179 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.1 151.11 17.4 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.663 ' CZ ' ' CG2' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -138.96 140.64 27.55 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 120.821 -1.4 . . . . 0.0 109.166 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.497 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 35.8 Cg_endo -76.69 145.14 25.57 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.72 2.28 . . . . 0.0 111.616 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 2.7 t -124.84 155.86 33.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.149 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -117.8 113.56 21.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.562 -1.336 . . . . 0.0 108.808 177.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.567 ' CG1' HG11 ' A' ' 17' ' ' VAL . 1.4 m -148.26 163.02 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.836 -1.165 . . . . 0.0 110.43 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.459 ' OD1' ' HA3' ' A' ' 2' ' ' GLY . 55.9 m-20 -114.81 -178.65 3.42 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.457 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 74.7 m -66.38 -1.14 3.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.928 -1.108 . . . . 0.0 110.511 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -98.81 -23.87 15.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.05 -1.031 . . . . 0.0 111.371 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.556 ' CB ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.8 129.04 4.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.735 -1.228 . . . . 0.0 109.092 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.588 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 25.1 m -74.93 6.16 4.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.476 -0.765 . . . . 0.0 111.6 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.61 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 28.3 mm 72.16 -32.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -78.75 -35.38 44.69 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.508 ' N ' HD11 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -58.28 -32.79 68.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 176.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.593 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -63.04 -42.95 99.88 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.787 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 5.6 mptt -70.25 -19.34 63.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 28.6 mm-40 -76.24 -49.9 15.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.572 -0.705 . . . . 0.0 109.502 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.574 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 46.8 t -65.14 -46.53 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.733 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 89.4 t -63.69 -34.14 66.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 29' ' ' LYS . . . -63.34 -29.08 70.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 21.9 mmmt -65.13 -47.45 77.07 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.691 0.758 . . . . 0.0 109.505 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -30.77 64.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.664 -0.647 . . . . 0.0 111.597 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.624 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -81.43 -15.17 55.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.685 -1.26 . . . . 0.0 110.525 -178.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.21 15.64 80.75 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.466 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -126.86 160.9 56.6 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.506 ' HG2' ' HG3' ' A' ' 42' ' ' GLN . 32.8 Cg_endo -76.75 140.48 20.86 Favored 'Trans proline' 0 C--N 1.292 -2.444 0 C-N-CA 123.311 2.674 . . . . 0.0 111.26 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.545 ' HB3' ' CB ' ' A' ' 29' ' ' LYS . . . -48.7 -20.17 0.44 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.774 -0.579 . . . . 0.0 110.372 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -63.0 -62.58 1.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.891 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.506 ' HG3' ' HG2' ' A' ' 39' ' ' PRO . 23.6 mt-30 -58.67 -50.67 73.0 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.616 1.198 . . . . 0.0 108.112 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.61 HD23 ' CG1' ' A' ' 32' ' ' VAL . 2.7 tp -62.95 142.18 58.44 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.627 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.787 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -154.71 117.79 4.44 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.249 -1.38 . . . . 0.0 111.855 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.593 ' CG2' HD13 ' A' ' 28' ' ' LEU . 1.4 t -87.8 120.86 37.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.093 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.461 HG22 ' HA ' ' A' ' 51' ' ' GLU . 10.4 mt -125.11 121.28 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.629 ' CE1' ' CB ' ' A' ' 48' ' ' ALA . 3.7 t80 -92.14 131.98 36.97 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.837 -1.164 . . . . 0.0 113.812 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.629 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 59.41 9.61 1.52 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.869 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.05 -9.95 58.25 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.183 -1.484 . . . . 0.0 110.118 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.471 ' O ' HD23 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -94.73 118.47 31.79 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.678 -1.484 . . . . 0.0 108.239 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.461 ' HA ' HG22 ' A' ' 46' ' ' ILE . 2.0 tt0 -74.46 106.39 6.04 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.282 -0.887 . . . . 0.0 108.766 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.565 ' CD2' ' CB ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -81.93 134.31 50.12 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.166 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HB2' ' CE1' ' A' ' 55' ' ' HIS . 31.4 Cg_endo -76.4 133.86 14.96 Favored 'Trans proline' 0 C--N 1.298 -2.11 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.605 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 3.0 p-10 -48.75 -51.66 27.8 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.35 -0.844 . . . . 0.0 111.771 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 2.4 p-80 -45.24 -35.24 3.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.403 -1.435 . . . . 0.0 109.734 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD12 ' CG ' ' A' ' 53' ' ' PRO . 14.2 mt -65.53 160.86 21.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.068 -1.02 . . . . 0.0 108.37 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -94.62 172.31 8.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.952 -1.092 . . . . 0.0 111.144 -178.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.556 HG23 ' CB ' ' A' ' 23' ' ' THR . 23.1 t -58.4 -35.98 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.389 0.614 . . . . 0.0 110.837 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.419 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -93.05 24.71 3.59 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.964 -1.085 . . . . 0.0 109.769 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.493 ' OD1' HD23 ' A' ' 56' ' ' LEU . 1.6 t30 -83.03 -62.88 1.48 Allowed 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 119.444 -0.903 . . . . 0.0 108.693 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.627 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -72.76 -14.89 61.64 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.627 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 4.1 t70 100.47 34.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.547 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.535 ' CD1' ' CD1' ' A' ' 52' ' ' LEU . 1.3 mt -55.72 -63.99 1.0 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 65' ' ' GLN . 19.8 mt-10 60.31 151.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.636 0.731 . . . . 0.0 111.871 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.608 ' CB ' ' CB ' ' A' ' 3' ' ' MET . 1.1 pp0? -33.89 127.51 0.4 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.984 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 17.2 tt0 74.58 110.18 0.07 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.452 ' OG ' ' CD2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -167.53 122.93 1.05 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 108.607 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.536 ' CD1' ' CB ' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -85.41 121.49 37.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.588 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -117.06 163.39 14.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -118.07 108.4 15.18 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.892 -1.13 . . . . 0.0 108.909 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.561 HD12 HD11 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -82.32 141.05 15.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.341 -0.849 . . . . 0.0 109.257 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 71' ' ' ILE . 58.4 t -140.08 132.62 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.989 -1.069 . . . . 0.0 109.131 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 6.0 tt0 -108.14 117.64 34.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 109.701 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -48.56 113.86 3.2 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.109 -0.994 . . . . 0.0 109.049 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -77.33 131.76 11.94 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.267 1.978 . . . . 0.0 111.61 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 78' ' ' ARG . 1.5 mmt180 -61.57 167.75 3.27 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -55.95 92.14 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 117.905 -1.518 . . . . 0.0 108.687 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.439 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 mtm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.3 0.572 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.6 160.91 28.95 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.612 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 4.3 ttm -124.59 164.27 20.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.406 -1.055 . . . . 0.0 110.661 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -71.77 141.24 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.634 -0.666 . . . . 0.0 109.814 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.554 ' CG2' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -97.51 148.15 5.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.525 ' CB ' HD11 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -93.79 108.41 20.18 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.219 -0.926 . . . . 0.0 109.196 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.576 ' CG1' HG22 ' A' ' 71' ' ' ILE . 41.3 t -90.96 112.06 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.781 -1.2 . . . . 0.0 109.164 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 2.7 mmm180 -91.38 93.84 9.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.843 ' CD1' HG12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -75.22 138.13 41.72 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 11' ' ' SER . 12.0 m-20 -36.69 147.98 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.793 -0.567 . . . . 0.0 109.622 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 1.5 m 78.08 -145.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.302 -0.874 . . . . 0.0 109.334 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -101.7 -0.06 35.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.095 -1.003 . . . . 0.0 110.013 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 1.5 m-85 -72.73 148.05 45.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.79 165.36 36.9 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.522 ' CE2' ' CD2' ' A' ' 9' ' ' PHE . 99.0 m-85 -152.93 125.32 3.92 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 120.809 -1.407 . . . . 0.0 111.001 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -81.87 90.33 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.437 2.091 . . . . 0.0 108.004 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.535 ' CG1' HG21 ' A' ' 5' ' ' VAL . 3.2 p -85.54 144.82 8.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 110.148 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.16 114.78 27.39 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.823 -1.173 . . . . 0.0 108.811 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.554 ' CG1' ' CG2' ' A' ' 5' ' ' VAL . 1.2 m -142.92 162.47 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.935 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' N ' HG21 ' A' ' 19' ' ' VAL . 2.1 m-20 -114.44 -179.08 3.53 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.479 ' OG ' ' HG3' ' A' ' 59' ' ' GLN . 20.0 m -61.72 -5.26 1.83 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.051 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -90.55 -34.29 15.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 110.862 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.59 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.29 116.14 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.91 -1.119 . . . . 0.0 109.444 -179.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 23' ' ' THR . 1.4 m -60.01 -131.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.598 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 36.6 mm -139.69 -32.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 120.417 -1.427 . . . . 0.0 109.772 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -77.84 -34.26 51.95 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 175.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.486 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.37 -31.68 61.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 175.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.612 HD12 ' CG2' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -64.99 -50.08 67.71 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.736 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 3.8 mptt -63.6 -20.17 65.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.446 -0.784 . . . . 0.0 109.06 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 44.5 mt-10 -77.09 -48.73 17.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 109.476 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.54 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . 74.0 t -63.01 -44.67 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.77 ' CG1' ' CE2' ' A' ' 9' ' ' PHE . 97.9 t -64.37 -35.22 73.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' VAL . . . -62.0 -24.44 67.04 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -69.54 -50.03 48.76 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.928 0.871 . . . . 0.0 110.012 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.581 ' NH1' ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -64.85 -34.4 78.28 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.714 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 1.1 mt-30 -108.52 -11.25 15.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.478 -1.389 . . . . 0.0 112.435 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.62 10.01 85.73 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.548 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -90.75 146.29 33.75 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.507 ' HD2' HG13 ' A' ' 38' ' ' VAL . 30.7 Cg_endo -73.83 124.1 8.96 Favored 'Trans proline' 0 C--N 1.293 -2.368 0 C-N-CA 122.212 1.942 . . . . 0.0 110.25 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.543 ' HB2' ' CB ' ' A' ' 29' ' ' LYS . . . -45.46 -23.38 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.228 0.537 . . . . 0.0 109.679 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -61.69 -66.34 0.55 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.622 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.529 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 3.2 mt-30 -62.18 -42.67 99.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.089 -1.007 . . . . 0.0 108.601 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.599 HD13 ' CD1' ' A' ' 71' ' ' ILE . 3.1 tp -63.1 140.64 58.89 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.736 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -153.57 116.41 4.5 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 117.616 -1.633 . . . . 0.0 111.922 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.612 ' CG2' HD12 ' A' ' 28' ' ' LEU . 2.3 t -87.73 123.94 40.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.46 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.446 HG21 ' O ' ' A' ' 50' ' ' LYS . 8.1 mt -128.02 120.26 53.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.602 ' CD1' ' C ' ' A' ' 47' ' ' PHE . 3.3 t80 -87.1 129.58 34.86 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.012 -1.055 . . . . 0.0 112.817 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . . . 59.35 7.33 0.91 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.979 -0.451 . . . . 0.0 111.764 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.47 -0.01 56.84 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.987 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -95.3 117.87 31.06 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.331 -1.688 . . . . 0.0 109.092 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HA ' HG21 ' A' ' 46' ' ' ILE . 29.9 tt0 -67.14 103.0 1.11 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.567 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 1.2 mt -85.18 135.43 39.27 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 121.395 -0.815 . . . . 0.0 109.843 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HD2' ' CD2' ' A' ' 56' ' ' LEU . 28.8 Cg_endo -67.69 133.83 30.83 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.821 1.681 . . . . 0.0 109.51 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.572 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 6.2 m-20 -53.02 -11.74 0.27 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 112.203 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.548 ' NE2' ' HB2' ' A' ' 53' ' ' PRO . 1.2 p-80 -99.38 27.51 5.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.248 -1.532 . . . . 0.0 112.214 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.592 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 1.1 pp -115.65 164.74 13.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.661 -1.275 . . . . 0.0 108.361 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -92.38 171.43 9.05 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 110.287 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.59 HG22 ' CB ' ' A' ' 23' ' ' THR . 5.4 t -61.48 -38.98 81.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.6 -0.687 . . . . 0.0 110.486 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.479 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 1.5 mt-30 -89.2 18.95 4.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.579 -1.326 . . . . 0.0 109.673 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.533 ' CB ' HD11 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -87.54 -62.68 1.44 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.481 -0.762 . . . . 0.0 110.128 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.661 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 26.3 t -71.32 -15.26 62.39 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.661 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 15.7 t0 105.43 30.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.3 mt -69.16 -62.76 1.25 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 65' ' ' GLN . 8.7 tt0 56.87 163.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.88 0.847 . . . . 0.0 111.913 177.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.612 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -37.85 122.84 1.02 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.931 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER 73.97 107.89 0.07 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -155.85 117.02 3.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.525 HD11 ' CB ' ' A' ' 6' ' ' PHE . 1.1 mp -83.35 120.29 34.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.581 ' CG1' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -115.42 166.65 9.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.43 0.633 . . . . 0.0 109.671 -176.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -121.48 106.21 11.2 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.944 -1.097 . . . . 0.0 108.972 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.843 HG12 ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -78.67 144.7 10.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 p -145.11 128.75 11.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 109.609 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.529 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -108.33 118.59 37.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.306 -0.871 . . . . 0.0 109.075 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.493 ' C ' ' O ' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -37.65 98.01 0.15 Allowed Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.504 ' N ' ' O ' ' A' ' 73' ' ' GLN . 32.7 Cg_endo -78.02 137.06 15.25 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.652 2.235 . . . . 0.0 111.18 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 78' ' ' ARG . 11.7 mtm-85 -61.71 169.64 2.35 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -54.17 91.67 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.433 -1.417 . . . . 0.0 108.909 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 76' ' ' ARG . 2.4 mtp180 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.332 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 mtp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.352 0.596 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.28 -179.35 33.09 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.6 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -126.59 166.89 16.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.221 -1.164 . . . . 0.0 111.171 -178.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -76.6 146.95 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.931 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.546 ' CG2' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -105.56 144.75 14.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.515 ' O ' HG21 ' A' ' 69' ' ' VAL . 1.8 t80 -87.47 106.89 18.28 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.728 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.585 ' CG1' HG23 ' A' ' 71' ' ' ILE . 54.1 t -90.51 115.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.957 -1.089 . . . . 0.0 109.133 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 1.6 mmm180 -94.96 96.2 9.13 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.522 -1.271 . . . . 0.0 108.247 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.813 ' CD1' HG12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -79.08 140.14 37.94 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 11' ' ' SER . 89.6 m-20 -39.99 153.46 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.241 -0.912 . . . . 0.0 109.559 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER 72.96 -151.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 109.696 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.67 2.88 56.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.574 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' A' ' 9' ' ' PHE . 16.8 m-30 -72.26 153.66 41.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 110.257 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.4 152.99 10.79 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.604 ' CE2' ' HB3' ' A' ' 35' ' ' ARG . 85.0 m-85 -144.99 126.56 7.8 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.831 -1.394 . . . . 0.0 111.189 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 4' ' ' ILE . 36.1 Cg_endo -80.31 85.78 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.434 2.089 . . . . 0.0 107.336 177.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 4' ' ' ILE . 5.8 p -79.42 150.12 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.708 -0.62 . . . . 0.0 111.133 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.429 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.1 tt0 -95.27 114.04 25.78 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 108.323 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.546 ' CG1' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -136.99 158.7 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.07 -1.019 . . . . 0.0 109.489 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -103.21 176.71 5.06 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 108.913 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 59' ' ' GLN . 9.7 m -67.73 -2.97 7.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.907 . . . . 0.0 109.56 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HA ' HG22 ' A' ' 57' ' ' THR . 58.9 m-20 -111.16 -9.58 14.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.11 -0.993 . . . . 0.0 110.532 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.578 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -58.28 125.12 21.89 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -56.78 -149.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.007 . . . . 0.0 110.955 -176.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.59 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 17.1 mm -126.01 -33.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.631 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -78.15 -32.21 50.16 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 102.628 -3.101 . . . . 0.0 102.628 175.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.503 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.7 OUTLIER -56.66 -32.45 65.39 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 175.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.614 HD12 ' CG2' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -65.68 -51.67 57.55 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.592 177.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.736 ' HG2' ' HA ' ' A' ' 44' ' ' ARG . 3.8 mptt -61.7 -21.55 64.57 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.507 -0.746 . . . . 0.0 109.601 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 13.5 mt-10 -76.82 -50.13 14.18 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.045 -1.034 . . . . 0.0 109.704 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.562 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 71.6 t -61.14 -47.28 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.769 ' CG1' ' CE2' ' A' ' 9' ' ' PHE . 78.9 t -62.35 -38.66 81.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 38' ' ' VAL . . . -58.9 -27.38 65.17 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -66.97 -52.96 36.37 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.785 0.802 . . . . 0.0 110.069 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.604 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -60.13 -33.89 72.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.914 -0.491 . . . . 0.0 112.103 -177.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.707 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -104.74 -6.76 20.06 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.841 -1.162 . . . . 0.0 111.587 -176.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.3 15.86 75.06 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -100.89 150.5 37.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.553 ' N ' HG21 ' A' ' 38' ' ' VAL . 31.2 Cg_endo -71.94 125.43 10.97 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 123.041 2.494 . . . . 0.0 111.991 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.55 ' HB1' ' CB ' ' A' ' 29' ' ' LYS . . . -50.39 -22.37 1.83 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.462 0.649 . . . . 0.0 109.502 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 4.4 m-20 -58.83 -61.65 2.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.453 -0.78 . . . . 0.0 109.786 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.521 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 19.7 mt-30 -68.13 -41.62 81.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.076 -1.015 . . . . 0.0 108.354 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.626 HD13 ' CD1' ' A' ' 71' ' ' ILE . 2.2 tp -62.84 141.74 58.52 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.736 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -154.53 116.21 4.15 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.062 -1.455 . . . . 0.0 111.3 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.614 ' CG2' HD12 ' A' ' 28' ' ' LEU . 2.4 t -88.64 125.14 41.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.802 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.433 ' CG2' ' O ' ' A' ' 50' ' ' LYS . 7.2 mt -129.58 118.12 44.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.607 ' CD1' ' C ' ' A' ' 47' ' ' PHE . 1.1 t80 -85.16 131.04 34.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 112.798 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.592 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . . . 62.26 10.87 4.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.718 -0.614 . . . . 0.0 110.341 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.66 12.46 77.73 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -94.75 122.61 37.54 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.942 -1.328 . . . . 0.0 108.332 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.439 ' C ' HD23 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -62.58 107.49 0.96 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.633 -0.667 . . . . 0.0 110.413 -178.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.553 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.2 mt -97.44 148.93 35.14 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.057 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 56' ' ' LEU . 34.3 Cg_endo -77.75 -164.29 0.26 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 N-CA-C 107.281 -1.853 . . . . 0.0 107.281 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.524 ' CB ' ' HB2' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -113.99 -30.78 6.59 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.653 -1.279 . . . . 0.0 109.711 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -80.66 -1.1 41.01 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.401 -0.812 . . . . 0.0 110.837 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.545 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 9.8 mt -80.7 169.54 17.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.654 -1.279 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -96.39 171.78 8.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.935 . . . . 0.0 110.549 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.578 HG22 ' CB ' ' A' ' 23' ' ' THR . 4.1 t -63.41 -46.6 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.596 -0.69 . . . . 0.0 109.98 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.481 ' CG ' ' HG3' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -84.84 15.78 3.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.074 -1.016 . . . . 0.0 109.956 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -86.04 -59.1 2.39 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.698 0.761 . . . . 0.0 109.39 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.654 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 6.1 m -69.59 -16.74 63.46 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.654 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 37.7 t0 107.12 31.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.708 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.509 ' CD2' ' HB2' ' A' ' 47' ' ' PHE . 1.4 mt -72.9 -77.84 0.1 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HG3' ' CG ' ' A' ' 59' ' ' GLN . 1.9 tt0 71.24 159.47 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.655 0.741 . . . . 0.0 111.612 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.6 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -37.99 122.62 1.03 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.487 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.1 tm0? 75.82 108.95 0.07 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.14 121.69 1.46 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.183 -0.948 . . . . 0.0 108.488 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.52 ' N ' HD11 ' A' ' 68' ' ' ILE . 1.2 mp -85.63 122.06 37.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.57 ' HB ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -114.33 168.81 5.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.313 0.578 . . . . 0.0 109.668 -177.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -125.86 107.14 10.21 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.063 -1.023 . . . . 0.0 108.911 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.813 HG12 ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -80.21 142.56 13.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.194 -0.941 . . . . 0.0 109.616 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.3 t -138.91 120.41 16.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 3.9 tt0 -117.61 114.12 22.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.228 -0.92 . . . . 0.0 110.084 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -51.2 107.15 0.76 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 109.096 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 73' ' ' GLN . 32.3 Cg_endo -78.67 135.84 13.2 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.445 2.096 . . . . 0.0 111.972 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 78' ' ' ARG . 3.6 mtt-85 -64.25 168.39 5.61 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 176.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.535 ' NH1' ' CG ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -55.37 92.32 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.257 -1.527 . . . . 0.0 108.885 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.077 -1.014 . . . . 0.0 109.695 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.561 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 3.1 ttm . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 121.594 0.712 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -73.18 144.26 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.855 . . . . 0.0 111.85 -177.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -103.43 163.84 3.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.086 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.859 ' HB3' HD12 ' A' ' 68' ' ' ILE . 6.7 t80 -101.73 103.3 14.05 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.306 -1.496 . . . . 0.0 109.676 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.761 HG13 ' CG2' ' A' ' 71' ' ' ILE . 6.0 t -91.69 112.77 26.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.117 -0.989 . . . . 0.0 109.132 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.694 ' O ' HG23 ' A' ' 71' ' ' ILE . 24.3 mmm-85 -82.26 97.94 8.53 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.727 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.727 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.3 Cg_endo -78.41 126.26 7.48 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.454 2.103 . . . . 0.0 110.695 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.634 ' CG2' HG11 ' A' ' 31' ' ' VAL . 11.3 p -111.75 148.05 15.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.499 -0.751 . . . . 0.0 109.235 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -102.2 112.06 24.59 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.792 -1.192 . . . . 0.0 108.755 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -139.03 160.17 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.03 -1.044 . . . . 0.0 109.714 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -97.97 176.18 5.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.404 ' C ' ' HB ' ' A' ' 58' ' ' VAL . 70.2 m -69.28 -0.19 5.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.083 -1.01 . . . . 0.0 110.278 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -102.88 -19.48 14.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.145 -0.972 . . . . 0.0 111.063 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.066 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -45.32 124.11 4.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.573 -1.329 . . . . 0.0 109.157 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.644 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -60.84 -142.4 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 24' ' ' SER . 23.7 mm -130.17 -31.11 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 120.909 -1.119 . . . . 0.0 109.457 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.823 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -81.78 -34.92 30.09 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 175.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.501 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.0 -33.15 71.59 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 175.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.986 ' CD1' HG21 ' A' ' 45' ' ' VAL . 1.4 tm? -68.88 -38.04 79.42 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.97 ' HG3' HG23 ' A' ' 45' ' ' VAL . 7.0 mttt -72.3 -20.3 61.52 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.621 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 7.3 mm-40 -76.34 -49.99 15.45 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.449 -0.782 . . . . 0.0 109.623 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.634 HG11 ' CG2' ' A' ' 17' ' ' VAL . 2.4 t -64.08 -48.03 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.005 HG12 HD21 ' A' ' 43' ' ' LEU . 85.5 t -63.23 -32.98 58.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.866 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -67.03 -29.68 69.56 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 14.5 mmmt -64.2 -53.8 43.62 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.774 0.797 . . . . 0.0 109.578 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -69.71 -22.4 63.4 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.837 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.664 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.89 -14.95 55.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.925 -1.109 . . . . 0.0 110.373 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.05 25.08 67.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.682 ' CG2' HD13 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -142.0 164.24 35.17 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.076 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.518 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 34.0 Cg_endo -78.15 141.36 18.46 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 123.662 2.908 . . . . 0.0 111.554 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.621 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -53.05 -22.22 5.66 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.438 -0.789 . . . . 0.0 110.122 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.61 -57.73 11.47 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 108.775 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.546 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 7.3 mt-30 -64.15 -44.75 91.17 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.283 1.04 . . . . 0.0 108.407 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.005 HD21 HG12 ' A' ' 32' ' ' VAL . 1.3 tp -67.49 143.1 56.37 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.538 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.798 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -154.35 116.99 4.37 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.638 -1.225 . . . . 0.0 111.539 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.986 HG21 ' CD1' ' A' ' 28' ' ' LEU . 1.4 t -91.17 127.01 43.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.261 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 50' ' ' LYS . 5.5 mt -130.03 119.94 48.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.683 ' HB2' HD23 ' A' ' 63' ' ' LEU . 1.2 t80 -87.67 127.34 35.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.909 -1.119 . . . . 0.0 112.76 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 59.61 7.76 1.11 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.977 -0.452 . . . . 0.0 111.297 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.45 6.47 57.48 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.878 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.64 119.28 34.84 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.564 -1.551 . . . . 0.0 108.718 179.54 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.72 109.27 2.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.381 -0.824 . . . . 0.0 108.79 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.578 HD22 ' SG ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -93.72 146.61 32.07 Favored Pre-proline 0 C--N 1.303 -1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.456 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.679 ' CG ' HD12 ' A' ' 56' ' ' LEU . 33.3 Cg_endo -76.5 142.39 23.42 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.358 2.039 . . . . 0.0 108.879 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.527 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 4.6 m-20 -65.19 -5.15 6.18 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.32 -0.863 . . . . 0.0 111.057 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -104.26 0.16 29.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.647 -1.283 . . . . 0.0 111.201 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.905 HD22 ' ND2' ' A' ' 60' ' ' ASN . 12.4 mt -89.92 162.97 15.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.645 -1.285 . . . . 0.0 109.055 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -91.53 171.16 9.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.099 -1.001 . . . . 0.0 110.887 -178.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.066 HG23 ' O ' ' A' ' 23' ' ' THR . 8.7 t -62.17 -40.09 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.657 -0.652 . . . . 0.0 110.43 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.538 ' CG ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -87.46 18.47 3.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.617 -1.302 . . . . 0.0 109.957 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.905 ' ND2' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -88.86 -62.3 1.52 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.314 -0.866 . . . . 0.0 110.339 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.652 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 42.1 t -69.46 -14.23 62.77 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.252 -0.905 . . . . 0.0 108.609 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 8.4 t70 103.78 30.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 47' ' ' PHE . 1.2 mt -72.9 -59.81 2.53 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.214 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HG2' ' CG ' ' A' ' 59' ' ' GLN . 3.5 mm-40 59.96 152.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.561 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 1.4 pt20 -48.73 140.14 8.82 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 7.8 tp-100 74.6 106.4 0.07 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.81 130.38 0.66 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.859 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -84.92 116.03 27.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 C-N-CA 117.698 -1.601 . . . . 0.0 107.595 -179.018 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.89 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -112.97 163.67 9.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -178.185 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -124.83 106.8 10.3 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.93 -1.106 . . . . 0.0 108.759 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.761 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -80.82 141.2 15.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 72' ' ' VAL . 14.9 p -136.41 125.95 38.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.961 -1.087 . . . . 0.0 109.877 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.546 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.578 ' HB3' ' CB ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.517 ' N ' ' HG3' ' A' ' 3' ' ' MET . 0.8 OUTLIER -70.41 143.83 14.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 111.755 -178.007 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.24 163.06 5.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.738 ' HB3' HD12 ' A' ' 68' ' ' ILE . 3.9 t80 -98.66 118.01 34.4 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 120.285 -1.509 . . . . 0.0 109.411 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.905 HG13 HG21 ' A' ' 71' ' ' ILE . 8.7 t -105.96 112.21 38.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.752 ' O ' HG23 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -79.37 100.44 7.62 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 117.625 -1.63 . . . . 0.0 108.274 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.698 ' HA ' HG12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.54 0 CA-C-O 121.679 0.752 . . . . 0.0 111.101 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.645 ' HE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.6 Cg_endo -76.18 127.83 10.16 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.124 1.882 . . . . 0.0 111.018 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.618 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 8.4 p -116.08 142.3 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -100.7 116.55 32.87 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.579 -1.325 . . . . 0.0 109.108 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.579 HG23 ' N ' ' A' ' 20' ' ' ASP . 1.8 m -149.43 165.81 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.132 -0.98 . . . . 0.0 109.641 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.579 ' N ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -119.5 -178.79 3.69 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.621 -0.674 . . . . 0.0 109.56 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.575 ' CB ' ' HG3' ' A' ' 59' ' ' GLN . 3.5 m -63.53 -3.31 2.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.491 -0.756 . . . . 0.0 110.692 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 23' ' ' THR . 5.7 m-20 -95.69 -35.8 11.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.071 -1.018 . . . . 0.0 110.867 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.067 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.96 126.38 3.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.852 -1.155 . . . . 0.0 109.41 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.565 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -61.24 -142.61 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.605 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 30.0 mm -129.57 -33.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 120.937 -1.102 . . . . 0.0 108.681 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.919 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -80.35 -34.68 36.35 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 176.154 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -56.79 -31.88 65.11 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 175.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.935 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -64.13 -45.34 88.97 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.071 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.78 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 3.9 mptt -68.95 -18.68 64.12 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.2 mm-40 -77.28 -50.69 12.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 109.493 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.6 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 71.1 t -63.94 -46.23 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.003 ' CG1' HD21 ' A' ' 43' ' ' LEU . 68.3 t -64.82 -35.81 76.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 29' ' ' LYS . . . -60.21 -27.54 67.25 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 4.0 mmmm -65.79 -50.95 62.82 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.656 0.741 . . . . 0.0 109.391 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.62 ' HD3' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -71.33 -22.51 61.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.691 -0.63 . . . . 0.0 111.026 -178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.674 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 1.8 mm-40 -87.98 -17.64 30.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.899 -1.125 . . . . 0.0 110.502 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.63 17.42 79.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.73 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 1.4 m -124.39 164.11 32.26 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 31.2 Cg_endo -77.31 138.53 17.85 Favored 'Trans proline' 0 C--N 1.293 -2.386 0 C-N-CA 123.037 2.491 . . . . 0.0 110.843 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 26' ' ' LEU . . . -51.84 -19.64 1.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.646 -0.659 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.523 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -62.3 -59.08 5.52 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.183 -0.948 . . . . 0.0 109.156 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.577 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 1.7 mt-30 -60.53 -48.96 79.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.132 0.967 . . . . 0.0 108.623 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.003 HD21 ' CG1' ' A' ' 32' ' ' VAL . 3.5 tp -63.8 140.49 58.88 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.659 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.759 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -152.84 117.2 4.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.058 -1.457 . . . . 0.0 111.797 178.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.052 HG13 HG11 ' A' ' 69' ' ' VAL . 17.8 t -88.77 119.24 35.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.055 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.753 HG23 ' HA ' ' A' ' 51' ' ' GLU . 6.0 mt -128.8 117.53 44.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.637 ' HB2' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -93.78 129.86 39.99 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -174.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 60.3 7.42 1.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.906 -0.496 . . . . 0.0 111.737 177.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.75 -3.47 45.71 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.689 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.402 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -96.18 114.55 26.25 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 120.454 -1.615 . . . . 0.0 108.715 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.753 ' HA ' HG23 ' A' ' 46' ' ' ILE . 21.6 tt0 -74.75 105.16 5.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.824 HD12 HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -91.98 152.27 42.72 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.782 ' HD2' HD12 ' A' ' 56' ' ' LEU . 34.2 Cg_endo -75.79 -170.92 0.91 Allowed 'Trans proline' 0 C--N 1.296 -2.198 0 C-N-CA 122.322 2.015 . . . . 0.0 108.595 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 10.5 p30 -91.71 -39.93 11.55 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 110.399 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.486 ' CE1' ' HG ' ' A' ' 56' ' ' LEU . 34.7 p80 -62.11 -39.2 91.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 111.272 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.869 HD22 ' OD1' ' A' ' 60' ' ' ASN . 12.4 mt -50.04 158.04 0.57 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.656 -1.278 . . . . 0.0 110.252 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 172.84 8.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.433 -0.792 . . . . 0.0 110.802 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.067 HG23 ' O ' ' A' ' 23' ' ' THR . 21.1 t -62.07 -44.21 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.587 0.708 . . . . 0.0 110.317 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.575 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 23.0 mt-30 -90.18 25.1 2.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.819 -1.176 . . . . 0.0 109.782 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.869 ' OD1' HD22 ' A' ' 56' ' ' LEU . 1.5 t-20 -84.33 -63.32 1.36 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.05 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.632 ' HB2' HD22 ' A' ' 52' ' ' LEU . 10.2 t -75.3 -48.78 21.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 4.6 m-20 155.02 36.61 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.824 HD11 HD12 ' A' ' 52' ' ' LEU . 1.3 mt -82.37 -57.66 3.27 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.419 -1.313 . . . . 0.0 108.306 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' CG ' ' HG2' ' A' ' 59' ' ' GLN . 0.1 OUTLIER 46.99 -154.34 0.06 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.578 ' CB ' ' HB3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.64 137.51 33.65 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 36.1 tp60 74.39 109.35 0.07 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.414 ' OG ' ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -175.87 129.84 0.24 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -177.447 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.738 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -83.26 122.56 37.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 117.861 -1.536 . . . . 0.0 108.076 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.052 HG11 HG13 ' A' ' 45' ' ' VAL . 2.5 t -109.9 160.64 8.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 121.725 0.774 . . . . 0.0 110.411 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.573 ' N ' ' CG1' ' A' ' 69' ' ' VAL . 7.0 t-80 -122.8 102.55 8.09 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.905 HG21 HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -89.57 143.17 11.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.564 -0.71 . . . . 0.0 109.186 -178.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 42' ' ' GLN . 11.3 p -139.49 137.92 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.011 -1.056 . . . . 0.0 109.172 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.577 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 110.403 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.551 ' CB ' ' HB3' ' A' ' 65' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.546 ' N ' ' HG3' ' A' ' 3' ' ' MET . 0.1 OUTLIER -73.2 143.28 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.093 -1.005 . . . . 0.0 112.367 -177.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.658 HG23 HG13 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -106.23 164.63 4.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.977 ' HB3' HD12 ' A' ' 68' ' ' ILE . 12.8 t80 -102.73 109.31 20.85 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.373 -1.454 . . . . 0.0 109.406 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.757 HG11 ' HE2' ' A' ' 15' ' ' PHE . 13.7 t -94.65 120.58 44.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.519 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.767 ' O ' HG23 ' A' ' 71' ' ' ILE . 14.5 mmm-85 -88.39 98.62 11.71 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.753 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.061 0.458 . . . . 0.0 110.745 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.757 ' HE2' HG11 ' A' ' 7' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.526 ' HB2' HD12 ' A' ' 4' ' ' ILE . 34.2 Cg_endo -75.9 127.82 10.35 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.328 2.019 . . . . 0.0 111.23 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.635 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 5.9 p -117.94 144.84 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.509 -0.744 . . . . 0.0 109.56 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -106.93 117.36 33.84 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.426 -1.422 . . . . 0.0 108.406 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.658 HG13 HG23 ' A' ' 5' ' ' VAL . 1.2 m -139.26 160.71 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.91 -1.119 . . . . 0.0 110.526 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' N ' HG23 ' A' ' 19' ' ' VAL . 2.5 m-20 -107.29 176.08 5.28 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -66.34 -5.09 9.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.932 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.536 ' HA ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -122.95 16.83 10.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.087 -1.008 . . . . 0.0 109.873 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.833 ' HB ' HG21 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -66.46 -9.36 33.53 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.136 -0.977 . . . . 0.0 109.548 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.544 ' OG ' ' HB2' ' A' ' 27' ' ' GLN . 5.7 p 69.31 -142.81 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 108.988 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.91 HD11 HD13 ' A' ' 63' ' ' LEU . 39.0 mm -144.15 -25.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.895 -1.128 . . . . 0.0 111.126 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.957 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -83.42 -37.41 23.27 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 177.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.663 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.75 -33.7 73.32 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 176.103 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.034 ' CD1' HG21 ' A' ' 45' ' ' VAL . 2.4 tm? -69.4 -37.17 77.37 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.963 ' HG3' HG23 ' A' ' 45' ' ' VAL . 4.3 mttt -70.0 -20.46 63.28 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.695 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 1.9 mm-40 -74.33 -52.81 11.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.697 -0.627 . . . . 0.0 109.674 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.623 HG11 HG23 ' A' ' 17' ' ' VAL . 27.5 t -61.79 -48.92 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.011 HG12 HD21 ' A' ' 43' ' ' LEU . 60.5 t -62.06 -33.47 58.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.862 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -68.23 -28.72 67.48 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.4 -0.813 . . . . 0.0 109.265 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 2.7 mmmm -65.61 -52.37 52.53 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.774 0.797 . . . . 0.0 109.39 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.457 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -71.85 -22.77 61.49 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.27 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.661 ' CG ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.27 -15.5 55.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.713 -1.242 . . . . 0.0 110.583 -179.059 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.2 21.22 61.15 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.663 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 1.6 m -142.78 164.82 30.1 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.738 -0.86 . . . . 0.0 108.679 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.502 ' N ' HG23 ' A' ' 38' ' ' VAL . 33.0 Cg_endo -78.67 143.02 18.52 Favored 'Trans proline' 0 C--N 1.293 -2.387 0 C-N-CA 123.437 2.758 . . . . 0.0 111.444 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.695 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -50.6 -21.06 1.38 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.755 -0.591 . . . . 0.0 110.196 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -61.49 -60.75 3.23 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 109.246 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 29.8 mt-30 -63.5 -43.68 96.54 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.011 HD21 HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -66.01 144.61 56.63 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.504 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.734 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -155.15 115.72 3.87 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.362 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.034 HG21 ' CD1' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -93.84 117.29 37.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.715 0.769 . . . . 0.0 110.602 -178.421 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.871 HG23 ' O ' ' A' ' 50' ' ' LYS . 6.4 mt -116.59 122.4 69.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.764 ' HB2' HD23 ' A' ' 63' ' ' LEU . 1.7 t80 -87.92 129.76 35.13 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.765 -1.209 . . . . 0.0 113.426 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 61.0 7.92 1.71 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.803 -0.561 . . . . 0.0 111.234 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.73 6.42 60.76 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.333 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -95.63 130.33 42.54 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.613 -1.522 . . . . 0.0 108.75 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.589 ' C ' HD23 ' A' ' 52' ' ' LEU . 26.4 tt0 -75.85 114.96 15.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.775 . . . . 0.0 109.092 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.909 HD22 ' HB2' ' A' ' 61' ' ' CYS . 0.4 OUTLIER -105.06 144.98 29.84 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.103 -0.998 . . . . 0.0 110.129 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.671 ' CG ' HD12 ' A' ' 56' ' ' LEU . 32.2 Cg_endo -77.34 131.25 11.55 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 122.342 2.028 . . . . 0.0 108.216 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 6.7 m-20 -48.88 -37.58 20.05 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.692 -0.63 . . . . 0.0 111.802 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -70.57 -31.42 68.43 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.781 -1.199 . . . . 0.0 112.053 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.954 HD22 ' CG ' ' A' ' 60' ' ' ASN . 10.9 mt -54.74 164.67 0.73 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.392 -1.443 . . . . 0.0 109.029 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -91.89 171.07 9.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.119 -0.988 . . . . 0.0 110.932 -178.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.833 HG21 ' HB ' ' A' ' 23' ' ' THR . 16.9 t -61.97 -39.65 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.403 0.62 . . . . 0.0 110.153 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -88.17 18.1 4.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.668 -1.27 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.954 ' CG ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -88.14 -62.34 1.51 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 110.681 -178.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.909 ' HB2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.17 -15.56 61.97 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.214 -0.929 . . . . 0.0 108.94 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.668 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 51.4 t0 109.13 32.77 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.91 HD13 HD11 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -79.4 -50.89 10.12 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.43 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.6 -157.51 0.12 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.573 0.701 . . . . 0.0 109.579 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.52 129.56 41.27 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 14.8 tm0? 80.23 111.54 0.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB2' HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -173.34 129.72 0.45 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -177.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.977 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -83.18 117.96 29.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 118.267 -1.373 . . . . 0.0 107.906 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.758 ' HB ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -116.03 167.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -177.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -124.58 109.32 13.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.956 -1.09 . . . . 0.0 108.435 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -84.32 142.95 12.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.263 -0.898 . . . . 0.0 110.109 -179.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -135.95 143.65 35.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 8.8 tt0 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.018 -1.051 . . . . 0.0 110.339 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.627 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 1.2 ttm . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 122.36 1.076 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.644 HG12 ' HB2' ' A' ' 16' ' ' PRO . 1.1 tp -77.46 139.31 18.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.262 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.648 HG23 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -95.72 153.18 3.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.896 ' HB3' HD12 ' A' ' 68' ' ' ILE . 5.4 t80 -91.34 108.58 19.98 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 120.769 -1.207 . . . . 0.0 109.248 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.892 HG13 HG21 ' A' ' 71' ' ' ILE . 2.1 t -94.92 110.77 24.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.26 -0.9 . . . . 0.0 109.692 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.624 ' O ' HG23 ' A' ' 71' ' ' ILE . 24.1 mmm-85 -78.2 93.01 4.52 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.701 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.457 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.658 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.644 ' HB2' HG12 ' A' ' 4' ' ' ILE . 34.6 Cg_endo -78.95 131.81 10.24 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.722 2.282 . . . . 0.0 111.062 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.648 HG13 HG23 ' A' ' 5' ' ' VAL . 3.3 p -113.98 151.18 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 0.0 109.013 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.477 ' HA ' HD12 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -102.28 119.33 38.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.554 -1.341 . . . . 0.0 108.793 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 28' ' ' LEU . 1.3 m -144.04 159.64 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.727 -1.233 . . . . 0.0 110.343 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 m-20 -102.53 177.06 4.97 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.519 ' CB ' ' HG3' ' A' ' 59' ' ' GLN . 37.3 m -71.62 0.73 7.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.01 . . . . 0.0 109.936 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -110.58 -10.05 14.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 111.427 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.721 ' OG1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -45.98 131.93 9.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.618 -1.301 . . . . 0.0 108.432 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.621 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 9.4 m -74.74 6.75 3.62 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.333 -0.854 . . . . 0.0 111.795 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.632 HG21 ' HB2' ' A' ' 52' ' ' LEU . 14.5 mm 72.35 -30.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 O-C-N 121.892 -0.505 . . . . 0.0 112.27 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.834 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -82.08 -35.57 28.5 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 176.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.502 ' N ' HD13 ' A' ' 26' ' ' LEU . 1.8 mm-40 -59.51 -35.59 74.45 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.945 ' CD1' HG21 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -63.46 -40.5 97.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 176.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.92 ' HG3' HG23 ' A' ' 45' ' ' VAL . 7.8 mttt -69.62 -20.97 63.6 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.6 mt-10 -75.08 -50.34 16.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.297 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.55 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.1 t -65.36 -48.15 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.038 HG12 HD21 ' A' ' 43' ' ' LEU . 87.5 t -62.07 -34.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.745 ' HB2' ' O ' ' A' ' 29' ' ' LYS . . . -64.43 -29.67 70.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -64.5 -54.16 36.72 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.819 0.819 . . . . 0.0 109.672 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -64.79 -30.21 71.21 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.595 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.781 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.5 mm100 -81.34 -7.39 59.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.712 -1.243 . . . . 0.0 110.216 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.53 17.24 72.54 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.826 ' CG2' HD13 ' A' ' 43' ' ' LEU . 16.2 m -125.85 158.35 65.86 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 33.5 Cg_endo -78.41 143.38 19.44 Favored 'Trans proline' 0 C--N 1.294 -2.297 0 C-N-CA 123.152 2.568 . . . . 0.0 111.08 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 29' ' ' LYS . . . -49.67 -20.49 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.376 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.18 -63.27 1.35 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.336 -0.853 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.531 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 34.6 mt-30 -61.3 -49.19 78.03 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.455 1.121 . . . . 0.0 108.395 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.038 HD21 HG12 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -64.94 141.04 58.91 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.71 -179.078 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.774 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 3.9 mpp_? -155.64 115.05 3.6 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.476 -1.29 . . . . 0.0 111.269 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.945 HG21 ' CD1' ' A' ' 28' ' ' LEU . 1.3 t -86.63 121.61 37.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.763 0.792 . . . . 0.0 110.704 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.898 ' O ' HG12 ' A' ' 69' ' ' VAL . 19.7 mt -118.35 151.62 20.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.717 ' HB3' HD21 ' A' ' 52' ' ' LEU . 9.0 t80 -107.95 120.03 41.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 119.835 -1.79 . . . . 0.0 113.621 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . . . 55.66 7.74 0.27 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.95 -15.07 11.18 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 118.965 -1.588 . . . . 0.0 111.202 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 114.14 25.82 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.488 -1.595 . . . . 0.0 108.894 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.781 ' HA ' HG23 ' A' ' 46' ' ' ILE . 44.3 tt0 -56.94 117.12 3.65 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.492 -0.755 . . . . 0.0 109.596 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.957 HD13 HD11 ' A' ' 63' ' ' LEU . 6.0 mt -85.72 132.36 44.55 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 109.349 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.741 ' CG ' HD12 ' A' ' 56' ' ' LEU . 30.9 Cg_endo -75.07 132.15 15.0 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 121.844 1.696 . . . . 0.0 108.246 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.525 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 4.5 m-20 -59.82 -30.64 69.07 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 110.411 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.634 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 13.6 p-80 -70.73 -22.87 62.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.61 -1.306 . . . . 0.0 110.06 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.868 HD13 ' OD1' ' A' ' 60' ' ' ASN . 14.3 mt -78.92 168.35 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.936 -1.102 . . . . 0.0 108.151 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -95.79 172.52 7.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.062 -1.024 . . . . 0.0 111.031 -178.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.95 ' O ' HD12 ' A' ' 63' ' ' LEU . 24.0 t -59.86 -41.04 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.762 -0.586 . . . . 0.0 110.547 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.519 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 9.2 mt-30 -86.97 19.58 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.62 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.868 ' OD1' HD13 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -84.44 -60.22 2.14 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.927 ' CB ' HD22 ' A' ' 52' ' ' LEU . 17.5 t -70.6 -16.16 62.82 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.628 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 16.3 t0 103.26 37.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.957 HD11 HD13 ' A' ' 52' ' ' LEU . 1.3 mt -66.6 -83.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.597 -1.241 . . . . 0.0 107.728 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 63' ' ' LEU . 2.9 tt0 76.45 162.26 0.23 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.833 0.825 . . . . 0.0 111.287 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.627 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 1.8 pt20 -40.88 121.97 1.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER 76.0 112.3 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.595 ' HB2' HG13 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -163.18 118.58 1.72 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.896 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.1 mp -81.99 117.49 28.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -116.92 151.16 18.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -107.76 110.16 21.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.376 -1.452 . . . . 0.0 108.231 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.892 HG21 HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -80.49 141.48 15.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.424 -0.798 . . . . 0.0 109.473 -178.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 42' ' ' GLN . 16.5 t -130.15 122.96 55.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.226 -0.921 . . . . 0.0 108.963 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.76 HE21 HG11 ' A' ' 38' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 110.155 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.585 ' HG2' ' HB3' ' A' ' 65' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.828 0.823 . . . . 0.0 109.877 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.481 HG12 ' HB2' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -69.98 141.05 17.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.868 0.842 . . . . 0.0 110.841 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.708 HG23 HG13 ' A' ' 19' ' ' VAL . 1.4 t -110.05 165.47 5.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.746 ' HB3' HD12 ' A' ' 68' ' ' ILE . 4.9 t80 -103.69 106.49 17.01 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.458 -1.401 . . . . 0.0 109.381 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.765 HG21 HG22 ' A' ' 32' ' ' VAL . 14.8 t -91.18 115.72 30.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.708 ' O ' HG23 ' A' ' 71' ' ' ILE . 11.6 mmm180 -82.18 92.31 6.87 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 117.144 -1.822 . . . . 0.0 106.985 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.718 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.718 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HB2' HG12 ' A' ' 4' ' ' ILE . 34.1 Cg_endo -75.88 124.69 8.23 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.358 2.039 . . . . 0.0 110.248 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.617 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 7.5 p -110.73 154.24 12.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.433 -0.792 . . . . 0.0 109.724 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -101.3 114.75 29.01 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.775 -1.203 . . . . 0.0 108.341 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.708 HG13 HG23 ' A' ' 5' ' ' VAL . 2.0 m -148.14 165.9 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 110.152 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.59 ' N ' HG23 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -127.42 -179.46 4.91 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 59' ' ' GLN . 1.0 OUTLIER -61.55 -8.54 4.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.152 -0.967 . . . . 0.0 110.435 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.86 18.47 13.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.894 -1.129 . . . . 0.0 110.693 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.833 ' HB ' HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -72.04 -5.73 37.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.074 -1.016 . . . . 0.0 109.672 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 27' ' ' GLN . 52.5 m 65.78 -144.53 0.2 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.735 HD11 HD11 ' A' ' 63' ' ' LEU . 9.4 mm -144.94 -28.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.739 -1.226 . . . . 0.0 110.607 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.848 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.5 OUTLIER -80.82 -33.84 34.37 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 176.628 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -61.81 -33.78 74.75 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.26 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.994 ' CD1' HG21 ' A' ' 45' ' ' VAL . 2.9 tm? -72.31 -32.58 66.67 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.928 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.0 mttt -71.33 -23.54 61.95 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.658 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.9 mm-40 -76.3 -52.19 10.46 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.631 -0.668 . . . . 0.0 110.114 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.545 HG11 HG23 ' A' ' 17' ' ' VAL . 85.1 t -61.77 -45.84 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.016 HG12 HD21 ' A' ' 43' ' ' LEU . 98.7 t -65.75 -32.63 59.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.782 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -66.78 -27.15 67.35 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.4 OUTLIER -69.25 -53.08 21.68 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.883 0.849 . . . . 0.0 109.287 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -70.97 -22.04 62.24 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.856 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.661 ' HG3' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -82.12 -14.07 56.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.801 -1.187 . . . . 0.0 110.241 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.63 25.78 66.82 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.694 HG22 HD13 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -144.27 161.7 43.5 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HG2' ' HG3' ' A' ' 42' ' ' GLN . 30.8 Cg_endo -76.86 141.9 21.9 Favored 'Trans proline' 0 C--N 1.293 -2.382 0 C-N-CA 123.224 2.616 . . . . 0.0 111.091 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.704 ' HB1' ' HB3' ' A' ' 29' ' ' LYS . . . -50.34 -20.4 1.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.602 -0.686 . . . . 0.0 110.046 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -60.45 -61.81 2.32 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.213 -0.929 . . . . 0.0 109.087 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.53 ' HB3' ' HG2' ' A' ' 73' ' ' GLN . 2.7 mt-30 -63.16 -43.83 97.19 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.016 HD21 HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -66.61 143.69 56.86 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.467 -179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.614 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -157.06 116.31 3.38 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.008 -1.057 . . . . 0.0 109.717 178.179 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.994 HG21 ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -101.84 116.99 46.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.641 0.734 . . . . 0.0 111.735 -177.351 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.9 mt -114.65 128.51 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -86.46 132.98 33.8 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.559 -1.338 . . . . 0.0 113.169 -176.352 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.715 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 62.14 10.06 3.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.326 0.584 . . . . 0.0 110.637 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.6 6.76 89.15 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -96.79 120.54 37.31 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.601 -1.529 . . . . 0.0 108.088 179.311 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -48.36 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.652 0.739 . . . . 0.0 110.333 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.702 HD21 HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -101.74 113.69 65.78 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.622 ' HD2' HD12 ' A' ' 56' ' ' LEU . 28.2 Cg_endo -63.55 163.78 23.03 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 123.46 2.773 . . . . 0.0 116.117 -172.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.683 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -66.56 -43.24 85.58 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.976 -178.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 42.8 p-80 -74.62 -43.9 53.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.987 -1.071 . . . . 0.0 111.721 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.867 HD22 ' CG ' ' A' ' 60' ' ' ASN . 12.5 mt -42.47 162.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.988 -1.07 . . . . 0.0 109.482 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -87.13 168.49 13.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.136 -0.977 . . . . 0.0 109.946 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.965 ' O ' HD12 ' A' ' 63' ' ' LEU . 16.5 t -61.47 -37.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.514 -0.741 . . . . 0.0 110.073 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 0.5 OUTLIER -89.34 20.17 3.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.887 -1.133 . . . . 0.0 109.449 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.867 ' CG ' HD22 ' A' ' 56' ' ' LEU . 2.0 t-20 -82.61 -60.17 2.27 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.608 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -73.26 -17.9 61.28 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 65.3 m-20 105.56 36.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.965 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.5 mt -61.7 -65.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.76 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 28.5 mt-10 62.94 144.33 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.303 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.585 ' HB3' ' HG2' ' A' ' 3' ' ' MET . 2.8 pp0? -37.14 135.83 0.46 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 17.8 tt0 73.59 105.55 0.07 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -167.66 128.57 1.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.746 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.2 mp -86.39 119.31 34.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 118.372 -1.331 . . . . 0.0 108.059 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.849 ' HB ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.94 169.81 3.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -126.15 107.3 10.26 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 109.332 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -86.84 141.65 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.351 -0.843 . . . . 0.0 110.161 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 42' ' ' GLN . 94.9 t -136.59 133.62 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.53 ' HG2' ' HB3' ' A' ' 42' ' ' GLN . 2.5 tt0 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.133 -0.979 . . . . 0.0 109.999 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.627 ' CB ' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 121.924 0.868 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -71.77 137.94 22.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.172 0.511 . . . . 0.0 109.664 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.617 ' CG2' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -99.31 146.54 8.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 176.486 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.848 ' HB3' HD12 ' A' ' 68' ' ' ILE . 5.0 t80 -90.92 107.91 19.51 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.786 -1.196 . . . . 0.0 109.951 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.819 HG11 HG23 ' A' ' 32' ' ' VAL . 16.9 t -96.94 117.26 41.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.028 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.661 ' O ' HG23 ' A' ' 71' ' ' ILE . 22.1 mmm-85 -83.4 93.99 7.88 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.98 ' CE1' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.334 0.588 . . . . 0.0 110.161 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.752 ' HE2' HG23 ' A' ' 32' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HB2' HG12 ' A' ' 4' ' ' ILE . 36.2 Cg_endo -77.66 128.34 9.35 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.467 2.111 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.633 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 14.7 p -120.14 145.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.58 -0.7 . . . . 0.0 109.445 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.73 115.06 27.52 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.917 -1.115 . . . . 0.0 109.007 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.617 HG13 ' CG2' ' A' ' 5' ' ' VAL . 2.0 m -145.55 167.59 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.61 ' N ' HG23 ' A' ' 19' ' ' VAL . 9.4 m-20 -129.73 -176.2 3.84 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.499 ' OG ' ' HG3' ' A' ' 59' ' ' GLN . 64.9 m -60.28 -5.59 1.17 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.037 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 23' ' ' THR . 1.8 m-20 -87.76 -41.82 13.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 110.378 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.079 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -43.25 116.46 0.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.748 -1.22 . . . . 0.0 109.425 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.586 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -60.61 -135.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.157 -0.964 . . . . 0.0 108.548 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 24' ' ' SER . 32.6 mm -135.81 -33.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.667 -1.271 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.963 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -78.36 -35.33 47.53 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 175.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.574 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -54.63 -32.09 58.42 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 175.645 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.966 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -65.52 -50.83 63.8 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.868 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.8 mptt -61.56 -19.85 62.62 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.067 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.639 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 2.7 mm-40 -76.14 -54.76 6.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.566 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 84.4 t -64.35 -46.81 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.077 HG13 ' CD2' ' A' ' 43' ' ' LEU . 6.2 p -63.53 -27.68 43.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.887 ' HA ' HD22 ' A' ' 43' ' ' LEU . . . -71.94 -29.61 64.46 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.152 -0.968 . . . . 0.0 108.93 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 3.2 mmmm -66.53 -49.78 65.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.782 0.801 . . . . 0.0 109.078 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -78.37 -21.51 49.31 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.32 -178.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.734 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -82.2 -12.07 58.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.654 -1.279 . . . . 0.0 110.593 -179.171 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.8 26.99 67.89 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.055 HG12 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -148.66 159.93 37.16 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 1.055 ' HD2' HG12 ' A' ' 38' ' ' VAL . 31.2 Cg_endo -78.06 140.71 18.14 Favored 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 122.853 2.369 . . . . 0.0 111.691 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -46.4 -27.34 1.04 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.429 0.633 . . . . 0.0 110.011 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.71 -64.14 1.04 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.434 -0.791 . . . . 0.0 109.535 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.563 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 35.3 mt-30 -61.21 -43.45 98.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.051 0.929 . . . . 0.0 108.782 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.077 ' CD2' HG13 ' A' ' 32' ' ' VAL . 3.2 tp -66.05 144.52 56.66 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.78 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -153.03 116.44 4.67 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.049 -1.46 . . . . 0.0 111.173 178.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.966 HG21 ' CD1' ' A' ' 28' ' ' LEU . 2.6 t -92.98 124.51 45.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.237 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 50' ' ' LYS . 4.1 mt -129.0 118.51 46.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.591 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -86.18 127.02 34.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.018 -1.051 . . . . 0.0 111.965 -176.516 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.438 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 60.6 10.85 2.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.483 -0.761 . . . . 0.0 110.131 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.04 18.91 60.15 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HB2' HD21 ' A' ' 52' ' ' LEU . 3.0 mmmm -100.35 120.17 39.54 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.819 -1.401 . . . . 0.0 109.201 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' C ' HD23 ' A' ' 52' ' ' LEU . 2.0 tt0 -73.28 104.81 4.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.498 -0.752 . . . . 0.0 110.037 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.871 HD22 ' HB2' ' A' ' 61' ' ' CYS . 0.4 OUTLIER -100.17 147.29 33.31 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.284 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.928 ' HD2' HD12 ' A' ' 56' ' ' LEU . 29.7 Cg_endo -76.37 132.88 14.04 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.267 1.978 . . . . 0.0 108.881 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.579 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 19.5 m-80 -50.74 -19.54 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.639 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 7.0 p-80 -91.83 20.75 5.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.359 -1.463 . . . . 0.0 111.272 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.928 HD12 ' HD2' ' A' ' 53' ' ' PRO . 14.3 mt -105.79 165.31 11.27 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.828 -1.17 . . . . 0.0 108.526 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -91.76 171.75 8.94 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.096 -1.002 . . . . 0.0 110.808 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.079 HG23 ' O ' ' A' ' 23' ' ' THR . 3.4 t -59.94 -39.35 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.477 0.656 . . . . 0.0 110.543 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.499 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 3.0 mt-30 -90.49 22.19 3.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.624 -1.298 . . . . 0.0 109.712 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.928 ' ND2' HD22 ' A' ' 56' ' ' LEU . 2.0 t-20 -83.21 -62.46 1.59 Allowed 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.341 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.871 ' HB2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.27 -16.85 61.92 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.629 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 16.6 t70 106.56 31.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.473 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.5 mt -59.84 -67.51 0.38 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.478 ' HG3' ' HG2' ' A' ' 59' ' ' GLN . 0.2 OUTLIER 61.96 165.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.966 0.889 . . . . 0.0 111.718 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.627 ' CB ' ' CB ' ' A' ' 3' ' ' MET . 1.2 pm0 -44.47 124.73 4.3 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 8.5 tt0 75.27 108.23 0.07 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -165.73 120.23 1.22 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -177.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.848 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.1 mp -86.02 121.26 37.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.714 -1.195 . . . . 0.0 108.114 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.831 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -113.65 164.63 9.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.053 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -120.71 109.03 14.71 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.705 -1.247 . . . . 0.0 109.536 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.698 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -88.31 141.79 13.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.227 -0.92 . . . . 0.0 109.121 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.44 137.61 20.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.104 -0.997 . . . . 0.0 109.333 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.563 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 1.2 tt0 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.446 -0.784 . . . . 0.0 109.765 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.582 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 1.1 ttm . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.569 ' N ' ' CG ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -73.49 145.35 11.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.091 0.948 . . . . 0.0 112.099 -177.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 67' ' ' SER . 1.7 t -109.11 168.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 176.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.787 ' O ' HG23 ' A' ' 69' ' ' VAL . 9.1 t80 -104.32 102.94 12.61 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.401 -1.437 . . . . 0.0 110.19 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.694 HG13 ' CG2' ' A' ' 71' ' ' ILE . 38.9 t -91.27 112.65 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.081 -1.012 . . . . 0.0 109.666 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.615 ' NE ' HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -82.92 95.7 8.05 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 117.969 -1.493 . . . . 0.0 107.08 177.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.726 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.553 -0.717 . . . . 0.0 109.782 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.726 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HB2' HG12 ' A' ' 4' ' ' ILE . 33.7 Cg_endo -76.73 128.2 10.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.419 2.079 . . . . 0.0 110.502 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 4' ' ' ILE . 14.3 p -112.35 153.43 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 0.0 109.398 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -108.56 116.73 32.53 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.621 -1.3 . . . . 0.0 108.533 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.534 HG11 ' CD2' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -149.51 159.26 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.784 -1.197 . . . . 0.0 110.311 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.09 176.82 4.96 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.545 ' HB3' ' CG ' ' A' ' 59' ' ' GLN . 0.8 OUTLIER -64.25 -6.56 7.05 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 109.98 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -96.5 -13.61 22.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.98 -1.075 . . . . 0.0 111.446 -178.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.714 ' OG1' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -48.43 128.91 15.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.356 -1.465 . . . . 0.0 108.35 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.605 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 19.4 m -73.47 6.17 3.21 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.028 -1.045 . . . . 0.0 112.082 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.759 HD11 HD13 ' A' ' 63' ' ' LEU . 1.7 mm 72.04 -35.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 O-C-N 121.927 -0.483 . . . . 0.0 111.866 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -79.27 -35.37 41.47 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 102.656 -3.091 . . . . 0.0 102.656 176.355 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.524 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.22 -33.7 73.91 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.993 ' CD1' HG21 ' A' ' 45' ' ' VAL . 1.6 tm? -64.52 -38.9 92.61 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.981 ' HG3' HG23 ' A' ' 45' ' ' VAL . 5.4 mttt -69.7 -22.93 63.37 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.678 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 58.6 mt-10 -73.54 -51.55 16.58 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.759 -0.588 . . . . 0.0 109.545 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.591 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 98.5 t -64.21 -49.18 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.026 HG12 HD21 ' A' ' 43' ' ' LEU . 83.9 t -61.59 -32.06 52.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.871 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -68.67 -29.82 68.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.451 -0.781 . . . . 0.0 108.899 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 12.0 mmmm -64.76 -52.92 54.39 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.897 0.856 . . . . 0.0 109.565 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -73.02 -22.33 60.67 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.857 -0.527 . . . . 0.0 111.421 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.65 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.71 -18.71 43.42 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.546 -1.346 . . . . 0.0 110.591 -178.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.88 23.45 45.7 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.696 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -146.67 163.42 29.37 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.593 -0.945 . . . . 0.0 108.615 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 31.0 Cg_endo -75.0 143.07 28.62 Favored 'Trans proline' 0 C--N 1.291 -2.459 0 C-N-CA 123.328 2.685 . . . . 0.0 111.21 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -49.7 -20.1 0.75 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.704 -0.622 . . . . 0.0 109.803 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.4 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 25.1 t0 -64.12 -62.74 1.43 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 108.935 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB3' ' HG3' ' A' ' 73' ' ' GLN . 19.5 mt-30 -59.19 -44.63 92.22 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.426 1.108 . . . . 0.0 108.072 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.026 HD21 HG12 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -68.68 144.19 54.52 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.029 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.773 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -156.43 117.3 3.74 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.37 -1.332 . . . . 0.0 111.467 178.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.993 HG21 ' CD1' ' A' ' 28' ' ' LEU . 1.6 t -93.77 122.77 45.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.643 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.9 mt -124.38 118.87 54.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.691 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -83.8 133.52 34.76 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.58 -0.7 . . . . 0.0 112.356 -176.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.691 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 63.17 9.93 4.25 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.44 0.638 . . . . 0.0 109.802 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 14.82 80.69 Favored Glycine 0 C--N 1.296 -1.642 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -98.2 122.49 41.41 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.67 -1.488 . . . . 0.0 108.956 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -48.48 96.88 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.893 HD22 ' CB ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -116.96 117.99 36.65 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.492 ' HD2' HD12 ' A' ' 56' ' ' LEU . 32.1 Cg_endo -72.81 -160.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 123.05 2.5 . . . . 0.0 113.313 -175.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.583 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 3.4 p30 -111.02 -52.34 2.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -0.794 . . . . 0.0 110.996 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.476 ' C ' ' O ' ' A' ' 54' ' ' ASN . 41.7 p-80 -43.07 -25.99 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.798 -1.189 . . . . 0.0 109.026 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.875 HD13 ' ND2' ' A' ' 60' ' ' ASN . 29.0 mt -74.43 159.38 32.38 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.51 172.02 9.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.757 -1.214 . . . . 0.0 110.285 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.714 HG21 ' OG1' ' A' ' 23' ' ' THR . 2.2 t -62.43 -28.73 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.601 -0.687 . . . . 0.0 110.477 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.545 ' CG ' ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -88.45 17.3 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 109.425 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.875 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -86.63 -60.11 2.08 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.788 0.804 . . . . 0.0 108.922 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.893 ' CB ' HD22 ' A' ' 52' ' ' LEU . 5.3 t -72.66 -9.13 58.25 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 9.1 t0 90.49 33.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.759 HD13 HD11 ' A' ' 25' ' ' ILE . 1.1 mt -75.86 -58.21 3.42 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.694 0.759 . . . . 0.0 109.678 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HG2' ' HG2' ' A' ' 59' ' ' GLN . 34.0 mt-10 51.86 -154.61 0.18 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.582 ' HB2' ' CG ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.44 143.08 26.71 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.24 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.1 tt0 72.9 106.25 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -175.41 131.93 0.29 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.784 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -83.89 114.76 24.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 117.613 -1.635 . . . . 0.0 107.691 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.873 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -108.74 163.31 6.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.047 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.403 ' CE1' HG23 ' A' ' 72' ' ' VAL . 2.1 t-80 -125.8 107.16 10.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.967 -1.083 . . . . 0.0 109.777 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.694 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -85.11 142.54 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.317 -0.864 . . . . 0.0 109.127 179.334 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.403 HG23 ' CE1' ' A' ' 70' ' ' HIS . 1.1 t -144.03 135.9 22.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.032 -1.043 . . . . 0.0 109.628 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.524 ' HG3' ' HB3' ' A' ' 42' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.608 ' CB ' ' CB ' ' A' ' 65' ' ' GLN . 21.7 tpp . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.901 0.858 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -72.91 140.92 17.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.59 ' CG2' HG13 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -101.03 142.67 15.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 177.406 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.77 ' HB3' HD12 ' A' ' 68' ' ' ILE . 1.3 t80 -86.11 106.38 17.2 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 120.789 -1.194 . . . . 0.0 109.462 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.92 HG13 HG21 ' A' ' 71' ' ' ILE . 2.1 t -93.38 108.19 20.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.177 -0.952 . . . . 0.0 109.289 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.628 ' O ' HG23 ' A' ' 71' ' ' ILE . 1.8 mmm180 -77.21 95.14 4.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.733 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.507 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.847 -177.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.759 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.497 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 35.8 Cg_endo -76.69 145.14 25.57 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.72 2.28 . . . . 0.0 111.616 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.697 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 2.7 t -124.84 155.86 33.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.149 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -117.8 113.56 21.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.562 -1.336 . . . . 0.0 108.808 177.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.59 HG13 ' CG2' ' A' ' 5' ' ' VAL . 1.4 m -148.26 163.02 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.836 -1.165 . . . . 0.0 110.43 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 19' ' ' VAL . 55.9 m-20 -114.81 -178.65 3.42 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.487 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 74.7 m -66.38 -1.14 3.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.928 -1.108 . . . . 0.0 110.511 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -98.81 -23.87 15.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.05 -1.031 . . . . 0.0 111.371 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.78 ' OG1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.8 129.04 4.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.735 -1.228 . . . . 0.0 109.092 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.594 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 25.1 m -74.93 6.16 4.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.476 -0.765 . . . . 0.0 111.6 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.755 HD11 HD13 ' A' ' 63' ' ' LEU . 28.3 mm 72.16 -32.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.987 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -78.75 -35.38 44.69 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.64 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -58.28 -32.79 68.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 176.344 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.895 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -63.04 -42.95 99.88 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 1.015 ' HG3' HG23 ' A' ' 45' ' ' VAL . 5.6 mptt -70.25 -19.34 63.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.62 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 28.6 mm-40 -76.24 -49.9 15.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.572 -0.705 . . . . 0.0 109.502 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.599 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 46.8 t -65.14 -46.53 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.011 ' CG1' HD21 ' A' ' 43' ' ' LEU . 89.4 t -63.69 -34.14 66.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.827 ' HB1' ' O ' ' A' ' 38' ' ' VAL . . . -63.34 -29.08 70.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 21.9 mmmt -65.13 -47.45 77.07 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.691 0.758 . . . . 0.0 109.505 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -30.77 64.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.664 -0.647 . . . . 0.0 111.597 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.648 ' HG3' ' CE1' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -81.43 -15.17 55.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.685 -1.26 . . . . 0.0 110.525 -178.658 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.21 15.64 80.75 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.827 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -126.86 160.9 56.6 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.52 ' HG2' ' HG3' ' A' ' 42' ' ' GLN . 32.8 Cg_endo -76.75 140.48 20.86 Favored 'Trans proline' 0 C--N 1.292 -2.444 0 C-N-CA 123.311 2.674 . . . . 0.0 111.26 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -48.7 -20.17 0.44 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.774 -0.579 . . . . 0.0 110.372 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -63.0 -62.58 1.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.891 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 73' ' ' GLN . 23.6 mt-30 -58.67 -50.67 73.0 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.616 1.198 . . . . 0.0 108.112 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.011 HD21 ' CG1' ' A' ' 32' ' ' VAL . 2.7 tp -62.95 142.18 58.44 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.627 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.844 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -154.71 117.79 4.44 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.249 -1.38 . . . . 0.0 111.855 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.015 HG23 ' HG3' ' A' ' 29' ' ' LYS . 1.4 t -87.8 120.86 37.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.093 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.714 HG23 ' HA ' ' A' ' 51' ' ' GLU . 10.4 mt -125.11 121.28 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.696 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 3.7 t80 -92.14 131.98 36.97 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.837 -1.164 . . . . 0.0 113.812 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.696 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 59.41 9.61 1.52 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.869 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.05 -9.95 58.25 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.183 -1.484 . . . . 0.0 110.118 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' C ' HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -94.73 118.47 31.79 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.678 -1.484 . . . . 0.0 108.239 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.714 ' HA ' HG23 ' A' ' 46' ' ' ILE . 2.0 tt0 -74.46 106.39 6.04 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.282 -0.887 . . . . 0.0 108.766 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.987 ' CD1' HD11 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -81.93 134.31 50.12 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.166 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.728 ' HD2' HD12 ' A' ' 56' ' ' LEU . 31.4 Cg_endo -76.4 133.86 14.96 Favored 'Trans proline' 0 C--N 1.298 -2.11 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 3.0 p-10 -48.75 -51.66 27.8 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.35 -0.844 . . . . 0.0 111.771 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.65 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 2.4 p-80 -45.24 -35.24 3.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.403 -1.435 . . . . 0.0 109.734 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.834 HD22 ' ND2' ' A' ' 60' ' ' ASN . 14.2 mt -65.53 160.86 21.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.068 -1.02 . . . . 0.0 108.37 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -94.62 172.31 8.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.952 -1.092 . . . . 0.0 111.144 -178.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.852 ' O ' HD12 ' A' ' 63' ' ' LEU . 23.1 t -58.4 -35.98 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.389 0.614 . . . . 0.0 110.837 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.437 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -93.05 24.71 3.59 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.964 -1.085 . . . . 0.0 109.769 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.834 ' ND2' HD22 ' A' ' 56' ' ' LEU . 1.3 t-20 -83.03 -62.88 1.48 Allowed 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 119.444 -0.903 . . . . 0.0 108.693 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.776 ' HB3' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.76 -14.89 61.64 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.296 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.627 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 4.1 t70 100.47 34.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.547 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.987 HD11 ' CD1' ' A' ' 52' ' ' LEU . 1.3 mt -55.72 -63.99 1.0 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 65' ' ' GLN . 19.8 mt-10 60.31 151.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.636 0.731 . . . . 0.0 111.871 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.608 ' CB ' ' CB ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -33.89 127.51 0.4 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.984 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 17.2 tt0 74.58 110.18 0.07 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.443 ' OG ' ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -167.53 122.93 1.05 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 108.607 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.77 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -85.41 121.49 37.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.635 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -117.06 163.39 14.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.71 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -118.07 108.4 15.18 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.892 -1.13 . . . . 0.0 108.909 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.92 HG21 HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -82.32 141.05 15.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.341 -0.849 . . . . 0.0 109.257 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.08 132.62 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.989 -1.069 . . . . 0.0 109.131 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.521 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 6.0 tt0 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 109.701 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.642 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 4.3 ttm . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.828 0.823 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -71.77 141.24 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.634 -0.666 . . . . 0.0 109.814 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.934 HG23 HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -97.51 148.15 5.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.758 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.669 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -93.79 108.41 20.18 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.219 -0.926 . . . . 0.0 109.196 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.613 HG13 HG22 ' A' ' 71' ' ' ILE . 41.3 t -90.96 112.06 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.781 -1.2 . . . . 0.0 109.164 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.547 ' O ' HG23 ' A' ' 71' ' ' ILE . 2.7 mmm180 -91.38 93.84 9.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.965 ' HE1' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.512 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.533 ' HB3' ' NH2' ' A' ' 35' ' ' ARG . 99.0 m-85 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.299 0.095 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -81.87 90.33 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.437 2.091 . . . . 0.0 108.004 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.934 HG13 HG23 ' A' ' 5' ' ' VAL . 3.2 p -85.54 144.82 8.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 110.148 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.16 114.78 27.39 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.823 -1.173 . . . . 0.0 108.811 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.704 HG12 HG22 ' A' ' 17' ' ' VAL . 1.2 m -142.92 162.47 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.935 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 19' ' ' VAL . 2.1 m-20 -114.44 -179.08 3.53 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.476 ' OG ' ' HG3' ' A' ' 59' ' ' GLN . 20.0 m -61.72 -5.26 1.83 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.051 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -90.55 -34.29 15.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 110.862 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.08 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.29 116.14 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.91 -1.119 . . . . 0.0 109.444 -179.347 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.607 ' O ' HD13 ' A' ' 25' ' ' ILE . 1.4 m -60.01 -131.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.61 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 36.6 mm -139.69 -32.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 120.417 -1.427 . . . . 0.0 109.772 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.034 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -77.84 -34.26 51.95 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 175.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.585 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.37 -31.68 61.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 175.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.961 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -64.99 -50.08 67.71 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.471 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.91 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.8 mptt -63.6 -20.17 65.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.446 -0.784 . . . . 0.0 109.06 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 44.5 mt-10 -77.09 -48.73 17.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 109.476 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.597 HG11 ' CG2' ' A' ' 17' ' ' VAL . 74.0 t -63.01 -44.67 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.77 ' CG1' ' CE2' ' A' ' 9' ' ' PHE . 97.9 t -64.37 -35.22 73.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 38' ' ' VAL . . . -62.0 -24.44 67.04 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -69.54 -50.03 48.76 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.928 0.871 . . . . 0.0 110.012 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.581 ' NH1' ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -64.85 -34.4 78.28 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.726 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 1.1 mt-30 -108.52 -11.25 15.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.478 -1.389 . . . . 0.0 112.435 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.62 10.01 85.73 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.761 ' HB ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -90.75 146.29 33.75 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.548 ' HD2' HG12 ' A' ' 38' ' ' VAL . 30.7 Cg_endo -73.83 124.1 8.96 Favored 'Trans proline' 0 C--N 1.293 -2.368 0 C-N-CA 122.212 1.942 . . . . 0.0 110.25 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -45.46 -23.38 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.228 0.537 . . . . 0.0 109.679 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -61.69 -66.34 0.55 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.622 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.532 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 3.2 mt-30 -62.18 -42.67 99.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.089 -1.007 . . . . 0.0 108.601 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.965 HD11 ' HE1' ' A' ' 9' ' ' PHE . 3.1 tp -63.1 140.64 58.89 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.772 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -153.57 116.41 4.5 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 117.616 -1.633 . . . . 0.0 111.922 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.961 HG21 ' CD1' ' A' ' 28' ' ' LEU . 2.3 t -87.73 123.94 40.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.46 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.488 HG23 ' O ' ' A' ' 50' ' ' LYS . 8.1 mt -128.02 120.26 53.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 3.3 t80 -87.1 129.58 34.86 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.012 -1.055 . . . . 0.0 112.817 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 59.35 7.33 0.91 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.979 -0.451 . . . . 0.0 111.764 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.47 -0.01 56.84 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.987 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.518 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -95.3 117.87 31.06 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.331 -1.688 . . . . 0.0 109.092 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.14 103.0 1.11 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.773 ' HB3' HD21 ' A' ' 56' ' ' LEU . 1.2 mt -85.18 135.43 39.27 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 121.395 -0.815 . . . . 0.0 109.843 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.887 ' O ' HD23 ' A' ' 56' ' ' LEU . 28.8 Cg_endo -67.69 133.83 30.83 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.821 1.681 . . . . 0.0 109.51 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.584 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 6.2 m-20 -53.02 -11.74 0.27 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 112.203 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.566 ' NE2' ' HB2' ' A' ' 53' ' ' PRO . 1.2 p-80 -99.38 27.51 5.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.248 -1.532 . . . . 0.0 112.214 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 53' ' ' PRO . 1.1 pp -115.65 164.74 13.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.661 -1.275 . . . . 0.0 108.361 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.841 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -92.38 171.43 9.05 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 110.287 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.08 HG23 ' O ' ' A' ' 23' ' ' THR . 5.4 t -61.48 -38.98 81.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.6 -0.687 . . . . 0.0 110.486 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.476 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 1.5 mt-30 -89.2 18.95 4.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.579 -1.326 . . . . 0.0 109.673 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.3 OUTLIER -87.54 -62.68 1.44 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.481 -0.762 . . . . 0.0 110.128 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.661 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 26.3 t -71.32 -15.26 62.39 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.661 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 15.7 t0 105.43 30.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.49 ' CD2' ' HB2' ' A' ' 47' ' ' PHE . 1.3 mt -69.16 -62.76 1.25 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 65' ' ' GLN . 8.7 tt0 56.87 163.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.88 0.847 . . . . 0.0 111.913 177.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.642 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -37.85 122.84 1.02 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.931 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 2.2 tt0 73.97 107.89 0.07 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -155.85 117.02 3.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.178 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.661 HD12 ' CB ' ' A' ' 6' ' ' PHE . 1.1 mp -83.35 120.29 34.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.924 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -115.42 166.65 9.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.43 0.633 . . . . 0.0 109.671 -176.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -121.48 106.21 11.2 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.944 -1.097 . . . . 0.0 108.972 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.864 HG12 ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -78.67 144.7 10.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 44' ' ' ARG . 2.3 p -145.11 128.75 11.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 109.609 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.532 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 O-C-N 121.306 -0.871 . . . . 0.0 109.075 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.629 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 122.393 1.092 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -76.6 146.95 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.931 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -105.56 144.75 14.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.376 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.727 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 t80 -87.47 106.89 18.28 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.728 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.614 HG13 HG22 ' A' ' 71' ' ' ILE . 54.1 t -90.51 115.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.957 -1.089 . . . . 0.0 109.133 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 1.6 mmm180 -94.96 96.2 9.13 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.522 -1.271 . . . . 0.0 108.247 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 1.061 ' HE1' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 35' ' ' ARG . 85.0 m-85 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 120.303 0.097 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.518 ' HB2' HG12 ' A' ' 4' ' ' ILE . 36.1 Cg_endo -80.31 85.78 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.434 2.089 . . . . 0.0 107.336 177.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.826 ' CG2' HG11 ' A' ' 31' ' ' VAL . 5.8 p -79.42 150.12 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.708 -0.62 . . . . 0.0 111.133 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.27 114.04 25.78 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 108.323 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.658 HG13 ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -136.99 158.7 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.07 -1.019 . . . . 0.0 109.489 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -103.21 176.71 5.06 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 108.913 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 59' ' ' GLN . 9.7 m -67.73 -2.97 7.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.907 . . . . 0.0 109.56 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -111.16 -9.58 14.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.11 -0.993 . . . . 0.0 110.532 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.089 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -58.28 125.12 21.89 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.631 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -56.78 -149.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.007 . . . . 0.0 110.955 -176.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.631 HD13 ' O ' ' A' ' 24' ' ' SER . 17.1 mm -126.01 -33.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.946 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -78.15 -32.21 50.16 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 102.628 -3.101 . . . . 0.0 102.628 175.473 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.484 ' HB2' ' CB ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -56.66 -32.45 65.39 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 175.176 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.983 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -65.68 -51.67 57.55 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.592 177.43 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.927 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.8 mptt -61.7 -21.55 64.57 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.507 -0.746 . . . . 0.0 109.601 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 13.5 mt-10 -76.82 -50.13 14.18 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.045 -1.034 . . . . 0.0 109.704 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.826 HG11 ' CG2' ' A' ' 17' ' ' VAL . 71.6 t -61.14 -47.28 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.784 HG12 HD21 ' A' ' 43' ' ' LEU . 78.9 t -62.35 -38.66 81.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.878 ' HB1' ' O ' ' A' ' 38' ' ' VAL . . . -58.9 -27.38 65.17 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -66.97 -52.96 36.37 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.785 0.802 . . . . 0.0 110.069 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.619 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -60.13 -33.89 72.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.914 -0.491 . . . . 0.0 112.103 -177.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.716 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -104.74 -6.76 20.06 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.841 -1.162 . . . . 0.0 111.587 -176.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.3 15.86 75.06 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.957 HG21 HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -100.89 150.5 37.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.44 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.643 ' HD2' HG23 ' A' ' 38' ' ' VAL . 31.2 Cg_endo -71.94 125.43 10.97 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 123.041 2.494 . . . . 0.0 111.991 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -50.39 -22.37 1.83 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.462 0.649 . . . . 0.0 109.502 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.484 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 4.4 m-20 -58.83 -61.65 2.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.453 -0.78 . . . . 0.0 109.786 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 19.7 mt-30 -68.13 -41.62 81.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.076 -1.015 . . . . 0.0 108.354 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.061 HD11 ' HE1' ' A' ' 9' ' ' PHE . 2.2 tp -62.84 141.74 58.52 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.764 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -154.53 116.21 4.15 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.062 -1.455 . . . . 0.0 111.3 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.983 HG21 ' CD1' ' A' ' 28' ' ' LEU . 2.4 t -88.64 125.14 41.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.802 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 50' ' ' LYS . 7.2 mt -129.58 118.12 44.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.1 t80 -85.16 131.04 34.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 112.798 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.641 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 62.26 10.87 4.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.718 -0.614 . . . . 0.0 110.341 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.66 12.46 77.73 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.778 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -94.75 122.61 37.54 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.942 -1.328 . . . . 0.0 108.332 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.479 ' C ' HD23 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -62.58 107.49 0.96 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.633 -0.667 . . . . 0.0 110.413 -178.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 61' ' ' CYS . 3.2 mt -97.44 148.93 35.14 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.057 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.683 ' CG ' HD12 ' A' ' 56' ' ' LEU . 34.3 Cg_endo -77.75 -164.29 0.26 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 N-CA-C 107.281 -1.853 . . . . 0.0 107.281 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.55 ' CB ' ' HB2' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -113.99 -30.78 6.59 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.653 -1.279 . . . . 0.0 109.711 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -80.66 -1.1 41.01 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.401 -0.812 . . . . 0.0 110.837 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.683 HD12 ' CG ' ' A' ' 53' ' ' PRO . 9.8 mt -80.7 169.54 17.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.654 -1.279 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.39 171.78 8.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.935 . . . . 0.0 110.549 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.089 HG23 ' O ' ' A' ' 23' ' ' THR . 4.1 t -63.41 -46.6 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.596 -0.69 . . . . 0.0 109.98 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.496 ' CG ' ' HG3' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -84.84 15.78 3.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.074 -1.016 . . . . 0.0 109.956 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.632 ' CG ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -86.04 -59.1 2.39 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.698 0.761 . . . . 0.0 109.39 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.654 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 6.1 m -69.59 -16.74 63.46 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.654 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 37.7 t0 107.12 31.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.708 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.4 mt -72.9 -77.84 0.1 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.496 ' HG3' ' CG ' ' A' ' 59' ' ' GLN . 1.9 tt0 71.24 159.47 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.655 0.741 . . . . 0.0 111.612 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.629 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -37.99 122.62 1.03 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.5 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 1.1 tm0? 75.82 108.95 0.07 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.14 121.69 1.46 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.183 -0.948 . . . . 0.0 108.488 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.533 HD12 ' CB ' ' A' ' 6' ' ' PHE . 1.2 mp -85.63 122.06 37.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.974 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -114.33 168.81 5.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.313 0.578 . . . . 0.0 109.668 -177.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -125.86 107.14 10.21 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.063 -1.023 . . . . 0.0 108.911 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.832 HG12 ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -80.21 142.56 13.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.194 -0.941 . . . . 0.0 109.616 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.3 t -138.91 120.41 16.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.608 ' HB2' HD12 ' A' ' 43' ' ' LEU . 21.0 tt0 . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.228 -0.92 . . . . 0.0 110.084 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mtt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.282 0.563 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 121.45 143.22 6.58 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.561 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 3.1 ttm -105.13 164.06 12.1 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.447 -1.031 . . . . 0.0 109.394 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -73.18 144.26 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.855 . . . . 0.0 111.85 -177.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -103.43 163.84 3.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.859 ' HB3' HD12 ' A' ' 68' ' ' ILE . 6.7 t80 -101.73 103.3 14.05 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.306 -1.496 . . . . 0.0 109.676 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.761 HG13 ' CG2' ' A' ' 71' ' ' ILE . 6.0 t -91.69 112.77 26.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.117 -0.989 . . . . 0.0 109.132 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.694 ' O ' HG23 ' A' ' 71' ' ' ILE . 24.3 mmm-85 -82.26 97.94 8.53 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.727 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -68.89 96.64 0.78 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 61.61 -131.31 0.68 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.192 -0.942 . . . . 0.0 108.507 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 12' ' ' SER . 30.6 p -126.27 137.86 53.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.755 -1.216 . . . . 0.0 109.839 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 11' ' ' SER . 2.9 t 77.6 -1.43 2.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.439 -0.788 . . . . 0.0 109.96 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 9' ' ' PHE . 5.9 t80 -130.81 112.73 13.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.137 -0.977 . . . . 0.0 109.306 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -123.41 134.48 9.43 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.727 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -129.75 131.46 23.56 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.154 -1.204 . . . . 0.0 108.955 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.3 Cg_endo -78.41 126.26 7.48 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.454 2.103 . . . . 0.0 110.695 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.634 ' CG2' HG11 ' A' ' 31' ' ' VAL . 11.3 p -111.75 148.05 15.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.499 -0.751 . . . . 0.0 109.235 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -102.2 112.06 24.59 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.792 -1.192 . . . . 0.0 108.755 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -139.03 160.17 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.03 -1.044 . . . . 0.0 109.714 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -97.97 176.18 5.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.404 ' C ' ' HB ' ' A' ' 58' ' ' VAL . 70.2 m -69.28 -0.19 5.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.083 -1.01 . . . . 0.0 110.278 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -102.88 -19.48 14.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.145 -0.972 . . . . 0.0 111.063 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.066 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -45.32 124.11 4.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.573 -1.329 . . . . 0.0 109.157 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.644 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -60.84 -142.4 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 24' ' ' SER . 23.7 mm -130.17 -31.11 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 120.909 -1.119 . . . . 0.0 109.457 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.823 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -81.78 -34.92 30.09 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 175.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.501 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.0 -33.15 71.59 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 175.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.986 ' CD1' HG21 ' A' ' 45' ' ' VAL . 1.4 tm? -68.88 -38.04 79.42 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.97 ' HG3' HG23 ' A' ' 45' ' ' VAL . 7.0 mttt -72.3 -20.3 61.52 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.621 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 7.3 mm-40 -76.34 -49.99 15.45 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.449 -0.782 . . . . 0.0 109.623 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.634 HG11 ' CG2' ' A' ' 17' ' ' VAL . 2.4 t -64.08 -48.03 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.005 HG12 HD21 ' A' ' 43' ' ' LEU . 85.5 t -63.23 -32.98 58.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.866 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -67.03 -29.68 69.56 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 14.5 mmmt -64.2 -53.8 43.62 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.774 0.797 . . . . 0.0 109.578 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -69.71 -22.4 63.4 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.837 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.664 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.89 -14.95 55.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.925 -1.109 . . . . 0.0 110.373 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.05 25.08 67.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.682 ' CG2' HD13 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -142.0 164.24 35.17 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.076 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.518 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 34.0 Cg_endo -78.15 141.36 18.46 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 123.662 2.908 . . . . 0.0 111.554 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.621 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -53.05 -22.22 5.66 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.438 -0.789 . . . . 0.0 110.122 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.61 -57.73 11.47 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 108.775 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.546 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 7.3 mt-30 -64.15 -44.75 91.17 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.283 1.04 . . . . 0.0 108.407 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.005 HD21 HG12 ' A' ' 32' ' ' VAL . 1.3 tp -67.49 143.1 56.37 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.538 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.798 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -154.35 116.99 4.37 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.638 -1.225 . . . . 0.0 111.539 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.986 HG21 ' CD1' ' A' ' 28' ' ' LEU . 1.4 t -91.17 127.01 43.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.261 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 50' ' ' LYS . 5.5 mt -130.03 119.94 48.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.683 ' HB2' HD23 ' A' ' 63' ' ' LEU . 1.2 t80 -87.67 127.34 35.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.909 -1.119 . . . . 0.0 112.76 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 59.61 7.76 1.11 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.977 -0.452 . . . . 0.0 111.297 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.45 6.47 57.48 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.878 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.64 119.28 34.84 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.564 -1.551 . . . . 0.0 108.718 179.54 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.72 109.27 2.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.381 -0.824 . . . . 0.0 108.79 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.578 HD22 ' SG ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -93.72 146.61 32.07 Favored Pre-proline 0 C--N 1.303 -1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.456 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.679 ' CG ' HD12 ' A' ' 56' ' ' LEU . 33.3 Cg_endo -76.5 142.39 23.42 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.358 2.039 . . . . 0.0 108.879 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.527 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 4.6 m-20 -65.19 -5.15 6.18 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.32 -0.863 . . . . 0.0 111.057 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -104.26 0.16 29.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.647 -1.283 . . . . 0.0 111.201 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.905 HD22 ' ND2' ' A' ' 60' ' ' ASN . 12.4 mt -89.92 162.97 15.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.645 -1.285 . . . . 0.0 109.055 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -91.53 171.16 9.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.099 -1.001 . . . . 0.0 110.887 -178.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.066 HG23 ' O ' ' A' ' 23' ' ' THR . 8.7 t -62.17 -40.09 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.657 -0.652 . . . . 0.0 110.43 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.538 ' CG ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -87.46 18.47 3.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.617 -1.302 . . . . 0.0 109.957 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.905 ' ND2' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -88.86 -62.3 1.52 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.314 -0.866 . . . . 0.0 110.339 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.652 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 42.1 t -69.46 -14.23 62.77 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.252 -0.905 . . . . 0.0 108.609 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 8.4 t70 103.78 30.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 47' ' ' PHE . 1.2 mt -72.9 -59.81 2.53 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.214 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HG2' ' CG ' ' A' ' 59' ' ' GLN . 3.5 mm-40 59.96 152.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.561 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 1.4 pt20 -48.73 140.14 8.82 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 7.8 tp-100 74.6 106.4 0.07 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.81 130.38 0.66 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.859 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -84.92 116.03 27.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 C-N-CA 117.698 -1.601 . . . . 0.0 107.595 -179.018 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.89 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -112.97 163.67 9.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -178.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -124.83 106.8 10.3 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.93 -1.106 . . . . 0.0 108.759 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.761 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -80.82 141.2 15.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 72' ' ' VAL . 14.9 p -136.41 125.95 38.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.961 -1.087 . . . . 0.0 109.877 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.546 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -123.57 111.39 16.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' C ' ' O ' ' A' ' 73' ' ' GLN . 1.1 mtm180 -39.57 96.95 0.12 Allowed Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.524 ' N ' ' O ' ' A' ' 73' ' ' GLN . 34.7 Cg_endo -82.44 124.5 4.17 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.829 2.353 . . . . 0.0 112.737 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.563 ' O ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -64.46 168.81 5.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 176.303 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 92.98 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.917 -1.513 . . . . 0.0 108.418 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 76' ' ' ARG . 7.4 tpt85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.195 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' C ' ' A' ' 2' ' ' GLY . 5.0 ttt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.241 0.543 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 19' ' ' VAL . . . -42.66 107.35 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.578 ' HB3' ' CB ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -67.1 166.21 14.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.517 ' N ' ' HG3' ' A' ' 3' ' ' MET . 0.8 OUTLIER -70.41 143.83 14.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 111.755 -178.007 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.24 163.06 5.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.738 ' HB3' HD12 ' A' ' 68' ' ' ILE . 3.9 t80 -98.66 118.01 34.4 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 120.285 -1.509 . . . . 0.0 109.411 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.905 HG13 HG21 ' A' ' 71' ' ' ILE . 8.7 t -105.96 112.21 38.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.752 ' O ' HG23 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -79.37 100.44 7.62 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 117.625 -1.63 . . . . 0.0 108.274 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.698 ' HA ' HG12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -81.69 136.24 35.49 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.679 0.752 . . . . 0.0 111.101 -177.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 62.12 -90.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.613 -0.679 . . . . 0.0 110.559 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 m -128.35 -71.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.6 -1.312 . . . . 0.0 110.383 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.8 -10.77 11.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.011 -1.055 . . . . 0.0 110.284 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -75.72 100.99 4.86 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 108.749 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 7' ' ' VAL . . . -94.86 127.14 9.0 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.052 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.645 ' HE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -102.31 135.81 19.53 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.563 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.6 Cg_endo -76.18 127.83 10.16 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.124 1.882 . . . . 0.0 111.018 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.618 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 8.4 p -116.08 142.3 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -100.7 116.55 32.87 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.579 -1.325 . . . . 0.0 109.108 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.579 HG23 ' N ' ' A' ' 20' ' ' ASP . 1.8 m -149.43 165.81 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.132 -0.98 . . . . 0.0 109.641 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.579 ' N ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -119.5 -178.79 3.69 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.621 -0.674 . . . . 0.0 109.56 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.575 ' CB ' ' HG3' ' A' ' 59' ' ' GLN . 3.5 m -63.53 -3.31 2.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.491 -0.756 . . . . 0.0 110.692 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 23' ' ' THR . 5.7 m-20 -95.69 -35.8 11.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.071 -1.018 . . . . 0.0 110.867 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.067 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.96 126.38 3.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.852 -1.155 . . . . 0.0 109.41 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.565 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -61.24 -142.61 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.605 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 30.0 mm -129.57 -33.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 120.937 -1.102 . . . . 0.0 108.681 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.919 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -80.35 -34.68 36.35 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 176.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -56.79 -31.88 65.11 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 175.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.935 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -64.13 -45.34 88.97 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.071 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.78 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 3.9 mptt -68.95 -18.68 64.12 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.2 mm-40 -77.28 -50.69 12.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 109.493 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.6 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 71.1 t -63.94 -46.23 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.003 ' CG1' HD21 ' A' ' 43' ' ' LEU . 68.3 t -64.82 -35.81 76.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 29' ' ' LYS . . . -60.21 -27.54 67.25 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 4.0 mmmm -65.79 -50.95 62.82 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.656 0.741 . . . . 0.0 109.391 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.62 ' HD3' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -71.33 -22.51 61.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.691 -0.63 . . . . 0.0 111.026 -178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.674 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 1.8 mm-40 -87.98 -17.64 30.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.899 -1.125 . . . . 0.0 110.502 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.63 17.42 79.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.73 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 1.4 m -124.39 164.11 32.26 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 31.2 Cg_endo -77.31 138.53 17.85 Favored 'Trans proline' 0 C--N 1.293 -2.386 0 C-N-CA 123.037 2.491 . . . . 0.0 110.843 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 26' ' ' LEU . . . -51.84 -19.64 1.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.646 -0.659 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.523 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -62.3 -59.08 5.52 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.183 -0.948 . . . . 0.0 109.156 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.577 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 1.7 mt-30 -60.53 -48.96 79.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.132 0.967 . . . . 0.0 108.623 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.003 HD21 ' CG1' ' A' ' 32' ' ' VAL . 3.5 tp -63.8 140.49 58.88 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.659 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.759 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -152.84 117.2 4.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.058 -1.457 . . . . 0.0 111.797 178.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.052 HG13 HG11 ' A' ' 69' ' ' VAL . 17.8 t -88.77 119.24 35.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.055 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.753 HG23 ' HA ' ' A' ' 51' ' ' GLU . 6.0 mt -128.8 117.53 44.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.637 ' HB2' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -93.78 129.86 39.99 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -174.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 60.3 7.42 1.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.906 -0.496 . . . . 0.0 111.737 177.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.75 -3.47 45.71 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.689 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.402 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -96.18 114.55 26.25 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 120.454 -1.615 . . . . 0.0 108.715 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.753 ' HA ' HG23 ' A' ' 46' ' ' ILE . 21.6 tt0 -74.75 105.16 5.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.824 HD12 HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -91.98 152.27 42.72 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.782 ' HD2' HD12 ' A' ' 56' ' ' LEU . 34.2 Cg_endo -75.79 -170.92 0.91 Allowed 'Trans proline' 0 C--N 1.296 -2.198 0 C-N-CA 122.322 2.015 . . . . 0.0 108.595 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 10.5 p30 -91.71 -39.93 11.55 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 110.399 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.486 ' CE1' ' HG ' ' A' ' 56' ' ' LEU . 34.7 p80 -62.11 -39.2 91.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 111.272 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.869 HD22 ' OD1' ' A' ' 60' ' ' ASN . 12.4 mt -50.04 158.04 0.57 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.656 -1.278 . . . . 0.0 110.252 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 172.84 8.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.433 -0.792 . . . . 0.0 110.802 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.067 HG23 ' O ' ' A' ' 23' ' ' THR . 21.1 t -62.07 -44.21 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.587 0.708 . . . . 0.0 110.317 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.575 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 23.0 mt-30 -90.18 25.1 2.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.819 -1.176 . . . . 0.0 109.782 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.869 ' OD1' HD22 ' A' ' 56' ' ' LEU . 1.5 t-20 -84.33 -63.32 1.36 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.05 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.632 ' HB2' HD22 ' A' ' 52' ' ' LEU . 10.2 t -75.3 -48.78 21.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 4.6 m-20 155.02 36.61 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.824 HD11 HD12 ' A' ' 52' ' ' LEU . 1.3 mt -82.37 -57.66 3.27 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.419 -1.313 . . . . 0.0 108.306 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' CG ' ' HG2' ' A' ' 59' ' ' GLN . 0.1 OUTLIER 46.99 -154.34 0.06 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.578 ' CB ' ' HB3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.64 137.51 33.65 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 36.1 tp60 74.39 109.35 0.07 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.414 ' OG ' ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -175.87 129.84 0.24 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -177.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.738 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -83.26 122.56 37.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 117.861 -1.536 . . . . 0.0 108.076 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.052 HG11 HG13 ' A' ' 45' ' ' VAL . 2.5 t -109.9 160.64 8.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 121.725 0.774 . . . . 0.0 110.411 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.573 ' N ' ' CG1' ' A' ' 69' ' ' VAL . 7.0 t-80 -122.8 102.55 8.09 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.905 HG21 HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -89.57 143.17 11.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.564 -0.71 . . . . 0.0 109.186 -178.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 42' ' ' GLN . 11.3 p -139.49 137.92 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.011 -1.056 . . . . 0.0 109.172 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.577 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -120.36 117.06 26.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 110.403 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.459 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 2.1 mmm180 -53.64 108.35 1.09 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 108.469 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 73' ' ' GLN . 33.2 Cg_endo -78.29 128.84 9.17 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.414 2.076 . . . . 0.0 112.245 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -64.32 171.79 2.9 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.462 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -53.7 92.28 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.411 -1.43 . . . . 0.0 108.77 -179.409 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 76' ' ' ARG . 2.2 ttt180 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.39 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.438 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.549 ' CA ' ' HA ' ' A' ' 20' ' ' ASP . . . -119.97 90.25 0.47 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.551 ' CB ' ' HB3' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -68.31 169.08 11.21 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.59 -0.947 . . . . 0.0 108.897 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.546 ' N ' ' HG3' ' A' ' 3' ' ' MET . 0.1 OUTLIER -73.2 143.28 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.093 -1.005 . . . . 0.0 112.367 -177.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.658 HG23 HG13 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -106.23 164.63 4.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.977 ' HB3' HD12 ' A' ' 68' ' ' ILE . 12.8 t80 -102.73 109.31 20.85 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.373 -1.454 . . . . 0.0 109.406 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.757 HG11 ' HE2' ' A' ' 15' ' ' PHE . 13.7 t -94.65 120.58 44.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.519 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.767 ' O ' HG23 ' A' ' 71' ' ' ILE . 14.5 mmm-85 -88.39 98.62 11.71 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.753 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -71.3 96.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.061 0.458 . . . . 0.0 110.745 -177.8 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER 54.46 162.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 0.0 110.892 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 22.7 m 34.89 -109.21 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.949 -0.469 . . . . 0.0 110.273 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -128.8 -6.64 5.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.931 -1.106 . . . . 0.0 109.724 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -48.12 153.74 0.65 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 108.376 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 7' ' ' VAL . . . -146.53 121.73 1.49 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.731 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.757 ' HE2' HG11 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -113.9 142.28 27.57 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.526 ' HB2' HD12 ' A' ' 4' ' ' ILE . 34.2 Cg_endo -75.9 127.82 10.35 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.328 2.019 . . . . 0.0 111.23 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.635 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 5.9 p -117.94 144.84 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.509 -0.744 . . . . 0.0 109.56 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -106.93 117.36 33.84 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.426 -1.422 . . . . 0.0 108.406 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.658 HG13 HG23 ' A' ' 5' ' ' VAL . 1.2 m -139.26 160.71 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.91 -1.119 . . . . 0.0 110.526 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.549 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 2.5 m-20 -107.29 176.08 5.28 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -66.34 -5.09 9.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.932 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.536 ' HA ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -122.95 16.83 10.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.087 -1.008 . . . . 0.0 109.873 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.833 ' HB ' HG21 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -66.46 -9.36 33.53 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.136 -0.977 . . . . 0.0 109.548 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.544 ' OG ' ' HB2' ' A' ' 27' ' ' GLN . 5.7 p 69.31 -142.81 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 108.988 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.91 HD11 HD13 ' A' ' 63' ' ' LEU . 39.0 mm -144.15 -25.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.895 -1.128 . . . . 0.0 111.126 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.957 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -83.42 -37.41 23.27 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 177.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.663 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.75 -33.7 73.32 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 176.103 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.034 ' CD1' HG21 ' A' ' 45' ' ' VAL . 2.4 tm? -69.4 -37.17 77.37 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.963 ' HG3' HG23 ' A' ' 45' ' ' VAL . 4.3 mttt -70.0 -20.46 63.28 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.695 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 1.9 mm-40 -74.33 -52.81 11.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.697 -0.627 . . . . 0.0 109.674 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.623 HG11 HG23 ' A' ' 17' ' ' VAL . 27.5 t -61.79 -48.92 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.011 HG12 HD21 ' A' ' 43' ' ' LEU . 60.5 t -62.06 -33.47 58.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.862 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -68.23 -28.72 67.48 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.4 -0.813 . . . . 0.0 109.265 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 2.7 mmmm -65.61 -52.37 52.53 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.774 0.797 . . . . 0.0 109.39 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.457 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -71.85 -22.77 61.49 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.27 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.661 ' CG ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.27 -15.5 55.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.713 -1.242 . . . . 0.0 110.583 -179.059 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.2 21.22 61.15 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.663 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 1.6 m -142.78 164.82 30.1 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.738 -0.86 . . . . 0.0 108.679 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.502 ' N ' HG23 ' A' ' 38' ' ' VAL . 33.0 Cg_endo -78.67 143.02 18.52 Favored 'Trans proline' 0 C--N 1.293 -2.387 0 C-N-CA 123.437 2.758 . . . . 0.0 111.444 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.695 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -50.6 -21.06 1.38 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.755 -0.591 . . . . 0.0 110.196 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -61.49 -60.75 3.23 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 109.246 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 29.8 mt-30 -63.5 -43.68 96.54 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.011 HD21 HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -66.01 144.61 56.63 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.504 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.734 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -155.15 115.72 3.87 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.362 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.034 HG21 ' CD1' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -93.84 117.29 37.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.715 0.769 . . . . 0.0 110.602 -178.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.871 HG23 ' O ' ' A' ' 50' ' ' LYS . 6.4 mt -116.59 122.4 69.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.764 ' HB2' HD23 ' A' ' 63' ' ' LEU . 1.7 t80 -87.92 129.76 35.13 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.765 -1.209 . . . . 0.0 113.426 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 61.0 7.92 1.71 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.803 -0.561 . . . . 0.0 111.234 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.73 6.42 60.76 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.333 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -95.63 130.33 42.54 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.613 -1.522 . . . . 0.0 108.75 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.589 ' C ' HD23 ' A' ' 52' ' ' LEU . 26.4 tt0 -75.85 114.96 15.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.775 . . . . 0.0 109.092 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.909 HD22 ' HB2' ' A' ' 61' ' ' CYS . 0.4 OUTLIER -105.06 144.98 29.84 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.103 -0.998 . . . . 0.0 110.129 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.671 ' CG ' HD12 ' A' ' 56' ' ' LEU . 32.2 Cg_endo -77.34 131.25 11.55 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 122.342 2.028 . . . . 0.0 108.216 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 6.7 m-20 -48.88 -37.58 20.05 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.692 -0.63 . . . . 0.0 111.802 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -70.57 -31.42 68.43 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.781 -1.199 . . . . 0.0 112.053 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.954 HD22 ' CG ' ' A' ' 60' ' ' ASN . 10.9 mt -54.74 164.67 0.73 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.392 -1.443 . . . . 0.0 109.029 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -91.89 171.07 9.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.119 -0.988 . . . . 0.0 110.932 -178.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.833 HG21 ' HB ' ' A' ' 23' ' ' THR . 16.9 t -61.97 -39.65 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.403 0.62 . . . . 0.0 110.153 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -88.17 18.1 4.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.668 -1.27 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.954 ' CG ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -88.14 -62.34 1.51 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 110.681 -178.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.909 ' HB2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.17 -15.56 61.97 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.214 -0.929 . . . . 0.0 108.94 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.668 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 51.4 t0 109.13 32.77 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.91 HD13 HD11 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -79.4 -50.89 10.12 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.43 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.6 -157.51 0.12 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.573 0.701 . . . . 0.0 109.579 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.52 129.56 41.27 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 14.8 tm0? 80.23 111.54 0.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB2' HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -173.34 129.72 0.45 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -177.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.977 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -83.18 117.96 29.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 118.267 -1.373 . . . . 0.0 107.906 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.758 ' HB ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -116.03 167.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -177.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -124.58 109.32 13.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.956 -1.09 . . . . 0.0 108.435 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -84.32 142.95 12.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.263 -0.898 . . . . 0.0 110.109 -179.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -135.95 143.65 35.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 8.8 tt0 -115.49 129.13 56.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.018 -1.051 . . . . 0.0 110.339 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.508 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 8.3 mmt85 -104.27 162.02 21.15 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.381 -0.825 . . . . 0.0 109.028 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 30.0 Cg_endo -78.31 156.12 29.12 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.761 2.308 . . . . 0.0 110.747 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -60.48 169.2 1.81 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 177.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.9 90.79 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 117.88 -1.528 . . . . 0.0 108.817 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 O-C-N 121.077 -1.014 . . . . 0.0 109.387 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.348 0.594 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.11 151.34 6.0 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.627 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 1.2 ttm -124.83 170.89 10.61 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.36 1.076 . . . . 0.0 111.128 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.644 HG12 ' HB2' ' A' ' 16' ' ' PRO . 1.1 tp -77.46 139.31 18.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.262 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.648 HG23 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -95.72 153.18 3.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.896 ' HB3' HD12 ' A' ' 68' ' ' ILE . 5.4 t80 -91.34 108.58 19.98 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 120.769 -1.207 . . . . 0.0 109.248 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.892 HG13 HG21 ' A' ' 71' ' ' ILE . 2.1 t -94.92 110.77 24.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.26 -0.9 . . . . 0.0 109.692 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.624 ' O ' HG23 ' A' ' 71' ' ' ILE . 24.1 mmm-85 -78.2 93.01 4.52 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.701 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.97 112.46 6.38 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 9' ' ' PHE . 3.6 t-20 61.62 -91.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.359 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.8 t -165.3 -63.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 109.751 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 m -72.63 -1.86 17.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.01 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 15.9 m-30 -105.3 -160.92 0.78 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.005 . . . . 0.0 109.61 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.36 118.07 0.5 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.658 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -137.94 136.05 19.38 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.077 -1.249 . . . . 0.0 109.465 -179.231 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.644 ' HB2' HG12 ' A' ' 4' ' ' ILE . 34.6 Cg_endo -78.95 131.81 10.24 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.722 2.282 . . . . 0.0 111.062 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.648 HG13 HG23 ' A' ' 5' ' ' VAL . 3.3 p -113.98 151.18 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 0.0 109.013 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.477 ' HA ' HD12 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -102.28 119.33 38.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.554 -1.341 . . . . 0.0 108.793 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 28' ' ' LEU . 1.3 m -144.04 159.64 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.727 -1.233 . . . . 0.0 110.343 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 m-20 -102.53 177.06 4.97 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.519 ' CB ' ' HG3' ' A' ' 59' ' ' GLN . 37.3 m -71.62 0.73 7.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.01 . . . . 0.0 109.936 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -110.58 -10.05 14.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 111.427 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.721 ' OG1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -45.98 131.93 9.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.618 -1.301 . . . . 0.0 108.432 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.621 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 9.4 m -74.74 6.75 3.62 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.333 -0.854 . . . . 0.0 111.795 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.632 HG21 ' HB2' ' A' ' 52' ' ' LEU . 14.5 mm 72.35 -30.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 O-C-N 121.892 -0.505 . . . . 0.0 112.27 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.834 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -82.08 -35.57 28.5 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 176.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.502 ' N ' HD13 ' A' ' 26' ' ' LEU . 1.8 mm-40 -59.51 -35.59 74.45 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.945 ' CD1' HG21 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -63.46 -40.5 97.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 176.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.92 ' HG3' HG23 ' A' ' 45' ' ' VAL . 7.8 mttt -69.62 -20.97 63.6 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.6 mt-10 -75.08 -50.34 16.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.297 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.55 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.1 t -65.36 -48.15 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.038 HG12 HD21 ' A' ' 43' ' ' LEU . 87.5 t -62.07 -34.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.745 ' HB2' ' O ' ' A' ' 29' ' ' LYS . . . -64.43 -29.67 70.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -64.5 -54.16 36.72 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.819 0.819 . . . . 0.0 109.672 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -64.79 -30.21 71.21 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.595 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.781 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.5 mm100 -81.34 -7.39 59.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.712 -1.243 . . . . 0.0 110.216 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.53 17.24 72.54 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.826 ' CG2' HD13 ' A' ' 43' ' ' LEU . 16.2 m -125.85 158.35 65.86 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 33.5 Cg_endo -78.41 143.38 19.44 Favored 'Trans proline' 0 C--N 1.294 -2.297 0 C-N-CA 123.152 2.568 . . . . 0.0 111.08 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 29' ' ' LYS . . . -49.67 -20.49 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.376 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.18 -63.27 1.35 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.336 -0.853 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.531 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 34.6 mt-30 -61.3 -49.19 78.03 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.455 1.121 . . . . 0.0 108.395 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.038 HD21 HG12 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -64.94 141.04 58.91 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.71 -179.078 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.774 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 3.9 mpp_? -155.64 115.05 3.6 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.476 -1.29 . . . . 0.0 111.269 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.945 HG21 ' CD1' ' A' ' 28' ' ' LEU . 1.3 t -86.63 121.61 37.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.763 0.792 . . . . 0.0 110.704 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.898 ' O ' HG12 ' A' ' 69' ' ' VAL . 19.7 mt -118.35 151.62 20.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.717 ' HB3' HD21 ' A' ' 52' ' ' LEU . 9.0 t80 -107.95 120.03 41.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 119.835 -1.79 . . . . 0.0 113.621 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . . . 55.66 7.74 0.27 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.95 -15.07 11.18 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 118.965 -1.588 . . . . 0.0 111.202 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 114.14 25.82 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.488 -1.595 . . . . 0.0 108.894 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.781 ' HA ' HG23 ' A' ' 46' ' ' ILE . 44.3 tt0 -56.94 117.12 3.65 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.492 -0.755 . . . . 0.0 109.596 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.957 HD13 HD11 ' A' ' 63' ' ' LEU . 6.0 mt -85.72 132.36 44.55 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 109.349 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.741 ' CG ' HD12 ' A' ' 56' ' ' LEU . 30.9 Cg_endo -75.07 132.15 15.0 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 121.844 1.696 . . . . 0.0 108.246 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.525 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 4.5 m-20 -59.82 -30.64 69.07 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 110.411 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.634 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 13.6 p-80 -70.73 -22.87 62.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.61 -1.306 . . . . 0.0 110.06 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.868 HD13 ' OD1' ' A' ' 60' ' ' ASN . 14.3 mt -78.92 168.35 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.936 -1.102 . . . . 0.0 108.151 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -95.79 172.52 7.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.062 -1.024 . . . . 0.0 111.031 -178.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.95 ' O ' HD12 ' A' ' 63' ' ' LEU . 24.0 t -59.86 -41.04 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.762 -0.586 . . . . 0.0 110.547 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.519 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 9.2 mt-30 -86.97 19.58 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.62 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.868 ' OD1' HD13 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -84.44 -60.22 2.14 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.927 ' CB ' HD22 ' A' ' 52' ' ' LEU . 17.5 t -70.6 -16.16 62.82 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.628 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 16.3 t0 103.26 37.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.957 HD11 HD13 ' A' ' 52' ' ' LEU . 1.3 mt -66.6 -83.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.597 -1.241 . . . . 0.0 107.728 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 63' ' ' LEU . 2.9 tt0 76.45 162.26 0.23 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.833 0.825 . . . . 0.0 111.287 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.627 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 1.8 pt20 -40.88 121.97 1.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER 76.0 112.3 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.595 ' HB2' HG13 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -163.18 118.58 1.72 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.896 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.1 mp -81.99 117.49 28.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -116.92 151.16 18.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -107.76 110.16 21.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.376 -1.452 . . . . 0.0 108.231 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.892 HG21 HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -80.49 141.48 15.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.424 -0.798 . . . . 0.0 109.473 -178.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 42' ' ' GLN . 16.5 t -130.15 122.96 55.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.226 -0.921 . . . . 0.0 108.963 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.76 HE21 HG11 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -120.51 109.24 15.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 110.155 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' O ' ' OE1' ' A' ' 73' ' ' GLN . 2.6 mmp_? -48.24 105.02 0.45 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.197 -0.939 . . . . 0.0 109.191 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 73' ' ' GLN . 30.8 Cg_endo -74.15 138.06 24.71 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.372 2.048 . . . . 0.0 111.75 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 78' ' ' ARG . 18.5 mtt180 -62.08 167.61 3.82 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -56.42 92.33 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 117.808 -1.557 . . . . 0.0 108.414 -179.132 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 109.228 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.366 0.603 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.97 146.35 6.91 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.585 ' HG2' ' HB3' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -122.22 174.14 7.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.367 -1.078 . . . . 0.0 109.877 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.481 HG12 ' HB2' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -69.98 141.05 17.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.868 0.842 . . . . 0.0 110.841 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.708 HG23 HG13 ' A' ' 19' ' ' VAL . 1.4 t -110.05 165.47 5.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.746 ' HB3' HD12 ' A' ' 68' ' ' ILE . 4.9 t80 -103.69 106.49 17.01 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.458 -1.401 . . . . 0.0 109.381 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.765 HG21 HG22 ' A' ' 32' ' ' VAL . 14.8 t -91.18 115.72 30.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.708 ' O ' HG23 ' A' ' 71' ' ' ILE . 11.6 mmm180 -82.18 92.31 6.87 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 117.144 -1.822 . . . . 0.0 106.985 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.718 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -67.53 130.39 42.9 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 1.4 m120 68.18 -84.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.416 -0.802 . . . . 0.0 109.376 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.2 -32.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.974 -1.079 . . . . 0.0 110.543 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 -5.4 17.41 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.967 -1.083 . . . . 0.0 110.346 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -111.75 166.12 11.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.188 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 7' ' ' VAL . . . -152.25 119.22 0.95 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.718 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -110.7 138.71 21.12 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.296 -1.12 . . . . 0.0 108.91 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HB2' HG12 ' A' ' 4' ' ' ILE . 34.1 Cg_endo -75.88 124.69 8.23 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.358 2.039 . . . . 0.0 110.248 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.617 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 7.5 p -110.73 154.24 12.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.433 -0.792 . . . . 0.0 109.724 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -101.3 114.75 29.01 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.775 -1.203 . . . . 0.0 108.341 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.708 HG13 HG23 ' A' ' 5' ' ' VAL . 2.0 m -148.14 165.9 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 110.152 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.59 ' N ' HG23 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -127.42 -179.46 4.91 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 59' ' ' GLN . 1.0 OUTLIER -61.55 -8.54 4.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.152 -0.967 . . . . 0.0 110.435 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.86 18.47 13.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.894 -1.129 . . . . 0.0 110.693 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.833 ' HB ' HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -72.04 -5.73 37.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.074 -1.016 . . . . 0.0 109.672 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 27' ' ' GLN . 52.5 m 65.78 -144.53 0.2 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.735 HD11 HD11 ' A' ' 63' ' ' LEU . 9.4 mm -144.94 -28.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.739 -1.226 . . . . 0.0 110.607 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.848 ' C ' HD13 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -80.82 -33.84 34.37 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 176.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -61.81 -33.78 74.75 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.26 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.994 ' CD1' HG21 ' A' ' 45' ' ' VAL . 2.9 tm? -72.31 -32.58 66.67 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.928 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.0 mttt -71.33 -23.54 61.95 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.658 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.9 mm-40 -76.3 -52.19 10.46 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.631 -0.668 . . . . 0.0 110.114 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.545 HG11 HG23 ' A' ' 17' ' ' VAL . 85.1 t -61.77 -45.84 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.016 HG12 HD21 ' A' ' 43' ' ' LEU . 98.7 t -65.75 -32.63 59.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.782 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -66.78 -27.15 67.35 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.4 OUTLIER -69.25 -53.08 21.68 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.883 0.849 . . . . 0.0 109.287 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -70.97 -22.04 62.24 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.856 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.661 ' HG3' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -82.12 -14.07 56.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.801 -1.187 . . . . 0.0 110.241 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.63 25.78 66.82 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.694 HG22 HD13 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -144.27 161.7 43.5 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HG2' ' HG3' ' A' ' 42' ' ' GLN . 30.8 Cg_endo -76.86 141.9 21.9 Favored 'Trans proline' 0 C--N 1.293 -2.382 0 C-N-CA 123.224 2.616 . . . . 0.0 111.091 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.704 ' HB1' ' HB3' ' A' ' 29' ' ' LYS . . . -50.34 -20.4 1.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.602 -0.686 . . . . 0.0 110.046 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -60.45 -61.81 2.32 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.213 -0.929 . . . . 0.0 109.087 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.53 ' HB3' ' HG2' ' A' ' 73' ' ' GLN . 2.7 mt-30 -63.16 -43.83 97.19 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.016 HD21 HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -66.61 143.69 56.86 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.467 -179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.614 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -157.06 116.31 3.38 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.008 -1.057 . . . . 0.0 109.717 178.179 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.994 HG21 ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -101.84 116.99 46.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.641 0.734 . . . . 0.0 111.735 -177.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.9 mt -114.65 128.51 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -86.46 132.98 33.8 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.559 -1.338 . . . . 0.0 113.169 -176.352 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.715 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 62.14 10.06 3.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.326 0.584 . . . . 0.0 110.637 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.6 6.76 89.15 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -96.79 120.54 37.31 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.601 -1.529 . . . . 0.0 108.088 179.311 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -48.36 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.652 0.739 . . . . 0.0 110.333 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.702 HD21 HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -101.74 113.69 65.78 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.622 ' HD2' HD12 ' A' ' 56' ' ' LEU . 28.2 Cg_endo -63.55 163.78 23.03 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 123.46 2.773 . . . . 0.0 116.117 -172.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.683 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -66.56 -43.24 85.58 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.976 -178.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 42.8 p-80 -74.62 -43.9 53.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.987 -1.071 . . . . 0.0 111.721 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.867 HD22 ' CG ' ' A' ' 60' ' ' ASN . 12.5 mt -42.47 162.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.988 -1.07 . . . . 0.0 109.482 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -87.13 168.49 13.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.136 -0.977 . . . . 0.0 109.946 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.965 ' O ' HD12 ' A' ' 63' ' ' LEU . 16.5 t -61.47 -37.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.514 -0.741 . . . . 0.0 110.073 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 0.5 OUTLIER -89.34 20.17 3.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.887 -1.133 . . . . 0.0 109.449 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.867 ' CG ' HD22 ' A' ' 56' ' ' LEU . 2.0 t-20 -82.61 -60.17 2.27 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.608 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -73.26 -17.9 61.28 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 65.3 m-20 105.56 36.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.965 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.5 mt -61.7 -65.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.76 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 28.5 mt-10 62.94 144.33 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.303 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.585 ' HB3' ' HG2' ' A' ' 3' ' ' MET . 2.8 pp0? -37.14 135.83 0.46 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 17.8 tt0 73.59 105.55 0.07 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -167.66 128.57 1.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.746 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.2 mp -86.39 119.31 34.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 118.372 -1.331 . . . . 0.0 108.059 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.849 ' HB ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.94 169.81 3.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -126.15 107.3 10.26 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 109.332 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -86.84 141.65 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.351 -0.843 . . . . 0.0 110.161 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 42' ' ' GLN . 94.9 t -136.59 133.62 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.53 ' HG2' ' HB3' ' A' ' 42' ' ' GLN . 2.5 tt0 -116.9 127.22 54.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.133 -0.979 . . . . 0.0 109.999 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.09 109.12 1.45 Allowed Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 73' ' ' GLN . 33.1 Cg_endo -78.94 129.08 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.207 1.938 . . . . 0.0 111.42 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 78' ' ' ARG . 13.4 mtt180 -62.33 165.11 6.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.88 92.06 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.237 -1.539 . . . . 0.0 108.735 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.572 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 mtt . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.472 ' HA3' ' OD1' ' A' ' 20' ' ' ASP . . . 90.75 168.23 42.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.627 ' CB ' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -124.37 169.07 12.18 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.442 -1.034 . . . . 0.0 110.35 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -71.77 137.94 22.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.172 0.511 . . . . 0.0 109.664 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.617 ' CG2' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -99.31 146.54 8.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 176.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.848 ' HB3' HD12 ' A' ' 68' ' ' ILE . 5.0 t80 -90.92 107.91 19.51 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.786 -1.196 . . . . 0.0 109.951 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.819 HG11 HG23 ' A' ' 32' ' ' VAL . 16.9 t -96.94 117.26 41.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.028 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.661 ' O ' HG23 ' A' ' 71' ' ' ILE . 22.1 mmm-85 -83.4 93.99 7.88 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.98 ' CE1' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -69.98 132.1 45.4 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.334 0.588 . . . . 0.0 110.161 -177.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' SER . 58.0 t30 66.77 -82.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.554 -0.716 . . . . 0.0 109.766 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 16.7 t 179.3 -31.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.719 -1.238 . . . . 0.0 109.811 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 m -107.66 -0.02 22.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.878 . . . . 0.0 110.005 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.51 166.66 15.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.725 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.52 122.92 1.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.752 ' HE2' HG23 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -112.38 126.49 28.29 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.096 -1.238 . . . . 0.0 109.469 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HB2' HG12 ' A' ' 4' ' ' ILE . 36.2 Cg_endo -77.66 128.34 9.35 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.467 2.111 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.633 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 14.7 p -120.14 145.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.58 -0.7 . . . . 0.0 109.445 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.73 115.06 27.52 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.917 -1.115 . . . . 0.0 109.007 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.617 HG13 ' CG2' ' A' ' 5' ' ' VAL . 2.0 m -145.55 167.59 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.61 ' N ' HG23 ' A' ' 19' ' ' VAL . 9.4 m-20 -129.73 -176.2 3.84 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.499 ' OG ' ' HG3' ' A' ' 59' ' ' GLN . 64.9 m -60.28 -5.59 1.17 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.037 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 23' ' ' THR . 1.8 m-20 -87.76 -41.82 13.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 110.378 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.079 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -43.25 116.46 0.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.748 -1.22 . . . . 0.0 109.425 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.586 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -60.61 -135.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.157 -0.964 . . . . 0.0 108.548 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 24' ' ' SER . 32.6 mm -135.81 -33.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.667 -1.271 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.963 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -78.36 -35.33 47.53 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 175.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.574 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -54.63 -32.09 58.42 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 175.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.966 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -65.52 -50.83 63.8 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.868 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.8 mptt -61.56 -19.85 62.62 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.067 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.639 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 2.7 mm-40 -76.14 -54.76 6.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.566 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 84.4 t -64.35 -46.81 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.077 HG13 ' CD2' ' A' ' 43' ' ' LEU . 6.2 p -63.53 -27.68 43.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.887 ' HA ' HD22 ' A' ' 43' ' ' LEU . . . -71.94 -29.61 64.46 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.152 -0.968 . . . . 0.0 108.93 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 3.2 mmmm -66.53 -49.78 65.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.782 0.801 . . . . 0.0 109.078 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -78.37 -21.51 49.31 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.32 -178.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.734 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -82.2 -12.07 58.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.654 -1.279 . . . . 0.0 110.593 -179.171 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.8 26.99 67.89 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.055 HG12 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -148.66 159.93 37.16 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 1.055 ' HD2' HG12 ' A' ' 38' ' ' VAL . 31.2 Cg_endo -78.06 140.71 18.14 Favored 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 122.853 2.369 . . . . 0.0 111.691 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -46.4 -27.34 1.04 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.429 0.633 . . . . 0.0 110.011 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.71 -64.14 1.04 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.434 -0.791 . . . . 0.0 109.535 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.563 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 35.3 mt-30 -61.21 -43.45 98.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.051 0.929 . . . . 0.0 108.782 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.077 ' CD2' HG13 ' A' ' 32' ' ' VAL . 3.2 tp -66.05 144.52 56.66 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.78 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -153.03 116.44 4.67 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.049 -1.46 . . . . 0.0 111.173 178.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.966 HG21 ' CD1' ' A' ' 28' ' ' LEU . 2.6 t -92.98 124.51 45.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.237 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 50' ' ' LYS . 4.1 mt -129.0 118.51 46.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.591 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -86.18 127.02 34.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.018 -1.051 . . . . 0.0 111.965 -176.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.438 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 60.6 10.85 2.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.483 -0.761 . . . . 0.0 110.131 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.04 18.91 60.15 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HB2' HD21 ' A' ' 52' ' ' LEU . 3.0 mmmm -100.35 120.17 39.54 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.819 -1.401 . . . . 0.0 109.201 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' C ' HD23 ' A' ' 52' ' ' LEU . 2.0 tt0 -73.28 104.81 4.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.498 -0.752 . . . . 0.0 110.037 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.871 HD22 ' HB2' ' A' ' 61' ' ' CYS . 0.4 OUTLIER -100.17 147.29 33.31 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.284 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.928 ' HD2' HD12 ' A' ' 56' ' ' LEU . 29.7 Cg_endo -76.37 132.88 14.04 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.267 1.978 . . . . 0.0 108.881 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.579 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 19.5 m-80 -50.74 -19.54 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.639 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 7.0 p-80 -91.83 20.75 5.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.359 -1.463 . . . . 0.0 111.272 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.928 HD12 ' HD2' ' A' ' 53' ' ' PRO . 14.3 mt -105.79 165.31 11.27 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.828 -1.17 . . . . 0.0 108.526 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -91.76 171.75 8.94 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.096 -1.002 . . . . 0.0 110.808 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.079 HG23 ' O ' ' A' ' 23' ' ' THR . 3.4 t -59.94 -39.35 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.477 0.656 . . . . 0.0 110.543 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.499 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 3.0 mt-30 -90.49 22.19 3.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.624 -1.298 . . . . 0.0 109.712 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.928 ' ND2' HD22 ' A' ' 56' ' ' LEU . 2.0 t-20 -83.21 -62.46 1.59 Allowed 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.341 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.871 ' HB2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.27 -16.85 61.92 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.629 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 16.6 t70 106.56 31.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.473 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.5 mt -59.84 -67.51 0.38 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.478 ' HG3' ' HG2' ' A' ' 59' ' ' GLN . 0.2 OUTLIER 61.96 165.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.966 0.889 . . . . 0.0 111.718 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.627 ' CB ' ' CB ' ' A' ' 3' ' ' MET . 1.2 pm0 -44.47 124.73 4.3 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 8.5 tt0 75.27 108.23 0.07 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -165.73 120.23 1.22 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -177.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.848 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.1 mp -86.02 121.26 37.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.714 -1.195 . . . . 0.0 108.114 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.831 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -113.65 164.63 9.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -120.71 109.03 14.71 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.705 -1.247 . . . . 0.0 109.536 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.698 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -88.31 141.79 13.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.227 -0.92 . . . . 0.0 109.121 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.44 137.61 20.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.104 -0.997 . . . . 0.0 109.333 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.563 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 1.2 tt0 -119.25 124.41 46.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.446 -0.784 . . . . 0.0 109.765 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -73.13 134.82 80.28 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 0.0 108.961 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -79.06 138.88 14.75 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.521 2.147 . . . . 0.0 111.243 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 78' ' ' ARG . 4.2 mtt-85 -62.88 166.9 5.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.94 91.83 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.134 -1.426 . . . . 0.0 108.727 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 76' ' ' ARG . 17.0 mtp180 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.581 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.418 ' O ' ' N ' ' A' ' 3' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -51.61 97.1 0.02 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.582 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 1.1 ttm -69.15 168.85 13.15 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.358 -1.083 . . . . 0.0 108.988 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.569 ' N ' ' CG ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -73.49 145.35 11.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.091 0.948 . . . . 0.0 112.099 -177.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 67' ' ' SER . 1.7 t -109.11 168.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 176.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.787 ' O ' HG23 ' A' ' 69' ' ' VAL . 9.1 t80 -104.32 102.94 12.61 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.401 -1.437 . . . . 0.0 110.19 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.694 HG13 ' CG2' ' A' ' 71' ' ' ILE . 38.9 t -91.27 112.65 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.081 -1.012 . . . . 0.0 109.666 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.615 ' NE ' HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -82.92 95.7 8.05 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 117.969 -1.493 . . . . 0.0 107.08 177.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.726 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -70.01 131.91 45.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.553 -0.717 . . . . 0.0 109.782 -178.386 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 58.27 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.701 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -145.95 -83.34 0.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.089 -1.007 . . . . 0.0 110.021 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.06 -8.67 47.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.822 . . . . 0.0 109.559 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.561 ' HB3' ' CB ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -76.97 158.14 30.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.341 -0.85 . . . . 0.0 109.585 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.07 94.12 0.12 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.726 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -103.63 138.45 19.54 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.23 -1.159 . . . . 0.0 109.457 -179.466 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HB2' HG12 ' A' ' 4' ' ' ILE . 33.7 Cg_endo -76.73 128.2 10.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.419 2.079 . . . . 0.0 110.502 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 4' ' ' ILE . 14.3 p -112.35 153.43 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 0.0 109.398 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -108.56 116.73 32.53 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.621 -1.3 . . . . 0.0 108.533 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.534 HG11 ' CD2' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -149.51 159.26 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.784 -1.197 . . . . 0.0 110.311 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.09 176.82 4.96 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.545 ' HB3' ' CG ' ' A' ' 59' ' ' GLN . 0.8 OUTLIER -64.25 -6.56 7.05 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 109.98 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -96.5 -13.61 22.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.98 -1.075 . . . . 0.0 111.446 -178.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.714 ' OG1' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -48.43 128.91 15.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.356 -1.465 . . . . 0.0 108.35 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.605 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 19.4 m -73.47 6.17 3.21 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.028 -1.045 . . . . 0.0 112.082 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.759 HD11 HD13 ' A' ' 63' ' ' LEU . 1.7 mm 72.04 -35.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 O-C-N 121.927 -0.483 . . . . 0.0 111.866 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -79.27 -35.37 41.47 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 102.656 -3.091 . . . . 0.0 102.656 176.355 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.524 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.22 -33.7 73.91 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.993 ' CD1' HG21 ' A' ' 45' ' ' VAL . 1.6 tm? -64.52 -38.9 92.61 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.981 ' HG3' HG23 ' A' ' 45' ' ' VAL . 5.4 mttt -69.7 -22.93 63.37 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.678 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 58.6 mt-10 -73.54 -51.55 16.58 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.759 -0.588 . . . . 0.0 109.545 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.591 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 98.5 t -64.21 -49.18 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.026 HG12 HD21 ' A' ' 43' ' ' LEU . 83.9 t -61.59 -32.06 52.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.871 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -68.67 -29.82 68.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.451 -0.781 . . . . 0.0 108.899 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 12.0 mmmm -64.76 -52.92 54.39 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.897 0.856 . . . . 0.0 109.565 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -73.02 -22.33 60.67 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.857 -0.527 . . . . 0.0 111.421 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.65 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.71 -18.71 43.42 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.546 -1.346 . . . . 0.0 110.591 -178.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.88 23.45 45.7 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.696 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -146.67 163.42 29.37 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.593 -0.945 . . . . 0.0 108.615 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 31.0 Cg_endo -75.0 143.07 28.62 Favored 'Trans proline' 0 C--N 1.291 -2.459 0 C-N-CA 123.328 2.685 . . . . 0.0 111.21 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -49.7 -20.1 0.75 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.704 -0.622 . . . . 0.0 109.803 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.4 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 25.1 t0 -64.12 -62.74 1.43 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 108.935 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB3' ' HG3' ' A' ' 73' ' ' GLN . 19.5 mt-30 -59.19 -44.63 92.22 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.426 1.108 . . . . 0.0 108.072 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.026 HD21 HG12 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -68.68 144.19 54.52 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.029 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.773 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -156.43 117.3 3.74 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.37 -1.332 . . . . 0.0 111.467 178.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.993 HG21 ' CD1' ' A' ' 28' ' ' LEU . 1.6 t -93.77 122.77 45.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.643 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.9 mt -124.38 118.87 54.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.691 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -83.8 133.52 34.76 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.58 -0.7 . . . . 0.0 112.356 -176.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.691 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 63.17 9.93 4.25 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.44 0.638 . . . . 0.0 109.802 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 14.82 80.69 Favored Glycine 0 C--N 1.296 -1.642 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -98.2 122.49 41.41 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.67 -1.488 . . . . 0.0 108.956 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -48.48 96.88 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.893 HD22 ' CB ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -116.96 117.99 36.65 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.492 ' HD2' HD12 ' A' ' 56' ' ' LEU . 32.1 Cg_endo -72.81 -160.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 123.05 2.5 . . . . 0.0 113.313 -175.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.583 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 3.4 p30 -111.02 -52.34 2.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -0.794 . . . . 0.0 110.996 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.476 ' C ' ' O ' ' A' ' 54' ' ' ASN . 41.7 p-80 -43.07 -25.99 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.798 -1.189 . . . . 0.0 109.026 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.875 HD13 ' ND2' ' A' ' 60' ' ' ASN . 29.0 mt -74.43 159.38 32.38 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.51 172.02 9.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.757 -1.214 . . . . 0.0 110.285 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.714 HG21 ' OG1' ' A' ' 23' ' ' THR . 2.2 t -62.43 -28.73 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.601 -0.687 . . . . 0.0 110.477 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.545 ' CG ' ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -88.45 17.3 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 109.425 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.875 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -86.63 -60.11 2.08 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.788 0.804 . . . . 0.0 108.922 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.893 ' CB ' HD22 ' A' ' 52' ' ' LEU . 5.3 t -72.66 -9.13 58.25 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 9.1 t0 90.49 33.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.759 HD13 HD11 ' A' ' 25' ' ' ILE . 1.1 mt -75.86 -58.21 3.42 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.694 0.759 . . . . 0.0 109.678 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HG2' ' HG2' ' A' ' 59' ' ' GLN . 34.0 mt-10 51.86 -154.61 0.18 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.582 ' HB2' ' CG ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.44 143.08 26.71 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.24 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.1 tt0 72.9 106.25 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -175.41 131.93 0.29 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.784 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -83.89 114.76 24.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 117.613 -1.635 . . . . 0.0 107.691 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.873 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -108.74 163.31 6.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.047 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.403 ' CE1' HG23 ' A' ' 72' ' ' VAL . 2.1 t-80 -125.8 107.16 10.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.967 -1.083 . . . . 0.0 109.777 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.694 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -85.11 142.54 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.317 -0.864 . . . . 0.0 109.127 179.334 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.403 HG23 ' CE1' ' A' ' 70' ' ' HIS . 1.1 t -144.03 135.9 22.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.032 -1.043 . . . . 0.0 109.628 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.524 ' HG3' ' HB3' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -107.83 124.48 50.14 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 73' ' ' GLN . 9.4 mmm180 -42.52 136.59 2.45 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.556 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -79.52 135.13 11.54 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.703 2.269 . . . . 0.0 110.93 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 78' ' ' ARG . 17.1 mtp180 -61.42 161.64 9.09 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 177.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HG2' ' NH1' ' A' ' 77' ' ' ARG . 2.3 ttt-85 -56.47 91.66 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 117.961 -1.496 . . . . 0.0 108.571 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.368 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.337 0.589 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.476 ' HA3' ' OD1' ' A' ' 20' ' ' ASP . . . -125.04 156.01 18.83 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.608 ' CB ' ' CB ' ' A' ' 65' ' ' GLN . 21.7 tpp -124.55 165.35 17.99 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.394 -1.063 . . . . 0.0 110.352 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -72.91 140.92 17.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.59 ' CG2' HG13 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -101.03 142.67 15.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 177.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.77 ' HB3' HD12 ' A' ' 68' ' ' ILE . 1.3 t80 -86.11 106.38 17.2 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 120.789 -1.194 . . . . 0.0 109.462 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.92 HG13 HG21 ' A' ' 71' ' ' ILE . 2.1 t -93.38 108.19 20.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.177 -0.952 . . . . 0.0 109.289 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.628 ' O ' HG23 ' A' ' 71' ' ' ILE . 1.8 mmm180 -77.21 95.14 4.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.733 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -68.11 139.92 56.2 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.847 -177.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 11' ' ' SER . 0.6 OUTLIER -32.86 150.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.133 0.492 . . . . 0.0 110.19 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 1.8 m 79.47 -141.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.494 -0.753 . . . . 0.0 109.106 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.96 0.87 14.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.852 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -87.27 133.28 33.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 110.179 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.1 151.11 17.4 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.759 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -138.96 140.64 27.55 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 120.821 -1.4 . . . . 0.0 109.166 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.497 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 35.8 Cg_endo -76.69 145.14 25.57 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.72 2.28 . . . . 0.0 111.616 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.697 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 2.7 t -124.84 155.86 33.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.149 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -117.8 113.56 21.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.562 -1.336 . . . . 0.0 108.808 177.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.59 HG13 ' CG2' ' A' ' 5' ' ' VAL . 1.4 m -148.26 163.02 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.836 -1.165 . . . . 0.0 110.43 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 19' ' ' VAL . 55.9 m-20 -114.81 -178.65 3.42 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.487 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 74.7 m -66.38 -1.14 3.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.928 -1.108 . . . . 0.0 110.511 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -98.81 -23.87 15.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.05 -1.031 . . . . 0.0 111.371 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.78 ' OG1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.8 129.04 4.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.735 -1.228 . . . . 0.0 109.092 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.594 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 25.1 m -74.93 6.16 4.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.476 -0.765 . . . . 0.0 111.6 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.755 HD11 HD13 ' A' ' 63' ' ' LEU . 28.3 mm 72.16 -32.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.987 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -78.75 -35.38 44.69 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.64 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -58.28 -32.79 68.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 176.344 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.895 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -63.04 -42.95 99.88 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 1.015 ' HG3' HG23 ' A' ' 45' ' ' VAL . 5.6 mptt -70.25 -19.34 63.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.62 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 28.6 mm-40 -76.24 -49.9 15.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.572 -0.705 . . . . 0.0 109.502 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.599 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 46.8 t -65.14 -46.53 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.011 ' CG1' HD21 ' A' ' 43' ' ' LEU . 89.4 t -63.69 -34.14 66.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.827 ' HB1' ' O ' ' A' ' 38' ' ' VAL . . . -63.34 -29.08 70.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 21.9 mmmt -65.13 -47.45 77.07 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.691 0.758 . . . . 0.0 109.505 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -30.77 64.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.664 -0.647 . . . . 0.0 111.597 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.648 ' HG3' ' CE1' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -81.43 -15.17 55.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.685 -1.26 . . . . 0.0 110.525 -178.658 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.21 15.64 80.75 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.827 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -126.86 160.9 56.6 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.52 ' HG2' ' HG3' ' A' ' 42' ' ' GLN . 32.8 Cg_endo -76.75 140.48 20.86 Favored 'Trans proline' 0 C--N 1.292 -2.444 0 C-N-CA 123.311 2.674 . . . . 0.0 111.26 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -48.7 -20.17 0.44 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.774 -0.579 . . . . 0.0 110.372 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -63.0 -62.58 1.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.891 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 73' ' ' GLN . 23.6 mt-30 -58.67 -50.67 73.0 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.616 1.198 . . . . 0.0 108.112 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.011 HD21 ' CG1' ' A' ' 32' ' ' VAL . 2.7 tp -62.95 142.18 58.44 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.627 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.844 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -154.71 117.79 4.44 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.249 -1.38 . . . . 0.0 111.855 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.015 HG23 ' HG3' ' A' ' 29' ' ' LYS . 1.4 t -87.8 120.86 37.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.093 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.714 HG23 ' HA ' ' A' ' 51' ' ' GLU . 10.4 mt -125.11 121.28 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.696 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 3.7 t80 -92.14 131.98 36.97 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.837 -1.164 . . . . 0.0 113.812 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.696 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 59.41 9.61 1.52 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.869 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.05 -9.95 58.25 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.183 -1.484 . . . . 0.0 110.118 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' C ' HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -94.73 118.47 31.79 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.678 -1.484 . . . . 0.0 108.239 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.714 ' HA ' HG23 ' A' ' 46' ' ' ILE . 2.0 tt0 -74.46 106.39 6.04 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.282 -0.887 . . . . 0.0 108.766 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.987 ' CD1' HD11 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -81.93 134.31 50.12 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.166 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.728 ' HD2' HD12 ' A' ' 56' ' ' LEU . 31.4 Cg_endo -76.4 133.86 14.96 Favored 'Trans proline' 0 C--N 1.298 -2.11 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 3.0 p-10 -48.75 -51.66 27.8 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.35 -0.844 . . . . 0.0 111.771 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.65 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 2.4 p-80 -45.24 -35.24 3.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.403 -1.435 . . . . 0.0 109.734 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.834 HD22 ' ND2' ' A' ' 60' ' ' ASN . 14.2 mt -65.53 160.86 21.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.068 -1.02 . . . . 0.0 108.37 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -94.62 172.31 8.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.952 -1.092 . . . . 0.0 111.144 -178.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.852 ' O ' HD12 ' A' ' 63' ' ' LEU . 23.1 t -58.4 -35.98 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.389 0.614 . . . . 0.0 110.837 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.437 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -93.05 24.71 3.59 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.964 -1.085 . . . . 0.0 109.769 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.834 ' ND2' HD22 ' A' ' 56' ' ' LEU . 1.3 t-20 -83.03 -62.88 1.48 Allowed 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 119.444 -0.903 . . . . 0.0 108.693 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.776 ' HB3' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.76 -14.89 61.64 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.296 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.627 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 4.1 t70 100.47 34.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.547 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.987 HD11 ' CD1' ' A' ' 52' ' ' LEU . 1.3 mt -55.72 -63.99 1.0 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 65' ' ' GLN . 19.8 mt-10 60.31 151.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.636 0.731 . . . . 0.0 111.871 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.608 ' CB ' ' CB ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -33.89 127.51 0.4 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.984 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 17.2 tt0 74.58 110.18 0.07 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.443 ' OG ' ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -167.53 122.93 1.05 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 108.607 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.77 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -85.41 121.49 37.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.635 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -117.06 163.39 14.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.71 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -118.07 108.4 15.18 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.892 -1.13 . . . . 0.0 108.909 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.92 HG21 HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -82.32 141.05 15.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.341 -0.849 . . . . 0.0 109.257 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.08 132.62 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.989 -1.069 . . . . 0.0 109.131 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.521 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 6.0 tt0 -108.14 117.64 34.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 109.701 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -48.56 113.86 3.2 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.109 -0.994 . . . . 0.0 109.049 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -77.33 131.76 11.94 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.267 1.978 . . . . 0.0 111.61 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 78' ' ' ARG . 1.5 mmt180 -61.57 167.75 3.27 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -55.95 92.14 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 117.905 -1.518 . . . . 0.0 108.687 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.439 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 mtm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.3 0.572 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.6 160.91 28.95 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.642 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 4.3 ttm -124.59 164.27 20.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.406 -1.055 . . . . 0.0 110.661 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -71.77 141.24 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.634 -0.666 . . . . 0.0 109.814 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.934 HG23 HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -97.51 148.15 5.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.669 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -93.79 108.41 20.18 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.219 -0.926 . . . . 0.0 109.196 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.613 HG13 HG22 ' A' ' 71' ' ' ILE . 41.3 t -90.96 112.06 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.781 -1.2 . . . . 0.0 109.164 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.547 ' O ' HG23 ' A' ' 71' ' ' ILE . 2.7 mmm180 -91.38 93.84 9.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.965 ' HE1' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -75.22 138.13 41.72 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 11' ' ' SER . 12.0 m-20 -36.69 147.98 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.793 -0.567 . . . . 0.0 109.622 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 1.5 m 78.08 -145.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.302 -0.874 . . . . 0.0 109.334 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -101.7 -0.06 35.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.095 -1.003 . . . . 0.0 110.013 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 1.5 m-85 -72.73 148.05 45.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.79 165.36 36.9 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.533 ' HB3' ' NH2' ' A' ' 35' ' ' ARG . 99.0 m-85 -152.93 125.32 3.92 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 120.809 -1.407 . . . . 0.0 111.001 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -81.87 90.33 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.437 2.091 . . . . 0.0 108.004 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.934 HG13 HG23 ' A' ' 5' ' ' VAL . 3.2 p -85.54 144.82 8.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 110.148 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.16 114.78 27.39 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.823 -1.173 . . . . 0.0 108.811 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.704 HG12 HG22 ' A' ' 17' ' ' VAL . 1.2 m -142.92 162.47 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.935 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 19' ' ' VAL . 2.1 m-20 -114.44 -179.08 3.53 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.476 ' OG ' ' HG3' ' A' ' 59' ' ' GLN . 20.0 m -61.72 -5.26 1.83 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.051 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -90.55 -34.29 15.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 110.862 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.08 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.29 116.14 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.91 -1.119 . . . . 0.0 109.444 -179.347 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.607 ' O ' HD13 ' A' ' 25' ' ' ILE . 1.4 m -60.01 -131.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.61 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 36.6 mm -139.69 -32.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 120.417 -1.427 . . . . 0.0 109.772 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.034 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -77.84 -34.26 51.95 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 175.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.585 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.37 -31.68 61.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 175.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.961 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -64.99 -50.08 67.71 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.91 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.8 mptt -63.6 -20.17 65.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.446 -0.784 . . . . 0.0 109.06 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 44.5 mt-10 -77.09 -48.73 17.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 109.476 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.597 HG11 ' CG2' ' A' ' 17' ' ' VAL . 74.0 t -63.01 -44.67 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.77 ' CG1' ' CE2' ' A' ' 9' ' ' PHE . 97.9 t -64.37 -35.22 73.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 38' ' ' VAL . . . -62.0 -24.44 67.04 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -69.54 -50.03 48.76 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.928 0.871 . . . . 0.0 110.012 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.581 ' NH1' ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -64.85 -34.4 78.28 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.726 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 1.1 mt-30 -108.52 -11.25 15.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.478 -1.389 . . . . 0.0 112.435 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.62 10.01 85.73 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.761 ' HB ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -90.75 146.29 33.75 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.548 ' HD2' HG12 ' A' ' 38' ' ' VAL . 30.7 Cg_endo -73.83 124.1 8.96 Favored 'Trans proline' 0 C--N 1.293 -2.368 0 C-N-CA 122.212 1.942 . . . . 0.0 110.25 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -45.46 -23.38 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.228 0.537 . . . . 0.0 109.679 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -61.69 -66.34 0.55 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.622 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.532 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 3.2 mt-30 -62.18 -42.67 99.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.089 -1.007 . . . . 0.0 108.601 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.965 HD11 ' HE1' ' A' ' 9' ' ' PHE . 3.1 tp -63.1 140.64 58.89 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.772 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -153.57 116.41 4.5 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 117.616 -1.633 . . . . 0.0 111.922 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.961 HG21 ' CD1' ' A' ' 28' ' ' LEU . 2.3 t -87.73 123.94 40.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.46 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.488 HG23 ' O ' ' A' ' 50' ' ' LYS . 8.1 mt -128.02 120.26 53.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 3.3 t80 -87.1 129.58 34.86 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.012 -1.055 . . . . 0.0 112.817 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 59.35 7.33 0.91 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.979 -0.451 . . . . 0.0 111.764 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.47 -0.01 56.84 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.987 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -95.3 117.87 31.06 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.331 -1.688 . . . . 0.0 109.092 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.14 103.0 1.11 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.773 ' HB3' HD21 ' A' ' 56' ' ' LEU . 1.2 mt -85.18 135.43 39.27 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 121.395 -0.815 . . . . 0.0 109.843 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.887 ' O ' HD23 ' A' ' 56' ' ' LEU . 28.8 Cg_endo -67.69 133.83 30.83 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.821 1.681 . . . . 0.0 109.51 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.584 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 6.2 m-20 -53.02 -11.74 0.27 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 112.203 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.566 ' NE2' ' HB2' ' A' ' 53' ' ' PRO . 1.2 p-80 -99.38 27.51 5.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.248 -1.532 . . . . 0.0 112.214 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 53' ' ' PRO . 1.1 pp -115.65 164.74 13.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.661 -1.275 . . . . 0.0 108.361 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.841 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -92.38 171.43 9.05 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 110.287 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.08 HG23 ' O ' ' A' ' 23' ' ' THR . 5.4 t -61.48 -38.98 81.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.6 -0.687 . . . . 0.0 110.486 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.476 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 1.5 mt-30 -89.2 18.95 4.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.579 -1.326 . . . . 0.0 109.673 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.3 OUTLIER -87.54 -62.68 1.44 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.481 -0.762 . . . . 0.0 110.128 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.661 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 26.3 t -71.32 -15.26 62.39 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.661 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 15.7 t0 105.43 30.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.49 ' CD2' ' HB2' ' A' ' 47' ' ' PHE . 1.3 mt -69.16 -62.76 1.25 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 65' ' ' GLN . 8.7 tt0 56.87 163.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.88 0.847 . . . . 0.0 111.913 177.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.642 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -37.85 122.84 1.02 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.931 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 2.2 tt0 73.97 107.89 0.07 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -155.85 117.02 3.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.661 HD12 ' CB ' ' A' ' 6' ' ' PHE . 1.1 mp -83.35 120.29 34.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.924 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -115.42 166.65 9.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.43 0.633 . . . . 0.0 109.671 -176.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -121.48 106.21 11.2 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.944 -1.097 . . . . 0.0 108.972 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.864 HG12 ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -78.67 144.7 10.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 44' ' ' ARG . 2.3 p -145.11 128.75 11.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 109.609 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.532 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -108.33 118.59 37.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.306 -0.871 . . . . 0.0 109.075 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.495 ' HB2' ' HG2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -37.65 98.01 0.15 Allowed Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.504 ' N ' ' O ' ' A' ' 73' ' ' GLN . 32.7 Cg_endo -78.02 137.06 15.25 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.652 2.235 . . . . 0.0 111.18 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 78' ' ' ARG . 11.7 mtm-85 -61.71 169.64 2.35 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -54.17 91.67 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.433 -1.417 . . . . 0.0 108.909 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 76' ' ' ARG . 2.4 mtp180 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.332 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 mtp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.352 0.596 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.28 -179.35 33.09 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.629 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -126.59 166.89 16.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.221 -1.164 . . . . 0.0 111.171 -178.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -76.6 146.95 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.931 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -105.56 144.75 14.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.376 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.727 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 t80 -87.47 106.89 18.28 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.728 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.614 HG13 HG22 ' A' ' 71' ' ' ILE . 54.1 t -90.51 115.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.957 -1.089 . . . . 0.0 109.133 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 1.6 mmm180 -94.96 96.2 9.13 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.522 -1.271 . . . . 0.0 108.247 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 1.061 ' HE1' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -79.08 140.14 37.94 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 11' ' ' SER . 89.6 m-20 -39.99 153.46 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.241 -0.912 . . . . 0.0 109.559 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER 72.96 -151.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 109.696 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.67 2.88 56.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.574 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.512 ' HB2' ' HB3' ' A' ' 9' ' ' PHE . 16.8 m-30 -72.26 153.66 41.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 110.257 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.4 152.99 10.79 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 35' ' ' ARG . 85.0 m-85 -144.99 126.56 7.8 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.831 -1.394 . . . . 0.0 111.189 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.518 ' HB2' HG12 ' A' ' 4' ' ' ILE . 36.1 Cg_endo -80.31 85.78 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.434 2.089 . . . . 0.0 107.336 177.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.826 ' CG2' HG11 ' A' ' 31' ' ' VAL . 5.8 p -79.42 150.12 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.708 -0.62 . . . . 0.0 111.133 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.27 114.04 25.78 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 108.323 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.658 HG13 ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -136.99 158.7 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.07 -1.019 . . . . 0.0 109.489 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -103.21 176.71 5.06 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 108.913 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 59' ' ' GLN . 9.7 m -67.73 -2.97 7.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.907 . . . . 0.0 109.56 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -111.16 -9.58 14.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.11 -0.993 . . . . 0.0 110.532 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.089 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -58.28 125.12 21.89 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.631 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -56.78 -149.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.007 . . . . 0.0 110.955 -176.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.631 HD13 ' O ' ' A' ' 24' ' ' SER . 17.1 mm -126.01 -33.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.946 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -78.15 -32.21 50.16 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 102.628 -3.101 . . . . 0.0 102.628 175.473 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.484 ' HB2' ' CB ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -56.66 -32.45 65.39 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 175.176 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.983 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -65.68 -51.67 57.55 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.592 177.43 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.927 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.8 mptt -61.7 -21.55 64.57 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.507 -0.746 . . . . 0.0 109.601 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 13.5 mt-10 -76.82 -50.13 14.18 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.045 -1.034 . . . . 0.0 109.704 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.826 HG11 ' CG2' ' A' ' 17' ' ' VAL . 71.6 t -61.14 -47.28 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.784 HG12 HD21 ' A' ' 43' ' ' LEU . 78.9 t -62.35 -38.66 81.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.878 ' HB1' ' O ' ' A' ' 38' ' ' VAL . . . -58.9 -27.38 65.17 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -66.97 -52.96 36.37 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.785 0.802 . . . . 0.0 110.069 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.619 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -60.13 -33.89 72.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.914 -0.491 . . . . 0.0 112.103 -177.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.716 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -104.74 -6.76 20.06 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.841 -1.162 . . . . 0.0 111.587 -176.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.3 15.86 75.06 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.957 HG21 HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -100.89 150.5 37.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.44 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.643 ' HD2' HG23 ' A' ' 38' ' ' VAL . 31.2 Cg_endo -71.94 125.43 10.97 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 123.041 2.494 . . . . 0.0 111.991 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -50.39 -22.37 1.83 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.462 0.649 . . . . 0.0 109.502 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.484 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 4.4 m-20 -58.83 -61.65 2.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.453 -0.78 . . . . 0.0 109.786 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 19.7 mt-30 -68.13 -41.62 81.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.076 -1.015 . . . . 0.0 108.354 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.061 HD11 ' HE1' ' A' ' 9' ' ' PHE . 2.2 tp -62.84 141.74 58.52 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.764 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -154.53 116.21 4.15 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.062 -1.455 . . . . 0.0 111.3 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.983 HG21 ' CD1' ' A' ' 28' ' ' LEU . 2.4 t -88.64 125.14 41.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.802 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 50' ' ' LYS . 7.2 mt -129.58 118.12 44.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.1 t80 -85.16 131.04 34.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 112.798 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.641 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 62.26 10.87 4.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.718 -0.614 . . . . 0.0 110.341 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.66 12.46 77.73 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.778 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -94.75 122.61 37.54 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.942 -1.328 . . . . 0.0 108.332 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.479 ' C ' HD23 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -62.58 107.49 0.96 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.633 -0.667 . . . . 0.0 110.413 -178.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 61' ' ' CYS . 3.2 mt -97.44 148.93 35.14 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.057 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.683 ' CG ' HD12 ' A' ' 56' ' ' LEU . 34.3 Cg_endo -77.75 -164.29 0.26 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 N-CA-C 107.281 -1.853 . . . . 0.0 107.281 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.55 ' CB ' ' HB2' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -113.99 -30.78 6.59 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.653 -1.279 . . . . 0.0 109.711 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -80.66 -1.1 41.01 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.401 -0.812 . . . . 0.0 110.837 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.683 HD12 ' CG ' ' A' ' 53' ' ' PRO . 9.8 mt -80.7 169.54 17.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.654 -1.279 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.39 171.78 8.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.935 . . . . 0.0 110.549 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.089 HG23 ' O ' ' A' ' 23' ' ' THR . 4.1 t -63.41 -46.6 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.596 -0.69 . . . . 0.0 109.98 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.496 ' CG ' ' HG3' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -84.84 15.78 3.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.074 -1.016 . . . . 0.0 109.956 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.632 ' CG ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -86.04 -59.1 2.39 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.698 0.761 . . . . 0.0 109.39 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.654 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 6.1 m -69.59 -16.74 63.46 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.654 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 37.7 t0 107.12 31.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.708 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.4 mt -72.9 -77.84 0.1 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' HG3' ' CG ' ' A' ' 59' ' ' GLN . 1.9 tt0 71.24 159.47 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.655 0.741 . . . . 0.0 111.612 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.629 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -37.99 122.62 1.03 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.5 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 1.1 tm0? 75.82 108.95 0.07 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.14 121.69 1.46 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.183 -0.948 . . . . 0.0 108.488 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.533 HD12 ' CB ' ' A' ' 6' ' ' PHE . 1.2 mp -85.63 122.06 37.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.974 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -114.33 168.81 5.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.313 0.578 . . . . 0.0 109.668 -177.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -125.86 107.14 10.21 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.063 -1.023 . . . . 0.0 108.911 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.832 HG12 ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -80.21 142.56 13.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.194 -0.941 . . . . 0.0 109.616 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.3 t -138.91 120.41 16.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.608 ' HB2' HD12 ' A' ' 43' ' ' LEU . 21.0 tt0 -117.61 114.12 22.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.228 -0.92 . . . . 0.0 110.084 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -51.2 107.15 0.76 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 109.096 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 73' ' ' GLN . 32.3 Cg_endo -78.67 135.84 13.2 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.445 2.096 . . . . 0.0 111.972 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 78' ' ' ARG . 3.6 mtt-85 -64.25 168.39 5.61 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 176.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.535 ' CG ' ' NH1' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -55.37 92.32 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.257 -1.527 . . . . 0.0 108.885 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.077 -1.014 . . . . 0.0 109.695 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.561 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 3.1 ttm . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 121.594 0.712 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -73.18 144.26 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.855 . . . . 0.0 111.85 -177.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -103.43 163.84 3.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.859 ' HB3' HD12 ' A' ' 68' ' ' ILE . 6.7 t80 -101.73 103.3 14.05 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.306 -1.496 . . . . 0.0 109.676 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.761 HG13 ' CG2' ' A' ' 71' ' ' ILE . 6.0 t -91.69 112.77 26.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.117 -0.989 . . . . 0.0 109.132 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.694 ' O ' HG23 ' A' ' 71' ' ' ILE . 24.3 mmm-85 -82.26 97.94 8.53 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.727 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.727 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.3 Cg_endo -78.41 126.26 7.48 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.454 2.103 . . . . 0.0 110.695 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.634 ' CG2' HG11 ' A' ' 31' ' ' VAL . 11.3 p -111.75 148.05 15.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.499 -0.751 . . . . 0.0 109.235 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -102.2 112.06 24.59 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.792 -1.192 . . . . 0.0 108.755 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -139.03 160.17 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.03 -1.044 . . . . 0.0 109.714 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -97.97 176.18 5.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.404 ' C ' ' HB ' ' A' ' 58' ' ' VAL . 70.2 m -69.28 -0.19 5.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.083 -1.01 . . . . 0.0 110.278 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -102.88 -19.48 14.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.145 -0.972 . . . . 0.0 111.063 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.066 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -45.32 124.11 4.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.573 -1.329 . . . . 0.0 109.157 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.644 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -60.84 -142.4 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 24' ' ' SER . 23.7 mm -130.17 -31.11 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 120.909 -1.119 . . . . 0.0 109.457 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.823 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -81.78 -34.92 30.09 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 175.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.501 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.0 -33.15 71.59 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 175.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.986 ' CD1' HG21 ' A' ' 45' ' ' VAL . 1.4 tm? -68.88 -38.04 79.42 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.97 ' HG3' HG23 ' A' ' 45' ' ' VAL . 7.0 mttt -72.3 -20.3 61.52 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.621 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 7.3 mm-40 -76.34 -49.99 15.45 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.449 -0.782 . . . . 0.0 109.623 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.634 HG11 ' CG2' ' A' ' 17' ' ' VAL . 2.4 t -64.08 -48.03 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.005 HG12 HD21 ' A' ' 43' ' ' LEU . 85.5 t -63.23 -32.98 58.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.866 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -67.03 -29.68 69.56 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 14.5 mmmt -64.2 -53.8 43.62 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.774 0.797 . . . . 0.0 109.578 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -69.71 -22.4 63.4 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.837 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.664 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.89 -14.95 55.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.925 -1.109 . . . . 0.0 110.373 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.05 25.08 67.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.682 ' CG2' HD13 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -142.0 164.24 35.17 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.518 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 34.0 Cg_endo -78.15 141.36 18.46 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 123.662 2.908 . . . . 0.0 111.554 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.621 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -53.05 -22.22 5.66 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.438 -0.789 . . . . 0.0 110.122 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.61 -57.73 11.47 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 108.775 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.546 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 7.3 mt-30 -64.15 -44.75 91.17 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.283 1.04 . . . . 0.0 108.407 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.005 HD21 HG12 ' A' ' 32' ' ' VAL . 1.3 tp -67.49 143.1 56.37 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.538 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.798 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -154.35 116.99 4.37 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.638 -1.225 . . . . 0.0 111.539 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.986 HG21 ' CD1' ' A' ' 28' ' ' LEU . 1.4 t -91.17 127.01 43.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.261 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 50' ' ' LYS . 5.5 mt -130.03 119.94 48.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.683 ' HB2' HD23 ' A' ' 63' ' ' LEU . 1.2 t80 -87.67 127.34 35.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.909 -1.119 . . . . 0.0 112.76 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 59.61 7.76 1.11 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.977 -0.452 . . . . 0.0 111.297 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.45 6.47 57.48 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.878 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.64 119.28 34.84 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.564 -1.551 . . . . 0.0 108.718 179.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.72 109.27 2.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.381 -0.824 . . . . 0.0 108.79 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.578 HD22 ' SG ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -93.72 146.61 32.07 Favored Pre-proline 0 C--N 1.303 -1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.456 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.679 ' CG ' HD12 ' A' ' 56' ' ' LEU . 33.3 Cg_endo -76.5 142.39 23.42 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.358 2.039 . . . . 0.0 108.879 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.527 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 4.6 m-20 -65.19 -5.15 6.18 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.32 -0.863 . . . . 0.0 111.057 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.471 ' CD2' ' C ' ' A' ' 55' ' ' HIS . 5.7 p-80 -104.26 0.16 29.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.647 -1.283 . . . . 0.0 111.201 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.905 HD22 ' ND2' ' A' ' 60' ' ' ASN . 12.4 mt -89.92 162.97 15.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.645 -1.285 . . . . 0.0 109.055 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -91.53 171.16 9.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.099 -1.001 . . . . 0.0 110.887 -178.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.066 HG23 ' O ' ' A' ' 23' ' ' THR . 8.7 t -62.17 -40.09 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.657 -0.652 . . . . 0.0 110.43 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.538 ' CG ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -87.46 18.47 3.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.617 -1.302 . . . . 0.0 109.957 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.905 ' ND2' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -88.86 -62.3 1.52 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.314 -0.866 . . . . 0.0 110.339 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.652 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 42.1 t -69.46 -14.23 62.77 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.252 -0.905 . . . . 0.0 108.609 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 8.4 t70 103.78 30.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 47' ' ' PHE . 1.2 mt -72.9 -59.81 2.53 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.214 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HG2' ' CG ' ' A' ' 59' ' ' GLN . 3.5 mm-40 59.96 152.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.561 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 1.4 pt20 -48.73 140.14 8.82 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 7.8 tp-100 74.6 106.4 0.07 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.81 130.38 0.66 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.859 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -84.92 116.03 27.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 C-N-CA 117.698 -1.601 . . . . 0.0 107.595 -179.018 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.89 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -112.97 163.67 9.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -178.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -124.83 106.8 10.3 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.93 -1.106 . . . . 0.0 108.759 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.761 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -80.82 141.2 15.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 72' ' ' VAL . 14.9 p -136.41 125.95 38.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.961 -1.087 . . . . 0.0 109.877 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.546 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.578 ' HB3' ' CB ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.517 ' N ' ' HG3' ' A' ' 3' ' ' MET . 0.8 OUTLIER -70.41 143.83 14.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 111.755 -178.007 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.24 163.06 5.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.738 ' HB3' HD12 ' A' ' 68' ' ' ILE . 3.9 t80 -98.66 118.01 34.4 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 120.285 -1.509 . . . . 0.0 109.411 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.905 HG13 HG21 ' A' ' 71' ' ' ILE . 8.7 t -105.96 112.21 38.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.752 ' O ' HG23 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -79.37 100.44 7.62 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 117.625 -1.63 . . . . 0.0 108.274 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.698 ' HA ' HG12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.54 0 CA-C-O 121.679 0.752 . . . . 0.0 111.101 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.645 ' HE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.6 Cg_endo -76.18 127.83 10.16 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.124 1.882 . . . . 0.0 111.018 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.618 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 8.4 p -116.08 142.3 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -100.7 116.55 32.87 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.579 -1.325 . . . . 0.0 109.108 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.579 HG23 ' N ' ' A' ' 20' ' ' ASP . 1.8 m -149.43 165.81 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.132 -0.98 . . . . 0.0 109.641 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.579 ' N ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -119.5 -178.79 3.69 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.621 -0.674 . . . . 0.0 109.56 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.575 ' CB ' ' HG3' ' A' ' 59' ' ' GLN . 3.5 m -63.53 -3.31 2.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.491 -0.756 . . . . 0.0 110.692 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 23' ' ' THR . 5.7 m-20 -95.69 -35.8 11.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.071 -1.018 . . . . 0.0 110.867 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.067 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.96 126.38 3.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.852 -1.155 . . . . 0.0 109.41 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.565 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -61.24 -142.61 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.605 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 30.0 mm -129.57 -33.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 120.937 -1.102 . . . . 0.0 108.681 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.919 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -80.35 -34.68 36.35 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 176.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -56.79 -31.88 65.11 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 175.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.935 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -64.13 -45.34 88.97 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.78 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 3.9 mptt -68.95 -18.68 64.12 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.2 mm-40 -77.28 -50.69 12.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 109.493 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.6 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 71.1 t -63.94 -46.23 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.003 ' CG1' HD21 ' A' ' 43' ' ' LEU . 68.3 t -64.82 -35.81 76.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 29' ' ' LYS . . . -60.21 -27.54 67.25 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 4.0 mmmm -65.79 -50.95 62.82 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.656 0.741 . . . . 0.0 109.391 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.62 ' HD3' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -71.33 -22.51 61.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.691 -0.63 . . . . 0.0 111.026 -178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.674 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 1.8 mm-40 -87.98 -17.64 30.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.899 -1.125 . . . . 0.0 110.502 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.63 17.42 79.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.73 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 1.4 m -124.39 164.11 32.26 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 31.2 Cg_endo -77.31 138.53 17.85 Favored 'Trans proline' 0 C--N 1.293 -2.386 0 C-N-CA 123.037 2.491 . . . . 0.0 110.843 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 26' ' ' LEU . . . -51.84 -19.64 1.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.646 -0.659 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.523 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -62.3 -59.08 5.52 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.183 -0.948 . . . . 0.0 109.156 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.577 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 1.7 mt-30 -60.53 -48.96 79.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.132 0.967 . . . . 0.0 108.623 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.003 HD21 ' CG1' ' A' ' 32' ' ' VAL . 3.5 tp -63.8 140.49 58.88 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.659 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.759 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -152.84 117.2 4.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.058 -1.457 . . . . 0.0 111.797 178.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.052 HG13 HG11 ' A' ' 69' ' ' VAL . 17.8 t -88.77 119.24 35.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.055 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.753 HG23 ' HA ' ' A' ' 51' ' ' GLU . 6.0 mt -128.8 117.53 44.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.637 ' HB2' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -93.78 129.86 39.99 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -174.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 60.3 7.42 1.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.906 -0.496 . . . . 0.0 111.737 177.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.75 -3.47 45.71 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.689 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.402 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -96.18 114.55 26.25 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 120.454 -1.615 . . . . 0.0 108.715 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.753 ' HA ' HG23 ' A' ' 46' ' ' ILE . 21.6 tt0 -74.75 105.16 5.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.824 HD12 HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -91.98 152.27 42.72 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.782 ' HD2' HD12 ' A' ' 56' ' ' LEU . 34.2 Cg_endo -75.79 -170.92 0.91 Allowed 'Trans proline' 0 C--N 1.296 -2.198 0 C-N-CA 122.322 2.015 . . . . 0.0 108.595 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 10.5 p30 -91.71 -39.93 11.55 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 110.399 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 21.0 p-80 -62.11 -39.2 91.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 111.272 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.019 HD22 ' ND2' ' A' ' 60' ' ' ASN . 12.4 mt -50.04 158.04 0.57 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.656 -1.278 . . . . 0.0 110.252 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 172.84 8.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.433 -0.792 . . . . 0.0 110.802 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.067 HG23 ' O ' ' A' ' 23' ' ' THR . 21.1 t -62.07 -44.21 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.587 0.708 . . . . 0.0 110.317 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.575 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 23.0 mt-30 -90.18 25.1 2.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.819 -1.176 . . . . 0.0 109.782 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 1.019 ' ND2' HD22 ' A' ' 56' ' ' LEU . 1.8 t30 -84.33 -63.32 1.36 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.05 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.632 ' HB2' HD22 ' A' ' 52' ' ' LEU . 10.2 t -75.3 -48.78 21.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 4.6 m-20 155.02 36.61 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.824 HD11 HD12 ' A' ' 52' ' ' LEU . 1.3 mt -82.37 -57.66 3.27 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.419 -1.313 . . . . 0.0 108.306 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' CG ' ' HG2' ' A' ' 59' ' ' GLN . 0.1 OUTLIER 46.99 -154.34 0.06 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.578 ' CB ' ' HB3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.64 137.51 33.65 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 36.1 tp60 74.39 109.35 0.07 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.414 ' OG ' ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -175.87 129.84 0.24 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -177.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.738 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -83.26 122.56 37.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 117.861 -1.536 . . . . 0.0 108.076 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.052 HG11 HG13 ' A' ' 45' ' ' VAL . 2.5 t -109.9 160.64 8.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 121.725 0.774 . . . . 0.0 110.411 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.573 ' N ' ' CG1' ' A' ' 69' ' ' VAL . 3.5 t60 -122.8 102.55 8.09 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.905 HG21 HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -89.57 143.17 11.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.564 -0.71 . . . . 0.0 109.186 -178.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 42' ' ' GLN . 11.3 p -139.49 137.92 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.011 -1.056 . . . . 0.0 109.172 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.577 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 110.403 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.551 ' CB ' ' HB3' ' A' ' 65' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.546 ' N ' ' HG3' ' A' ' 3' ' ' MET . 0.1 OUTLIER -73.2 143.28 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.093 -1.005 . . . . 0.0 112.367 -177.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.658 HG23 HG13 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -106.23 164.63 4.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.977 ' HB3' HD12 ' A' ' 68' ' ' ILE . 12.8 t80 -102.73 109.31 20.85 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.373 -1.454 . . . . 0.0 109.406 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.757 HG11 ' HE2' ' A' ' 15' ' ' PHE . 13.7 t -94.65 120.58 44.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.519 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.767 ' O ' HG23 ' A' ' 71' ' ' ILE . 14.5 mmm-85 -88.39 98.62 11.71 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.753 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.061 0.458 . . . . 0.0 110.745 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.757 ' HE2' HG11 ' A' ' 7' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.526 ' HB2' HD12 ' A' ' 4' ' ' ILE . 34.2 Cg_endo -75.9 127.82 10.35 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.328 2.019 . . . . 0.0 111.23 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.635 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 5.9 p -117.94 144.84 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.509 -0.744 . . . . 0.0 109.56 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -106.93 117.36 33.84 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.426 -1.422 . . . . 0.0 108.406 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.658 HG13 HG23 ' A' ' 5' ' ' VAL . 1.2 m -139.26 160.71 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.91 -1.119 . . . . 0.0 110.526 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' N ' HG23 ' A' ' 19' ' ' VAL . 2.5 m-20 -107.29 176.08 5.28 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -66.34 -5.09 9.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.932 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.536 ' HA ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -122.95 16.83 10.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.087 -1.008 . . . . 0.0 109.873 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.833 ' HB ' HG21 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -66.46 -9.36 33.53 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.136 -0.977 . . . . 0.0 109.548 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.544 ' OG ' ' HB2' ' A' ' 27' ' ' GLN . 5.7 p 69.31 -142.81 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 108.988 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.91 HD11 HD13 ' A' ' 63' ' ' LEU . 39.0 mm -144.15 -25.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.895 -1.128 . . . . 0.0 111.126 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.957 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -83.42 -37.41 23.27 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 177.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.663 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.75 -33.7 73.32 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 176.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.034 ' CD1' HG21 ' A' ' 45' ' ' VAL . 2.4 tm? -69.4 -37.17 77.37 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.963 ' HG3' HG23 ' A' ' 45' ' ' VAL . 4.3 mttt -70.0 -20.46 63.28 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.695 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 1.9 mm-40 -74.33 -52.81 11.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.697 -0.627 . . . . 0.0 109.674 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.623 HG11 HG23 ' A' ' 17' ' ' VAL . 27.5 t -61.79 -48.92 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.011 HG12 HD21 ' A' ' 43' ' ' LEU . 60.5 t -62.06 -33.47 58.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.862 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -68.23 -28.72 67.48 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.4 -0.813 . . . . 0.0 109.265 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 2.7 mmmm -65.61 -52.37 52.53 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.774 0.797 . . . . 0.0 109.39 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.457 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -71.85 -22.77 61.49 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.27 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.661 ' CG ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.27 -15.5 55.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.713 -1.242 . . . . 0.0 110.583 -179.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.2 21.22 61.15 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.663 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 1.6 m -142.78 164.82 30.1 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.738 -0.86 . . . . 0.0 108.679 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.502 ' N ' HG23 ' A' ' 38' ' ' VAL . 33.0 Cg_endo -78.67 143.02 18.52 Favored 'Trans proline' 0 C--N 1.293 -2.387 0 C-N-CA 123.437 2.758 . . . . 0.0 111.444 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.695 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -50.6 -21.06 1.38 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.755 -0.591 . . . . 0.0 110.196 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -61.49 -60.75 3.23 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 109.246 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 29.8 mt-30 -63.5 -43.68 96.54 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.011 HD21 HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -66.01 144.61 56.63 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.504 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.734 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -155.15 115.72 3.87 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.362 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.034 HG21 ' CD1' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -93.84 117.29 37.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.715 0.769 . . . . 0.0 110.602 -178.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.871 HG23 ' O ' ' A' ' 50' ' ' LYS . 6.4 mt -116.59 122.4 69.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.764 ' HB2' HD23 ' A' ' 63' ' ' LEU . 1.7 t80 -87.92 129.76 35.13 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.765 -1.209 . . . . 0.0 113.426 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 61.0 7.92 1.71 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.803 -0.561 . . . . 0.0 111.234 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.73 6.42 60.76 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.333 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -95.63 130.33 42.54 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.613 -1.522 . . . . 0.0 108.75 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.589 ' C ' HD23 ' A' ' 52' ' ' LEU . 26.4 tt0 -75.85 114.96 15.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.775 . . . . 0.0 109.092 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.909 HD22 ' HB2' ' A' ' 61' ' ' CYS . 0.4 OUTLIER -105.06 144.98 29.84 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.103 -0.998 . . . . 0.0 110.129 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.671 ' CG ' HD12 ' A' ' 56' ' ' LEU . 32.2 Cg_endo -77.34 131.25 11.55 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 122.342 2.028 . . . . 0.0 108.216 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 2.3 m120 -48.88 -37.58 20.05 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.692 -0.63 . . . . 0.0 111.802 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.521 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 7.0 p-80 -70.57 -31.42 68.43 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.781 -1.199 . . . . 0.0 112.053 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.954 HD22 ' CG ' ' A' ' 60' ' ' ASN . 10.9 mt -54.74 164.67 0.73 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.392 -1.443 . . . . 0.0 109.029 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -91.89 171.07 9.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.119 -0.988 . . . . 0.0 110.932 -178.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.833 HG21 ' HB ' ' A' ' 23' ' ' THR . 16.9 t -61.97 -39.65 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.403 0.62 . . . . 0.0 110.153 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -88.17 18.1 4.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.668 -1.27 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.954 ' CG ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -88.14 -62.34 1.51 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 110.681 -178.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.909 ' HB2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.17 -15.56 61.97 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.214 -0.929 . . . . 0.0 108.94 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.668 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 51.4 t0 109.13 32.77 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.91 HD13 HD11 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -79.4 -50.89 10.12 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.43 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.6 -157.51 0.12 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.573 0.701 . . . . 0.0 109.579 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.52 129.56 41.27 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 14.8 tm0? 80.23 111.54 0.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB2' HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -173.34 129.72 0.45 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -177.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.977 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -83.18 117.96 29.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 118.267 -1.373 . . . . 0.0 107.906 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.758 ' HB ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -116.03 167.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -177.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -124.58 109.32 13.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.956 -1.09 . . . . 0.0 108.435 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -84.32 142.95 12.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.263 -0.898 . . . . 0.0 110.109 -179.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -135.95 143.65 35.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 8.8 tt0 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.018 -1.051 . . . . 0.0 110.339 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.627 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 1.2 ttm . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 122.36 1.076 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.644 HG12 ' HB2' ' A' ' 16' ' ' PRO . 1.1 tp -77.46 139.31 18.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.262 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.648 HG23 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -95.72 153.18 3.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.896 ' HB3' HD12 ' A' ' 68' ' ' ILE . 5.4 t80 -91.34 108.58 19.98 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 120.769 -1.207 . . . . 0.0 109.248 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.892 HG13 HG21 ' A' ' 71' ' ' ILE . 2.1 t -94.92 110.77 24.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.26 -0.9 . . . . 0.0 109.692 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.624 ' O ' HG23 ' A' ' 71' ' ' ILE . 24.1 mmm-85 -78.2 93.01 4.52 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.701 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.457 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.658 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.644 ' HB2' HG12 ' A' ' 4' ' ' ILE . 34.6 Cg_endo -78.95 131.81 10.24 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.722 2.282 . . . . 0.0 111.062 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.648 HG13 HG23 ' A' ' 5' ' ' VAL . 3.3 p -113.98 151.18 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 0.0 109.013 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.477 ' HA ' HD12 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -102.28 119.33 38.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.554 -1.341 . . . . 0.0 108.793 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 28' ' ' LEU . 1.3 m -144.04 159.64 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.727 -1.233 . . . . 0.0 110.343 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 m-20 -102.53 177.06 4.97 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.519 ' CB ' ' HG3' ' A' ' 59' ' ' GLN . 37.3 m -71.62 0.73 7.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.01 . . . . 0.0 109.936 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -110.58 -10.05 14.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 111.427 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.721 ' OG1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -45.98 131.93 9.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.618 -1.301 . . . . 0.0 108.432 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.621 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 9.4 m -74.74 6.75 3.62 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.333 -0.854 . . . . 0.0 111.795 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.632 HG21 ' HB2' ' A' ' 52' ' ' LEU . 14.5 mm 72.35 -30.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 O-C-N 121.892 -0.505 . . . . 0.0 112.27 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.834 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -82.08 -35.57 28.5 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 176.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.502 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -59.51 -35.59 74.45 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.945 ' CD1' HG21 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -63.46 -40.5 97.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 176.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.92 ' HG3' HG23 ' A' ' 45' ' ' VAL . 7.8 mttt -69.62 -20.97 63.6 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.6 mt-10 -75.08 -50.34 16.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.297 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.55 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.1 t -65.36 -48.15 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.038 HG12 HD21 ' A' ' 43' ' ' LEU . 87.5 t -62.07 -34.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.745 ' HB2' ' O ' ' A' ' 29' ' ' LYS . . . -64.43 -29.67 70.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -64.5 -54.16 36.72 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.819 0.819 . . . . 0.0 109.672 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -64.79 -30.21 71.21 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.595 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.781 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.5 mm100 -81.34 -7.39 59.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.712 -1.243 . . . . 0.0 110.216 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.53 17.24 72.54 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.826 ' CG2' HD13 ' A' ' 43' ' ' LEU . 16.2 m -125.85 158.35 65.86 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 33.5 Cg_endo -78.41 143.38 19.44 Favored 'Trans proline' 0 C--N 1.294 -2.297 0 C-N-CA 123.152 2.568 . . . . 0.0 111.08 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 29' ' ' LYS . . . -49.67 -20.49 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.376 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.18 -63.27 1.35 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.336 -0.853 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.531 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 34.6 mt-30 -61.3 -49.19 78.03 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.455 1.121 . . . . 0.0 108.395 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.038 HD21 HG12 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -64.94 141.04 58.91 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.71 -179.078 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.774 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 3.9 mpp_? -155.64 115.05 3.6 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.476 -1.29 . . . . 0.0 111.269 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.945 HG21 ' CD1' ' A' ' 28' ' ' LEU . 1.3 t -86.63 121.61 37.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.763 0.792 . . . . 0.0 110.704 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.898 ' O ' HG12 ' A' ' 69' ' ' VAL . 19.7 mt -118.35 151.62 20.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.717 ' HB3' HD21 ' A' ' 52' ' ' LEU . 9.0 t80 -107.95 120.03 41.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 119.835 -1.79 . . . . 0.0 113.621 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . . . 55.66 7.74 0.27 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.95 -15.07 11.18 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 118.965 -1.588 . . . . 0.0 111.202 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 114.14 25.82 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.488 -1.595 . . . . 0.0 108.894 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.781 ' HA ' HG23 ' A' ' 46' ' ' ILE . 44.3 tt0 -56.94 117.12 3.65 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.492 -0.755 . . . . 0.0 109.596 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.957 HD13 HD11 ' A' ' 63' ' ' LEU . 6.0 mt -85.72 132.36 44.55 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 109.349 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.741 ' CG ' HD12 ' A' ' 56' ' ' LEU . 30.9 Cg_endo -75.07 132.15 15.0 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 121.844 1.696 . . . . 0.0 108.246 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.525 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 4.5 m-20 -59.82 -30.64 69.07 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 110.411 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.634 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 13.6 p-80 -70.73 -22.87 62.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.61 -1.306 . . . . 0.0 110.06 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.868 HD13 ' OD1' ' A' ' 60' ' ' ASN . 14.3 mt -78.92 168.35 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.936 -1.102 . . . . 0.0 108.151 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -95.79 172.52 7.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.062 -1.024 . . . . 0.0 111.031 -178.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.95 ' O ' HD12 ' A' ' 63' ' ' LEU . 24.0 t -59.86 -41.04 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.762 -0.586 . . . . 0.0 110.547 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.519 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 9.2 mt-30 -86.97 19.58 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.62 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.868 ' OD1' HD13 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -84.44 -60.22 2.14 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.927 ' CB ' HD22 ' A' ' 52' ' ' LEU . 17.5 t -70.6 -16.16 62.82 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.628 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 16.3 t0 103.26 37.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.957 HD11 HD13 ' A' ' 52' ' ' LEU . 1.3 mt -66.6 -83.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.597 -1.241 . . . . 0.0 107.728 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 63' ' ' LEU . 2.9 tt0 76.45 162.26 0.23 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.833 0.825 . . . . 0.0 111.287 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.627 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 1.8 pt20 -40.88 121.97 1.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER 76.0 112.3 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.595 ' HB2' HG13 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -163.18 118.58 1.72 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.896 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.1 mp -81.99 117.49 28.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -116.92 151.16 18.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -107.76 110.16 21.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.376 -1.452 . . . . 0.0 108.231 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.892 HG21 HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -80.49 141.48 15.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.424 -0.798 . . . . 0.0 109.473 -178.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 42' ' ' GLN . 16.5 t -130.15 122.96 55.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.226 -0.921 . . . . 0.0 108.963 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.76 HE21 HG11 ' A' ' 38' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 110.155 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.585 ' HG2' ' HB3' ' A' ' 65' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.828 0.823 . . . . 0.0 109.877 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.481 HG12 ' HB2' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -69.98 141.05 17.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.868 0.842 . . . . 0.0 110.841 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.708 HG23 HG13 ' A' ' 19' ' ' VAL . 1.4 t -110.05 165.47 5.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.746 ' HB3' HD12 ' A' ' 68' ' ' ILE . 4.9 t80 -103.69 106.49 17.01 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.458 -1.401 . . . . 0.0 109.381 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.765 HG21 HG22 ' A' ' 32' ' ' VAL . 14.8 t -91.18 115.72 30.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.708 ' O ' HG23 ' A' ' 71' ' ' ILE . 11.6 mmm180 -82.18 92.31 6.87 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 117.144 -1.822 . . . . 0.0 106.985 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.718 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.718 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HB2' HG12 ' A' ' 4' ' ' ILE . 34.1 Cg_endo -75.88 124.69 8.23 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.358 2.039 . . . . 0.0 110.248 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.617 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 7.5 p -110.73 154.24 12.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.433 -0.792 . . . . 0.0 109.724 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -101.3 114.75 29.01 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.775 -1.203 . . . . 0.0 108.341 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.708 HG13 HG23 ' A' ' 5' ' ' VAL . 2.0 m -148.14 165.9 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 110.152 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.59 ' N ' HG23 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -127.42 -179.46 4.91 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 59' ' ' GLN . 1.0 OUTLIER -61.55 -8.54 4.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.152 -0.967 . . . . 0.0 110.435 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.86 18.47 13.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.894 -1.129 . . . . 0.0 110.693 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.833 ' HB ' HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -72.04 -5.73 37.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.074 -1.016 . . . . 0.0 109.672 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 27' ' ' GLN . 52.5 m 65.78 -144.53 0.2 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.735 HD11 HD11 ' A' ' 63' ' ' LEU . 9.4 mm -144.94 -28.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.739 -1.226 . . . . 0.0 110.607 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.848 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.5 OUTLIER -80.82 -33.84 34.37 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 176.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -61.81 -33.78 74.75 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.994 ' CD1' HG21 ' A' ' 45' ' ' VAL . 2.9 tm? -72.31 -32.58 66.67 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.928 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.0 mttt -71.33 -23.54 61.95 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.658 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.9 mm-40 -76.3 -52.19 10.46 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.631 -0.668 . . . . 0.0 110.114 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.545 HG11 HG23 ' A' ' 17' ' ' VAL . 85.1 t -61.77 -45.84 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.016 HG12 HD21 ' A' ' 43' ' ' LEU . 98.7 t -65.75 -32.63 59.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.782 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -66.78 -27.15 67.35 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.4 OUTLIER -69.25 -53.08 21.68 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.883 0.849 . . . . 0.0 109.287 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -70.97 -22.04 62.24 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.856 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.661 ' HG3' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -82.12 -14.07 56.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.801 -1.187 . . . . 0.0 110.241 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.63 25.78 66.82 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.694 HG22 HD13 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -144.27 161.7 43.5 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HG2' ' HG3' ' A' ' 42' ' ' GLN . 30.8 Cg_endo -76.86 141.9 21.9 Favored 'Trans proline' 0 C--N 1.293 -2.382 0 C-N-CA 123.224 2.616 . . . . 0.0 111.091 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.704 ' HB1' ' HB3' ' A' ' 29' ' ' LYS . . . -50.34 -20.4 1.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.602 -0.686 . . . . 0.0 110.046 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -60.45 -61.81 2.32 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.213 -0.929 . . . . 0.0 109.087 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.53 ' HB3' ' HG2' ' A' ' 73' ' ' GLN . 2.7 mt-30 -63.16 -43.83 97.19 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.016 HD21 HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -66.61 143.69 56.86 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.467 -179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.614 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -157.06 116.31 3.38 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.008 -1.057 . . . . 0.0 109.717 178.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.994 HG21 ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -101.84 116.99 46.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.641 0.734 . . . . 0.0 111.735 -177.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.9 mt -114.65 128.51 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -86.46 132.98 33.8 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.559 -1.338 . . . . 0.0 113.169 -176.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.715 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 62.14 10.06 3.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.326 0.584 . . . . 0.0 110.637 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.6 6.76 89.15 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -96.79 120.54 37.31 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.601 -1.529 . . . . 0.0 108.088 179.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -48.36 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.652 0.739 . . . . 0.0 110.333 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.702 HD21 HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -101.74 113.69 65.78 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.622 ' HD2' HD12 ' A' ' 56' ' ' LEU . 28.2 Cg_endo -63.55 163.78 23.03 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 123.46 2.773 . . . . 0.0 116.117 -172.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.683 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -66.56 -43.24 85.58 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.976 -178.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 42.8 p-80 -74.62 -43.9 53.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.987 -1.071 . . . . 0.0 111.721 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.867 HD22 ' CG ' ' A' ' 60' ' ' ASN . 12.5 mt -42.47 162.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.988 -1.07 . . . . 0.0 109.482 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -87.13 168.49 13.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.136 -0.977 . . . . 0.0 109.946 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.965 ' O ' HD12 ' A' ' 63' ' ' LEU . 16.5 t -61.47 -37.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.514 -0.741 . . . . 0.0 110.073 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 0.5 OUTLIER -89.34 20.17 3.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.887 -1.133 . . . . 0.0 109.449 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.867 ' CG ' HD22 ' A' ' 56' ' ' LEU . 1.3 t30 -82.61 -60.17 2.27 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.608 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -73.26 -17.9 61.28 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 65.3 m-20 105.56 36.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.965 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.5 mt -61.7 -65.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.76 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 28.5 mt-10 62.94 144.33 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.303 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.585 ' HB3' ' HG2' ' A' ' 3' ' ' MET . 2.8 pp0? -37.14 135.83 0.46 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 17.8 tt0 73.59 105.55 0.07 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -167.66 128.57 1.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.746 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.2 mp -86.39 119.31 34.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 118.372 -1.331 . . . . 0.0 108.059 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.849 ' HB ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.94 169.81 3.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -126.15 107.3 10.26 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 109.332 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -86.84 141.65 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.351 -0.843 . . . . 0.0 110.161 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 42' ' ' GLN . 94.9 t -136.59 133.62 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.53 ' HG2' ' HB3' ' A' ' 42' ' ' GLN . 2.5 tt0 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.133 -0.979 . . . . 0.0 109.999 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.627 ' CB ' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 121.924 0.868 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -71.77 137.94 22.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.172 0.511 . . . . 0.0 109.664 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.617 ' CG2' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -99.31 146.54 8.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 176.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.848 ' HB3' HD12 ' A' ' 68' ' ' ILE . 5.0 t80 -90.92 107.91 19.51 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.786 -1.196 . . . . 0.0 109.951 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.819 HG11 HG23 ' A' ' 32' ' ' VAL . 16.9 t -96.94 117.26 41.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.028 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.661 ' O ' HG23 ' A' ' 71' ' ' ILE . 22.1 mmm-85 -83.4 93.99 7.88 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.98 ' CE1' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.334 0.588 . . . . 0.0 110.161 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.752 ' HE2' HG23 ' A' ' 32' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HB2' HG12 ' A' ' 4' ' ' ILE . 36.2 Cg_endo -77.66 128.34 9.35 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.467 2.111 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.633 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 14.7 p -120.14 145.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.58 -0.7 . . . . 0.0 109.445 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.73 115.06 27.52 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.917 -1.115 . . . . 0.0 109.007 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.617 HG13 ' CG2' ' A' ' 5' ' ' VAL . 2.0 m -145.55 167.59 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.61 ' N ' HG23 ' A' ' 19' ' ' VAL . 9.4 m-20 -129.73 -176.2 3.84 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.499 ' OG ' ' HG3' ' A' ' 59' ' ' GLN . 64.9 m -60.28 -5.59 1.17 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.037 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 23' ' ' THR . 1.8 m-20 -87.76 -41.82 13.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 110.378 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.079 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -43.25 116.46 0.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.748 -1.22 . . . . 0.0 109.425 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.586 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -60.61 -135.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.157 -0.964 . . . . 0.0 108.548 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 24' ' ' SER . 32.6 mm -135.81 -33.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.667 -1.271 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.963 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -78.36 -35.33 47.53 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 175.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.574 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -54.63 -32.09 58.42 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 175.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.966 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -65.52 -50.83 63.8 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.868 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.8 mptt -61.56 -19.85 62.62 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.067 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.639 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 2.7 mm-40 -76.14 -54.76 6.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.566 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 84.4 t -64.35 -46.81 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.077 HG13 ' CD2' ' A' ' 43' ' ' LEU . 6.2 p -63.53 -27.68 43.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.887 ' HA ' HD22 ' A' ' 43' ' ' LEU . . . -71.94 -29.61 64.46 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.152 -0.968 . . . . 0.0 108.93 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 3.2 mmmm -66.53 -49.78 65.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.782 0.801 . . . . 0.0 109.078 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -78.37 -21.51 49.31 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.32 -178.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.734 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -82.2 -12.07 58.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.654 -1.279 . . . . 0.0 110.593 -179.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.8 26.99 67.89 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.055 HG12 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -148.66 159.93 37.16 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 1.055 ' HD2' HG12 ' A' ' 38' ' ' VAL . 31.2 Cg_endo -78.06 140.71 18.14 Favored 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 122.853 2.369 . . . . 0.0 111.691 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -46.4 -27.34 1.04 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.429 0.633 . . . . 0.0 110.011 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.71 -64.14 1.04 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.434 -0.791 . . . . 0.0 109.535 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.563 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 35.3 mt-30 -61.21 -43.45 98.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.051 0.929 . . . . 0.0 108.782 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.077 ' CD2' HG13 ' A' ' 32' ' ' VAL . 3.2 tp -66.05 144.52 56.66 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.78 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -153.03 116.44 4.67 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.049 -1.46 . . . . 0.0 111.173 178.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.966 HG21 ' CD1' ' A' ' 28' ' ' LEU . 2.6 t -92.98 124.51 45.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.237 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 50' ' ' LYS . 4.1 mt -129.0 118.51 46.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.591 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -86.18 127.02 34.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.018 -1.051 . . . . 0.0 111.965 -176.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.438 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 60.6 10.85 2.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.483 -0.761 . . . . 0.0 110.131 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.04 18.91 60.15 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HB2' HD21 ' A' ' 52' ' ' LEU . 3.0 mmmm -100.35 120.17 39.54 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.819 -1.401 . . . . 0.0 109.201 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' C ' HD23 ' A' ' 52' ' ' LEU . 2.0 tt0 -73.28 104.81 4.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.498 -0.752 . . . . 0.0 110.037 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.871 HD22 ' HB2' ' A' ' 61' ' ' CYS . 0.4 OUTLIER -100.17 147.29 33.31 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.284 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.928 ' HD2' HD12 ' A' ' 56' ' ' LEU . 29.7 Cg_endo -76.37 132.88 14.04 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.267 1.978 . . . . 0.0 108.881 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.579 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 19.5 m-80 -50.74 -19.54 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.639 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 7.0 p-80 -91.83 20.75 5.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.359 -1.463 . . . . 0.0 111.272 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.928 HD12 ' HD2' ' A' ' 53' ' ' PRO . 14.3 mt -105.79 165.31 11.27 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.828 -1.17 . . . . 0.0 108.526 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -91.76 171.75 8.94 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.096 -1.002 . . . . 0.0 110.808 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.079 HG23 ' O ' ' A' ' 23' ' ' THR . 3.4 t -59.94 -39.35 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.477 0.656 . . . . 0.0 110.543 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.499 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 3.0 mt-30 -90.49 22.19 3.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.624 -1.298 . . . . 0.0 109.712 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.807 ' CG ' HD22 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -83.21 -62.46 1.59 Allowed 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.341 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.871 ' HB2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.27 -16.85 61.92 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.629 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 16.6 t70 106.56 31.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.473 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.5 mt -59.84 -67.51 0.38 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.478 ' HG3' ' HG2' ' A' ' 59' ' ' GLN . 0.2 OUTLIER 61.96 165.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.966 0.889 . . . . 0.0 111.718 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.627 ' CB ' ' CB ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -44.47 124.73 4.3 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 8.5 tt0 75.27 108.23 0.07 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -165.73 120.23 1.22 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -177.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.848 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.1 mp -86.02 121.26 37.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.714 -1.195 . . . . 0.0 108.114 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.831 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -113.65 164.63 9.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -120.71 109.03 14.71 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.705 -1.247 . . . . 0.0 109.536 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.698 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -88.31 141.79 13.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.227 -0.92 . . . . 0.0 109.121 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.44 137.61 20.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.104 -0.997 . . . . 0.0 109.333 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.563 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 1.2 tt0 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.446 -0.784 . . . . 0.0 109.765 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.582 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 1.1 ttm . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.569 ' N ' ' CG ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -73.49 145.35 11.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.091 0.948 . . . . 0.0 112.099 -177.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 67' ' ' SER . 1.7 t -109.11 168.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 176.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.787 ' O ' HG23 ' A' ' 69' ' ' VAL . 9.1 t80 -104.32 102.94 12.61 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.401 -1.437 . . . . 0.0 110.19 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.694 HG13 ' CG2' ' A' ' 71' ' ' ILE . 38.9 t -91.27 112.65 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.081 -1.012 . . . . 0.0 109.666 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.615 ' NE ' HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -82.92 95.7 8.05 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 117.969 -1.493 . . . . 0.0 107.08 177.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.726 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.553 -0.717 . . . . 0.0 109.782 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.726 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HB2' HG12 ' A' ' 4' ' ' ILE . 33.7 Cg_endo -76.73 128.2 10.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.419 2.079 . . . . 0.0 110.502 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 4' ' ' ILE . 14.3 p -112.35 153.43 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 0.0 109.398 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -108.56 116.73 32.53 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.621 -1.3 . . . . 0.0 108.533 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.534 HG11 ' CD2' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -149.51 159.26 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.784 -1.197 . . . . 0.0 110.311 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.09 176.82 4.96 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.545 ' HB3' ' CG ' ' A' ' 59' ' ' GLN . 0.8 OUTLIER -64.25 -6.56 7.05 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 109.98 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -96.5 -13.61 22.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.98 -1.075 . . . . 0.0 111.446 -178.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.714 ' OG1' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -48.43 128.91 15.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.356 -1.465 . . . . 0.0 108.35 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.605 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 19.4 m -73.47 6.17 3.21 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.028 -1.045 . . . . 0.0 112.082 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.759 HD11 HD13 ' A' ' 63' ' ' LEU . 1.7 mm 72.04 -35.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 O-C-N 121.927 -0.483 . . . . 0.0 111.866 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.875 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -79.27 -35.37 41.47 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 102.656 -3.091 . . . . 0.0 102.656 176.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.524 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.22 -33.7 73.91 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.993 ' CD1' HG21 ' A' ' 45' ' ' VAL . 1.6 tm? -64.52 -38.9 92.61 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.981 ' HG3' HG23 ' A' ' 45' ' ' VAL . 5.4 mttt -69.7 -22.93 63.37 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.678 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 58.6 mt-10 -73.54 -51.55 16.58 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.759 -0.588 . . . . 0.0 109.545 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.591 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 98.5 t -64.21 -49.18 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.026 HG12 HD21 ' A' ' 43' ' ' LEU . 83.9 t -61.59 -32.06 52.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.871 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -68.67 -29.82 68.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.451 -0.781 . . . . 0.0 108.899 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 12.0 mmmm -64.76 -52.92 54.39 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.897 0.856 . . . . 0.0 109.565 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -73.02 -22.33 60.67 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.857 -0.527 . . . . 0.0 111.421 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.65 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.71 -18.71 43.42 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.546 -1.346 . . . . 0.0 110.591 -178.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.88 23.45 45.7 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.696 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -146.67 163.42 29.37 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.593 -0.945 . . . . 0.0 108.615 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 31.0 Cg_endo -75.0 143.07 28.62 Favored 'Trans proline' 0 C--N 1.291 -2.459 0 C-N-CA 123.328 2.685 . . . . 0.0 111.21 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -49.7 -20.1 0.75 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.704 -0.622 . . . . 0.0 109.803 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.4 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 25.1 t0 -64.12 -62.74 1.43 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 108.935 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB3' ' HG3' ' A' ' 73' ' ' GLN . 19.5 mt-30 -59.19 -44.63 92.22 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.426 1.108 . . . . 0.0 108.072 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.026 HD21 HG12 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -68.68 144.19 54.52 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.029 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.773 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -156.43 117.3 3.74 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.37 -1.332 . . . . 0.0 111.467 178.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.993 HG21 ' CD1' ' A' ' 28' ' ' LEU . 1.6 t -93.77 122.77 45.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.643 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.9 mt -124.38 118.87 54.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.691 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -83.8 133.52 34.76 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.58 -0.7 . . . . 0.0 112.356 -176.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.691 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 63.17 9.93 4.25 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.44 0.638 . . . . 0.0 109.802 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 14.82 80.69 Favored Glycine 0 C--N 1.296 -1.642 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -98.2 122.49 41.41 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.67 -1.488 . . . . 0.0 108.956 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -48.48 96.88 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.893 HD22 ' CB ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -116.96 117.99 36.65 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.492 ' HD2' HD12 ' A' ' 56' ' ' LEU . 32.1 Cg_endo -72.81 -160.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 123.05 2.5 . . . . 0.0 113.313 -175.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.583 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 3.4 p30 -111.02 -52.34 2.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -0.794 . . . . 0.0 110.996 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.476 ' C ' ' O ' ' A' ' 54' ' ' ASN . 41.7 p-80 -43.07 -25.99 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.798 -1.189 . . . . 0.0 109.026 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.875 HD13 ' ND2' ' A' ' 60' ' ' ASN . 29.0 mt -74.43 159.38 32.38 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.51 172.02 9.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.757 -1.214 . . . . 0.0 110.285 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.714 HG21 ' OG1' ' A' ' 23' ' ' THR . 2.2 t -62.43 -28.73 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.601 -0.687 . . . . 0.0 110.477 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.545 ' CG ' ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -88.45 17.3 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 109.425 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.875 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -86.63 -60.11 2.08 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.788 0.804 . . . . 0.0 108.922 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.893 ' CB ' HD22 ' A' ' 52' ' ' LEU . 5.3 t -72.66 -9.13 58.25 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 9.1 t0 90.49 33.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.759 HD13 HD11 ' A' ' 25' ' ' ILE . 1.1 mt -75.86 -58.21 3.42 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.694 0.759 . . . . 0.0 109.678 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HG2' ' HG2' ' A' ' 59' ' ' GLN . 34.0 mt-10 51.86 -154.61 0.18 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.582 ' HB2' ' CG ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.44 143.08 26.71 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.1 tt0 72.9 106.25 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -175.41 131.93 0.29 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.784 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -83.89 114.76 24.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 117.613 -1.635 . . . . 0.0 107.691 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.873 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -108.74 163.31 6.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -125.8 107.16 10.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.967 -1.083 . . . . 0.0 109.777 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.694 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -85.11 142.54 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.317 -0.864 . . . . 0.0 109.127 179.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.1 t -144.03 135.9 22.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.032 -1.043 . . . . 0.0 109.628 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.524 ' HG3' ' HB3' ' A' ' 42' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.608 ' CB ' ' CB ' ' A' ' 65' ' ' GLN . 21.7 tpp . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.901 0.858 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -72.91 140.92 17.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.59 ' CG2' HG13 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -101.03 142.67 15.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 177.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.77 ' HB3' HD12 ' A' ' 68' ' ' ILE . 1.3 t80 -86.11 106.38 17.2 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 120.789 -1.194 . . . . 0.0 109.462 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.92 HG13 HG21 ' A' ' 71' ' ' ILE . 2.1 t -93.38 108.19 20.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.177 -0.952 . . . . 0.0 109.289 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.628 ' O ' HG23 ' A' ' 71' ' ' ILE . 1.8 mmm180 -77.21 95.14 4.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.733 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.507 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.847 -177.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.759 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.497 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 35.8 Cg_endo -76.69 145.14 25.57 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.72 2.28 . . . . 0.0 111.616 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.697 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 2.7 t -124.84 155.86 33.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.149 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -117.8 113.56 21.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.562 -1.336 . . . . 0.0 108.808 177.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.59 HG13 ' CG2' ' A' ' 5' ' ' VAL . 1.4 m -148.26 163.02 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.836 -1.165 . . . . 0.0 110.43 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 19' ' ' VAL . 55.9 m-20 -114.81 -178.65 3.42 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.487 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 74.7 m -66.38 -1.14 3.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.928 -1.108 . . . . 0.0 110.511 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -98.81 -23.87 15.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.05 -1.031 . . . . 0.0 111.371 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.78 ' OG1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.8 129.04 4.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.735 -1.228 . . . . 0.0 109.092 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.594 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 25.1 m -74.93 6.16 4.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.476 -0.765 . . . . 0.0 111.6 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.755 HD11 HD13 ' A' ' 63' ' ' LEU . 28.3 mm 72.16 -32.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.987 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -78.75 -35.38 44.69 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.64 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -58.28 -32.79 68.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 176.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.895 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -63.04 -42.95 99.88 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 1.015 ' HG3' HG23 ' A' ' 45' ' ' VAL . 5.6 mptt -70.25 -19.34 63.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.62 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 28.6 mm-40 -76.24 -49.9 15.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.572 -0.705 . . . . 0.0 109.502 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.599 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 46.8 t -65.14 -46.53 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.011 ' CG1' HD21 ' A' ' 43' ' ' LEU . 89.4 t -63.69 -34.14 66.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.827 ' HB1' ' O ' ' A' ' 38' ' ' VAL . . . -63.34 -29.08 70.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 21.9 mmmt -65.13 -47.45 77.07 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.691 0.758 . . . . 0.0 109.505 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -30.77 64.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.664 -0.647 . . . . 0.0 111.597 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.648 ' HG3' ' CE1' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -81.43 -15.17 55.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.685 -1.26 . . . . 0.0 110.525 -178.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.21 15.64 80.75 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.827 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -126.86 160.9 56.6 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.52 ' HG2' ' HG3' ' A' ' 42' ' ' GLN . 32.8 Cg_endo -76.75 140.48 20.86 Favored 'Trans proline' 0 C--N 1.292 -2.444 0 C-N-CA 123.311 2.674 . . . . 0.0 111.26 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -48.7 -20.17 0.44 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.774 -0.579 . . . . 0.0 110.372 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -63.0 -62.58 1.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.891 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 73' ' ' GLN . 23.6 mt-30 -58.67 -50.67 73.0 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.616 1.198 . . . . 0.0 108.112 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.011 HD21 ' CG1' ' A' ' 32' ' ' VAL . 2.7 tp -62.95 142.18 58.44 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.627 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.844 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -154.71 117.79 4.44 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.249 -1.38 . . . . 0.0 111.855 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.015 HG23 ' HG3' ' A' ' 29' ' ' LYS . 1.4 t -87.8 120.86 37.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.093 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.714 HG23 ' HA ' ' A' ' 51' ' ' GLU . 10.4 mt -125.11 121.28 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.696 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 3.7 t80 -92.14 131.98 36.97 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.837 -1.164 . . . . 0.0 113.812 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.696 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 59.41 9.61 1.52 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.869 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.05 -9.95 58.25 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.183 -1.484 . . . . 0.0 110.118 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' C ' HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -94.73 118.47 31.79 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.678 -1.484 . . . . 0.0 108.239 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.714 ' HA ' HG23 ' A' ' 46' ' ' ILE . 2.0 tt0 -74.46 106.39 6.04 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.282 -0.887 . . . . 0.0 108.766 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.987 ' CD1' HD11 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -81.93 134.31 50.12 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.166 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.728 ' HD2' HD12 ' A' ' 56' ' ' LEU . 31.4 Cg_endo -76.4 133.86 14.96 Favored 'Trans proline' 0 C--N 1.298 -2.11 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 3.0 p-10 -48.75 -51.66 27.8 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.35 -0.844 . . . . 0.0 111.771 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.65 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 2.4 p-80 -45.24 -35.24 3.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.403 -1.435 . . . . 0.0 109.734 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.794 HD22 ' CG ' ' A' ' 60' ' ' ASN . 14.2 mt -65.53 160.86 21.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.068 -1.02 . . . . 0.0 108.37 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -94.62 172.31 8.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.952 -1.092 . . . . 0.0 111.144 -178.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.852 ' O ' HD12 ' A' ' 63' ' ' LEU . 23.1 t -58.4 -35.98 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.389 0.614 . . . . 0.0 110.837 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.437 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -93.05 24.71 3.59 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.964 -1.085 . . . . 0.0 109.769 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.794 ' CG ' HD22 ' A' ' 56' ' ' LEU . 1.6 t30 -83.03 -62.88 1.48 Allowed 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 119.444 -0.903 . . . . 0.0 108.693 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.776 ' HB3' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.76 -14.89 61.64 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.627 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 4.1 t70 100.47 34.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.547 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.987 HD11 ' CD1' ' A' ' 52' ' ' LEU . 1.3 mt -55.72 -63.99 1.0 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 65' ' ' GLN . 19.8 mt-10 60.31 151.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.636 0.731 . . . . 0.0 111.871 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.608 ' CB ' ' CB ' ' A' ' 3' ' ' MET . 1.1 pp0? -33.89 127.51 0.4 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.984 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 17.2 tt0 74.58 110.18 0.07 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.443 ' OG ' ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -167.53 122.93 1.05 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 108.607 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.77 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -85.41 121.49 37.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.635 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -117.06 163.39 14.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -118.07 108.4 15.18 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.892 -1.13 . . . . 0.0 108.909 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.92 HG21 HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -82.32 141.05 15.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.341 -0.849 . . . . 0.0 109.257 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.08 132.62 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.989 -1.069 . . . . 0.0 109.131 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.521 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 6.0 tt0 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 109.701 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.642 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 4.3 ttm . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.828 0.823 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -71.77 141.24 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.634 -0.666 . . . . 0.0 109.814 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.934 HG23 HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -97.51 148.15 5.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.669 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -93.79 108.41 20.18 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.219 -0.926 . . . . 0.0 109.196 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.613 HG13 HG22 ' A' ' 71' ' ' ILE . 41.3 t -90.96 112.06 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.781 -1.2 . . . . 0.0 109.164 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.547 ' O ' HG23 ' A' ' 71' ' ' ILE . 2.7 mmm180 -91.38 93.84 9.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.965 ' HE1' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.512 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.533 ' HB3' ' NH2' ' A' ' 35' ' ' ARG . 99.0 m-85 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.299 0.095 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -81.87 90.33 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.437 2.091 . . . . 0.0 108.004 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.934 HG13 HG23 ' A' ' 5' ' ' VAL . 3.2 p -85.54 144.82 8.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 110.148 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.16 114.78 27.39 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.823 -1.173 . . . . 0.0 108.811 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.704 HG12 HG22 ' A' ' 17' ' ' VAL . 1.2 m -142.92 162.47 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.935 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 19' ' ' VAL . 2.1 m-20 -114.44 -179.08 3.53 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.476 ' OG ' ' HG3' ' A' ' 59' ' ' GLN . 20.0 m -61.72 -5.26 1.83 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.051 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -90.55 -34.29 15.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 110.862 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.08 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.29 116.14 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.91 -1.119 . . . . 0.0 109.444 -179.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.607 ' O ' HD13 ' A' ' 25' ' ' ILE . 1.4 m -60.01 -131.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.61 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 36.6 mm -139.69 -32.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 120.417 -1.427 . . . . 0.0 109.772 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.034 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -77.84 -34.26 51.95 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 175.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.585 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.37 -31.68 61.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 175.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.961 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -64.99 -50.08 67.71 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.91 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.8 mptt -63.6 -20.17 65.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.446 -0.784 . . . . 0.0 109.06 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 44.5 mt-10 -77.09 -48.73 17.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 109.476 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.597 HG11 ' CG2' ' A' ' 17' ' ' VAL . 74.0 t -63.01 -44.67 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.77 ' CG1' ' CE2' ' A' ' 9' ' ' PHE . 97.9 t -64.37 -35.22 73.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 38' ' ' VAL . . . -62.0 -24.44 67.04 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -69.54 -50.03 48.76 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.928 0.871 . . . . 0.0 110.012 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.581 ' NH1' ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -64.85 -34.4 78.28 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.726 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 1.1 mt-30 -108.52 -11.25 15.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.478 -1.389 . . . . 0.0 112.435 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.62 10.01 85.73 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.761 ' HB ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -90.75 146.29 33.75 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.548 ' HD2' HG12 ' A' ' 38' ' ' VAL . 30.7 Cg_endo -73.83 124.1 8.96 Favored 'Trans proline' 0 C--N 1.293 -2.368 0 C-N-CA 122.212 1.942 . . . . 0.0 110.25 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -45.46 -23.38 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.228 0.537 . . . . 0.0 109.679 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -61.69 -66.34 0.55 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.622 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.532 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 3.2 mt-30 -62.18 -42.67 99.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.089 -1.007 . . . . 0.0 108.601 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.965 HD11 ' HE1' ' A' ' 9' ' ' PHE . 3.1 tp -63.1 140.64 58.89 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.772 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -153.57 116.41 4.5 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 117.616 -1.633 . . . . 0.0 111.922 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.961 HG21 ' CD1' ' A' ' 28' ' ' LEU . 2.3 t -87.73 123.94 40.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.46 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.488 HG23 ' O ' ' A' ' 50' ' ' LYS . 8.1 mt -128.02 120.26 53.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 3.3 t80 -87.1 129.58 34.86 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.012 -1.055 . . . . 0.0 112.817 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 59.35 7.33 0.91 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.979 -0.451 . . . . 0.0 111.764 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.47 -0.01 56.84 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.987 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.518 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -95.3 117.87 31.06 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.331 -1.688 . . . . 0.0 109.092 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.14 103.0 1.11 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.773 ' HB3' HD21 ' A' ' 56' ' ' LEU . 1.2 mt -85.18 135.43 39.27 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 121.395 -0.815 . . . . 0.0 109.843 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.887 ' O ' HD23 ' A' ' 56' ' ' LEU . 28.8 Cg_endo -67.69 133.83 30.83 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.821 1.681 . . . . 0.0 109.51 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.584 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 6.2 m-20 -53.02 -11.74 0.27 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 112.203 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.566 ' NE2' ' HB2' ' A' ' 53' ' ' PRO . 1.2 p-80 -99.38 27.51 5.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.248 -1.532 . . . . 0.0 112.214 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 53' ' ' PRO . 1.1 pp -115.65 164.74 13.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.661 -1.275 . . . . 0.0 108.361 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.841 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -92.38 171.43 9.05 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 110.287 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.08 HG23 ' O ' ' A' ' 23' ' ' THR . 5.4 t -61.48 -38.98 81.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.6 -0.687 . . . . 0.0 110.486 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.476 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 1.5 mt-30 -89.2 18.95 4.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.579 -1.326 . . . . 0.0 109.673 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.3 OUTLIER -87.54 -62.68 1.44 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.481 -0.762 . . . . 0.0 110.128 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.661 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 26.3 t -71.32 -15.26 62.39 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.661 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 15.7 t0 105.43 30.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.49 ' CD2' ' HB2' ' A' ' 47' ' ' PHE . 1.3 mt -69.16 -62.76 1.25 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 65' ' ' GLN . 8.7 tt0 56.87 163.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.88 0.847 . . . . 0.0 111.913 177.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.642 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -37.85 122.84 1.02 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.931 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER 73.97 107.89 0.07 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -155.85 117.02 3.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.661 HD12 ' CB ' ' A' ' 6' ' ' PHE . 1.1 mp -83.35 120.29 34.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.924 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -115.42 166.65 9.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.43 0.633 . . . . 0.0 109.671 -176.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -121.48 106.21 11.2 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.944 -1.097 . . . . 0.0 108.972 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.864 HG12 ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -78.67 144.7 10.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 44' ' ' ARG . 2.3 p -145.11 128.75 11.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 109.609 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.532 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 O-C-N 121.306 -0.871 . . . . 0.0 109.075 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.629 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 122.393 1.092 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -76.6 146.95 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.931 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -105.56 144.75 14.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.727 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 t80 -87.47 106.89 18.28 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.728 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.614 HG13 HG22 ' A' ' 71' ' ' ILE . 54.1 t -90.51 115.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.957 -1.089 . . . . 0.0 109.133 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 1.6 mmm180 -94.96 96.2 9.13 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.522 -1.271 . . . . 0.0 108.247 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 1.061 ' HE1' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 35' ' ' ARG . 85.0 m-85 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 120.303 0.097 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.518 ' HB2' HG12 ' A' ' 4' ' ' ILE . 36.1 Cg_endo -80.31 85.78 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.434 2.089 . . . . 0.0 107.336 177.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.826 ' CG2' HG11 ' A' ' 31' ' ' VAL . 5.8 p -79.42 150.12 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.708 -0.62 . . . . 0.0 111.133 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.27 114.04 25.78 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 108.323 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.658 HG13 ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -136.99 158.7 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.07 -1.019 . . . . 0.0 109.489 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -103.21 176.71 5.06 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 108.913 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 59' ' ' GLN . 9.7 m -67.73 -2.97 7.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.907 . . . . 0.0 109.56 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -111.16 -9.58 14.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.11 -0.993 . . . . 0.0 110.532 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.089 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -58.28 125.12 21.89 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.631 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -56.78 -149.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.007 . . . . 0.0 110.955 -176.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.631 HD13 ' O ' ' A' ' 24' ' ' SER . 17.1 mm -126.01 -33.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.946 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -78.15 -32.21 50.16 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 102.628 -3.101 . . . . 0.0 102.628 175.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.484 ' HB2' ' CB ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -56.66 -32.45 65.39 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 175.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.983 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -65.68 -51.67 57.55 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.592 177.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.927 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.8 mptt -61.7 -21.55 64.57 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.507 -0.746 . . . . 0.0 109.601 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 13.5 mt-10 -76.82 -50.13 14.18 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.045 -1.034 . . . . 0.0 109.704 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.826 HG11 ' CG2' ' A' ' 17' ' ' VAL . 71.6 t -61.14 -47.28 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.784 HG12 HD21 ' A' ' 43' ' ' LEU . 78.9 t -62.35 -38.66 81.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.878 ' HB1' ' O ' ' A' ' 38' ' ' VAL . . . -58.9 -27.38 65.17 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -66.97 -52.96 36.37 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.785 0.802 . . . . 0.0 110.069 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.619 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -60.13 -33.89 72.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.914 -0.491 . . . . 0.0 112.103 -177.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.716 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -104.74 -6.76 20.06 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.841 -1.162 . . . . 0.0 111.587 -176.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.3 15.86 75.06 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.957 HG21 HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -100.89 150.5 37.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.643 ' HD2' HG23 ' A' ' 38' ' ' VAL . 31.2 Cg_endo -71.94 125.43 10.97 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 123.041 2.494 . . . . 0.0 111.991 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -50.39 -22.37 1.83 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.462 0.649 . . . . 0.0 109.502 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.484 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 4.4 m-20 -58.83 -61.65 2.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.453 -0.78 . . . . 0.0 109.786 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 19.7 mt-30 -68.13 -41.62 81.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.076 -1.015 . . . . 0.0 108.354 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.061 HD11 ' HE1' ' A' ' 9' ' ' PHE . 2.2 tp -62.84 141.74 58.52 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.764 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -154.53 116.21 4.15 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.062 -1.455 . . . . 0.0 111.3 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.983 HG21 ' CD1' ' A' ' 28' ' ' LEU . 2.4 t -88.64 125.14 41.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.802 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 50' ' ' LYS . 7.2 mt -129.58 118.12 44.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.1 t80 -85.16 131.04 34.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 112.798 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.641 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 62.26 10.87 4.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.718 -0.614 . . . . 0.0 110.341 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.66 12.46 77.73 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.778 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -94.75 122.61 37.54 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.942 -1.328 . . . . 0.0 108.332 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.479 ' C ' HD23 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -62.58 107.49 0.96 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.633 -0.667 . . . . 0.0 110.413 -178.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 61' ' ' CYS . 3.2 mt -97.44 148.93 35.14 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.057 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.683 ' CG ' HD12 ' A' ' 56' ' ' LEU . 34.3 Cg_endo -77.75 -164.29 0.26 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 N-CA-C 107.281 -1.853 . . . . 0.0 107.281 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.55 ' CB ' ' HB2' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -113.99 -30.78 6.59 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.653 -1.279 . . . . 0.0 109.711 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -80.66 -1.1 41.01 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.401 -0.812 . . . . 0.0 110.837 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.683 HD12 ' CG ' ' A' ' 53' ' ' PRO . 9.8 mt -80.7 169.54 17.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.654 -1.279 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.39 171.78 8.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.935 . . . . 0.0 110.549 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.089 HG23 ' O ' ' A' ' 23' ' ' THR . 4.1 t -63.41 -46.6 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.596 -0.69 . . . . 0.0 109.98 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.496 ' CG ' ' HG3' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -84.84 15.78 3.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.074 -1.016 . . . . 0.0 109.956 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.632 ' CG ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -86.04 -59.1 2.39 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.698 0.761 . . . . 0.0 109.39 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.654 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 6.1 m -69.59 -16.74 63.46 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.654 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 37.7 t0 107.12 31.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.708 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.4 mt -72.9 -77.84 0.1 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.496 ' HG3' ' CG ' ' A' ' 59' ' ' GLN . 1.9 tt0 71.24 159.47 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.655 0.741 . . . . 0.0 111.612 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.629 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -37.99 122.62 1.03 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.5 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 1.1 tm0? 75.82 108.95 0.07 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.14 121.69 1.46 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.183 -0.948 . . . . 0.0 108.488 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.533 HD12 ' CB ' ' A' ' 6' ' ' PHE . 1.2 mp -85.63 122.06 37.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.974 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -114.33 168.81 5.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.313 0.578 . . . . 0.0 109.668 -177.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -125.86 107.14 10.21 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.063 -1.023 . . . . 0.0 108.911 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.832 HG12 ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -80.21 142.56 13.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.194 -0.941 . . . . 0.0 109.616 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.3 t -138.91 120.41 16.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.608 ' HB2' HD12 ' A' ' 43' ' ' LEU . 3.9 tt0 . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.228 -0.92 . . . . 0.0 110.084 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mtt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.282 0.563 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 121.45 143.22 6.58 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.561 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 3.1 ttm -105.13 164.06 12.1 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.447 -1.031 . . . . 0.0 109.394 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -73.18 144.26 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.855 . . . . 0.0 111.85 -177.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -103.43 163.84 3.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.859 ' HB3' HD12 ' A' ' 68' ' ' ILE . 6.7 t80 -101.73 103.3 14.05 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.306 -1.496 . . . . 0.0 109.676 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.761 HG13 ' CG2' ' A' ' 71' ' ' ILE . 6.0 t -91.69 112.77 26.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.117 -0.989 . . . . 0.0 109.132 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.694 ' O ' HG23 ' A' ' 71' ' ' ILE . 24.3 mmm-85 -82.26 97.94 8.53 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.727 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -68.89 96.64 0.78 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 61.61 -131.31 0.68 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.192 -0.942 . . . . 0.0 108.507 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 12' ' ' SER . 30.6 p -126.27 137.86 53.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.755 -1.216 . . . . 0.0 109.839 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 11' ' ' SER . 2.9 t 77.6 -1.43 2.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.439 -0.788 . . . . 0.0 109.96 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 9' ' ' PHE . 5.9 t80 -130.81 112.73 13.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.137 -0.977 . . . . 0.0 109.306 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -123.41 134.48 9.43 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.727 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -129.75 131.46 23.56 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.154 -1.204 . . . . 0.0 108.955 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.3 Cg_endo -78.41 126.26 7.48 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.454 2.103 . . . . 0.0 110.695 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.634 ' CG2' HG11 ' A' ' 31' ' ' VAL . 11.3 p -111.75 148.05 15.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.499 -0.751 . . . . 0.0 109.235 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -102.2 112.06 24.59 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.792 -1.192 . . . . 0.0 108.755 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -139.03 160.17 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.03 -1.044 . . . . 0.0 109.714 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -97.97 176.18 5.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.404 ' C ' ' HB ' ' A' ' 58' ' ' VAL . 70.2 m -69.28 -0.19 5.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.083 -1.01 . . . . 0.0 110.278 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -102.88 -19.48 14.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.145 -0.972 . . . . 0.0 111.063 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.066 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -45.32 124.11 4.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.573 -1.329 . . . . 0.0 109.157 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.644 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -60.84 -142.4 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 24' ' ' SER . 23.7 mm -130.17 -31.11 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 120.909 -1.119 . . . . 0.0 109.457 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.823 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -81.78 -34.92 30.09 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 175.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.501 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.0 -33.15 71.59 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 175.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.986 ' CD1' HG21 ' A' ' 45' ' ' VAL . 1.4 tm? -68.88 -38.04 79.42 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.97 ' HG3' HG23 ' A' ' 45' ' ' VAL . 7.0 mttt -72.3 -20.3 61.52 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.621 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 7.3 mm-40 -76.34 -49.99 15.45 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.449 -0.782 . . . . 0.0 109.623 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.634 HG11 ' CG2' ' A' ' 17' ' ' VAL . 2.4 t -64.08 -48.03 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.005 HG12 HD21 ' A' ' 43' ' ' LEU . 85.5 t -63.23 -32.98 58.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.866 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -67.03 -29.68 69.56 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 14.5 mmmt -64.2 -53.8 43.62 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.774 0.797 . . . . 0.0 109.578 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -69.71 -22.4 63.4 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.837 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.664 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.89 -14.95 55.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.925 -1.109 . . . . 0.0 110.373 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.05 25.08 67.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.682 ' CG2' HD13 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -142.0 164.24 35.17 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.518 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 34.0 Cg_endo -78.15 141.36 18.46 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 123.662 2.908 . . . . 0.0 111.554 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.621 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -53.05 -22.22 5.66 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.438 -0.789 . . . . 0.0 110.122 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.61 -57.73 11.47 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 108.775 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.546 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 7.3 mt-30 -64.15 -44.75 91.17 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.283 1.04 . . . . 0.0 108.407 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.005 HD21 HG12 ' A' ' 32' ' ' VAL . 1.3 tp -67.49 143.1 56.37 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.538 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.798 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -154.35 116.99 4.37 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.638 -1.225 . . . . 0.0 111.539 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.986 HG21 ' CD1' ' A' ' 28' ' ' LEU . 1.4 t -91.17 127.01 43.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.261 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 50' ' ' LYS . 5.5 mt -130.03 119.94 48.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.683 ' HB2' HD23 ' A' ' 63' ' ' LEU . 1.2 t80 -87.67 127.34 35.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.909 -1.119 . . . . 0.0 112.76 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 59.61 7.76 1.11 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.977 -0.452 . . . . 0.0 111.297 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.45 6.47 57.48 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.878 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.64 119.28 34.84 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.564 -1.551 . . . . 0.0 108.718 179.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.72 109.27 2.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.381 -0.824 . . . . 0.0 108.79 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.578 HD22 ' SG ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -93.72 146.61 32.07 Favored Pre-proline 0 C--N 1.303 -1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.456 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.679 ' CG ' HD12 ' A' ' 56' ' ' LEU . 33.3 Cg_endo -76.5 142.39 23.42 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.358 2.039 . . . . 0.0 108.879 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.527 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 4.6 m-20 -65.19 -5.15 6.18 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.32 -0.863 . . . . 0.0 111.057 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.471 ' CD2' ' C ' ' A' ' 55' ' ' HIS . 5.7 p-80 -104.26 0.16 29.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.647 -1.283 . . . . 0.0 111.201 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.905 HD22 ' ND2' ' A' ' 60' ' ' ASN . 12.4 mt -89.92 162.97 15.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.645 -1.285 . . . . 0.0 109.055 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -91.53 171.16 9.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.099 -1.001 . . . . 0.0 110.887 -178.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.066 HG23 ' O ' ' A' ' 23' ' ' THR . 8.7 t -62.17 -40.09 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.657 -0.652 . . . . 0.0 110.43 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.538 ' CG ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -87.46 18.47 3.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.617 -1.302 . . . . 0.0 109.957 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.905 ' ND2' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -88.86 -62.3 1.52 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.314 -0.866 . . . . 0.0 110.339 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.652 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 42.1 t -69.46 -14.23 62.77 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.252 -0.905 . . . . 0.0 108.609 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 8.4 t70 103.78 30.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 47' ' ' PHE . 1.2 mt -72.9 -59.81 2.53 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.214 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HG2' ' CG ' ' A' ' 59' ' ' GLN . 3.5 mm-40 59.96 152.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.561 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 1.4 pt20 -48.73 140.14 8.82 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 7.8 tp-100 74.6 106.4 0.07 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.81 130.38 0.66 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.859 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -84.92 116.03 27.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 C-N-CA 117.698 -1.601 . . . . 0.0 107.595 -179.018 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.89 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -112.97 163.67 9.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -178.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -124.83 106.8 10.3 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.93 -1.106 . . . . 0.0 108.759 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.761 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -80.82 141.2 15.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 72' ' ' VAL . 14.9 p -136.41 125.95 38.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.961 -1.087 . . . . 0.0 109.877 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.546 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -123.57 111.39 16.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' C ' ' O ' ' A' ' 73' ' ' GLN . 1.1 mtm180 -39.57 96.95 0.12 Allowed Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.524 ' N ' ' O ' ' A' ' 73' ' ' GLN . 34.7 Cg_endo -82.44 124.5 4.17 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.829 2.353 . . . . 0.0 112.737 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.563 ' O ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -64.46 168.81 5.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 176.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 92.98 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.917 -1.513 . . . . 0.0 108.418 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 76' ' ' ARG . 7.4 tpt85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.195 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' C ' ' A' ' 2' ' ' GLY . 5.0 ttt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.241 0.543 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 19' ' ' VAL . . . -42.66 107.35 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.578 ' HB3' ' CB ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -67.1 166.21 14.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.517 ' N ' ' HG3' ' A' ' 3' ' ' MET . 0.8 OUTLIER -70.41 143.83 14.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 111.755 -178.007 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.24 163.06 5.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.738 ' HB3' HD12 ' A' ' 68' ' ' ILE . 3.9 t80 -98.66 118.01 34.4 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 120.285 -1.509 . . . . 0.0 109.411 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.905 HG13 HG21 ' A' ' 71' ' ' ILE . 8.7 t -105.96 112.21 38.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.752 ' O ' HG23 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -79.37 100.44 7.62 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 117.625 -1.63 . . . . 0.0 108.274 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.698 ' HA ' HG12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -81.69 136.24 35.49 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.679 0.752 . . . . 0.0 111.101 -177.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 62.12 -90.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.613 -0.679 . . . . 0.0 110.559 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 m -128.35 -71.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.6 -1.312 . . . . 0.0 110.383 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.8 -10.77 11.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.011 -1.055 . . . . 0.0 110.284 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -75.72 100.99 4.86 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 108.749 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 7' ' ' VAL . . . -94.86 127.14 9.0 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.052 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.645 ' HE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -102.31 135.81 19.53 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.6 Cg_endo -76.18 127.83 10.16 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.124 1.882 . . . . 0.0 111.018 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.618 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 8.4 p -116.08 142.3 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -100.7 116.55 32.87 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.579 -1.325 . . . . 0.0 109.108 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.579 HG23 ' N ' ' A' ' 20' ' ' ASP . 1.8 m -149.43 165.81 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.132 -0.98 . . . . 0.0 109.641 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.579 ' N ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -119.5 -178.79 3.69 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.621 -0.674 . . . . 0.0 109.56 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.575 ' CB ' ' HG3' ' A' ' 59' ' ' GLN . 3.5 m -63.53 -3.31 2.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.491 -0.756 . . . . 0.0 110.692 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 23' ' ' THR . 5.7 m-20 -95.69 -35.8 11.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.071 -1.018 . . . . 0.0 110.867 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.067 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.96 126.38 3.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.852 -1.155 . . . . 0.0 109.41 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.565 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -61.24 -142.61 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.605 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 30.0 mm -129.57 -33.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 120.937 -1.102 . . . . 0.0 108.681 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.919 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -80.35 -34.68 36.35 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 176.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -56.79 -31.88 65.11 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 175.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.935 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -64.13 -45.34 88.97 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.78 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 3.9 mptt -68.95 -18.68 64.12 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.2 mm-40 -77.28 -50.69 12.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 109.493 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.6 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 71.1 t -63.94 -46.23 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.003 ' CG1' HD21 ' A' ' 43' ' ' LEU . 68.3 t -64.82 -35.81 76.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 29' ' ' LYS . . . -60.21 -27.54 67.25 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 4.0 mmmm -65.79 -50.95 62.82 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.656 0.741 . . . . 0.0 109.391 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.62 ' HD3' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -71.33 -22.51 61.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.691 -0.63 . . . . 0.0 111.026 -178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.674 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 1.8 mm-40 -87.98 -17.64 30.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.899 -1.125 . . . . 0.0 110.502 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.63 17.42 79.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.73 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 1.4 m -124.39 164.11 32.26 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 31.2 Cg_endo -77.31 138.53 17.85 Favored 'Trans proline' 0 C--N 1.293 -2.386 0 C-N-CA 123.037 2.491 . . . . 0.0 110.843 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 26' ' ' LEU . . . -51.84 -19.64 1.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.646 -0.659 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.523 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -62.3 -59.08 5.52 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.183 -0.948 . . . . 0.0 109.156 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.577 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 1.7 mt-30 -60.53 -48.96 79.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.132 0.967 . . . . 0.0 108.623 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.003 HD21 ' CG1' ' A' ' 32' ' ' VAL . 3.5 tp -63.8 140.49 58.88 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.659 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.759 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -152.84 117.2 4.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.058 -1.457 . . . . 0.0 111.797 178.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.052 HG13 HG11 ' A' ' 69' ' ' VAL . 17.8 t -88.77 119.24 35.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.055 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.753 HG23 ' HA ' ' A' ' 51' ' ' GLU . 6.0 mt -128.8 117.53 44.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.637 ' HB2' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -93.78 129.86 39.99 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -174.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 60.3 7.42 1.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.906 -0.496 . . . . 0.0 111.737 177.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.75 -3.47 45.71 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.689 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.402 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -96.18 114.55 26.25 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 120.454 -1.615 . . . . 0.0 108.715 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.753 ' HA ' HG23 ' A' ' 46' ' ' ILE . 21.6 tt0 -74.75 105.16 5.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.824 HD12 HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -91.98 152.27 42.72 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.782 ' HD2' HD12 ' A' ' 56' ' ' LEU . 34.2 Cg_endo -75.79 -170.92 0.91 Allowed 'Trans proline' 0 C--N 1.296 -2.198 0 C-N-CA 122.322 2.015 . . . . 0.0 108.595 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 10.5 p30 -91.71 -39.93 11.55 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 110.399 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 21.0 p-80 -62.11 -39.2 91.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 111.272 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.019 HD22 ' ND2' ' A' ' 60' ' ' ASN . 12.4 mt -50.04 158.04 0.57 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.656 -1.278 . . . . 0.0 110.252 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 172.84 8.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.433 -0.792 . . . . 0.0 110.802 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.067 HG23 ' O ' ' A' ' 23' ' ' THR . 21.1 t -62.07 -44.21 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.587 0.708 . . . . 0.0 110.317 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.575 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 23.0 mt-30 -90.18 25.1 2.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.819 -1.176 . . . . 0.0 109.782 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 1.019 ' ND2' HD22 ' A' ' 56' ' ' LEU . 1.8 t30 -84.33 -63.32 1.36 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.05 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.632 ' HB2' HD22 ' A' ' 52' ' ' LEU . 10.2 t -75.3 -48.78 21.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 4.6 m-20 155.02 36.61 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.824 HD11 HD12 ' A' ' 52' ' ' LEU . 1.3 mt -82.37 -57.66 3.27 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.419 -1.313 . . . . 0.0 108.306 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' CG ' ' HG2' ' A' ' 59' ' ' GLN . 0.1 OUTLIER 46.99 -154.34 0.06 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.578 ' CB ' ' HB3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.64 137.51 33.65 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 36.1 tp60 74.39 109.35 0.07 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.414 ' OG ' ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -175.87 129.84 0.24 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -177.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.738 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -83.26 122.56 37.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 117.861 -1.536 . . . . 0.0 108.076 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.052 HG11 HG13 ' A' ' 45' ' ' VAL . 2.5 t -109.9 160.64 8.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 121.725 0.774 . . . . 0.0 110.411 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.573 ' N ' ' CG1' ' A' ' 69' ' ' VAL . 3.5 t60 -122.8 102.55 8.09 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.905 HG21 HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -89.57 143.17 11.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.564 -0.71 . . . . 0.0 109.186 -178.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 42' ' ' GLN . 11.3 p -139.49 137.92 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.011 -1.056 . . . . 0.0 109.172 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.577 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -120.36 117.06 26.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 110.403 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.459 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 2.1 mmm180 -53.64 108.35 1.09 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 108.469 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 73' ' ' GLN . 33.2 Cg_endo -78.29 128.84 9.17 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.414 2.076 . . . . 0.0 112.245 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -64.32 171.79 2.9 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.462 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -53.7 92.28 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.411 -1.43 . . . . 0.0 108.77 -179.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 76' ' ' ARG . 2.2 ttt180 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.39 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.438 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.549 ' CA ' ' HA ' ' A' ' 20' ' ' ASP . . . -119.97 90.25 0.47 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.551 ' CB ' ' HB3' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -68.31 169.08 11.21 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.59 -0.947 . . . . 0.0 108.897 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.546 ' N ' ' HG3' ' A' ' 3' ' ' MET . 0.1 OUTLIER -73.2 143.28 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.093 -1.005 . . . . 0.0 112.367 -177.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.658 HG23 HG13 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -106.23 164.63 4.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.977 ' HB3' HD12 ' A' ' 68' ' ' ILE . 12.8 t80 -102.73 109.31 20.85 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.373 -1.454 . . . . 0.0 109.406 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.757 HG11 ' HE2' ' A' ' 15' ' ' PHE . 13.7 t -94.65 120.58 44.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.519 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.767 ' O ' HG23 ' A' ' 71' ' ' ILE . 14.5 mmm-85 -88.39 98.62 11.71 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.753 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -71.3 96.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.061 0.458 . . . . 0.0 110.745 -177.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER 54.46 162.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 0.0 110.892 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 22.7 m 34.89 -109.21 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.949 -0.469 . . . . 0.0 110.273 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -128.8 -6.64 5.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.931 -1.106 . . . . 0.0 109.724 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -48.12 153.74 0.65 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 108.376 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 7' ' ' VAL . . . -146.53 121.73 1.49 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.731 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.757 ' HE2' HG11 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -113.9 142.28 27.57 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.526 ' HB2' HD12 ' A' ' 4' ' ' ILE . 34.2 Cg_endo -75.9 127.82 10.35 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.328 2.019 . . . . 0.0 111.23 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.635 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 5.9 p -117.94 144.84 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.509 -0.744 . . . . 0.0 109.56 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -106.93 117.36 33.84 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.426 -1.422 . . . . 0.0 108.406 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.658 HG13 HG23 ' A' ' 5' ' ' VAL . 1.2 m -139.26 160.71 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.91 -1.119 . . . . 0.0 110.526 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.549 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 2.5 m-20 -107.29 176.08 5.28 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -66.34 -5.09 9.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.932 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.536 ' HA ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -122.95 16.83 10.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.087 -1.008 . . . . 0.0 109.873 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.833 ' HB ' HG21 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -66.46 -9.36 33.53 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.136 -0.977 . . . . 0.0 109.548 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.544 ' OG ' ' HB2' ' A' ' 27' ' ' GLN . 5.7 p 69.31 -142.81 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 108.988 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.91 HD11 HD13 ' A' ' 63' ' ' LEU . 39.0 mm -144.15 -25.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.895 -1.128 . . . . 0.0 111.126 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.957 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -83.42 -37.41 23.27 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 177.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.663 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.75 -33.7 73.32 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 176.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.034 ' CD1' HG21 ' A' ' 45' ' ' VAL . 2.4 tm? -69.4 -37.17 77.37 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.963 ' HG3' HG23 ' A' ' 45' ' ' VAL . 4.3 mttt -70.0 -20.46 63.28 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.695 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 1.9 mm-40 -74.33 -52.81 11.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.697 -0.627 . . . . 0.0 109.674 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.623 HG11 HG23 ' A' ' 17' ' ' VAL . 27.5 t -61.79 -48.92 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.011 HG12 HD21 ' A' ' 43' ' ' LEU . 60.5 t -62.06 -33.47 58.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.862 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -68.23 -28.72 67.48 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.4 -0.813 . . . . 0.0 109.265 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 2.7 mmmm -65.61 -52.37 52.53 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.774 0.797 . . . . 0.0 109.39 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.457 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -71.85 -22.77 61.49 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.27 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.661 ' CG ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.27 -15.5 55.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.713 -1.242 . . . . 0.0 110.583 -179.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.2 21.22 61.15 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.663 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 1.6 m -142.78 164.82 30.1 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.738 -0.86 . . . . 0.0 108.679 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.502 ' N ' HG23 ' A' ' 38' ' ' VAL . 33.0 Cg_endo -78.67 143.02 18.52 Favored 'Trans proline' 0 C--N 1.293 -2.387 0 C-N-CA 123.437 2.758 . . . . 0.0 111.444 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.695 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -50.6 -21.06 1.38 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.755 -0.591 . . . . 0.0 110.196 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -61.49 -60.75 3.23 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 109.246 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 29.8 mt-30 -63.5 -43.68 96.54 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.011 HD21 HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -66.01 144.61 56.63 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.504 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.734 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -155.15 115.72 3.87 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.362 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.034 HG21 ' CD1' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -93.84 117.29 37.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.715 0.769 . . . . 0.0 110.602 -178.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.871 HG23 ' O ' ' A' ' 50' ' ' LYS . 6.4 mt -116.59 122.4 69.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.764 ' HB2' HD23 ' A' ' 63' ' ' LEU . 1.7 t80 -87.92 129.76 35.13 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.765 -1.209 . . . . 0.0 113.426 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 61.0 7.92 1.71 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.803 -0.561 . . . . 0.0 111.234 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.73 6.42 60.76 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.333 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -95.63 130.33 42.54 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.613 -1.522 . . . . 0.0 108.75 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.589 ' C ' HD23 ' A' ' 52' ' ' LEU . 26.4 tt0 -75.85 114.96 15.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.775 . . . . 0.0 109.092 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.909 HD22 ' HB2' ' A' ' 61' ' ' CYS . 0.4 OUTLIER -105.06 144.98 29.84 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.103 -0.998 . . . . 0.0 110.129 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.671 ' CG ' HD12 ' A' ' 56' ' ' LEU . 32.2 Cg_endo -77.34 131.25 11.55 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 122.342 2.028 . . . . 0.0 108.216 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 2.3 m120 -48.88 -37.58 20.05 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.692 -0.63 . . . . 0.0 111.802 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.521 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 7.0 p-80 -70.57 -31.42 68.43 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.781 -1.199 . . . . 0.0 112.053 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.954 HD22 ' CG ' ' A' ' 60' ' ' ASN . 10.9 mt -54.74 164.67 0.73 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.392 -1.443 . . . . 0.0 109.029 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -91.89 171.07 9.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.119 -0.988 . . . . 0.0 110.932 -178.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.833 HG21 ' HB ' ' A' ' 23' ' ' THR . 16.9 t -61.97 -39.65 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.403 0.62 . . . . 0.0 110.153 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -88.17 18.1 4.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.668 -1.27 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.954 ' CG ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -88.14 -62.34 1.51 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 110.681 -178.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.909 ' HB2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.17 -15.56 61.97 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.214 -0.929 . . . . 0.0 108.94 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.668 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 51.4 t0 109.13 32.77 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.91 HD13 HD11 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -79.4 -50.89 10.12 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.43 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.6 -157.51 0.12 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.573 0.701 . . . . 0.0 109.579 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.52 129.56 41.27 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 14.8 tm0? 80.23 111.54 0.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB2' HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -173.34 129.72 0.45 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -177.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.977 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -83.18 117.96 29.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 118.267 -1.373 . . . . 0.0 107.906 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.758 ' HB ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -116.03 167.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -177.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -124.58 109.32 13.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.956 -1.09 . . . . 0.0 108.435 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -84.32 142.95 12.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.263 -0.898 . . . . 0.0 110.109 -179.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -135.95 143.65 35.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 8.8 tt0 -115.49 129.13 56.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.018 -1.051 . . . . 0.0 110.339 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.508 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 8.3 mmt85 -104.27 162.02 21.15 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.381 -0.825 . . . . 0.0 109.028 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 30.0 Cg_endo -78.31 156.12 29.12 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.761 2.308 . . . . 0.0 110.747 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -60.48 169.2 1.81 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 177.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.9 90.79 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 117.88 -1.528 . . . . 0.0 108.817 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 O-C-N 121.077 -1.014 . . . . 0.0 109.387 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.348 0.594 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.11 151.34 6.0 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.627 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 1.2 ttm -124.83 170.89 10.61 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.36 1.076 . . . . 0.0 111.128 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.644 HG12 ' HB2' ' A' ' 16' ' ' PRO . 1.1 tp -77.46 139.31 18.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.262 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.648 HG23 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -95.72 153.18 3.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.896 ' HB3' HD12 ' A' ' 68' ' ' ILE . 5.4 t80 -91.34 108.58 19.98 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 120.769 -1.207 . . . . 0.0 109.248 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.892 HG13 HG21 ' A' ' 71' ' ' ILE . 2.1 t -94.92 110.77 24.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.26 -0.9 . . . . 0.0 109.692 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.624 ' O ' HG23 ' A' ' 71' ' ' ILE . 24.1 mmm-85 -78.2 93.01 4.52 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.701 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.97 112.46 6.38 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 9' ' ' PHE . 3.6 t-20 61.62 -91.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.359 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.8 t -165.3 -63.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 109.751 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 m -72.63 -1.86 17.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.01 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 15.9 m-30 -105.3 -160.92 0.78 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.005 . . . . 0.0 109.61 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.36 118.07 0.5 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.658 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -137.94 136.05 19.38 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.077 -1.249 . . . . 0.0 109.465 -179.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.644 ' HB2' HG12 ' A' ' 4' ' ' ILE . 34.6 Cg_endo -78.95 131.81 10.24 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.722 2.282 . . . . 0.0 111.062 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.648 HG13 HG23 ' A' ' 5' ' ' VAL . 3.3 p -113.98 151.18 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 0.0 109.013 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.477 ' HA ' HD12 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -102.28 119.33 38.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.554 -1.341 . . . . 0.0 108.793 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 28' ' ' LEU . 1.3 m -144.04 159.64 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.727 -1.233 . . . . 0.0 110.343 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 m-20 -102.53 177.06 4.97 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.519 ' CB ' ' HG3' ' A' ' 59' ' ' GLN . 37.3 m -71.62 0.73 7.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.01 . . . . 0.0 109.936 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -110.58 -10.05 14.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 111.427 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.721 ' OG1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -45.98 131.93 9.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.618 -1.301 . . . . 0.0 108.432 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.621 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 9.4 m -74.74 6.75 3.62 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.333 -0.854 . . . . 0.0 111.795 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.632 HG21 ' HB2' ' A' ' 52' ' ' LEU . 14.5 mm 72.35 -30.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 O-C-N 121.892 -0.505 . . . . 0.0 112.27 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.834 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -82.08 -35.57 28.5 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 176.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.502 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -59.51 -35.59 74.45 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.945 ' CD1' HG21 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -63.46 -40.5 97.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 176.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.92 ' HG3' HG23 ' A' ' 45' ' ' VAL . 7.8 mttt -69.62 -20.97 63.6 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.6 mt-10 -75.08 -50.34 16.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.297 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.55 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.1 t -65.36 -48.15 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.038 HG12 HD21 ' A' ' 43' ' ' LEU . 87.5 t -62.07 -34.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.745 ' HB2' ' O ' ' A' ' 29' ' ' LYS . . . -64.43 -29.67 70.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -64.5 -54.16 36.72 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.819 0.819 . . . . 0.0 109.672 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -64.79 -30.21 71.21 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.595 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.781 ' HB3' HG22 ' A' ' 38' ' ' VAL . 1.5 mm100 -81.34 -7.39 59.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.712 -1.243 . . . . 0.0 110.216 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.53 17.24 72.54 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.826 ' CG2' HD13 ' A' ' 43' ' ' LEU . 16.2 m -125.85 158.35 65.86 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 33.5 Cg_endo -78.41 143.38 19.44 Favored 'Trans proline' 0 C--N 1.294 -2.297 0 C-N-CA 123.152 2.568 . . . . 0.0 111.08 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 29' ' ' LYS . . . -49.67 -20.49 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.376 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.18 -63.27 1.35 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.336 -0.853 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.531 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 34.6 mt-30 -61.3 -49.19 78.03 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.455 1.121 . . . . 0.0 108.395 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.038 HD21 HG12 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -64.94 141.04 58.91 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.71 -179.078 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.774 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 3.9 mpp_? -155.64 115.05 3.6 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.476 -1.29 . . . . 0.0 111.269 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.945 HG21 ' CD1' ' A' ' 28' ' ' LEU . 1.3 t -86.63 121.61 37.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.763 0.792 . . . . 0.0 110.704 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.898 ' O ' HG12 ' A' ' 69' ' ' VAL . 19.7 mt -118.35 151.62 20.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.717 ' HB3' HD21 ' A' ' 52' ' ' LEU . 9.0 t80 -107.95 120.03 41.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 119.835 -1.79 . . . . 0.0 113.621 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . . . 55.66 7.74 0.27 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.95 -15.07 11.18 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 118.965 -1.588 . . . . 0.0 111.202 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 114.14 25.82 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.488 -1.595 . . . . 0.0 108.894 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.781 ' HA ' HG23 ' A' ' 46' ' ' ILE . 44.3 tt0 -56.94 117.12 3.65 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.492 -0.755 . . . . 0.0 109.596 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.957 HD13 HD11 ' A' ' 63' ' ' LEU . 6.0 mt -85.72 132.36 44.55 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 109.349 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.741 ' CG ' HD12 ' A' ' 56' ' ' LEU . 30.9 Cg_endo -75.07 132.15 15.0 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 121.844 1.696 . . . . 0.0 108.246 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.525 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 4.5 m-20 -59.82 -30.64 69.07 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 110.411 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.634 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 13.6 p-80 -70.73 -22.87 62.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.61 -1.306 . . . . 0.0 110.06 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.868 HD13 ' OD1' ' A' ' 60' ' ' ASN . 14.3 mt -78.92 168.35 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.936 -1.102 . . . . 0.0 108.151 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -95.79 172.52 7.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.062 -1.024 . . . . 0.0 111.031 -178.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.95 ' O ' HD12 ' A' ' 63' ' ' LEU . 24.0 t -59.86 -41.04 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.762 -0.586 . . . . 0.0 110.547 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.519 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 9.2 mt-30 -86.97 19.58 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.62 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.868 ' OD1' HD13 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -84.44 -60.22 2.14 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.927 ' CB ' HD22 ' A' ' 52' ' ' LEU . 17.5 t -70.6 -16.16 62.82 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.628 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 16.3 t0 103.26 37.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.957 HD11 HD13 ' A' ' 52' ' ' LEU . 1.3 mt -66.6 -83.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.597 -1.241 . . . . 0.0 107.728 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 63' ' ' LEU . 2.9 tt0 76.45 162.26 0.23 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.833 0.825 . . . . 0.0 111.287 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.627 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 1.8 pt20 -40.88 121.97 1.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER 76.0 112.3 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.595 ' HB2' HG13 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -163.18 118.58 1.72 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.896 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.1 mp -81.99 117.49 28.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -116.92 151.16 18.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -107.76 110.16 21.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.376 -1.452 . . . . 0.0 108.231 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.892 HG21 HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -80.49 141.48 15.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.424 -0.798 . . . . 0.0 109.473 -178.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 42' ' ' GLN . 16.5 t -130.15 122.96 55.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.226 -0.921 . . . . 0.0 108.963 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.76 HE21 HG11 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -120.51 109.24 15.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 110.155 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' O ' ' OE1' ' A' ' 73' ' ' GLN . 2.6 mmp_? -48.24 105.02 0.45 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.197 -0.939 . . . . 0.0 109.191 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 73' ' ' GLN . 30.8 Cg_endo -74.15 138.06 24.71 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.372 2.048 . . . . 0.0 111.75 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 78' ' ' ARG . 18.5 mtt180 -62.08 167.61 3.82 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -56.42 92.33 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 117.808 -1.557 . . . . 0.0 108.414 -179.132 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 109.228 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.366 0.603 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.97 146.35 6.91 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.585 ' HG2' ' HB3' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -122.22 174.14 7.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.367 -1.078 . . . . 0.0 109.877 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.481 HG12 ' HB2' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -69.98 141.05 17.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.868 0.842 . . . . 0.0 110.841 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.708 HG23 HG13 ' A' ' 19' ' ' VAL . 1.4 t -110.05 165.47 5.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.746 ' HB3' HD12 ' A' ' 68' ' ' ILE . 4.9 t80 -103.69 106.49 17.01 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.458 -1.401 . . . . 0.0 109.381 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.765 HG21 HG22 ' A' ' 32' ' ' VAL . 14.8 t -91.18 115.72 30.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.708 ' O ' HG23 ' A' ' 71' ' ' ILE . 11.6 mmm180 -82.18 92.31 6.87 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 117.144 -1.822 . . . . 0.0 106.985 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.718 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -67.53 130.39 42.9 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 1.4 m120 68.18 -84.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.416 -0.802 . . . . 0.0 109.376 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.2 -32.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.974 -1.079 . . . . 0.0 110.543 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 -5.4 17.41 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.967 -1.083 . . . . 0.0 110.346 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -111.75 166.12 11.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.188 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 7' ' ' VAL . . . -152.25 119.22 0.95 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.718 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -110.7 138.71 21.12 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.296 -1.12 . . . . 0.0 108.91 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HB2' HG12 ' A' ' 4' ' ' ILE . 34.1 Cg_endo -75.88 124.69 8.23 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.358 2.039 . . . . 0.0 110.248 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.617 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 7.5 p -110.73 154.24 12.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.433 -0.792 . . . . 0.0 109.724 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -101.3 114.75 29.01 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.775 -1.203 . . . . 0.0 108.341 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.708 HG13 HG23 ' A' ' 5' ' ' VAL . 2.0 m -148.14 165.9 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 110.152 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.59 ' N ' HG23 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -127.42 -179.46 4.91 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 59' ' ' GLN . 1.0 OUTLIER -61.55 -8.54 4.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.152 -0.967 . . . . 0.0 110.435 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.86 18.47 13.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.894 -1.129 . . . . 0.0 110.693 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.833 ' HB ' HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -72.04 -5.73 37.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.074 -1.016 . . . . 0.0 109.672 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 27' ' ' GLN . 52.5 m 65.78 -144.53 0.2 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.735 HD11 HD11 ' A' ' 63' ' ' LEU . 9.4 mm -144.94 -28.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.739 -1.226 . . . . 0.0 110.607 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.848 ' C ' HD13 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -80.82 -33.84 34.37 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 176.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -61.81 -33.78 74.75 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.994 ' CD1' HG21 ' A' ' 45' ' ' VAL . 2.9 tm? -72.31 -32.58 66.67 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.928 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.0 mttt -71.33 -23.54 61.95 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.658 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.9 mm-40 -76.3 -52.19 10.46 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.631 -0.668 . . . . 0.0 110.114 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.545 HG11 HG23 ' A' ' 17' ' ' VAL . 85.1 t -61.77 -45.84 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.016 HG12 HD21 ' A' ' 43' ' ' LEU . 98.7 t -65.75 -32.63 59.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.782 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -66.78 -27.15 67.35 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.4 OUTLIER -69.25 -53.08 21.68 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.883 0.849 . . . . 0.0 109.287 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -70.97 -22.04 62.24 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.856 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.661 ' HG3' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -82.12 -14.07 56.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.801 -1.187 . . . . 0.0 110.241 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.63 25.78 66.82 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.694 HG22 HD13 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -144.27 161.7 43.5 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HG2' ' HG3' ' A' ' 42' ' ' GLN . 30.8 Cg_endo -76.86 141.9 21.9 Favored 'Trans proline' 0 C--N 1.293 -2.382 0 C-N-CA 123.224 2.616 . . . . 0.0 111.091 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.704 ' HB1' ' HB3' ' A' ' 29' ' ' LYS . . . -50.34 -20.4 1.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.602 -0.686 . . . . 0.0 110.046 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -60.45 -61.81 2.32 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.213 -0.929 . . . . 0.0 109.087 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.53 ' HB3' ' HG2' ' A' ' 73' ' ' GLN . 2.7 mt-30 -63.16 -43.83 97.19 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.016 HD21 HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -66.61 143.69 56.86 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.467 -179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.614 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -157.06 116.31 3.38 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.008 -1.057 . . . . 0.0 109.717 178.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.994 HG21 ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -101.84 116.99 46.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.641 0.734 . . . . 0.0 111.735 -177.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.9 mt -114.65 128.51 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -86.46 132.98 33.8 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.559 -1.338 . . . . 0.0 113.169 -176.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.715 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 62.14 10.06 3.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.326 0.584 . . . . 0.0 110.637 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.6 6.76 89.15 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -96.79 120.54 37.31 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.601 -1.529 . . . . 0.0 108.088 179.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -48.36 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.652 0.739 . . . . 0.0 110.333 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.702 HD21 HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -101.74 113.69 65.78 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.622 ' HD2' HD12 ' A' ' 56' ' ' LEU . 28.2 Cg_endo -63.55 163.78 23.03 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 123.46 2.773 . . . . 0.0 116.117 -172.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.683 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -66.56 -43.24 85.58 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.976 -178.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 42.8 p-80 -74.62 -43.9 53.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.987 -1.071 . . . . 0.0 111.721 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.867 HD22 ' CG ' ' A' ' 60' ' ' ASN . 12.5 mt -42.47 162.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.988 -1.07 . . . . 0.0 109.482 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -87.13 168.49 13.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.136 -0.977 . . . . 0.0 109.946 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.965 ' O ' HD12 ' A' ' 63' ' ' LEU . 16.5 t -61.47 -37.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.514 -0.741 . . . . 0.0 110.073 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 0.5 OUTLIER -89.34 20.17 3.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.887 -1.133 . . . . 0.0 109.449 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.867 ' CG ' HD22 ' A' ' 56' ' ' LEU . 1.3 t30 -82.61 -60.17 2.27 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.608 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -73.26 -17.9 61.28 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 65.3 m-20 105.56 36.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.965 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.5 mt -61.7 -65.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.76 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 28.5 mt-10 62.94 144.33 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.303 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.585 ' HB3' ' HG2' ' A' ' 3' ' ' MET . 2.8 pp0? -37.14 135.83 0.46 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 17.8 tt0 73.59 105.55 0.07 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -167.66 128.57 1.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.746 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.2 mp -86.39 119.31 34.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 118.372 -1.331 . . . . 0.0 108.059 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.849 ' HB ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.94 169.81 3.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -126.15 107.3 10.26 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 109.332 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -86.84 141.65 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.351 -0.843 . . . . 0.0 110.161 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 42' ' ' GLN . 94.9 t -136.59 133.62 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.53 ' HG2' ' HB3' ' A' ' 42' ' ' GLN . 2.5 tt0 -116.9 127.22 54.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.133 -0.979 . . . . 0.0 109.999 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.09 109.12 1.45 Allowed Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 73' ' ' GLN . 33.1 Cg_endo -78.94 129.08 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.207 1.938 . . . . 0.0 111.42 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 78' ' ' ARG . 13.4 mtt180 -62.33 165.11 6.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.88 92.06 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.237 -1.539 . . . . 0.0 108.735 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.572 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 mtt . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.472 ' HA3' ' OD1' ' A' ' 20' ' ' ASP . . . 90.75 168.23 42.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.627 ' CB ' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -124.37 169.07 12.18 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.442 -1.034 . . . . 0.0 110.35 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -71.77 137.94 22.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.172 0.511 . . . . 0.0 109.664 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.617 ' CG2' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -99.31 146.54 8.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 176.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.848 ' HB3' HD12 ' A' ' 68' ' ' ILE . 5.0 t80 -90.92 107.91 19.51 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.786 -1.196 . . . . 0.0 109.951 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.819 HG11 HG23 ' A' ' 32' ' ' VAL . 16.9 t -96.94 117.26 41.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.028 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.661 ' O ' HG23 ' A' ' 71' ' ' ILE . 22.1 mmm-85 -83.4 93.99 7.88 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.98 ' CE1' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -69.98 132.1 45.4 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.334 0.588 . . . . 0.0 110.161 -177.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' SER . 58.0 t30 66.77 -82.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.554 -0.716 . . . . 0.0 109.766 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 16.7 t 179.3 -31.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.719 -1.238 . . . . 0.0 109.811 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 m -107.66 -0.02 22.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.878 . . . . 0.0 110.005 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.51 166.66 15.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.725 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.52 122.92 1.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.752 ' HE2' HG23 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -112.38 126.49 28.29 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.096 -1.238 . . . . 0.0 109.469 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HB2' HG12 ' A' ' 4' ' ' ILE . 36.2 Cg_endo -77.66 128.34 9.35 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.467 2.111 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.633 ' HB ' ' CZ ' ' A' ' 15' ' ' PHE . 14.7 p -120.14 145.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.58 -0.7 . . . . 0.0 109.445 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.73 115.06 27.52 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.917 -1.115 . . . . 0.0 109.007 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.617 HG13 ' CG2' ' A' ' 5' ' ' VAL . 2.0 m -145.55 167.59 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.61 ' N ' HG23 ' A' ' 19' ' ' VAL . 9.4 m-20 -129.73 -176.2 3.84 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.499 ' OG ' ' HG3' ' A' ' 59' ' ' GLN . 64.9 m -60.28 -5.59 1.17 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.037 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 23' ' ' THR . 1.8 m-20 -87.76 -41.82 13.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 110.378 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.079 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -43.25 116.46 0.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.748 -1.22 . . . . 0.0 109.425 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.586 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -60.61 -135.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.157 -0.964 . . . . 0.0 108.548 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 24' ' ' SER . 32.6 mm -135.81 -33.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.667 -1.271 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.963 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -78.36 -35.33 47.53 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 175.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.574 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -54.63 -32.09 58.42 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 175.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.966 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -65.52 -50.83 63.8 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.868 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.8 mptt -61.56 -19.85 62.62 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.067 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.639 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 2.7 mm-40 -76.14 -54.76 6.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.566 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 84.4 t -64.35 -46.81 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.077 HG13 ' CD2' ' A' ' 43' ' ' LEU . 6.2 p -63.53 -27.68 43.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.887 ' HA ' HD22 ' A' ' 43' ' ' LEU . . . -71.94 -29.61 64.46 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.152 -0.968 . . . . 0.0 108.93 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 3.2 mmmm -66.53 -49.78 65.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.782 0.801 . . . . 0.0 109.078 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -78.37 -21.51 49.31 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.32 -178.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.734 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -82.2 -12.07 58.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.654 -1.279 . . . . 0.0 110.593 -179.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.8 26.99 67.89 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.055 HG12 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -148.66 159.93 37.16 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 1.055 ' HD2' HG12 ' A' ' 38' ' ' VAL . 31.2 Cg_endo -78.06 140.71 18.14 Favored 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 122.853 2.369 . . . . 0.0 111.691 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -46.4 -27.34 1.04 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.429 0.633 . . . . 0.0 110.011 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.71 -64.14 1.04 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.434 -0.791 . . . . 0.0 109.535 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.563 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 35.3 mt-30 -61.21 -43.45 98.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.051 0.929 . . . . 0.0 108.782 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.077 ' CD2' HG13 ' A' ' 32' ' ' VAL . 3.2 tp -66.05 144.52 56.66 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.78 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -153.03 116.44 4.67 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.049 -1.46 . . . . 0.0 111.173 178.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.966 HG21 ' CD1' ' A' ' 28' ' ' LEU . 2.6 t -92.98 124.51 45.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.237 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 50' ' ' LYS . 4.1 mt -129.0 118.51 46.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.591 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -86.18 127.02 34.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.018 -1.051 . . . . 0.0 111.965 -176.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.438 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . 60.6 10.85 2.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.483 -0.761 . . . . 0.0 110.131 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.04 18.91 60.15 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HB2' HD21 ' A' ' 52' ' ' LEU . 3.0 mmmm -100.35 120.17 39.54 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.819 -1.401 . . . . 0.0 109.201 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' C ' HD23 ' A' ' 52' ' ' LEU . 2.0 tt0 -73.28 104.81 4.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.498 -0.752 . . . . 0.0 110.037 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.871 HD22 ' HB2' ' A' ' 61' ' ' CYS . 0.4 OUTLIER -100.17 147.29 33.31 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.284 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.928 ' HD2' HD12 ' A' ' 56' ' ' LEU . 29.7 Cg_endo -76.37 132.88 14.04 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.267 1.978 . . . . 0.0 108.881 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.579 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 19.5 m-80 -50.74 -19.54 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.639 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 7.0 p-80 -91.83 20.75 5.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.359 -1.463 . . . . 0.0 111.272 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.928 HD12 ' HD2' ' A' ' 53' ' ' PRO . 14.3 mt -105.79 165.31 11.27 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.828 -1.17 . . . . 0.0 108.526 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -91.76 171.75 8.94 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.096 -1.002 . . . . 0.0 110.808 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.079 HG23 ' O ' ' A' ' 23' ' ' THR . 3.4 t -59.94 -39.35 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.477 0.656 . . . . 0.0 110.543 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.499 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 3.0 mt-30 -90.49 22.19 3.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.624 -1.298 . . . . 0.0 109.712 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.807 ' CG ' HD22 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -83.21 -62.46 1.59 Allowed 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.341 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.871 ' HB2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.27 -16.85 61.92 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.629 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 16.6 t70 106.56 31.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.473 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.5 mt -59.84 -67.51 0.38 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.478 ' HG3' ' HG2' ' A' ' 59' ' ' GLN . 0.2 OUTLIER 61.96 165.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.966 0.889 . . . . 0.0 111.718 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.627 ' CB ' ' CB ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -44.47 124.73 4.3 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 8.5 tt0 75.27 108.23 0.07 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -165.73 120.23 1.22 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -177.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.848 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.1 mp -86.02 121.26 37.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.714 -1.195 . . . . 0.0 108.114 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.831 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -113.65 164.63 9.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -120.71 109.03 14.71 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.705 -1.247 . . . . 0.0 109.536 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.698 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -88.31 141.79 13.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.227 -0.92 . . . . 0.0 109.121 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.44 137.61 20.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.104 -0.997 . . . . 0.0 109.333 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.563 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 1.2 tt0 -119.25 124.41 46.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.446 -0.784 . . . . 0.0 109.765 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -73.13 134.82 80.28 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 0.0 108.961 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -79.06 138.88 14.75 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.521 2.147 . . . . 0.0 111.243 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 78' ' ' ARG . 4.2 mtt-85 -62.88 166.9 5.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.94 91.83 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.134 -1.426 . . . . 0.0 108.727 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 76' ' ' ARG . 17.0 mtp180 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.581 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.418 ' O ' ' N ' ' A' ' 3' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -51.61 97.1 0.02 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.582 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 1.1 ttm -69.15 168.85 13.15 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.358 -1.083 . . . . 0.0 108.988 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.569 ' N ' ' CG ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -73.49 145.35 11.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.091 0.948 . . . . 0.0 112.099 -177.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 67' ' ' SER . 1.7 t -109.11 168.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 176.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.787 ' O ' HG23 ' A' ' 69' ' ' VAL . 9.1 t80 -104.32 102.94 12.61 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.401 -1.437 . . . . 0.0 110.19 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.694 HG13 ' CG2' ' A' ' 71' ' ' ILE . 38.9 t -91.27 112.65 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.081 -1.012 . . . . 0.0 109.666 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.615 ' NE ' HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -82.92 95.7 8.05 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 117.969 -1.493 . . . . 0.0 107.08 177.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.726 ' CE2' ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -70.01 131.91 45.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.553 -0.717 . . . . 0.0 109.782 -178.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 58.27 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.701 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -145.95 -83.34 0.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.089 -1.007 . . . . 0.0 110.021 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.06 -8.67 47.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.822 . . . . 0.0 109.559 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.561 ' HB3' ' CB ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -76.97 158.14 30.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.341 -0.85 . . . . 0.0 109.585 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.07 94.12 0.12 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.726 ' CD2' ' CE2' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -103.63 138.45 19.54 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.23 -1.159 . . . . 0.0 109.457 -179.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HB2' HG12 ' A' ' 4' ' ' ILE . 33.7 Cg_endo -76.73 128.2 10.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.419 2.079 . . . . 0.0 110.502 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 4' ' ' ILE . 14.3 p -112.35 153.43 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 0.0 109.398 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -108.56 116.73 32.53 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.621 -1.3 . . . . 0.0 108.533 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.534 HG11 ' CD2' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -149.51 159.26 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.784 -1.197 . . . . 0.0 110.311 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.09 176.82 4.96 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.545 ' HB3' ' CG ' ' A' ' 59' ' ' GLN . 0.8 OUTLIER -64.25 -6.56 7.05 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 109.98 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -96.5 -13.61 22.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.98 -1.075 . . . . 0.0 111.446 -178.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.714 ' OG1' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -48.43 128.91 15.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.356 -1.465 . . . . 0.0 108.35 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.605 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 19.4 m -73.47 6.17 3.21 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.028 -1.045 . . . . 0.0 112.082 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.759 HD11 HD13 ' A' ' 63' ' ' LEU . 1.7 mm 72.04 -35.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 O-C-N 121.927 -0.483 . . . . 0.0 111.866 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -79.27 -35.37 41.47 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 102.656 -3.091 . . . . 0.0 102.656 176.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.524 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.22 -33.7 73.91 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.993 ' CD1' HG21 ' A' ' 45' ' ' VAL . 1.6 tm? -64.52 -38.9 92.61 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.981 ' HG3' HG23 ' A' ' 45' ' ' VAL . 5.4 mttt -69.7 -22.93 63.37 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.678 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 58.6 mt-10 -73.54 -51.55 16.58 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.759 -0.588 . . . . 0.0 109.545 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.591 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 98.5 t -64.21 -49.18 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.026 HG12 HD21 ' A' ' 43' ' ' LEU . 83.9 t -61.59 -32.06 52.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.871 ' CA ' HD22 ' A' ' 43' ' ' LEU . . . -68.67 -29.82 68.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.451 -0.781 . . . . 0.0 108.899 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 12.0 mmmm -64.76 -52.92 54.39 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.897 0.856 . . . . 0.0 109.565 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -73.02 -22.33 60.67 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.857 -0.527 . . . . 0.0 111.421 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.65 ' CG ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -81.71 -18.71 43.42 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.546 -1.346 . . . . 0.0 110.591 -178.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.88 23.45 45.7 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.696 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -146.67 163.42 29.37 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.593 -0.945 . . . . 0.0 108.615 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 31.0 Cg_endo -75.0 143.07 28.62 Favored 'Trans proline' 0 C--N 1.291 -2.459 0 C-N-CA 123.328 2.685 . . . . 0.0 111.21 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -49.7 -20.1 0.75 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.704 -0.622 . . . . 0.0 109.803 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.4 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 25.1 t0 -64.12 -62.74 1.43 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 108.935 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB3' ' HG3' ' A' ' 73' ' ' GLN . 19.5 mt-30 -59.19 -44.63 92.22 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.426 1.108 . . . . 0.0 108.072 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.026 HD21 HG12 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -68.68 144.19 54.52 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.029 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.773 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -156.43 117.3 3.74 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.37 -1.332 . . . . 0.0 111.467 178.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.993 HG21 ' CD1' ' A' ' 28' ' ' LEU . 1.6 t -93.77 122.77 45.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.643 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.9 mt -124.38 118.87 54.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.691 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -83.8 133.52 34.76 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.58 -0.7 . . . . 0.0 112.356 -176.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.691 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 63.17 9.93 4.25 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.44 0.638 . . . . 0.0 109.802 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 14.82 80.69 Favored Glycine 0 C--N 1.296 -1.642 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -98.2 122.49 41.41 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.67 -1.488 . . . . 0.0 108.956 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -48.48 96.88 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.893 HD22 ' CB ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -116.96 117.99 36.65 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.492 ' HD2' HD12 ' A' ' 56' ' ' LEU . 32.1 Cg_endo -72.81 -160.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 123.05 2.5 . . . . 0.0 113.313 -175.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.583 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 3.4 p30 -111.02 -52.34 2.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -0.794 . . . . 0.0 110.996 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.476 ' C ' ' O ' ' A' ' 54' ' ' ASN . 41.7 p-80 -43.07 -25.99 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.798 -1.189 . . . . 0.0 109.026 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.875 HD13 ' ND2' ' A' ' 60' ' ' ASN . 29.0 mt -74.43 159.38 32.38 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.51 172.02 9.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.757 -1.214 . . . . 0.0 110.285 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.714 HG21 ' OG1' ' A' ' 23' ' ' THR . 2.2 t -62.43 -28.73 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.601 -0.687 . . . . 0.0 110.477 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.545 ' CG ' ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -88.45 17.3 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 109.425 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.875 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -86.63 -60.11 2.08 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.788 0.804 . . . . 0.0 108.922 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.893 ' CB ' HD22 ' A' ' 52' ' ' LEU . 5.3 t -72.66 -9.13 58.25 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 9.1 t0 90.49 33.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.759 HD13 HD11 ' A' ' 25' ' ' ILE . 1.1 mt -75.86 -58.21 3.42 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.694 0.759 . . . . 0.0 109.678 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HG2' ' HG2' ' A' ' 59' ' ' GLN . 34.0 mt-10 51.86 -154.61 0.18 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.582 ' HB2' ' CG ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -94.44 143.08 26.71 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 1.1 tt0 72.9 106.25 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -175.41 131.93 0.29 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.784 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -83.89 114.76 24.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 117.613 -1.635 . . . . 0.0 107.691 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.873 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -108.74 163.31 6.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -125.8 107.16 10.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.967 -1.083 . . . . 0.0 109.777 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.694 ' CG2' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -85.11 142.54 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.317 -0.864 . . . . 0.0 109.127 179.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.1 t -144.03 135.9 22.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.032 -1.043 . . . . 0.0 109.628 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.524 ' HG3' ' HB3' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -107.83 124.48 50.14 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 73' ' ' GLN . 9.4 mmm180 -42.52 136.59 2.45 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.556 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -79.52 135.13 11.54 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.703 2.269 . . . . 0.0 110.93 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 78' ' ' ARG . 17.1 mtp180 -61.42 161.64 9.09 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 177.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HG2' ' NH1' ' A' ' 77' ' ' ARG . 2.3 ttt-85 -56.47 91.66 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 117.961 -1.496 . . . . 0.0 108.571 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.368 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.337 0.589 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.476 ' HA3' ' OD1' ' A' ' 20' ' ' ASP . . . -125.04 156.01 18.83 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.608 ' CB ' ' CB ' ' A' ' 65' ' ' GLN . 21.7 tpp -124.55 165.35 17.99 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.394 -1.063 . . . . 0.0 110.352 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -72.91 140.92 17.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.59 ' CG2' HG13 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -101.03 142.67 15.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 177.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.77 ' HB3' HD12 ' A' ' 68' ' ' ILE . 1.3 t80 -86.11 106.38 17.2 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 120.789 -1.194 . . . . 0.0 109.462 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.92 HG13 HG21 ' A' ' 71' ' ' ILE . 2.1 t -93.38 108.19 20.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.177 -0.952 . . . . 0.0 109.289 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.628 ' O ' HG23 ' A' ' 71' ' ' ILE . 1.8 mmm180 -77.21 95.14 4.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.733 ' CE1' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -68.11 139.92 56.2 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.847 -177.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 11' ' ' SER . 0.6 OUTLIER -32.86 150.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.133 0.492 . . . . 0.0 110.19 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 1.8 m 79.47 -141.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.494 -0.753 . . . . 0.0 109.106 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.96 0.87 14.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.852 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -87.27 133.28 33.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 110.179 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.1 151.11 17.4 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.759 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -138.96 140.64 27.55 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 120.821 -1.4 . . . . 0.0 109.166 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.497 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 35.8 Cg_endo -76.69 145.14 25.57 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.72 2.28 . . . . 0.0 111.616 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.697 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 2.7 t -124.84 155.86 33.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.149 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -117.8 113.56 21.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.562 -1.336 . . . . 0.0 108.808 177.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.59 HG13 ' CG2' ' A' ' 5' ' ' VAL . 1.4 m -148.26 163.02 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.836 -1.165 . . . . 0.0 110.43 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 19' ' ' VAL . 55.9 m-20 -114.81 -178.65 3.42 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.487 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 74.7 m -66.38 -1.14 3.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.928 -1.108 . . . . 0.0 110.511 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -98.81 -23.87 15.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.05 -1.031 . . . . 0.0 111.371 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.78 ' OG1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.8 129.04 4.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.735 -1.228 . . . . 0.0 109.092 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.594 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 25.1 m -74.93 6.16 4.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.476 -0.765 . . . . 0.0 111.6 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.755 HD11 HD13 ' A' ' 63' ' ' LEU . 28.3 mm 72.16 -32.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.987 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -78.75 -35.38 44.69 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.64 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -58.28 -32.79 68.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 176.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.895 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -63.04 -42.95 99.88 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 1.015 ' HG3' HG23 ' A' ' 45' ' ' VAL . 5.6 mptt -70.25 -19.34 63.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.62 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 28.6 mm-40 -76.24 -49.9 15.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.572 -0.705 . . . . 0.0 109.502 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.599 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 46.8 t -65.14 -46.53 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.011 ' CG1' HD21 ' A' ' 43' ' ' LEU . 89.4 t -63.69 -34.14 66.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.827 ' HB1' ' O ' ' A' ' 38' ' ' VAL . . . -63.34 -29.08 70.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 21.9 mmmt -65.13 -47.45 77.07 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.691 0.758 . . . . 0.0 109.505 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -30.77 64.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.664 -0.647 . . . . 0.0 111.597 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.648 ' HG3' ' CE1' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -81.43 -15.17 55.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.685 -1.26 . . . . 0.0 110.525 -178.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.21 15.64 80.75 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.827 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -126.86 160.9 56.6 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.52 ' HG2' ' HG3' ' A' ' 42' ' ' GLN . 32.8 Cg_endo -76.75 140.48 20.86 Favored 'Trans proline' 0 C--N 1.292 -2.444 0 C-N-CA 123.311 2.674 . . . . 0.0 111.26 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -48.7 -20.17 0.44 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.774 -0.579 . . . . 0.0 110.372 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -63.0 -62.58 1.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.891 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 73' ' ' GLN . 23.6 mt-30 -58.67 -50.67 73.0 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.616 1.198 . . . . 0.0 108.112 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.011 HD21 ' CG1' ' A' ' 32' ' ' VAL . 2.7 tp -62.95 142.18 58.44 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.627 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.844 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -154.71 117.79 4.44 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.249 -1.38 . . . . 0.0 111.855 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.015 HG23 ' HG3' ' A' ' 29' ' ' LYS . 1.4 t -87.8 120.86 37.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.093 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.714 HG23 ' HA ' ' A' ' 51' ' ' GLU . 10.4 mt -125.11 121.28 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.696 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 3.7 t80 -92.14 131.98 36.97 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.837 -1.164 . . . . 0.0 113.812 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.696 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 59.41 9.61 1.52 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.869 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.05 -9.95 58.25 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.183 -1.484 . . . . 0.0 110.118 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' C ' HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -94.73 118.47 31.79 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.678 -1.484 . . . . 0.0 108.239 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.714 ' HA ' HG23 ' A' ' 46' ' ' ILE . 2.0 tt0 -74.46 106.39 6.04 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.282 -0.887 . . . . 0.0 108.766 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.987 ' CD1' HD11 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -81.93 134.31 50.12 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.166 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.728 ' HD2' HD12 ' A' ' 56' ' ' LEU . 31.4 Cg_endo -76.4 133.86 14.96 Favored 'Trans proline' 0 C--N 1.298 -2.11 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 3.0 p-10 -48.75 -51.66 27.8 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.35 -0.844 . . . . 0.0 111.771 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.65 ' CE1' ' HB2' ' A' ' 53' ' ' PRO . 2.4 p-80 -45.24 -35.24 3.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.403 -1.435 . . . . 0.0 109.734 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.794 HD22 ' CG ' ' A' ' 60' ' ' ASN . 14.2 mt -65.53 160.86 21.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.068 -1.02 . . . . 0.0 108.37 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -94.62 172.31 8.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.952 -1.092 . . . . 0.0 111.144 -178.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.852 ' O ' HD12 ' A' ' 63' ' ' LEU . 23.1 t -58.4 -35.98 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.389 0.614 . . . . 0.0 110.837 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.437 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -93.05 24.71 3.59 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.964 -1.085 . . . . 0.0 109.769 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.794 ' CG ' HD22 ' A' ' 56' ' ' LEU . 1.6 t30 -83.03 -62.88 1.48 Allowed 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 119.444 -0.903 . . . . 0.0 108.693 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.776 ' HB3' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.76 -14.89 61.64 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.627 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 4.1 t70 100.47 34.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.547 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.987 HD11 ' CD1' ' A' ' 52' ' ' LEU . 1.3 mt -55.72 -63.99 1.0 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 65' ' ' GLN . 19.8 mt-10 60.31 151.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.636 0.731 . . . . 0.0 111.871 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.608 ' CB ' ' CB ' ' A' ' 3' ' ' MET . 1.1 pp0? -33.89 127.51 0.4 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.984 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 17.2 tt0 74.58 110.18 0.07 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.443 ' OG ' ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -167.53 122.93 1.05 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 108.607 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.77 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -85.41 121.49 37.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.635 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -117.06 163.39 14.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -118.07 108.4 15.18 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.892 -1.13 . . . . 0.0 108.909 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.92 HG21 HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -82.32 141.05 15.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.341 -0.849 . . . . 0.0 109.257 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.08 132.62 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.989 -1.069 . . . . 0.0 109.131 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.521 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 6.0 tt0 -108.14 117.64 34.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 109.701 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -48.56 113.86 3.2 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.109 -0.994 . . . . 0.0 109.049 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -77.33 131.76 11.94 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.267 1.978 . . . . 0.0 111.61 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 78' ' ' ARG . 1.5 mmt180 -61.57 167.75 3.27 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -55.95 92.14 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 117.905 -1.518 . . . . 0.0 108.687 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.439 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 mtm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.3 0.572 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.6 160.91 28.95 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.642 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 4.3 ttm -124.59 164.27 20.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.406 -1.055 . . . . 0.0 110.661 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -71.77 141.24 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.634 -0.666 . . . . 0.0 109.814 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.934 HG23 HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -97.51 148.15 5.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.669 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -93.79 108.41 20.18 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.219 -0.926 . . . . 0.0 109.196 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.613 HG13 HG22 ' A' ' 71' ' ' ILE . 41.3 t -90.96 112.06 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.781 -1.2 . . . . 0.0 109.164 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.547 ' O ' HG23 ' A' ' 71' ' ' ILE . 2.7 mmm180 -91.38 93.84 9.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.965 ' HE1' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -75.22 138.13 41.72 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 11' ' ' SER . 12.0 m-20 -36.69 147.98 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.793 -0.567 . . . . 0.0 109.622 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 1.5 m 78.08 -145.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.302 -0.874 . . . . 0.0 109.334 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -101.7 -0.06 35.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.095 -1.003 . . . . 0.0 110.013 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 1.5 m-85 -72.73 148.05 45.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.79 165.36 36.9 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.533 ' HB3' ' NH2' ' A' ' 35' ' ' ARG . 99.0 m-85 -152.93 125.32 3.92 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 120.809 -1.407 . . . . 0.0 111.001 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -81.87 90.33 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.437 2.091 . . . . 0.0 108.004 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.934 HG13 HG23 ' A' ' 5' ' ' VAL . 3.2 p -85.54 144.82 8.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 110.148 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.16 114.78 27.39 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.823 -1.173 . . . . 0.0 108.811 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.704 HG12 HG22 ' A' ' 17' ' ' VAL . 1.2 m -142.92 162.47 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.935 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 19' ' ' VAL . 2.1 m-20 -114.44 -179.08 3.53 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.476 ' OG ' ' HG3' ' A' ' 59' ' ' GLN . 20.0 m -61.72 -5.26 1.83 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.051 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -90.55 -34.29 15.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 110.862 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.08 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -42.29 116.14 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.91 -1.119 . . . . 0.0 109.444 -179.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.607 ' O ' HD13 ' A' ' 25' ' ' ILE . 1.4 m -60.01 -131.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.61 ' O ' ' HD2' ' A' ' 29' ' ' LYS . 36.6 mm -139.69 -32.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 120.417 -1.427 . . . . 0.0 109.772 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.034 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -77.84 -34.26 51.95 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 175.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.585 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.37 -31.68 61.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 175.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.961 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -64.99 -50.08 67.71 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.91 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.8 mptt -63.6 -20.17 65.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.446 -0.784 . . . . 0.0 109.06 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 44.5 mt-10 -77.09 -48.73 17.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 109.476 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.597 HG11 ' CG2' ' A' ' 17' ' ' VAL . 74.0 t -63.01 -44.67 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.77 ' CG1' ' CE2' ' A' ' 9' ' ' PHE . 97.9 t -64.37 -35.22 73.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 38' ' ' VAL . . . -62.0 -24.44 67.04 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -69.54 -50.03 48.76 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.928 0.871 . . . . 0.0 110.012 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.581 ' NH1' ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -64.85 -34.4 78.28 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.726 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 1.1 mt-30 -108.52 -11.25 15.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.478 -1.389 . . . . 0.0 112.435 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.62 10.01 85.73 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.761 ' HB ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -90.75 146.29 33.75 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.548 ' HD2' HG12 ' A' ' 38' ' ' VAL . 30.7 Cg_endo -73.83 124.1 8.96 Favored 'Trans proline' 0 C--N 1.293 -2.368 0 C-N-CA 122.212 1.942 . . . . 0.0 110.25 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -45.46 -23.38 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.228 0.537 . . . . 0.0 109.679 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -61.69 -66.34 0.55 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.622 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.532 ' HB3' ' CG ' ' A' ' 73' ' ' GLN . 3.2 mt-30 -62.18 -42.67 99.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.089 -1.007 . . . . 0.0 108.601 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.965 HD11 ' HE1' ' A' ' 9' ' ' PHE . 3.1 tp -63.1 140.64 58.89 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.772 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -153.57 116.41 4.5 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 117.616 -1.633 . . . . 0.0 111.922 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.961 HG21 ' CD1' ' A' ' 28' ' ' LEU . 2.3 t -87.73 123.94 40.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.46 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.488 HG23 ' O ' ' A' ' 50' ' ' LYS . 8.1 mt -128.02 120.26 53.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 3.3 t80 -87.1 129.58 34.86 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.012 -1.055 . . . . 0.0 112.817 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 59.35 7.33 0.91 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.979 -0.451 . . . . 0.0 111.764 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.47 -0.01 56.84 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.987 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' O ' ' CD2' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -95.3 117.87 31.06 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.331 -1.688 . . . . 0.0 109.092 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.14 103.0 1.11 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.773 ' HB3' HD21 ' A' ' 56' ' ' LEU . 1.2 mt -85.18 135.43 39.27 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 121.395 -0.815 . . . . 0.0 109.843 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.887 ' O ' HD23 ' A' ' 56' ' ' LEU . 28.8 Cg_endo -67.69 133.83 30.83 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.821 1.681 . . . . 0.0 109.51 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.584 ' HB3' ' CB ' ' A' ' 26' ' ' LEU . 6.2 m-20 -53.02 -11.74 0.27 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 112.203 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.566 ' NE2' ' HB2' ' A' ' 53' ' ' PRO . 1.2 p-80 -99.38 27.51 5.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.248 -1.532 . . . . 0.0 112.214 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 53' ' ' PRO . 1.1 pp -115.65 164.74 13.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.661 -1.275 . . . . 0.0 108.361 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.841 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -92.38 171.43 9.05 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 110.287 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.08 HG23 ' O ' ' A' ' 23' ' ' THR . 5.4 t -61.48 -38.98 81.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.6 -0.687 . . . . 0.0 110.486 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.476 ' HG3' ' OG ' ' A' ' 21' ' ' SER . 1.5 mt-30 -89.2 18.95 4.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.579 -1.326 . . . . 0.0 109.673 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.3 OUTLIER -87.54 -62.68 1.44 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.481 -0.762 . . . . 0.0 110.128 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.661 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 26.3 t -71.32 -15.26 62.39 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.661 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 15.7 t0 105.43 30.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.49 ' CD2' ' HB2' ' A' ' 47' ' ' PHE . 1.3 mt -69.16 -62.76 1.25 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 65' ' ' GLN . 8.7 tt0 56.87 163.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.88 0.847 . . . . 0.0 111.913 177.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.642 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -37.85 122.84 1.02 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.931 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER 73.97 107.89 0.07 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -155.85 117.02 3.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.661 HD12 ' CB ' ' A' ' 6' ' ' PHE . 1.1 mp -83.35 120.29 34.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.924 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -115.42 166.65 9.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.43 0.633 . . . . 0.0 109.671 -176.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -121.48 106.21 11.2 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.944 -1.097 . . . . 0.0 108.972 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.864 HG12 ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -78.67 144.7 10.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 44' ' ' ARG . 2.3 p -145.11 128.75 11.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 109.609 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.532 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -108.33 118.59 37.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.306 -0.871 . . . . 0.0 109.075 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.495 ' HB2' ' HG2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -37.65 98.01 0.15 Allowed Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.504 ' N ' ' O ' ' A' ' 73' ' ' GLN . 32.7 Cg_endo -78.02 137.06 15.25 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.652 2.235 . . . . 0.0 111.18 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 78' ' ' ARG . 11.7 mtm-85 -61.71 169.64 2.35 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -54.17 91.67 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.433 -1.417 . . . . 0.0 108.909 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 76' ' ' ARG . 2.4 mtp180 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.332 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 mtp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.352 0.596 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.28 -179.35 33.09 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.629 ' CB ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -126.59 166.89 16.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.221 -1.164 . . . . 0.0 111.171 -178.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -76.6 146.95 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.931 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -105.56 144.75 14.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.727 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 t80 -87.47 106.89 18.28 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.728 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.614 HG13 HG22 ' A' ' 71' ' ' ILE . 54.1 t -90.51 115.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.957 -1.089 . . . . 0.0 109.133 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 69' ' ' VAL . 1.6 mmm180 -94.96 96.2 9.13 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.522 -1.271 . . . . 0.0 108.247 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 1.061 ' HE1' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -79.08 140.14 37.94 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 11' ' ' SER . 89.6 m-20 -39.99 153.46 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.241 -0.912 . . . . 0.0 109.559 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER 72.96 -151.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 109.696 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.67 2.88 56.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.574 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.512 ' HB2' ' HB3' ' A' ' 9' ' ' PHE . 16.8 m-30 -72.26 153.66 41.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 110.257 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.4 152.99 10.79 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 35' ' ' ARG . 85.0 m-85 -144.99 126.56 7.8 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.831 -1.394 . . . . 0.0 111.189 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.518 ' HB2' HG12 ' A' ' 4' ' ' ILE . 36.1 Cg_endo -80.31 85.78 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.434 2.089 . . . . 0.0 107.336 177.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.826 ' CG2' HG11 ' A' ' 31' ' ' VAL . 5.8 p -79.42 150.12 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.708 -0.62 . . . . 0.0 111.133 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.27 114.04 25.78 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 108.323 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.658 HG13 ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -136.99 158.7 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.07 -1.019 . . . . 0.0 109.489 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -103.21 176.71 5.06 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 108.913 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 59' ' ' GLN . 9.7 m -67.73 -2.97 7.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.907 . . . . 0.0 109.56 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -111.16 -9.58 14.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.11 -0.993 . . . . 0.0 110.532 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.089 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -58.28 125.12 21.89 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.631 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -56.78 -149.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.007 . . . . 0.0 110.955 -176.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.631 HD13 ' O ' ' A' ' 24' ' ' SER . 17.1 mm -126.01 -33.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.946 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -78.15 -32.21 50.16 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 102.628 -3.101 . . . . 0.0 102.628 175.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.484 ' HB2' ' CB ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -56.66 -32.45 65.39 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 175.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.983 ' CD1' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -65.68 -51.67 57.55 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.592 177.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.927 ' HG3' HG23 ' A' ' 45' ' ' VAL . 3.8 mptt -61.7 -21.55 64.57 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.507 -0.746 . . . . 0.0 109.601 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 13.5 mt-10 -76.82 -50.13 14.18 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.045 -1.034 . . . . 0.0 109.704 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.826 HG11 ' CG2' ' A' ' 17' ' ' VAL . 71.6 t -61.14 -47.28 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.784 HG12 HD21 ' A' ' 43' ' ' LEU . 78.9 t -62.35 -38.66 81.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.878 ' HB1' ' O ' ' A' ' 38' ' ' VAL . . . -58.9 -27.38 65.17 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -66.97 -52.96 36.37 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.785 0.802 . . . . 0.0 110.069 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.619 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -60.13 -33.89 72.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.914 -0.491 . . . . 0.0 112.103 -177.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.716 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -104.74 -6.76 20.06 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.841 -1.162 . . . . 0.0 111.587 -176.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.3 15.86 75.06 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.957 HG21 HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -100.89 150.5 37.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.643 ' HD2' HG23 ' A' ' 38' ' ' VAL . 31.2 Cg_endo -71.94 125.43 10.97 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 123.041 2.494 . . . . 0.0 111.991 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . . . -50.39 -22.37 1.83 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.462 0.649 . . . . 0.0 109.502 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.484 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 4.4 m-20 -58.83 -61.65 2.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.453 -0.78 . . . . 0.0 109.786 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 19.7 mt-30 -68.13 -41.62 81.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.076 -1.015 . . . . 0.0 108.354 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.061 HD11 ' HE1' ' A' ' 9' ' ' PHE . 2.2 tp -62.84 141.74 58.52 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.764 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -154.53 116.21 4.15 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.062 -1.455 . . . . 0.0 111.3 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.983 HG21 ' CD1' ' A' ' 28' ' ' LEU . 2.4 t -88.64 125.14 41.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.802 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 50' ' ' LYS . 7.2 mt -129.58 118.12 44.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.1 t80 -85.16 131.04 34.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 112.798 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.641 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . . . 62.26 10.87 4.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.718 -0.614 . . . . 0.0 110.341 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.66 12.46 77.73 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.778 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -94.75 122.61 37.54 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.942 -1.328 . . . . 0.0 108.332 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.479 ' C ' HD23 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -62.58 107.49 0.96 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.633 -0.667 . . . . 0.0 110.413 -178.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 61' ' ' CYS . 3.2 mt -97.44 148.93 35.14 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.057 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.683 ' CG ' HD12 ' A' ' 56' ' ' LEU . 34.3 Cg_endo -77.75 -164.29 0.26 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 N-CA-C 107.281 -1.853 . . . . 0.0 107.281 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.55 ' CB ' ' HB2' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -113.99 -30.78 6.59 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.653 -1.279 . . . . 0.0 109.711 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -80.66 -1.1 41.01 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.401 -0.812 . . . . 0.0 110.837 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.683 HD12 ' CG ' ' A' ' 53' ' ' PRO . 9.8 mt -80.7 169.54 17.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.654 -1.279 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.39 171.78 8.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.935 . . . . 0.0 110.549 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.089 HG23 ' O ' ' A' ' 23' ' ' THR . 4.1 t -63.41 -46.6 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.596 -0.69 . . . . 0.0 109.98 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.496 ' CG ' ' HG3' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -84.84 15.78 3.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.074 -1.016 . . . . 0.0 109.956 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.632 ' CG ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -86.04 -59.1 2.39 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.698 0.761 . . . . 0.0 109.39 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.654 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 6.1 m -69.59 -16.74 63.46 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.654 ' CB ' ' O ' ' A' ' 61' ' ' CYS . 37.7 t0 107.12 31.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.708 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 58' ' ' VAL . 1.4 mt -72.9 -77.84 0.1 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' HG3' ' CG ' ' A' ' 59' ' ' GLN . 1.9 tt0 71.24 159.47 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.655 0.741 . . . . 0.0 111.612 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.629 ' HB2' ' CB ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -37.99 122.62 1.03 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.5 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 1.1 tm0? 75.82 108.95 0.07 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.14 121.69 1.46 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.183 -0.948 . . . . 0.0 108.488 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.533 HD12 ' CB ' ' A' ' 6' ' ' PHE . 1.2 mp -85.63 122.06 37.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.974 ' CG1' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -114.33 168.81 5.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.313 0.578 . . . . 0.0 109.668 -177.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -125.86 107.14 10.21 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.063 -1.023 . . . . 0.0 108.911 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.832 HG12 ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -80.21 142.56 13.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.194 -0.941 . . . . 0.0 109.616 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.3 t -138.91 120.41 16.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.608 ' HB2' HD12 ' A' ' 43' ' ' LEU . 3.9 tt0 -117.61 114.12 22.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.228 -0.92 . . . . 0.0 110.084 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -51.2 107.15 0.76 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 109.096 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 73' ' ' GLN . 32.3 Cg_endo -78.67 135.84 13.2 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.445 2.096 . . . . 0.0 111.972 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 78' ' ' ARG . 3.6 mtt-85 -64.25 168.39 5.61 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 176.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.535 ' CG ' ' NH1' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -55.37 92.32 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.257 -1.527 . . . . 0.0 108.885 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.077 -1.014 . . . . 0.0 109.695 -179.779 . . . . . . . . 2 2 . 1 stop_ save_